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FOR MY PARENTS , WIFE AND CHILDREN 
FRONTISPIECE 
Scanning electron microscopy of a Mitroflow bovine 
pericardial heart valve , which had been implanted in a baboon 
for 36 days. Mesothelial covering cells have been lost 
exposing bare collagen , which is partially covered by 
histiocytes (cells with ruffled cytoplasmic processes) , 
erythrocytes (some of which are crenated) and scanty fibrin . 





STATEMENT OF CANDIDATE ........................... . 
ACKNOWLEDGEMENTS ................................. . 
ABSTRACT ......................................... . 
INTRODUCTION ..................................... . 
DEFINITION OF TERMS .............................. . 
ABBREVIATIONS AND SYMBOLS ........................ . 
METHODOLOGY ...................................... . 
CHAPTER 1 
HISTORICAL ASPECTS OF CARDIAC VALVE REPLACEMENT ... 
CHAPTER 2 
DATA ON VARIOUS TYPES OF HEART VALVE PROSTHESES ... 
A.MECHANICAL PROSTHESES 
1. CAGED-BALL VALVES .............................. . 
(i) STARR-EDWARDS PROSTHESIS 
(ii) SMELOFF-CUTTER VALVE 












(iv) MAGOVERN-CROMIE VALVE 
(v) BRAUNWALD-CUTTER VALVE 
(vi) DEBAKEY-SURGITOOL VALVE 
CONTENTS 
2. CAGED-DISC VALVES .............................. . 
( i) HUFNAGEL-CONRAD VALVE 
(ii) CROSS-JONES VALVE 
(iii) KAY-SUZUKI VALVE 
(iv) HARKEN-CROMIE VALVE 
( V) UNIVERSITY OF CAPE TOWN 
(vi) KAY-SHILEY VALVE 
(vii) BEALL-SURGITOOL VALVE 
(viii)STARR-EDWARDS DISC VALVE 
(ix) COOLEY-CUTTER VALVE 
VALVE 
(x) UNIVERSITY OF STELLENBOSCH VALVE 
3.HINGED-LEAFLET (LOW-PROFILE) VALVE ............. . 
4.CAGELESS,CENTRAL-FLOW,TILTING/PIVOTING DISC, 
LOW-PROFILE VALVES ................ . 
(i) PIERCE VALVE 
(ii) WADA-CUTTER VALVE 
(iii) BJORK-SHILEY VALVE 
(iv) LILLEHEI-KASTER VALVE 
(v) LILLEHEI-MEDICAL VALVE 
(vi) HAMMERSMITH VALVE 
(vii) HALL-KASTER VALVE 
(viii)OMNISCIENCE VALVE 
(ix) OMNICARBON VALVE 
(x) SORIN VALVE 
S.BILEAFLET HEART VALVE PROSTHESES ............... . 







(ii) St JUDE MEDICAL VALVE 
B.TISSUE HEART VALVES 
l.HOMOGRAFT AORTIC VALVES ........................ . 
(i) FRESH HOMOGRAFT AORTIC VALVE 
(ii) STERILIZED AORTIC HOMOGRAFT VALVES 
2.XENOGRAFT AORTIC VALVES ........................ . 
(i) UNFIXED XENOGRAFT VALVES 
(ii) FORMALDEHYDE-TREATED VALVE 






3.AUTOLOGOUS FASCIA LATA VALVE ................... . 
4.DURA MATER HOMOGRAFT VALVE ..................... . 
S.BOVINE PERICARDIAL XENOGRAFT BIOPROSTHESES ..... . 
(i) IONESCU-SHILEY VALVE 
(ii) EDWARDS VALVE 
(iii) MITROFLOW VALVE 
(iv) MEDOX UNICUSPID VALVE 
C.VALVE-CONTAINING CONDUITS ...................... . 
I.PULMONARY ARTERY AND VALVE SUBSTITUTES 









3.REPLACEMENT OF AORTIC VALVE AND ASCENDING 
AORTA 
CHAPTER 3 
PATHOLOGY OF NATURAL HEART VALVES AND 
INDICATIONS FOR HEART VALVE REPLACEMENT ....... . 
A.PATHOLOGY OF CARDIAC VALVES WARRANTING 
REPLACEMENT BY VALVE PROSTHESES ................. . 
l.ACQUIRED VALVULAR HEART DISEASE 
2.CONGENITAL HEART DISEASE 
B.CLINICAL INDICATIONS FOR HEART VALVE 
REPLACEMENT ....................... . 
l.ACQUIRED VALVULAR HEART DISEASE 
MITRAL VALVE DISEASE 
AORTIC VALVE DISEASE 
MULTIVALVULAR DISEASE 
TRICUSPID VALVE DISEASE 
2.CONGENITAL HEART DISEASE 
C.MATCHING PROSTHESIS TO PATIENT ................. . 
l.GUIDELINES FOR THE USE OF TISSUE VALVES 







D.TRENDS IN CARDIAC SURGERY AT THE 
UNIVERSITY OF CAPE TOWN .............. . 
E.TYPES OF PROSTHETIC HEART VALVES IMPLANTED 
IN PATIENTS AT THE · UNIVERSITY OF 
CAPE TOWN BETWEEN 1962-1982 .............. . 
F.AETIOLOGY OF THE NATIVE VALVULAR DISEASE 
IN 100 CONSECUTIVE VALVE REPLACEMENT 
OPERATIONS ................. . 
G.INCIDENCE OF ASCHOFF BODIES IN SURGICALLY 
REMOVED CARDIAC TISSUE ................. . 
MECHANICAL VALVES 
CHAPTER 4 
UNIVERSITY OF CAPE TOWN CARDIAC VALVE PROSTHESIS .. 
AORTIC VALVE REPLACEMENT .................... . 
MITRAL VALVE REPLACEMENT .................... . 
TRICUSPID VALVE REPLACEMENT ................. . 
MULTIPLE VALVE REPLACEMENT .................. . 















STARR-EDWARDS BALL-VALVE PROSTHESIS .............. . 198 
MITRAL VALVE REPLACEMENT .................... . 199 
AORTIC VALVE REPLACEMENT .................... . 207 
DOUBLE VALVE REPLACEMENT .................... . 209 
COMMENT ..................................... . 211 
CHAPTER 6 
BJORK-SHILEY PROSTHESIS .......................... . 216 
AORTIC VALVE REPLACEMENT .................... . 217 
MITRAL VALVE REPLACEMENT .................... . 223 
DOUBLE VALVE REPLACEMENT .................... . 225 
COMMENT ..................................... . 227 
CHAPTER 7 
LILLEHEI-KASTER PROSTHESIS ....................... . 232 
AORTIC VALVE REPLACEMENT .................... . 233 
MITRAL VALVE REPLACEMENT .................... . 240 
DOUBLE VALVE REPLACEMENT .................... . 242 
10 
CONTENTS Page 
COMMENT. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 243 
CHAPTER 8 
St JUDE MEDICAL PROSTHESIS ....................... . 247 
AORTIC VALVE REPLACEMENT .................... . 250 
MITRAL VALVE REPLACEMENT .................... . 253 
DOUBLE VALVE REPLACEMENT .................... . 255 
COMMENT ..................................... . 259 
TISSUE VALVES 
CHAPTER 9 
FORMALDEHYDE-TREATED PORCINE AORTIC VALVE 
XENOGRAFT PROSTHESIS ............ . 264 
CHAPTER 10 
HANCOCK PORCINE XENOGRAFT CARDIAC VALVE 
BIOPROSTHESIS ...................... . 275 
MITRAL VALVE REPLACEMENT .................... . 276 
AORTIC VALVE REPLACEMENT .................... . 280 
11 
CONTENTS Page 
DOUBLE VALVE REPLACEMENT..................... 280 
COMMENT. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 281 
CHAPTER 11 
CARPENTIER-EDWARDS PORCINE AORTIC VALVE 
XENOGRAFT BIOPROSTHESIS ............ . 287 
AORTIC VALVE REPLACEMENT .................... . 288 
MITRAL VALVE REPLACEMENT .................... . 292 
MORE THAN ONE PROSTHESIS IN THE SAME HEART ... 296 
SURGICALLY RESECTED BIOPROSTHESES ........... . 297 
COMMENT ..................................... . 300 
CHAPTER 12 
CALCIFICATION OF GLUTARALDEHYDE-PRESERVED 
PORCINE XENOGRAFT VALVES IN YOUNG PATIENTS ...... . 306 
CHAPTER 13 
MISCELLANEOUS TISSUE VALVES ...................... . 319 
AUTOLOGOUS FASCIA LATA HEART VALVE PROSTHESIS ..... 320 
IONESCU-SHILEY BOVINE PERICARDIAL XENOGRAFT 
HEART VALVE PROSTHESIS ................... . 320 
12 
CONTENTS 
VARIOUS PROSTHETIC HEART VALVES 
CHAPTER 14 
MIXED TYPES OF PROSTHESES IN THE SAME HEART ...... . 326 
CHAPTER 15 
VALVE PROSTHESES SITUATED WITHIN 
TUBE GRAFTS .......................... . 334 
CHAPTER 16 
EXPERIMENTAL EVALUATION OF THE MITROFLOW BOVINE 
PERICARDIAL XENOGRAFT BIOPROSTHESIS ........... . 339 
CHAPTER 17 
MISCELLANEOUS ASPECTS OF THE PATHOLOGY 
OF HEART VALVE REPLACEMENT ............... . 359 
A.CONDUCTION SYSTEM OF THE HEART ................. . 360 
B. RENAL HAEMOSIDEROSIS ........................... . 369 
C.SUBVALVULAR LEFT VENTRICULAR FALSE ANEURYSM 
COMPLICATING MITRAL VALVE REPLACEMENT ........... . 380 
D.INFECTIVE ENDOCARDITIS ......................... . 388 
E.SMALL CORONARY ARTERIES ........................ . 397 
13 
CONTENTS Page 
F.MAJOR CORONARY ARTERIES......................... 402 




H. POST-PERFUSION LUNG ............................ . 
I. PANCREATIC FIBROSIS ............................ . 
CHAPTER 18 
OVERALL REVIEW OF THE FINDINGS IN PATIENTS 
WITH PROSTHETIC CARDIAC VALVES .................. . 
A.NATIVE VALVULAR DISEASES LEADING TO CARDIAC 
VALVE REPLACEMENT ................................ . 
B.THROMBOSIS AND THROMBOEMBOLISM ................. . 
C.PRINCIPAL CAUSES OF DEATH ...................... . 
DISCUSSION ....................................... . 
CHAPTER 19 












REFERENCES ....................................... . 458 
LIST OF ILLUSTRATIONS ............................ . 621 
TYPES OF VALVES IMPLANTED IN AUTOPSIED PATIENTS .. 626 
DATA ON CONTROL PATIENTS ........................ . 627 
15 
STATEMENT OF CANDIDATE 
I declare that the work on which this thesis is based is 
original (except where acknowledgements indicate otherwise) 
and that neither the whole work nor any part of it has been, 
is being, or is to be submitted for another degree in this or 







I gratefully acknowledge the kindness of Professor W. 
Beck and other members of the Cardiac Clinic, Department of 
Medicine, Groote Schuur Hospital and University of Cape Town, 
especially Drs R. Forman and P.J. Commerford, in allowing me 
access to the clinical records of the autopsied patients with 
valvular prostheses studied in this work. Mrs C. Lawley 
(Department of Medical Informatics, Groote Schuur Hospital) 
supplied survival tables and embolism event-free tables of all 
Groote Schuur Hospital patients with various types of cardiac 
valvular prostheses, who were entered in the hospital's 
computerized records. I am equally indebted to Professor C.N. 
Barnard and other staff members of the Department of Cardiac 
Surgery, especially Drs J. Hassoulas, J. de Nobrega, D.K.C. 
Cooper, D. Novitsky and H. Sanchez for sharing with me their 
frank opinions as to the causes of death of these patients. 
The latter information was of great value since the patients' 
hospital notes usually do not provide a detailed account of 
all of the circumstances surrounding the individual patient's 
death. I am also grateful to these surgeons for allowing me to 
examine several surgically excised prosthetic heart valves, 
which are not ordinarily submitted for histopathological 
examination. 
Professor L.S. Smith and his colleagues in the Department 
of Forensic Medicine, especially Dr G.J. Knobel and Dr L. van 
Ieperen have allowed me to examine the hearts of patients who 
died shortly post-operatively (so-called "anaesthetic deaths") 
and who were autopsied at the State Mortuary. I am grateful to 
these colleagues for supplying information regarding the 
general autopsy findings in many of these patients. 
My thanks are also due to Professor C.J.Uys, Head of the 
Department of Pathology for stimulating me to embark on 
thesis and for allowing me unrestricted use of 
this 
the 
pathological material used in this work. I am also grateful to 
my colleagues in the Department of Pathology for referring 
hearts with implanted cardiac valvular prostheses to me for 
18 
ACKNOWLEDGEMENTS 
examination. Thanks for photographic assistance go to Ms J. 
Buron and Ms C. Bilobrk for the black and white photographic 
prints . Mr J . R.P. Dale and Mr M. Emms provided electron 
microscopical technical assistance . Part-time technical 
assistance provided intermittently by the Chris Barnard Fund 
for various research projects over the past 10 years has 
allowed me to examine these patients ' hearts in greater 
microscopical detail than would have been possible under 
standard laboratory conditions . The Chris Barnard Fund and the 
South African Medical Research Council have provided support 
for consumable items required for the microcomputer, which was 
used in several research projects included in this thesis . 
Drs C.A . Curcio , P . J. Commerford , J . E. Stevens and 
Professor M.S . Barnard supplied clinical and 
angiocardiographic data on the young patients with calcified 
glutaraldehyde-preserved porcine xenografts . I am indebted to 
Mr G . K. Gielding , President/Technical Director of Mitral 
Medical Inc. for providing data on the manufacturing 
procedures for the Mitroflow pericardial heart valves. Dr 0 . 
Ayzenberg analyzed the cardiac catheterization data of the 
baboons with Mitroflow valves , which had been surgically 
implanted by Dr J . Hassoulas . 
Mr S. Isaacs, statistician in the Department of Medical 
Informatics, Groote Schuur Hospital gave advice on the 
statistical methods used in this work . Mrs M. Stansfield 








This study reviews the pathological findings and principal 
causes of death in 290 patients with 360 implanted heart valve 
prostheses . It is preceded by a survey of the dramatic history 
of the development of cardiac valve surgery , which spans the 
relatively short period from 1896 to the present time . The 
autopsy incidence of various forms of valvular heart disease 
as reflected in the autopsy records of the University of Cape 
Town Department of Pathology is also reviewed. Acquired 
valvular heart disease was encountered in 6 . 8 % of 18 , 132 
autopsies performed over a 30-year period (and most often 
involved the mitral valve) . Congenital heart disease was 
encountered in 2% of the same group of autopsy patients . The 
clinical indications for heart valve replacement and trends in 
cardiac surgery at the University of Cape Town are briefly 
reviewed . 
Retrospective analysis of the pathology of 100 
consecutively replaced natural heart valves in conjunction 
with the operation notes and the information given to the 
original examining pathologist revealed that the most helpful 
information for the pathologist is that which is contained in 
the operation notes and pertains to the appearance of the 
valve prior to excision . This is especially so in the case of 
the aortic valve , which is usually removed as multiple 
fragments . Aschoff bodies were encountered in 10 . 3% of 
surgically removed atrial appendages (and in 11 . 3 % of of those 
removed from patients suspected of having rheumatic valvular 
disease). About 25 % of atrial appendages removed from patients 
with mitral stenosis showed positive Aschoff bodies . Only 0 . 9 % 
of autopsy patients with implanted cardiac valve prostheses 
showed Aschoff bodies . Rheumatic fever was the underlying 
disease leading to cardiac valve replacement in 73 % of all 
patients with implanted valvular prostheses 
series. 
in this autopsy 
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ABSTRACT 
Design criteria fo r the ideal heart valve substitute are 
summarized and most of the commercially available heart valve 
prostheses are classified and their structure described . An 
approach to the identification of heart valve prostheses by 
macroscopical examination and radiological means is also 
given . 
The body of the thesis details the pathology and 
principal causes of death in each of the different types of 
mechanical and tissue valves that have been used at Groote 
Schuur Hospital , Cape Town. These valves include the 
University of Cape Town prosthesis , Starr-Edwards ball-valve , 
Bjork-Shiley tilting - disc prosthesis , Lillehei-Kaster 
pivoting - disc valve , St Jude Medical valve , the University of 
Cape Town formaldehyde - preserved xenograft porcine aortic 
valve , the Hancock prosthesis, and the Carpentier - Edwards 
valve. Details of limited experience with autologous fascia 
lata and Ionescu-Shiley prostheses are also given. Patients 
with mixed (more than one type of valve prosthesis) in the 
same heart are dealt with as a separate group , 
prostheses situated within tube grafts . 
as are valve 
Miscellaneous aspects of the pathology of valve 
replacement examined include the cardiac conduction system , 
renal haemosiderosis , subvalvular aneurysm complicating mitral 
valve replacement, the state of the major and small coronary 
arteries and the myocardium the post-perfusion pulmonary 
syndrome and pancreatic changes related to heart failure . 
Conduction system haemorrhage is commonly associated with 
heart valve replacement , and may be related to relative 
hypoxia during bypass rather than direct surgical trauma . 
Significant renal haemosiderosis was observed in 25% of 
patients with valvular prostheses and was confined to the 
mechanical prosthetic group only. None of the patients had 
gallstones . Excessive excision of a (calcified) mitral ring 
may lead to loss of atrioventricular continuity and 
development of a sub-epicardial haematoma . The latter may be 







heavier hearts than 
myocardial failure had 
those without failure . 
Myocardial necrosis was more severe in patients with implanted 
valvular prostheses compared to non-operated controls . For 
some unexplained reason patients with Starr-Edwards prostheses 
showed significantly more necrosis compared to patients with 
other types of prostheses . No significant difference in 
necrosis scores was noted between the following categories of 
patients (i) two groups of patients with different types of 
myocardial protection (intermittent coronary perfusion with a 
beating heart versus cold cardioplegic cardiac arrest) during 
cardiopulmonary bypass ; (ii) intermittent versus continuous 
coronary arterial perfusion with blood during bypass ; (iii) 
regularly beating hearts versus those hearts which fibrillated 
during bypass (iv) early (less than one month) surviving 
patients compared to those that died later . 
Although the hearts of most patients showed some 
histological evidence of fibrosis , naked eye examination 
revealed sub-endocardial fibrosis in only 8% of the operated 
patients and trans-mural fibrosis in 3% . Morphometry 
(point-counting) revealed no significant difference in the 
amounts of myocardial fibrosis in patients with prostheses 
compared to non-operated controls . Assessment of fibrosis 
using a more subjective morphological scoring system showed 
higher scores for replacement and interstitial fibrosis in 
patient with prostheses compared to controls and replacement 
fibrosis was more common in the longer surviving operated 
patients . Morphometrical assessment of fibrosis in functional 
classes of valvular dysfunction showed that patients with 
pre-operative aortic 
disease yielded higher 
incompetence or 
fibrosis scores 
mixed aortic valvular 
than controls with 
similar valvular dysfunction . The general conclusion from the 
present study is that overall patients with implanted valvular 
prostheses show a similar degree of myocardial fibrosis to 
that seen in non-operated controls with valvular disease . 
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ABSTRACT 
Comparison of results in the different types of valves showed 
that the tissue valves bore significantly fewer thrombi and 
that, in general, the thrombus was much scantier in amount 
than that observed on the mechanical prostheses. These two 
groups of valves showed no significant difference with regard 
to infarcts of systemic organs. Patients with prostheses 
showed infarcts of the spleen, brain and heart more often than 
did non-operated controls with (predominantly) rheumatic 
valvular disease. Renal infarcts were just as frequently seen 
in the control patients, who also showed a higher incidence of 
pulmonary infarcts. Amongst the mechanical valves, patients 
with Starr-Edwards valves showed the greatest incidence of 
fatal thromboembolism. Prosthesis-related problems formed the 
biggest single principal cause of death in all patients with 
valve prostheses. This was because the mechanical valve group, 
which comprised 82% of the total, had prosthesis-related 
problems as the prime cause of death. In the tissue valve 
group this complication ranked third 
unknown causes and diseases unrelated 
Analysis of the valve-related causes of 
in importance after 
to valve surgery. 
death showed that 
thrombosis and infection of the prosthesis were more important 
in the mechanical valves, whereas structural failure was more 
common with the tissue valves. The University of Cape Town 
valve, the Lillehei-Kaster valve, and the Starr-Edwards valve 
had the highest incidence of prosthesis-related complications, 
whilst the Bjork-Shiley, Carpentier-Edwards, Hancock and St 
Jude Medical valve prostheses gave better results in this 
regard. Examination of the total group of autopsy patients 
with valvular prostheses revealed that prosthesis-related 
fatal complications were present in 13% of the patients who 
died within 30 days post-operatively, and in 61% of those who 
died later. 
Creation of the ideal heart valve substitute is still a 
long way off, and even the most modern "state-of-the-art" 
prosthetic valve e.g., the St Jude Medical mechanical valve is 
still greatly dependent upon continuous anticoagulation for 
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ABSTRACT 
its adequate function. Experimental evaluation in baboons of a 
newly developed bovine pericardial (Mitroflow) valve showed no 
significant advantage over another similar commercially 
available valve. Over the short period of evaluation, 
thrombosis and host tissue overgrowth were significant 
complications . Unlike the overall development of cardiac 
surgery , which has made dramatic advances about once every 5 
years, improvements in the design and function of prosthetic 
heart valves seems to occur as a steady slow march with 







The human heart is a unique pump system which , using a 
few watts of power , circulates nearly 3 million litres of 
blood through the body of an average-sized adult each year(l) . 
The efficiency of a well-functioning heart depends upon the 
adequate function of the heart valves and thus advanced 
valvular heart disease may severely disable the heart ' s 
pumping capacity and lead eventually to death. Cardiac valve 
replacement aims to restore the circulatory haemodynamics to 
normal , or to as near normal as possible. The need for heart 
valve replacement is clearly established . Nevertheless, there 
is often considerable uncertainty regarding the optimal timing 
for surgery , the appropriate prosthesis to use , and the 
ultimate prognosis for the individual patient(2). 
Many varieties of prosthetic valves have been used in 
clinical practice , but recently tilting disc valves and 
xenografts have been more commonly used . However , no 
prosthetic valve as perfect as the normal human heart valve 
has yet been developed . Replacement valves , although generally 
helpful in returning patients to normal life , may also cause 
significant complications . Many serious problems associated 
with heart valve replacement remain unsolved . According to 
Hwang et al . (l) the prominent problem areas are : (i)thrombus 
formation and thromboembolism , (ii)damage to the blood 
elements by mechanical stress , (iii)damage to the endothelial 
lining by mechanical stress, (iv)tissue overgrowth , 
(v)mechanical failure due to fatigue or chemical change in the 
valve materials , (vi)biochemical reactions , (vii)suture 
tearing , and (viii)infections . In addition to continuous 
clinical evaluation of heart valve prostheses, the solution to 
most of these problems will depend on inter-disciplinary 
contributions from biomedical engineering , material science , 
biochemistry , pathology and related fields . Whilst there is a 
plethora of reports detailing the clinical and haemodynamic 
effects of various prosthetic heart valves, there are far 
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INTRODUCTION 
fewer articles describing the cardiac pathology and general 
autopsy findings in patients who have died following 
implantation of such prostheses . Despite the fact that more 
than 30 , 000 patients in the United States of America alone 
undergo this procedure each year , few studies have analysed 
the autopsy-determined causes of death in a large population 
of such patients(3) . 
Research and development for newer and better prosthetic 
valves is being actively undertaken(4). However, the ultimate 
evaluation of a replacement heart valve can only be obtained 
from patients with implants . Clear identification of fatal 
complications following heart valve replacement is of the 
greatest importance in planning means of lowering the 
post-operative mortality rate . Autopsy evaluation of a 
patient's cause of death is more accurate than a solely 
clinical assessment(S-7). If an autopsy has been performed , 
one has substantial evidence as to whether or not the death 
was valve related(8) . 
The main aim of the present study is to determine the 
principal causes of death in all patients with heart valve 
prostheses who were autopsied in the University of Cape Town 
Department of Pathology from the beginning of 1962 up to the 
end of 1982. In some cases , possibly more than one explanation 
of the cause of death was valid, but a judgement was made as 
to which factor appeared to be the dominant cause . Although 
there may be some disagreement regarding a particular 
patient ' s principal cause of death , as long as the same person 
is making the judgement, the information is useful in 
comparing one prosthesis , or one patient with a prosthesis , 
with another(9) . Other associated aetiological factors 
favouring a fatal outcome were also examined . In addition to 
the autopsied patients , information obtained from surgically 
excised heart valves and from experimentally implanted 
prostheses was also analysed . 
The thesis is arranged so that following on the 
methodology , historical review , and a description of the 
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INTRODUCTION 
various types of prosthetic heart valves, the pathology of 
each type of prosthesis implanted in patients at Groote Schuur 
Hospital is dealt with separately. Certain pathological 
conditions common to all of the patients are examined in 
Chapter 17. Chapter 18 reviews the pathological findings in 
all of the autopsied patients with prosthetic heart valves. 
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30 
DEFINITION OF TERMS 
POPPET (BOBBIN,OCCLUDER) is the mobile portion of the 
prosthesis which seals the prosthetic orifice. It may take the 
form of a ball, disc or leaflet. 
BASE RING is the circular structure in the plane of the 
valve annulus, which in the case of mechanical prostheses 
supports the cage, and which supports the stent of xenograft 
prostheses. 
SEWING RING is that portion of the valve through which 
sutures are passed to tether the prosthesis in the native 
valve ring. The sewing ring surrounds, and is attached to, the 
base ring. 
CAGE is that portion of a mechanical prosthesis which, in 
conjunction with the base ring, limits the excursion of the 
ball, disc or leaflet. 
The cage is composed of STRUTS which join the cage to the 
base ring. If all the struts emerge on one side of the base 
ring plane, the cage is SINGLE. If the struts emerge on both 
sides of the base ring plane, the cage is DOUBLE. If 
converging struts are not connected, the cage is OPEN 
otherwise the cage is CLOSED. 
STENT is the supporting structural framework of a tissue 
valve. It arises at a right angle to the base ring of a 
xenograft prosthesis and supports the valve leaflets. 
AORTIC NODULAR SCLEROSIS is an alternative term for 
SENILE TRICUSPID ACQUIRED CALCIFIC AORTIC VALVE STENOSIS. 
ABBREVIATIONS AND SYMBOLS 
AS=AORTIC STENOSIS 
AI=AORTIC INCOMPETENCE 
AV =AORTIC VALVE 
AVN=ATRIO - VENTRICULAR NO DE 
AVR=AORTIC VALVE REPLACEMENT 
BH=BUNDLE OF HIS 
B-S =BJORK-SHILEY 









et al .=ET ALIA :' AND OTHERS ' 
GPVs=GLUTARALDEHYDE PRESERVED PORCINE AORTIC VALVES 





i . e . =ID EST : ' THAT IS ' 
I-S=IONESCU - SHILEY 





MI =MITRAL INCOMPETENCE 
MIXED PROSTHESES=MORE THAN ONE TYPE OF PROSTHETIC VALVE IN 
THE SAME HEART 




MVR=MITRAL VALVE REPLACEMENT 





PROPOR . =PROPORTIONAL 
p . (SING . )=PAGINA :' PAGE '; pp.(PL . ): 'PAGES' 
PVD=PULMONARY VALVULAR DISEASE 
PVIE=PROSTHETIC VALVE INFECTIVE ENDOCARDITIS 
PTS . =PATIENTS 
PV=PULMONARY VALVE 




sic=thus used , spelt 
SJM=St JUDE MEDICAL 
SMCs=SMOOTH MUSCLE CELLS 
TV=TRICUSPID VALVE 




VSD=VENTRICULAR SEPTAL DEFECT 
UCT=UNIVERSITY OF CAPE TOWN 






METHODS APPLIED FOR THE STUDY OF THE PATHOLOGY OF HEART VALVE 
REPLACEMENT BY VALVULAR PROSTHESES . 
l . HISTORICAL ASPECTS OF CARDIAC VALVE REPLACEMENT (See Chapter 
1 ) . 
The broad outline of the history of surgical replacement 
of cardiac valves was examined by reviewing the literature in 
the following sequence (a) early general historical 
landmarks , (b) indirect surgical techniques for mitral 
stenosis , (c) closed heart procedures for mitral 
regurgitation , (d) closed heart procedures for aortic stenosis 
and incompetence, and (e) open heart valve surgery on 
cardiopulmonary bypass . 
2 . STRUCTURAL DATA ON VARIOUS TYPES OF PROSTHETIC HEART VALVES 
(see Chapter 2) . 
Design criteria for the ideal prosthetic heart valve were 
summarized and the various types of commercially available 
mechanical and tissue heart valve prostheses were classified 
and their structure described . Details of the various models 
of the more widely used types of prostheses were also given . 
The advantages and disadvantages of prostheses which have not 
been used at Groote Schuur Hospital , Cape Town were 
high-lighted . An approach for the identification of prosthetic 
heart valves by pathologists based upon the morphological and 
radiological appearances of the prosthetic valve is also 
given . 
3.INDICATIONS FOR HEART VALVE REPLACEMENT (see Chapter 3) . 
A. PATHOLOGY OF NATURAL CAR DIAC VALVES WARRANTING REPLACEMENT 
BY VALVULAR PROSTHESIS . 
The cardiac valvular pathology encountered in the 18 , 132 
autopsies performed in the Department of Pathology , University 
35 
METHODOLOGY 
of Cape Town , during the 30 year period 1950-1979 was surveyed 
where available the by reviewing the postmortem reports and 
fixed specimens and/or photographs . The aetiology 
as well 
of the 
acquired valvular heart disease was noted , as the 
different functional classes and combinations of valvular 
lesions . The rates of rheumatic mitral stenosis per 100 
autopsies for each of the 3 decades 1950-1959 , 1960-1969 and 
1970-1979 was determined . The various types of congenital 
heart disease encountered at autopsy over the same 30 year 
period was also recorded . The incidence of diseases , which are 
not necessarily treated by valve replacement or use of a 
valved conduit e . g ., Fallot's tetralogy , were noted for 
comparative purposes . 
B . CLINICAL INDICATIONS FOR HEART VALVE REPLACEMENT . 
Clinical indications for heart valve replacement in the 
literature and those applied at Groote Schuur Hospital were 
discussed under the following headings (i) Acquired valvular 
disease mitral valve disease , aortic valve disease , 
multi valvular disease , 
Congenital heart disease . 
and tricuspid valve disease . 
C.MATCHING PROSTHESIS TO PATIENT . 
The problem posed by the choice of an appropriate 
prosthesis in the unique circumstances posed by 
individual patient was considered and guidelines were 
down for the use of tissue valves and mechanical heart 






D . TRENDS IN CARDIAC SURGERY AT THE UNIVERSITY OF CAPE TOWN . 
Trends in cardiac surgery at the University of Cape Town 
between 1951 and 1981 were analysed on the basis of the three 
reports(l-3) which have emanated from the Departments of 
Cardiac Surgery and 






(Cardiac Clinic) of that 
for the 5 year period 
E . TYPES OF PROSTHETIC HEART VALVES IMPLANTED AT THE UNIVERSITY 
OF CAPE TOWN BETWEEN 1962-1982. 
The numbers of patients who received the different types 
of prosthetic heart valves in use at Groote Schuur Hospital 
were obtained by examination of the operation notes filed in 
the Department of Cardiac Surgery and the computerized data 
(available from 1976 onwards) of the Cardiac Clinic and the 
Department of Medical Informatics on patients who have 
undergone valve replacement at Groote Schuur Hospital . 
F.AETIOLOGICAL DATA ON 100 CONSECUTIVE VALVE REPLACEMENT 
OPERATIONS . 
One hundred consecutive patients who underwent heart 
valve replacement were randomly selected from the operation 
notes filed in the Department of Cardiac Surgery . The file 
randomly chosen was that for the year 1973 and the first 100 
valve replacement operations in that file were analysed with 
regard to the aetiology of the native valvular disease which 
led to the valve surgery . The information on the pathology 
request form which accompanied the valve, and the 
pathologist ' s report after macroscopical and microscopical 
examination of the excised valve were also noted . These data 
were compared with one another and I then reviewed the 
pathological diagnosis of the likely aetiology of the native 
heart valve disease by combining the personally reviewed 
valvular histology , the macroscopical description and the 
operation note details regarding the appearance at operation 
of the diseased valve. The latter information had often not 




G.INCIDENCE OF ASCHOFF BODIES IN SURGICALLY SAMPLED CARDIAC 
TISSUE . 
The incidence of granulomatous phase Aschoff bodies was 
examined in 2 groups of patients who had undergone heart valve 
replacement (i) The first group consisted of one hundred 
consecutive patients who underwent heart valve replacement 
(same group who were studied regarding aetiology in section F 
above) . I examined the histology of their atrial appendages , 
papillary muscles (where appropriate), and valves for 
granulomatous phase Aschoff bodies . (ii) The second group 
consisted of 468 patients who were operated upon during the 
years 19 7 3-1982 and who had atrial appendages excised at the 
time of surgery for mitral stenosis or mixed mitral valve 
disease in which stenosis predominated . The incidence of 
Aschoff bodies as diagnosed by a variety of pathologists in 
this group of patients was recorded . I then reviewed the 
histology of those patients in whom Aschoff bodies had been 
diagnosed . In this review only granulomatous phase Aschoff 
bodies were accepted as positive Aschoff bodies . The criteria 
used for defining the gran u lomatous (proliferative) phase 
Aschoff body are essentially those of Fassbender(4) and 
Silver(5) and are summarized in Chapter 3 , (Incidence of 
Aschoff bodies in surgically sampled cardiac tissue). 
4 . STUDY OF THE PRINCIPAL CAUSES OF DEATH AND THE MAJOR 
COMPLICATIONS CONTRIBUTING TO DEATH FOLLOWING HEART VALVE 
REPLACEMENT (see Chapters 4 to 15) . 
A total of 290 autopsied patients with implanted cardiac 
valvular prostheses was encountered between 1962 and 1982 
(3 . 1 % of 9291 autopsies). The types of valves inserted are 
listed in the Appendix (page 626) . For the reasons given on 
page 450 , 15 patients were excluded from the final analysis . 
Before describing the pathology of each type of cardiac valve 
implanted a table will be given indicating the cumulative 
survival rates and the cumulative embolism event-free rates of 
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all patients with that particular type of valvular prosthesis 
implanted between 1976 and 1982 at Groote Schuur Hospital. 
Actuarial methods described by Anderson et al.(6) were used to 
analyse the survival rates and thromboembolic complications. 
The following approach to the pathology of heart valve 
replacement by prostheses was applied to the various types of 
prosthetic heart valves that have been implanted in patients 
at Groote Schuur Hospital,Cape Town. Detailed autopsy reports 
were available on each of the 290 patients with implanted 
cardiac valvular prostheses included in this study and the 
preserved hearts of 243 of these patients were available for 
re-examination. In each patient note was made of the age, 
race, sex and period of post-operative survival heart 
weight, presence or absence of thrombus on the prosthesis ( 




If a patient 
and other miscellaneous 
died within two weeks 
after valve replacement re-operation necessitated by failure 
of a previously inserted valve prosthesis, then that patient's 
death was attributed to the original valve prosthesis. Such a 
situation was encountered in 12 out of the patients studied. 
Methods used to evaluate the state of the coronary arteries 
and myocardium are described below. An attempt was made to 
pinpoint a single principal cause of death for each patient 
after valve replacement using the approach of Roberts(7). The 
causes of early deaths (less than one month after surgery) 
were compared with those occurring later. The principal causes 
of death were classified as follows using a modification of 
the systematic approach of Silver(S) 
(1) Error in pre-operative diagnosis e.g., unrecognized 
significant associated valvular disease. 
(2) Error in operative technique. This may be related to the 
anaesthetic, to the extracorporeal circulation, or to the 
surgical technique and it may affect the valvular prosthesis, 
the valve rings, blood vessels or the conducting tissues. 
(3) Valve prosthesis-related problems e.g., thrombus, infected 
vegetations, anticoagulant-related complications, or 
design/structural problems inherent in the prosthesis. 
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(4) Post-operative complications affecting non-cardiac 
organs. 
(S) Complications unrelated to valve surgery. 
(6) The final category consisted of those patients in whom no 
morphological cause of death was found. 
I also applied this same classification of the principal 
causes of death to pathological reports in the literature 
which describe autopsy-determined causes of death in large 
groups of patients, who died following heart valve 
replacement. A few of the latter reports regarded early deaths 
as those occurring up to 2 months post-operatively. 
The pattern of organ infarcts in my patients with 
implanted cardiac valvular prostheses was also analysed for 
each type of prosthesis and the incidence was compared with 
that observed in 103 non-operated subjects with valvular heart 
disease. 
8.STUDY OF MISCELLANEOUS ALTERATIONS COMMON TO ALL PATIENTS 
WITH PROSTHETIC HEART VALVES. 
A.CONDUCTION SYSTEM IN PROSTHETIC HEART VALVE REPLACEMENT, 
(see Chapter 17 ). 
The atrioventricular node (AVN), the bundle of His and 
the proximal portions of the right and left bundle branches 
were examined microscopically in 41 patients 27 had 
implanted prosthetic heart valves and 14 routine autopsy 
patients served as controls. The 27 patients with valvular 
prostheses were divided into two groups. Group A consisted of 
15 patients who died 5 days or less after valve replacement. 
Group B comprised 12 patients who died more than 5 days 
post-operatively. The control autopsy patients had died of 
diseases such as carcinoma of the lung, 
aneurysm and pneumonia. 
ruptured aortic 
40 
The tissue blocks for examining the AVN and bundle of His 
were fashioned according to the method of Hudson(8) . A 
vertical incision was made through the upper inter-ventricular 
septum , which transected the bundle of His . Blocks were then 
taken backwards and forwards , to include the whole of the 
bundle and the AVN, as well as the bifurcation of the bundle 
into its left and right branches . According to Davies(9) , in 
order to study the whole conduction system of the heart in an 
average case , between 200 to 300 sections will have to be 
examined from the 6000 to 9000 serial sections which are made 
available by this technique. Each such case will provide about 
5 days ' work for a competent histology technologist. Under the 
standard laboratory conditions which were available to me for 
the present study , it was impracticable to prepare serial 
sections of the conduction system of these 41 hearts . The 
technique was modified , so that the blocks of each heart were 
examined histologically by looking at representative sections 
cut at intervals of about 2 mm . Sections were stained by the 
haematoxylin-eosin and van Gieson (Verhoeff ' s counterstain for 
elastin) methods . 
B . RENAL HAEMOSIDEROSIS ( see Chapter 17 ) . 
Sections of the kidneys of 105 patients with implanted 
cardiac valvular prostheses were examined . These 105 patients 
comprised 50 patients with University of Cape Town (UCT) 
prostheses , 17 with mixed prostheses , 14 with Starr-Edwards 
valves , 7 with Lillehei-Kaster valves , 3 with Bjork-Shiley 
valves , 3 with Hancock prostheses , 5 with Carpentier-Edwards 
valves and 6 with St Jude Medical prostheses . 
Two control groups of patients were studied . Firstly, the 
kidneys of 32 patients who died with advanced chronic 
rheumatic-type valvular deformities were examined for 
haemosiderin . None of these 32 patients had a prosthesis and 
most had died of cardiac failure. The second control group 
consisted of 21 consecutive routine adult autopsies . 
All kidney sections studied were stained by the 
haematoxylin-eosin , periodic acid-Schiff methods and the 
amount of renal iron (haemosiderin) present was assessed on 
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sections stained by the Perl ' s Prussian blue method . Renal 
haemosiderosis was graded as follows : 0 , no iron present ; + , 
scanty iron ; ++ , moderate amounts of iron +++, abundant 
iron is present . For the purposes of this study the term 
0 significant haemosiderosis ' refers to moderate or abundant 
iron deposits . Sections of liver and spleen in these 159 
patients were similarly evaluated for the presence of iron. 
Local lesions ( e . g ., infarcts ) were disregarded in the 
assessment of iron content . 
(iii) DISEASES OF THE MAJOR EPICARDIAL CORONARY ARTERIES (see 
Chapter 1 7 ) . 





was 75% or more narrowing 
one or more of the 3 major 
epicardial coronary arteries . 
of 
The usual cause of such 
narrowing was atherosclerosis , but embolism and intimal 
(post-cannulation injury) fibrous intimal thickening were also 
looked for. The arteries were sectioned transversely at 
approximately 5 mm intervals throughout their length . 
Representative sections were taken of normal-appearing 
arteries and of all lesions of grade 2 severity or greater ( 
25% or more luminal narrowing ). The arterial sections were 
stained by the haematoxylin-eosin and van Gieson (Verhoeff's 
counterstain) methods ; the latter stain is referred to as the 
0 elastic van Gieson ' method in this study . 
(iv) DISEASES OF THE SMALL CORONARY ARTERIES 
1 7 ) • 
(see Chapter 
Abnormalities in the small (intra-myocardial) coronary 
arteries (haematoxylin-eosin sections) in the patients with 
prostheses were compared with the changes observed in the 
corresponding vessels in control patients with non-operated, 
similar natural valvular dysfunction to that which 
necessitated valve replacement in the study group and with 
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changes in 50 routine autopsy control patients. 
(v) THE STATE OF THE MYOCARDIUM (see Chapter 17). 
The state of the myocardium in 275 patients with 
prostheses was compared with that of 85 non-operated controls 
with native heart valve dysfunction similar to that which 
existed in the former prior to surgery. Myocardial necrosis in 
45 randomly selected patients with implanted heart valves who 
underwent intermittent coronary arterial perfusion with blood 
from the pump-oxygenator machine (cooling to 32 degrees 
Centigrade) and had a beating heart during cardioplumonary 
bypass was compared with that in 42 patients treated by cold 
cardioplegic cardiac arrest . The latter hearts had been cooled 
down to less than 20 degrees Centigrade and cardiac arrest in 
diastole had been achieved by potassium administration . 
Necrosis and fibrosis were also assessed in 14 patients with 
intermittent and 21 patients with continuous coronary 
perfusion during bypass . Similarly , 16 patients with regularly 
beating hearts were compared with 21 others whose hearts 
fibrillated during bypass . 
A minimum of five tissue blocks were taken from the same 
standard sites in the transversely sectioned ventricles of 
each heart at a level corresponding to the free margins of the 
mitral valve cusps . In 8 hearts of patients with University of 
Cape Town prostheses only between 2 and 4 random myocardial 
sections were available . The standard sites sectioned were the 
inter-ventricular septum , the anterior, lateral and posterior 
(inferior) walls of the left ventricle and the free wall of 
the right ventricle . Sites that were avoided were the vent 
wound at the left ventricular 
papillary muscles if the 
apex and the 
atrioventricular 
stumps of the 
valves had been 
replaced. The tissue was processed routinely for paraffin 
embedding. Two consecutive 5 micron thickness sections from 
each tissue block 
E.) and elastic 
were 
van 
stained by the haematoxylin-eosin (H . & 
Gieson (EVG) methods. (These two stains 
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were also used for the examination of coronary arteries , but 
H. & E . alone was used for the other routine autopsy sections) . 
All slides used to assess the myocardium were labelled with a 
randomly selected non-sequential code number to conceal their 
identity, and examined by light microscopy. 
MYOCARDIAL NECROSIS . 
Three forms of acute myocardial 
semi-quantitatively histologically 
damage were evaluated 
contraction band necrosis 
coagulative necrosis , 
(myofibrillar 
degeneration/coagulative myocytolysis) and colliquative 
myocytolysis(lO) . The severity of these 3 types of necrosis 
were graded on an arbitrary scale of O ( no abnormality ) to 3 
( severe extensive , abnormality ) . Other forms of necrosis 
that were looked for included concentric , haemorrhagic , 
sub-endocardial necrosis(S) and the clinicopathological entity 
of the " stone heart " (Sa). 
MYOCARDIAL FIBROSIS . 
Myocardial fibrosis of the left ventricle was appraised 
morphologically with the light microscope and an additional 
quantitative analysis was performed : 
(A) The severity of four histopathological types of 
myocardial fibrosis(ll) was estimated using an arbitrary scale 
of O ( no fibrosis ) to 3 ( marked fibrosis ). Four types of 
microscopical fibrosis were recorded (i) Replacement 
fibrosis , which results from destruction of myocardium and its 
relationship to the surrounding myocardium suggests that it 
lies in a position previously occupied by muscle cells. Such 
fibrosis may be discrete or confluent . (ii) Interstitial 
fibrosis appears as fine strands of collagenous connective 
tissue encircling and separating individual muscle fibres. 
When mild in degree it tends to be focal and subendocardial . 
(iii) Perivascular fibrosis links up myocardial blood vessels 
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( adventitia to adventitia) and thereby delineates groups of 
muscle fibres into bundles or fascicles . (iv) Plexiform 
fibrosis is noted in areas of myofibre disarray similar to 
that seen in hypertrophic cardiomyopathy. Foci of collagenous 
fibrous tissue of irregular size and shape with jagged borders 
lie interlaced between myocardial fibres. 
(B) The amount of fibrous connective tissue in the 
myocardium of the left ventricle in 
and in non-operated controls was 
patients with prostheses 
also determined on a 
morphometric basis . Any tissue is made up of a compact mass of 
three dimensional objects which can be penetrated by fixative , 
and cut in thin sections,still preserving the two dimensional 
relationships between structures. The section, however , cuts 
through the tissue in a random fashion and thus presents flat 
profiles of the components . Simple quantitative relations 
exist between the average dimensions of large numbers of 
profiles of particular organelles . Thus, the aggregate of 
profiles per unit area of tissue is quantitatively 
representative of the aggregate of organelles contained in the 
unit volume of tissue , so that the measurements on sections of 
tissue can be interpreted in terms of structural dimensions by 
means of mathematical relationships(l2,13) . 
In simple terms , a volumetric analysis of tissue sections 
is achieved by point counting . This analysis is done by 
superimposing a point lattice (a test grid,which is a grid of 
lines drawn at right angles to each other using the 
intersections as the point lattice) over a microscope image or 
photographic print of the section , and counting the number of 
points (intersections) which happen to fall on the component 
being investigated . The ratio of points falling on the 
component 0 i 1 being investigated to the total number of points 
falling on the test tissue within the area of the test grid , 
i . e . Pi/Ptotal is equal to the volume of component 0 i 1 in the 
tissue volume encompassed by the test grid (14 , 15) . 
Ten random fields from two different sections , one from 
the anterior wall and the other from the posterior (inferior) 
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wall of the left ventricle were studied at a magnification of 
400X . The connective tissue content was determined by using a 
square grid (an ocular micrometer) of 121 points inserted in 
the microscope eyepiece . By this method, a total of 1210 
points was counted in each specimen. The percentage connective 
tissue was calculated using the relationship : 
Pct 100 
Vet = X 
Ptot 1 
where Vet is the volume of connective tissue per unit volume 
of cardiac muscle , Pct the number of points falling on 
connective tissue and Ptot , the number of points in the point 
lattice . These fields were taken from areas of myocardial 
tissue in which no large blood vessels were encountered and 
which were well clear of the endocardium . This was done to 
avoid the large aggregations of connective tissue which are 
normally found at these sites . 
ASCHOFF BODIES. 
The presence or absence of granulomatous (proliferative) 
phase Aschoff bodies ( as defined above in section 3 G) was 
noted in the myocardial sections of the hearts containing 
valvular prostheses . 
(vi) ORGAN INFARCTS . 
The distribution pattern of organ infarcts in patients 
with prostheses and in 103 non - operated controls with similar 
native valvular dysfunction was also studied . 
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(vii) PANCREATIC FIBROSIS RELATED TO CHRONIC HEART FAILURE. 
The amount of fibrous tissue in the pancreas was assessed 
morphometrically using the (ocular micrometer) point-counting 
method and counting 1210 points in each case (using the same 
method that was used to assess myocardial fibrosis above). Two 
groups of autopsy patients were assessed firstly 112 
patients with implanted prosthetic heart valves, (178 patients 
were excluded from this analysis due to autolysis or the lack 
of a section of the pancreas) and secondly in 20 routine 
autopsy control patients. The amount of pancreatic fibrosis 
was scored as follows : 0 = normal ; 1 = mild fibrosis ; 2 = 
moderate and 3 = severe fibrosis. Patients with other 
possible causes of pancreatic disease were excluded as 
controls e.g., alcoholism, cortisol therapy or gallstones. 
6 . METHODS USED TO STUDY UCT FORMALDEHYDE-TREATED XENOGRAFT 
PORCINE AORTIC VALVE BIOPROSTHESIS IN THE MITRAL POSITION, 
(see Chapter 9) 
Aortic valves were obtained from pigs aged 1 to 2 years 
and weighing between 150 and 300 kg. After trimming, the 
valves were mounted according to the method of Ionescu et 
al.(16), packed with cotton wool and immersed in 4% 
formol-saline (buffered at pH 5.6). Following implantation of 
a number of these locally prepared xenograft prostheses in 
patients, subsequent dysfunction led to a number of the valves 
being surgically removed 
pathological evaluation. 
and 11 were submitted for 
The 11 valves were submitted in 5% formaldehyde solution 
for pathological examination. Each valve, still mounted on its 
Dacron cloth-covered titanium ring, was examined with the 
naked eye for signs of thrombosis, rupture or incompetence. 
Any other abnormal feature was also noted. Sections taken from 
the centre of each of the 3 valve cusps were stained by the 
haematoxylin-eosin, alcian blue and elastic van Gieson 
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methods . A series of 14 control pig aortic valves were 
similarly examined nine of these valves had been 
frame-mounted and treated with formaldehyde in an identical 
manner to those used in the 11 patients . 
Transmission electron microscopy was performed on 
cuspidal tissue from two of the failed xenograft valves (cases 
2 and 10) and on three of the control valves. This was 
considered worthwhile in 





in the collagen , 
formaldehyde-fixed 
material . Blocks for electron microscopy , about 2mm thick , 
were cut from the valve cusps in such a fashion as to include 
the full thickness of the cusp. The blocks were post-fixed in 
osmic acid (Palade ' s fixative) for one hour , dehydrated in 
graded ethanols and embedded in Araldite. The blocks of 
embedded tissue were orientated for sectioning so that the 
fibrosa of each cusp was included in the section. Ultrathin 
sections were 
uranyl acetate. 
stained with Reynold ' s lead citrate and with 
7 • METHODS USED FOR THE EVALUATION OF HANCOCK AND 
CARPENTIER-EDWARDS BIOPROSTHESES , (see Chapters 10 and 11). 
The xenograft valves were examined and photographed in 
situ in the autopsied hearts , then excised and x-rayed for 
detection of calcification which might have not been 
recognized naked eye . Sections for light microscopy were taken 
from the mid-portion of each cusp from the free edge to the 
junction with the host tissue . Such sections were fixed in 5% 
buffered formaldehyde and processed in the routine manner. 
Sections were stained by the haematoxylin-eosin, elastic van 
Gieson, von Kossa , Martius scarlet blue and sulphated alcian 
blue methods . 
Tissue samples of the cusps taken for electron microscopy 
were treated in an identical manner to that described above 
for the formaldehyde-treated porcine xenograft aortic valve . 
48 
METHODOLOGY 
8. METHODS USED FOR THE EXPERIMENTAL EVALUATION OF THE 
MITROFLOW BOVINE PERICARDIAL XENOGRAFT HEART VALVE PROSTHESIS, 
(see Chapter 16). 
GROUPS OF BOVINE PERICARDIAL XENOGRAFT VALVES EVALUATED 
(i) ORIGINAL "PILOT PROCESS" : these 7 Mitroflow valves were 
prepared by a proprietary process of fixation, the details of 
which have not been divulged by Mitral Medical Inc. 
implanted in the mitral position. 
All were 
(ii) "PROCESS G" This process was based on a simple 
glutaraldehyde-fixation. No attempt was made to enhance the 
pericardial tissue for anticalcific or antithrombogenic 
characteristics. 
A. The pericardium was shipped to the manufacturing plant 
from the slaughterhouse either (a) dry on ice, or (b) in a 25 % 
isopropanol solution in phosphate buffered saline containing 
ethylene diamine tetra-acetic acid (EDTA). Option (b) attempts 
to minimize microbial growth and enzymatic degradation by 
micro-organisms or autolysis. Isopropanol dehydrates and 
stabilizes the tissue, but also dissolves lipids and may 
change the surface properties of the tissues. 
B. On arrival at the plant the tissue was washed in phosphate 
buffered saline (PBS) to remove blood and loose debris, and 
stored for time periods ranging from 40 - 96 hours. Some 
valves were washed with 25% isopropanol in PBS. (Isopropanol 
will continue to dissolve lipids, stabilize the tissue and 
have mild bacteriostatic properties, but autolysis is not 
inhibited). 
C. The tissue was cleaned down and stored in PBS, 25% 
i sopropanol in PBS or in PBS containing EDTA. The latter 
provides calcium chelating properties which will suppress both 
bacterial and autolytic enzyme degradation. 
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D. The valves were then assembled in the same types of 
solutions and fixation was carried out in 0 . 2% glutaraldehyde 
in PBS for 11 days or in 0 . 4% glutaraldehyde in 25% 
isopropanol in PBS for up to 21 days. 
E . Sterilization was carried out in 2% glutaraldehyde , 3% 
formaldehyde and 20% isopropanol in PBS at pH 5 . 7 for 48 
hours . 
F . The valves were packaged in 4% formaldehyde at pH 5 . 7 
(iii) " PROCESS F" This process of tissue fixation by 
glutaraldehyde relies on cross - linking of collagen molecules 
via the epsilon-amino groups of lysine after biological 
species designed to inhibit the calcification tendency have 
been attached through pendant carboxyl groups of aspartic and 
glutamic acid residues . 
A . The tissue was transported from the slaughterhouse to the 
plant and rinsed in 25% isopropanol in PBS within 6 hours of 
harvesting . Gross cleaning was performed in 25% isopropanol in 
PBS and the final clean down and storage was carried out in 
PBS containing EDTA . 
B . Valve assembly was carried out in PBS containing EDTA . 
C . The development of anti-calcification properties was 
attempted as follows : firstly the tissue was infiltrated with 
1 : 6 diaminohexane in PBS in order to increase the 
concentration of primary amino groups within the tissue 
matrix . Secondly, the tissue containing the proposed increased 
concentration of primary amino groups was equilibrated with 1% 
chondroitin-6-sulphate in PBS at 4 degrees Centigrade and pH 
7 . 4 overnight . l-ethyl-3-(3-dimethylamino propyl) carbodiimide 
was used to couple the chondroitin sulphate through its 
carboxyl groups to the primary amino groups of the modified 
collagen . This should produce a more hydrophilic surface 
containing sulphate groups , which in themselves may reduce 
protein adsorption and therefore lower the thrombogenic and 
calcification tendencies of the xenograft . 
D. The valve was stored in PBS containing EDTA and 
so 
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sterilization consisted of 48 hours treatment in 2% 
glutaraldehyde, 
pH 7 . 4. 
3% formaldehyde and 20% isopropanol in PBS at 
E. The valve prosthesis was packaged and shipped in 4% 
formaldehyde in sodium acetate/acetic acid buffer at pH 5 . 6. 
(iv) " PRE-HUMAN PROCESS " : No details are available regarding 
this latest method of preparation of the Mitroflow valve 
prosthesis . All of the Mitroflow valves in this series, apart 
from one valve in this group , were implanted in the mitral 
position - the one exception being a tricuspid implant. 
(v) CONTROL XENOGRAFT VALVULAR PROSTHESES : Four commercially 
available Ionescu - Shiley pericardial heart valves were 
implanted in baboons as controls. Three were placed in the 
mitral position and one in the tricuspid position. 
OPERATIVE TECHNIQUE 
Thirty-five Mitroflow (Mitroflow Medical Inc . ) bovine 
pericardial heart valve prostheses were implanted in Chacma 
baboons between October 1980 and July 1982 by Dr J. Hassoulas 
of the Department of Cardiac Surgery , Groote Schuur Hospital 
and University of Cape Town . All , apart from one tricuspid 
implant , were inserted in the mitral position . The Mitroflow 
valves used all had a diameter of 21 mm . A further four ( size 
19 mm ) Ionescu-Shiley pericardial xenograft cardiac valve 
prostheses (Shiley Laboratories Inc . ) were implanted as 
controls , 3 in the mitral position and 1 in the tricuspid 
position . 
The Chacma baboons which received the implanted valves 
had a mean body weight of 21.9 Kg (S.D.= 5 . 7) with a range of 
15 to 32 Kg . Standard cardiopulmonary bypass techniques were 
used with cardioplegic myocardial protection and the body 
temperature was reduced to 28 degrees Centigrade . The mitral 
valve was approached through the usual left atrial incision on 
the right heart border . In order to augment the strength of 
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the normal mitral valve for suturing, substantial leaflet 
tissue was left behind. Sutures were arranged in an 
interrupted fashion and as a figure-of-eight. The test and 
control valves were all inserted in a similar fashion. Once 
bypass had been discontinued, and there was haemodynamic 
stability, a left atrial and left ventricular apex infusion 
catheter were inserted for pressure measurements. These 
catheters were connected to Statham P23H pressure transducers, 
the left atrial and left ventricular pressures were recorded, 
and the transvalvular gradient was calculated. 
Post-operatively the animals were carefully monitored and 
were eventually sacrificed selectively at pre-determined time 
intervals. Left and right heart catheterizations were 
performed immediately prior to sacrifice in all animals and 
some animals were also catheterized earlier during the 
post-operative survival period. 
catheterization a 7F thromodilution 
For the pre-sacrificial 
cardiac output catheter 
(American Edwards Laboratories) was inserted and cardiac 
output was estimated using a model 9510 American Edwards 
cardiac output computer. Left ventricular pressure 
measurements were obtained via a small infusion catheter 
inserted into the left ventricle through a small stab wound 
and connected to a P23H Statham pressure transducer. These 
measurements, together with the wedge pressure, were used to 
calculate the pre-sacrifice trans-valvular gradient. The 
percentage reduction in the valve orifice area was also 
calculated. The animals were heparinised prior to sacrifice. 
The heart and lungs were removed en-bloc for histopathological 
examination and the abdominal organs were examined grossly for 
signs of passive congestion or infarction. 
PATHOLOGY 
MACROSCOPICAL EXAMINATION 
On receipt in the Department of Pathology, the fresh 
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heart and lungs of each animal were examined macroscopically. 
The heart and lungs were separated and the heart was opened in 
the routine manner following the course of the blood flow 
within the heart. The interior of the heart was washed gently 
in fresh water and the implanted heart valve was photographed 
in situ. The first 4 Mitroflow valves examined were also 
x-rayed to make sure that one was not missing minute amounts 
of calcification not detected naked eye or histologically. All 
of these x-rayed valves were negative for calcification. Each 
prosthetic valve was excised including a rim of surrounding 
host tissue. 
LIGHT MICROSCOPICAL EXAMINATION 
A section was taken from the mid-portion of each valve 
cusp showing any naked eye abnormality. The section extended 
from the free margin to the base and included the junction 
with the host tissue. Since I had been requested to leave the 
prosthesis as intact as possible for re-examination by Mitral 
Medical Inc., in instances where the cusps looked normal, only 
one cusp was sampled. The valve samples, together with 
sections of lung and of other organs, were fixed in 5% 
buffered formaldehyde and processed in the routine manner for 
paraffin-embedded histological sections. The latter were 
stained by the haematoxylin-eosin, 
Martius scarlet blue methods. 
TRANSMISSION ELECTRON MICROSCOPY 
elastic van Gieson and 
Tissue samples of the cusps taken for electron microscopy 
were treated in an identical manner to that described above 
for the formaldehyde-treated porcine xenograft aortic valve. 
Two Mitroflow valves of the pilot series, 1 of the "F" 
process, 2 of the pre-human and 1 Ionescu-Shiley control valve 
were examined ultrastructurally. The duration of implantation 
of these valves are indicated in Table 16.4 of Chapter 16. 
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SCANNING ELECTRON MICROSCOPY 
Scanning elec tr-on microscopy was performed upon 3 
Mi tr of low valves derived from the "pilot", "F" process and 
"pre-human" series - the valves having been implanted for 
periods of 6 ' 36 and 122 days respectively. Samples of the 
valve cusps of these 3 valves, which were taken from areas 
devoid of thrombi, were freeze dried and then coated with 
evaporated carbon and evaporated gold. The surface examined 
was the contact surface of the cusps, which is the portion of 
the bovine pericardium, which has been trimmed of 
fibroadipose tissue during manufacture. 
9. CONTROL PATIENTS (See too Appendix, page 627). 
attached 
Control patients were studied in an identical manner to 
the patients with implanted cardiac valvular prostheses. 
A. ORGAN INFARCTS 
One hundred and three autopsy patients with significant 
valvular heart disease, excluding patients with infective 
endocarditis, served as controls for studying the distribution 
of organ infarcts due to thromboembolism. Eighty-seven percent 
had a rheumatic aetiology for the valvular disease. Mitral 
valvular disease was the dominant lesion in 60 patients and 
aortic valvular disease was present in 43. 
B. CONDUCTING TISSUES 
Fourteen routine autopsy control patients, who had died 
of a variety of diseases e.g., carcinoma, pneumonia and 




C. RENAL HAEMOSIDEROSIS 
Two groups of control patients were studied. Firstly, 
there were 32 patients with advanced chronic rheumatic-type 
valvular deformities, most of whom had died in congestive 
heart failure. Secondly, 21 consecutive routine autopsies were 
studied. 
D. SMALL CORONARY ARTERY DISEASE 
Three control groups of patients were evaluated. Thirteen 
patients with floridly active granulomatous phase Aschoff 
bodies comprised the first group ; 26 patients with healed 
rheumatic fever (no Aschoff bodies) formed the second group. 
The latter patients all had well documented histories of 
repeated attacks of acute rheumatic fever and also had severe 
mitral stenosis at autopsy. Twenty routine autopsy patients 
formed the third group. 
E. MYOCARDIAL NECROSIS AND FIBROSIS 
Eighty-five autopsy patients with uncorrected valvular 
heart disease which had led directly to the death of the 
patient served as controls for evaluation of the ventricular 
myocardium in patients with valvular prostheses. Thirty-one 
patients had mitral valvular disease and the other 54 had 
aortic valvular disease. 
F. PANCREATIC FIBROSIS 
Twenty consecutive routine autopsy patients served as 
controls, excuding patients with chronic excessive ethanol 
ingestion, gallstones or idiopathic chronic pancreatitis. 
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10 . CONTROL ANIMAL TISSUE 
A. FORMALDEHYDE-TREATED PORCINE AORTIC XENOGRAFT VALVES 
Fourteen aortic valves from adult Landrace pigs were used 
as controls. Five aortic valves were obtained freshly from the 
abbatoir and fixed promptly in 5% buffered formaldehyde 
solution . Nine valves had been frame-mounted and treated with 
formaldehyde in an identical manner to the 11 test valves that 
had been implanted in human patients . 
B . IONESCU-SHILEY BIOPROSTHESES 
Four commercially available Ionescu-Shiley bovine 
pericardial heart valves were implanted into baboons as 
controls for assessment of the Mitroflow bovine pericardial 
heart valve . 
11. STATISTICAL METHODS . 
The Chi-square evaluation was performed upon data 
obtained by morphological assessment (using a 
semi-quantitative scoring system) of various forms of 
myocardial necrosis and fibrosis . The t statistic for two 
means (null 
difference 
hypothesis) was used to test for a significant 
between values obtained by morphometry 
(point-counting) of the fibrous tissue component of the 
myocardium and for differences in heart weights. Actuarial 
methods described by Anderson et al.(6) were used to analyse 
the survival rates and thromboembolic 
patients with implanted valvular prostheses . 
complications of 
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HISTORICAL ASPECTS OF CARDIAC VALVE REPLACEMENT 
INTRODUCTION 
An old platitude about the growth of surgery(l) suggests 
that in each decade since 1870 surgical advances have occurred 
in the form of a steady march as some new area of the body was 
opened to surgical correction. However, cardiac surgery 
differs it has undergone a convulsive and revolutionary 
advance about once every 5 years. Each advance is associated 
with the names of one or two individuals : constrictive 
pericarditis (Churchill in 1933), the patent ductus arteriosus 
(Gross in 1938)(2), closed mitral repair (Harken in 1948), the 
pump oxygenator (Gibbon in 1953)(3), valve prostheses 
(Hufnagel 1952 Harken and Starr,1958), reconstruction of the 
congenitally malformed heart (Kirklin,1963), cardiac 
transplantation (Barnard,1967), and saphenous vein bypass 
grafting of coronary arteries (Favoloro,1970). In this review 
I shall focus on the principal historical landmarks in the 
history of surgical replacement of diseased heart valves. 
The chief landmarks in the history of heart valve 
replacement will be dealt with under the following headings : 
(i) general historical landmarks (ii) indirect surgical 
techniques for mitral stenosis culminating in closed direct 
surgery for mitral stenosis in 1949 (iii) closed heart 
procedures for mitral regurgitation and (iv) closed heart 
procedures for aortic stenosis and incompetence. (v) The 
introduction of cardiopulmonary bypass by Gibbon in 1953 
ushered in the era of open heart valve repair for mitral and 
aortic valvular disease(3). Partial replacement of the mitral 
valve with immobile and mobile prostheses, mono- and 
multicuspid valves as well as valves with artificial chordae 
tendineae were superceded by the successful insertion of a 
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ball-valve prosthesis b y Starr in the mitral position about 
two decades ago . Earlier in the same year (1960) , Harken had 
been the first to successfully replace a diseased aortic valve 
with a caged-ball prosthesis . 
l . GENERAL HISTORICAL ASPECTS(4-9) : 
The pathology of mitral stenosis was first described by 
Raymond Vieussens at Montpelier in 1715 in a textbook entitled 
" Traite nouveau de la structure et des causes du mouvement 
naturel du coeur ". In 1882 , Block sutured cardiac wounds in 
experimental animals . However , cardiac surgery had an uphill 
battle against the dogma of the day . In 1893 Billroth(lO) 
stated that " Any surgeon who would attempt an operation on the 
heart should lose the respect of his colleagues ." Paget (1896) 
wrote that " the surgery of the heart has probably reached the 
limits set by nature to all surgery ." 
Undeterred by this , Rehn repaired a right ventricular 
stab wound in 1896. In 1898, Samways proposed the surgical 
relief of mitral stenosis. In 1902, Brunton opened stenosed 
mitral valves in cadavers and operated on the normal mitral 
valve of dead cats using a transventricular tenotomy knife . In 
the same year Sauerbruch and Meyer used pressure chambers to 
overcome the problem of surgically induced pneumothorax . In 
1908 , Cushing and Branch unsuccessfully operated on a dog with 
mitral stenosis. This is the first recorded operation for 
acquired mitral valve disease . In 1909 Meltzer and Auer 
introduced an endotracheal tube which simplified gas 
anaesthesia for thoracic surgery . In 1910, Carrel suggested 
that a finger may be used to dilate a stenosed mitral valve. 
Prior to this the use of instruments had always been stressed. 
Carrel , who was awarded the 1912 Nobel Prize for Physiology 
and Medicine for his accomplishments in the new field of 
cardiovascular surgery, had perfected the basic techniques of 
vascular anastomoses and patch graft angioplasty on the canine 
thoracic aorta. Using 2-3 minutes of ischaemic cardiac arrest , 
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he had subsequently either cauterized the aortic valve , 
sutured pulmonary valve leaflets , patched the right 
ventricular outflow tract , or positioned a graft between the 
cardiac apex and the descending thoracic aorta . 
In 1913 Doyen attempted the first operation on a human 
cardiac valve. The patient died early post-operatively and 
autopsy revealed muscular 
valvular stenosis . Tuffier 
subpulmonary stenosis rather than 
performed the first successful 
operation on a human heart valve in 1914 using a finger to 
invaginate the ascending aorta and to dilate a stenotic aortic 
valve . 
Important advances also occurred in the ancillary services 
In 1929 , Forssmann(ll) performed the first documented human 
cardiac catheterization (on his own heart) . Thereafter, 
Cournand(l2) and Richards(l3) propagated the use of this new 
technique in the study of patients with congestive heart 
failure . These three men were awarded the Nobel Prize for 
Medicine in 1956 for this work. However,Bleichroeder(l4) had 
performed the same experiment as Forssmann as early as 1912 at 
a time when no radiological assistance was available. Although 
this work was acknowledged by Forssmann in an addendum to his 
publication, the courageous achievement of Bleichroeder has 
been largely ignored . In 1933, Charles and Scott(lS) purified 
heparin so that it could be used clinically for 
anticoagulation e . g . , for extracorporeal circulation. The 
first blood bank was established by Fantus(l6) in the United 
States of America in 1937 . 
MITRAL STENOSIS . 
CLOSED HEART PROCEDURES FOR MITRAL STENOSIS 
In 1922 , Allen and Graham(l7) employed a cardioscope to 
inspect the mitral valve. In 1923 , Cutler(l8) performed the 
first successful operation for mitral stenosis using tenotome 
knives and a cardiovalvulotome inserted through the left 
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ventricular apex. Mitral regurgitation was a serious 
complication of this procedure. In 1925 Souttar performed the 
second successful operation for mitral stenosis using a 
transatrial approach(l9). He was able to detect severe mitral 
incompetence and dilated the orifice with his right index 
finger, rather than magnifying the incompetence by cutting 
into the valve. His patient was the first to have a successful 
result from such an operation. During the period 1930 to 1945, 
cardiac valve surgery was in the doldrums due to the initially 
poor results. Thirty years later one of Cutler's co-workers Dr 
C.S.Beck(20) said of the cardiovalvulotome which he had helped 
to develop : "The creation of this instrument probably delayed 
the development of the operation for mitral stenosis by some 
twenty years." Powers(21-23) documented the serious 
consequences of producing mitral insufficiency when operating 
for mitral stenosis. His work on dogs was performed at the 
Peter Bent Brigham Hospital where Cutler had earlier done his 
pioneering efforts. Unfortunately no successful operation was 
developed. 
INDIRECT SURGICAL TECHNIQUES FOR MITRAL STENOSIS 
Attempts to relieve the symptoms of mitral stenosis other 
than by valve directed surgery had been suggested as early as 
1913 by Jeger, who proposed inserting a valved vein between a 
pulmonary vein and the left ventricle to decompress the left 
atrium. Litwak created such a graft in a dog, but the graft 
thrombosed. No such attempt was made in humans. In 1913, 
Schepelmann linked the two atrial appendages of a rabbit with 
an aortic graft. In 1926 Dmitrieff perforated the atrial 
septum both via the jugular veins and at thoracotomy. Such a 
procedure was performed by Harken et al. in 1948(24) and by 
Bailey(25) in the following year, but later the efficacy of 
the operation was questioned(26). Similar results were 
achieved by Sweet(27) and d'Allaines(28) in man by 
anastomosing a branch of a pulmonary vein to the azygous vein. 
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Tricuspid valvulotomy was proposed by Cossio and Perianes(29) 
as a palliation for mitral stenosis . 
THE MODERN ERA 1949 ONWARDS 
The current era of 
Bailey(25), Harken(24) 
valve surgery began in 1949 when 
and Brock(4,30), all working 
independently, first successfully repaired stenotic mitral 
valves . Bailey(25) performed a successful mitral 
commissurotomy using digital palpation to guide the ensheathed 
mitral valve cutting blade . Murray excised portion of the 
posterior mitral leaflet and reduced incompetence by placing 
an everted vein graft containing palmaris longus tendon across 
the left ventricular cavity so that it occluded the mitral 
valve orifice during ventricular systole. Harken(24) performed 
a similar operation 6 days after Bailey using a valvulotome to 
cut the fused commissures. Only a few months after the 
successful operations of Bailey and Harken, Brock(30) 
performed finger fracture of a stenotic mitral valve using 
experience gained with successful operations for pulmonary 
stenosis . (Sellors(31) and Brock(32) had divided the stenosed 
pulmonary valve with an instrument introduced through a small 
incision in the right ventricle). 
Between 1950 and 1955 several hundred successful 
commissurotomies were performed world-wide . 
mitral 
Further 
refinements in technique,improved patient selection and 
preparation, plus improved post-operative care followed 
thereafter . In 1954, Dubost et al.(33) described a transatrial 
mechanical dilator for correcting mitral stenosis . By 1962 he 
had achieved several hundred valvulotomies with only a 2% 
mortality rate(34). In 1959 , Logan and Turner(35) described 
their results with the mechanical dilator using a 
transventricular approach . Initially they had used a dilator 
devised locally by Dr M.Brown, but later Dubost ' s instrument 
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became available. The dilator first used had a maximum spread 
of 3 . 5 cm and this was often too small to fully open both 
commissures . An ideal spread of 5 cm was provided by the 
instrument later designed for them by Mr O . S . Tubbs(35,36). In 
time the Tubbs' dilator became widely used world-wide . 
MITRAL INCOMPETENCE 
Although many of the experimental studies on the mitral 
valve involved the production of mitral insufficiency , the 
concept of the surgical relief of this lesion was slow in 
developing(9) . For many years surgeons erroneously believed 
that mitral incompetence was not a significant lesion and that 
it had little effect on the heart . In 1910 , Carrel(37) tried 
to relieve mitral incompetence in dogs by producing a slight 
stenosis of the upper part of the left ventricle by resecting 
part of the mural muscle. 
CLOSED HEART PROCEDURES FOR MITRAL REGURGITATION 
These took the form of blindly inserting autogenous or 
plastic materials to support or augment the posterior mitral 
leaflet , or of using a circumferential suture to narrow the 
mitral valve ring. In 1949 Templeton and Gibbon(38) reported 
cardiac valve reconstruction by venous and pericardial grafts. 
Atrium was also used later by others for such 
"trans-ventricular tamponage" . Bailey et al ' s(39) 
"commissurorrhaphy" operation involved suturing the valve 
leaflets together using strips of pericardium . During the 
1950s a variety of plastic materials of various sizes and 
shapes were used to support or augment the posterior mitral 
leaflet e . g., methyl methacrylate (Lucite(40,41) , 
Plexiglas(42)) and polyvinyl formalinized plastic 
(Ivalon(43,44)). This technique was used clinically for mitral 
incompetence in the early years of open heart surgery . In 
1955, Jordan and Wible(45) sited a nylon leaflet mounted on an 
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Elgiloy spring frame below the mitral valve to prevent mitral 
regurgitation. 
Between 1955 and 1957 , Kay and Cross(46) and Nichols(47) 
obtained palliative results using a closed-heart version of 
what later was called posteromedial annuloplasty(4) . In 1958 
Davila et al . (48) described a technique of external 
circumferential suture (using umbilical tape) of the mitral 
valve ring to correct incompetence. Unfortunately the 
operation was followed by a high rate of recurrence of the 
regurgitation . All of the closed techniques for the correction 
of mitral incompetence were unsatisfactory and no further 
surgical advances were made until bloodless field mitral valve 
surgery became possible. 
CLOSED HEART PROCEDURES FOR AORTIC STENOSIS AND REGURGITATION 
In 1948, Smithy et al . (49) devised a method of performing 
transaortic and transventricular aortic valvotomy in 
experimental animals. In 1950 , Bailey et al . (50) reported 
their results with retrograde aortic valve incision and 
dilatation . This approach was abandoned due to arterial 
dissections and the development of aortic incompetence . A 
transventricular approach yielded better results(51) . 
Enormous strides towards the advent of valvular surgery 
were made in the 1950s . Bailey and Likoff(52) and Taylor et 
al.(53) unsuccessfully tried to alleviate aortic incompetence 
by tying a suture around the base of the aorta to narrow the 
aortic ring. Campbell(54) and Hufnagel(55) independently 
designed artificial heart valves composed of a mobile, 
spherical poppet within a Lucite tube using the caged-ball 
principle devised by Williams(56) in his bottle stopper patent 
of 1858. Campbell and Hufnagel initially tested their 
prostheses in the descending thoracic aorta of dogs . On 
September 1 1 , 1952 Hufnagel (57) ushered in the era of 
prosthetic valve surgery by successfully inserting his 
caged-ball valve into the descending thoracic aorta of a 
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patient suffering from severe aortic incompetence. 
In 1953 Gibbon(58) dramatically anounced 








in humans . 
with the 
This , together with 
caged-ball aortic 
the stage for future surgical attempts to 
replace diseased heart valves with artificial substitutes . In 
the succeeding ten years more advances took place in this type 
of surgery than had occurred throughout the preceding 
centuries . 
The provision of a pump to take on the function of the 
heart was relatively simple compared to the problems faced in 
developing an artificial lung. The artificial lung developed 
by Gibbons was subsequently incorporated into the Gibbons-Mayo 
pump . Lillehei and colleagues(59) in Minnesota initially made 
use of a human donor to supply oxygenated blood in 30 patients 
with complicated congenital heart lesions and later developed 
their bubble oxygenator . Melrose(60) published details of his 
heart-lung apparatus. Later , following a fruitful 
collaboration with Gerbode(61) , his machine gained worldwide 
acceptance. Modifications and refinements of the heart-lung 
machine continued to be made during the 1960s and 1970s and 
the next major step was the development of the membrane 
oxygenator . 
OPEN HEART VALVE REPAIR PROCEDURES 
As a result of the above two major milestones , surgeons 
were stimulated to try and correct valvular lesions by 
directing their attentions to the abnormal valves themselves , 
particularly the aortic valve(62-64) . 
OPEN HEART SURGERY FOR MITRAL VALVE DISEASE 
Between 1956 and 1968 the heart-lung bypass machine was 
used initially for operative correction of congenital valvular 
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diseases(4) , but later it was also used for acquired valvular 
diseases(65-72) . Lillehei and the Minnesota group at first 
performed paediatric intracardiac surgery using another person 
as an oxygenator (controlled cross-circulation) . The De 
Wall-Lillehei bubble oxygenator , which was introduced later , 
was simple to use ; it was also cheap and disposable , but 
perfusion rates were slow . The perfusion equipment which has 
now superceded it is simpler and more reliable and these 
membrane oxygenators have faster perfusion rates. The first 
successful open heart operation for acquired mitral valve 
disease was performed on 29th August , 1956 at the University of 
Minnesota by Dr C . Walton Lillehei(66) . 
MITRAL STENOSIS 
Open heart surgery for mitral stenosis was used to break 
down fused commissures or to remove calcium from the edges of 
the valve. Because the site of commissural fusion was often 
difficult to localize, some surgeons still used a dilator . 
However , direct vision was of great assistance in surgical 
correction of areas of subvalvular fusion(9) . In recent years 
there has been a swing towards doing open mitral valvotomies 
in all patients with significant mitral stenosis(73 , 74). 
MITRAL INCOMPETENCE 
Numerous open reconstructive techniques have been 
attempted in order to correct the regurgitant mitral valve . 
These include : (a) repair by direct suture of cuspidal tears 
or perforations due to infective endocarditis(75,76) , 
trauma(77) e . g. , after mitral commissurotomy for rheumatic 
fever(9) . (b) Increasing the surface area of the deficient 
leaflet : Nichols et al.(68) inserted an elliptical segment of 
compressed polyvinyl sponge between the annulus and the 
leaflet . Sauvage and Wood(78) sutured patches within shrunken 
leaflets to augment the surface area. Associated chordal 
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abnormalities frequently limited the operative results . (c) 
Repair of ruptured chordae tendineae , (which are encountered 
in about 20% of patients with pure mitral incompetence(79)) , 
was attempted by immobilizing the flail area(80) , resuturing 
chordae to the papillary muscle(68) , plicating the ruptured 
leaflet(81) with posteromedial annuloplasty(82), or 
constructing artificial chordae of silk(83) , Dacron(84) or 
Teflon(85) . (d) Narrowing the mitral annulus increases the 
area of cuspidal apposition and this operation had been 
earlier performed as a closed procedure. 
Lillehei et al . (66) were the first to perform mitral 
annuloplasty under direct vision. Heavy through-and-through 
silk sutures were placed 
commissures . According 
procedures helped 50% of 
in the mitral ring at one or both 
to Lefrak and Starr(4) annuloplasty 
patients with moderate or severe 
isolated mitral regurgitation , especially those with ring 
dilatation , but it was less successful if the cusps were 
severely fibrosed or shrunken. Poor results(83,86 , 87) were 
obtained using artificial chordae prepared from silk, Teflon 
or Dacron fibre , but McGoon's plication procedure gave better 
results(81) . Later failures led to technical modifications 
such as using Ivalon or Teflon to buttress the sutures and 
prevent them cutting through the tissues(70,88) . However , the 
annuloplasty technique(9) that has provided the best long - term 
results is postero-medial annuloplasty or modifications 
thereof(71) . The procedure achieves mitral annular narrowing 
at the expense of the posterior leaflet and there is little 
danger of disruption of the sutures which are placed in the 
tough, fibrous mitral ring. 
REPLACEMENT OF THE MITRAL VALVE WITH A PROSTHESIS 
Unfortunately, the above described reconstructive 
techniques were not applicable to most rheumatic patients with 
calcified , immobile , stenotic and incompetent mitral valves . 
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(A) PARTIAL REPLACEMENT OF THE MITRAL VALVE WITH AN IMMOBILE 
PROSTHESIS 
This technique was only applicable to those patients whose 
mitral incompetence was due to a shrunken, immobile posterior 
leaflet , with the anterior leaflet remaining pliable and 
mobile . Gott et al . (89) sutured a cylinder of compressed 
Ivalon underneath the leading edge of the posterior leaflet . 
Barnard and Schrire(90,91) described how an immobile Ivalon 
baffle (Figures 1 . 1 and 1 . 2) could be sutured so as to augment 
a shrunken posterior mitral valve leaflet. During left 
ventricular systole the anterior leaflet closes against the 
baffle. Barnard(91) sutured a cylindrical piece of compressed 
Ivalon on the ventricular surface of the posterolateral part 
of the mitral ring in four patients. In another 12 patients a 
spindle-shaped piece of compressed Ivalon was attached to the 
non-ventricular surface of the valve . Infection was a 
significant complication in some of these patients(91). This 
operation(66) and related variants thereof(85,92 , 93) gave poor 
late results due to infection, mitral stenosis and emboli . 
Mitral valve replacement superceded this operation . 
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Figure 1.1 Ivalon sponge prosthesis compensates for 
deficient posterior mitral valve leaflet. 
Figure 1.2 Bisected Ivalon sponge prosthesis and posterior 
mitral leaflet are viewed in profile. 
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(B) PARTIAL REPLACEMENT OF THE MITRAL VALVE WITH A MOBILE 
PROSTHESIS 
Partial replacement of the mitral valve with a mobile 
prosthesis was attempted in order to try and avoid the mitral 
stenosis which complicated partial replacement of the valve 
with an immobile prosthesis . Silicone rubber (Silastic) 
leaflets, Silastic-covered Teflon leaflets with attached 
chordae tendineae and knitted Teflon leaflets with chordal 
extensions were unsuccessfully tested in animals and were not 
used in humans(9) . Techniques used clinically included 
replacement of the posterior mitral leaflet with knitted 
Dacron(94) or the use of autologous pericardial leaflets for 
the same purpose(95 , 96). 
(C) TOTAL REPLACEMENT OF THE MITRAL VALVE WITH A PROSTHESIS 
EXPERIMENTAL RESULTS 
Experimental mitral valve replacement in the dog yielded 
disappointing results(9) due to problems with perfusion, 
operative techniques , poor valve design and inappropriate 
selection of synthetic materials . Thromboembolism was a major 
problem . A variety of MONOCUSPID FLAP VALVES were evaluated 
including some made of stainless steel(97) a flexible 
monocusp Mylar valve with multiple hinges(98) , and a Silastic 
valve(99) . Similarly poor results were achieved with 
MULTICUSPID PROSTHETIC MITRAL VALVES made from Silastic(lOO) , 
Teflon(lOl) or from polyurethrane(l02) . In order 
overcome these poor results , PROSTHESES WITH 
to try and 
ARTIFICIAL 
CHORDAE TENDINEAE were fashioned which aimed to mimic the 
normal mitral valve . Such prostheses , made from polyurethrane 
reinforced with Dacron(l03) , Dacron mesh infiltrated with 




The first experimentally successful prosthetic BALL VALVE 
had a Lucite ball and a base made of Teflon(9). Despite 
survivals of up to 6 months, thrombosis and poor mechanical 
fixation were major problems . Ball valves were also 
constructed entirely of Lucite(l06) , Ivalon(l07) or of 
steel(l08). Starr(l09 , 110) tried out many materials before 
selecting a prosthesis having a Silastic ball contained within 
a Lucite cage. A Silastic shield placed over the intracardiac 
sutures reduced the frequency of thrombosis(lll) . Cartwright 
et al . (112) used a double-caged valve made of titanium and 
Silastic . 
CLINICAL RESULTS(ll2-114) 
MONOCUSPID VALVES : Ellis(ll6) used a monocuspid valve made of 
laminated Mylar covered with knitted Teflon . While the early 
results with this valve and its modifications were good, its 
use was discontinued due to late valve dysfunction. Malowney 
and Paton(99) used a monocuspid prosthesis made of Silastic . 
MULTICUSPID VALVES : Silastic bicuspid valves were utilized by 
Long et al.(116) and by Young et al . (117). The latter 
prosthesis , which was more successful, had two flexible 
leaflets made of a silicone-coated Dacron fabric enclosed in a 
Lexan housing, which had an antithrombogenic covering layer. 
VALVES WITH ARTIFICIAL CHORDAE TENDINEAE A moulded 
polyurethrane valve with Teflon chordae tendineae was inserted 
into the mitral area of five patients(l03) . There were three 
operative deaths and the other patients survived 14 hours and 
3 months respectively . 
BALL VALVES : The introduction of the ball-valve prosthesis 
into clinical surgery by Starr(ll8) represents the greatest 
major recent advance in surgery for acquired valvular 
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disease(9). An early model of the Starr-Edwards prosthesis had 
a Silastic ball contained within a rigid cage made of 
Stellite 21 (Vitallium) and attached to a Teflon fabric sewing 
ring . In recent years a number of modifications have been 
made, mainly to try and obviate cloth wear . This aspect will 
be dealt with later in Chapter 2 . 
OPEN HEART PROCEDURES FOR AORTIC VALVE DISEASE 
In 1956 Murray(62) reported the use of homograft aortic 
valve segments in the descending thoracic aorta . However, the 
incomplete relief obtained by using the Hufnagel valve in the 
descending 
the aortic 
thoracic aorta led cardiac surgeons to operate on 
valve itself . In 1958 , Lillehei et al . (119) 
performed one of the first human cardiac valve replacements 
ever performed when they implanted a bicuspid silicone rubber 
flap-valve device in the sub-coronary position of a 
56-year-old woman . The patient did well for 6 years before 
malfunction neccessitated replacement of the prosthesis . In 
1959 , Garamella et al . (120) , Baird et al . (121) as well as 
Bailey and Zimmerman(63) treated aortic insufficiency by 
converting the tricuspid aortic valve into a bicuspid valve by 
excising or plicating the non-coronary cusp . This effectively 
narrowed the aortic valve ring. Attempts were also made to 
create a flap valve from the aortic wall just above the 
incompetent aortic valve . Others(64 , 122) sutured Ivalon to the 
free edge of one of the aortic cusps. In 1967 , Hurley et 
al . (123) recommended open debridement of calcified material , 
plus commissurotomy for aortic stenosis . However, restenosis 
frequently occurred and many valves were too contracted and 
calcified to obtain significant haemodynamic improvement(4) . 
Following his work with a design engineer called 
W.C . Birtwell , Harken in 1960 was the first to successfully 
replace a diseased aortic valve with a prosthetic caged-ball 
valve in the natural position(65). He reported the survival of 
2 out of seven patients with ball valves inserted in the 
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sub-coronary position for aortic incompetence. (In September 
of the same year Starr(ll8) accomplished a similar feat in a 
patient with mitral valve disease). Despite the encouraging 
initial results in dogs(l24), the early caged-ball valves had 
a high incidence of thromboembolism ; they were noisy the 
silicone rubber balls were subject to deterioration, and there 
were high rates of paravalvular leakage and infection. 
Alterations in design were soon introduced. After the first 









thousands of Starr-Edwards 
world-wide(9,125-129). The 
modern era of surgical replacement of diseased heart valves 
began at that time. The overall results were good and 
clinicians were able for the first time to compare the natural 
history of valvular heart disease with the effect of 
correcting an obstructed or leaking heart valve. Furthermore, 
a major advance in the understanding of valvular heart disease 
was achieved now that it was possible to 
dysfunction from myocardial disability(4). 
separate valvular 
THE EVOLUTION OF CARDIAC SURGERY IN CAPE TOWN. 
In 1942, Professor C.F.M. Saint, who was Professor of 
surgery at the University of Cape Town, ligated the patent 
ductus arteriosus in several patients. In 1949, Dr Walter 
L.Phillips was appointed to the newly created post of honorary 
thoracic surgeon at the Groote Schuur Hospital in Cape 
Town(l30). Thoracic surgery was still in its infancy and his 
work consisted mainly of pulmonary surgery, ligation of a 
patent ductus arteriosus, excision of aortic coarctation and 
pericardiectomies. Later, Dr Phillips performed some of the 
first closed mitral valvotomies done in Cape Town. 
However, many years were to pass before open-heart surgery 
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Town. Following a period of 
in America , Dr Christiaan N. 
was to be performed in Cape 
training in cardiac surgery 
Barnard returned to Groote 
Surgery bringing with him a 
knowledge of how to use it 
Schuur Hospital's Department of 
heart-lung machine and the 
safely . The first open-heart 
operation on the African continent was performed at Groote 
Schuur Hospital on July 28th , 1958 by Drs Phillips and Barnard 
with Dr J.Ozinsky as the anaesthetist(l31) . The patient was a 
15-year-old girl suffering from pulmonary valve stenosis. 
Dr R.P . Hewitson acted as interim head of the Department 
of Cardio-Thoracic Surgery. Dr Barnard succeeded Dr Phillips 
as head of the Cardiothoracic Department . Supported by the 
excellent Cardiac Clinic built up by the late Professor Velva 
Schrire , an open-heart surgical unit of international standing 
was created . Valuable support was also provided to this end by 
such ancillary services as the Blood Transfusion Service, and 
the Departments of Chemical Pathology and Bacteriology . Once 
the cardiac surgical unit had been fully established , Dr 
Barnard was responsible for the development of several 
innovative surgical techniques(l31) including e.g ., a 
precursor of what is today known as the Mustard operation 
and the insertion of a tricuspid valve prosthesis to treat 
Ebstein's anomaly. 
By 1962 , (the same year that the Starr-Edwards caged-ball 
valve was introduced) , the Cape Town cardiac surgical team had 
designed and produced a plastic tethered-plunger prosthetic 
heart valve , later known as the University of Cape Town 
(U.C.T . ) prosthesis(l32 , 133) . Barnard and co-workers decided 
to eliminate a cage in their prosthetic design since they 
believed it could impinge on the ventricular wall and cause 
fatal arrhythmias . Problems with thromboembolism later led to 




From the chance stabbing of an Austrian labourer, which 
led Rehn to show that sutures could be placed in the living 
heart, to the modern speciality which can treat a wide range 
of cardiac disease is a germination without parallel in 
surgery. However, Moore(l) points out that despite the many 
achievements, the heart remains a central organ, acute 
post-operative disorders are poorly tolerated, and the 
mortality remains high in several types of cardiac operation. 
The patient pays a severe price for any technical error, be it 
valvular insufficiency due to failure of a single suture, 
hemiparesis due to dislodgement of a small thrombus, or a 
lethal arrhythmia from a poorly placed suture in the bundle of 
His. Like intra-cranial surgery, cardiac surgery has but a 
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CHAPTER 2 . 
DATA ON VARIOUS TYPES OF HEART VALVE PROSTHESES 
DESIGN CRITERIA FOR PROSTHETIC HEART VALVES(l , 2) 
For satisfactory long-term function in man , a prosthetic 
heart valve must fulfill numerous design criteria : 
(i) It must be chemically inert and be compatible with human 
tissues . There should be an absence of a host reaction 
deleterious to the prosthesis. 
(ii) The valve should cause little trauma to the formed 
elements of the blood . 
(iii) It must have a low thrombogenicity . In third world 
countries a lack of need for anticoagulants is an advantage, 
as too, is a low price. 
(iv) It should be durable enough to retain its physical and 
geometric properties over many years of function, bearing in 
mind that such a prosthesis has to open and close about 
100 , 000 times a day(3) . The valve should outlast the life - span 
of the patient. 
(v) The prosthetic valve should present minimal obstruction to 
forward blood flow when open it should open and close 
quickly in response to changes in pressure gradients it 
should also be relatively competent in the closed position. 
(vi) Permanent fixation in a physiological position must be 
technically feasible, safe , and secure over many years. 
(vii) The valve should not annoy the patient by being noisy, 
and it should not require the patient to modify his lifestyle 
appreciably(4) . 
(viii) The valve should be resistant to infection. 
A wide variety of heart valve prostheses have been 
designed in order to achieve these objectives. Illustrations 
of many models,some no longer in use , may be found in the 
literature(S-10) . Silver and Wilson(ll) illustrate some of the 
valvular prostheses that have been recently introduced . 
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Figures 2.1 to 2.3 summarize the process of heart valve 
development, the designs of currently used major categories of 
prostheses and the "rise and fall" in popularity of various 
valves. 
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( IN-VITRO HYDRODYNAMICS} 
PULSE ACCELERATION 
( IN-VITRO DURABILITY} 
1-------
ANIMAL IMPLANTATION 
CLINICAL TRIALS CQt,,,1PUCATIONS 
GENERAL CLINICAL USE 1----~ 
Figure 2.1 Flow chart of heart valve development process. 
(Reproduced from Schoen, F.J., et al. : Ann. Biomed. Engin. 
1982 ; 10 : 97). 
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CAGED-DISK 
CAGED-BALL 
TILTING- DISK TISSUE 
Figure 2 . 2 Representative designs and flow patterns 
(schematic) of major categories of prosthetic heart valves . 
(Reproduced from Schoen , F . J ., et al . Ann. Biomed . Engin. 
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Tilling disc valve 









" rise a nd fall " i n popularity of ca r diac 
over 2 d ecades . (R e p rod u ced fro m McGoo n, 
D. C. Amer . J . Cardiol . 1 982 so 62 1 ) . 
The "Rise and Fall" of Replacement Valves 
Reason For 
Type of Valve Introduction Decline in Use 
Cloth cusp Hydrodynamic• Failure in durabil ity 
Central disc Hydrodynamic• Failure in durability 
Bare strut ball Hydrodynamic· Thrombogenicity 
1 
Homograft Less thrombogenic Failure in durability : 
limited availability 
Tilting disc Hydrodynamic Failure in 
" durability" 1 1; 
thrombogenicity 1 
Heterograft Less thrombogenic Failure in durability ' 
Cloth-covered ball Less thrombogenic Failure in durabil ity: 
valve not less 
thrombogenic 
Pericardia! Hydrodynamic ?Failure in durability ' 
Bileaflet Hydrodynamic ? 
• Compared with previously unreplaceable diseased valve. 
1 Valve 
remains popular but would be even more successful without_ the limi-
tation given. t " Durability" in this usage refers to thrombotic immo-
bilization of the disc. 
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TABLE 2 . 1 CLASSIFICATION OF THE VARIOUS TYPES OF 
PROSTHETIC HEART VALVES 
A. MECHANICAL PROSTHESES . 
l . CAGED-BALL VALVES . 
(i)Starr-Edwards ball valve . (*) 
(ii)Smeloff-Cutter valve. 
(iii)Harken valve. 
(iv)Magovern-Cromie valve . 
(v)Braunwald-Cutter valve . 
(vi)DeBakey-Surgitool valve . 
2 . CAGED-DISC VALVES . 
(i)Hufnagel-Conrad valve . 
(ii)Cross-Jones valve . 
(iii)Kay-Suzuki valve. 
(iv)Harken-Cromie valve . 
(v)University of Cape Town valve.(*) 
(vi)Kay-Shiley valve . 
(vii)Beall-Surgitool valve . 
(viii)Starr-Edwards disc valve . 
(ix)Cooley-Cutter valve . 
(x)University of Stellenbosch valve . 
3 . HINGED-LEAFLET VALVE . 
Gott-Daggett hinged-leaflet valve . 
4 . CAGELESS , CENTRAL- FLOW , LOW-PROFILE , TILTING DISC VALVES. 
(i)Pierce valve . 
(ii)Wada-Cutter valve . 
(iii)Bjork-Shiley valve . (*) 
(iv)Lillehei-Kaster valve.(*) 
(v)Lillehei-Medical valve . 
(vi)Hammersmith valve . 
(vii)Hall-Kaster (Medtronic-Hall) valve . 
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(viii)Omniscience valve. 
(ix)Omnicarbon valve. 
S.BILEAFLET (BIVALVE) PROSTHESES. 
(i)Kalke-Lillehei valve. 
(ii)St. Jude Medical valve.(*) 
B.TISSUE VALVES. 
l.HOMOGRAFT AORTIC VALVES. 
(i)Fresh homograft aortic valve. 
(ii)Sterilized homograft aortic valve. 
2.XENOGRAFT AORTIC VALVES. 







3.AUTOLOGOUS FASCIA LATA VALVE.(*) 
4.DURA MATER HOMOGRAFT VALVE. 
S.BOVINE PERICARDIAL XENOGRAFT VALVES. 
(i)Ionescu-Shiley valve.(*) 
(ii)Edwards Laboratory valve. 
(iii)Mitroflow pericardial heart valve.(*) 
(iv)Medox unicuspid pericardial heart valve. 
6.POLYMERIC TRILEAFLET VALVE PROSTHESIS. 
Abiomed heart valve prosthesis. 
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C.VALVE-CONTAINING CONDUITS. 
l . Pulmonary artery and valve substitutes. 
2 . Left ventricle-to-aorta bypass . 
3 . Replacement of ascending aorta and aortic valve . 
(*) INDICATES VALVES ENCOUNTERED IN THE PRESENT STUDY. 
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SURVEY OF THE VARIOUS TYPES OF HEART VALVE PROSTHESES 
A wide variety of heart valves have been implanted in 
patients worldwide . However , not all of these valves have been 
used clinically in each centre performing cardiac surgery . 
There are thus prominent regional differences in the 
utilization of the various prostheses . Table 2 . 1 gives a 
classification of most of the various types of prosthetic 
heart valves previously and currently available and lists most 
of the prostheses falling into each category . Prostheses which 
have been inserted in patients in Cape Town are indicated thus 
(*) . The major advantages and disadvantages of prostheses 
which have not been used in Cape Town will be high - lighted . 
STRUCTURAL DATA AND DIFFERENCES BETWEEN VARIOUS TYPES AND 
MODELS OF PROSTHETIC HEART VALVES (Tables 2 . 1 - 2 . 3) 
A.MECHANICAL PROSTHESES . 
l . CAGED-BALL VALVES . 
(i)STARR - EDWARDS PROSTHESIS 
The Starr-Edwards ball valve prosthesis has remained 
virtually unchanged in its basic design since its introduction 
in 1960 , although numerous modifications have been made 
(Tables 2.2A 2 . 2D) . The initial Starr-Edwards prostheses 
(model 1000 aortic , 6000 mitral) had a Stellite-21 cage , a 
compression-moulded Silastic (silicone - rubber) poppet and a 
knitted Teflon (polytetrafluoroethylene) sewing ring . Stellite 
is an alloy composed of cobalt, chromium, molybdenum and 
nickel, which was earlier used in orthopaedic appliances . 
Because of embolism and poppet shrinkage , the design was 
changed in 1965 so that cloth covered the valve seat (models 
1260 aortic and 6120 mitral) . This reduced thromboembolism and 
a modified curing technique greatly diminished deterioration 
of the Silastic ball(l2). In 
endothelialization and so further 
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entire cage was cloth-covered in the models 2300 aortic and 
6300 mitral valves which were introduced in 1967. 
However,reduction of thromboembolism was at the cost of 
impaired hydraulic performance due to the smaller orifice size 
consequent to the cloth covering, as well as tissue ingrowth 
which was excessive in some patients. 
The 2310-2320 aortic and the 6310-6320 mitral prostheses 
were characterized by protective metal studs on the inner 
aspect of the valve ring. These studs protruded through the 
covering cloth and protected the latter from the hollow 
Stellite-21 metal ball which was introduced in 1967. The 
change of the ball structure from Silastic to Stellite-21 was 
made in order to abolish the problem of ball variance. These 
prostheses had a larger orifice size and there was less risk 
of tissue ingrowth.Due to strut cloth wear the struts were 
lined by tracks made of Stellite-21 in the models 2400 aortic 
and 6400 mitral prostheses introduced in 1972. 
It was not long before others introduced modifications to 
the Starr-Edwards prosthesis. Smeloff et al's valve(l6) had a 
double cage. Harken's modification was a prosthesis having an 









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































This full-orifice (non-overlapping) caged-ball prosthesis 
was developed during the early 1960s by Drs Smeloff , 
Cartwright , Davey and Kaufman(l9 - 21) . The Smeloff-Cutter valve 
prosthesis (Table 2 . 3) is machined from a single piece of pure 
titanium. The orifice and struts are bare metal. The two cages 
each have 3 struts , which are not continuous across the ring . 
The full orifice design aims to reduce thromboembolism by a 
washing effect produced by regurgitation of blood . around the 
ball . The one cage is shorter than the other . In the mitral 
position the poppet occupies less of the left ventricular 
cavity than is the case with the Starr-Edwards 
prosthesis , because the poppet rests partially in the left 
atrium in systole . This is an advantage if the left ventricle 
is not dilated , as there is less chance of the valve causing 
left ventricular outflow tract obstruction . Because of its 
full-orifice design , the Smeloff-Cutter valve, when used in 
the aortic position , allows a larger prosthetic orifice than 
is possible with a conventional ball valve . 
Design-related complications included ball swelling due to 
lipid absorption which was corrected in 1966 by altering the 
curing process ; rarely the tip of a metal strut (open-ended 
cages) perforated the endocardium or became entangled in a 
papillary muscle remnant(22). Cardiac catheterization studies 
failed to show the improved haemodynamics expected of the 
full-orifice prosthesis(23-27). Diastolic pressure gradients 
across the mitral prosthesis of 5mm Hg at rest and 10-12mm Hg 
during exercise are not dissimilar to those of most other 
prosthetic heart valves . With the use of anticoagulants 
average thromboembolic rates of 3% per year after aortic valve 
replacement(25 , 28) and 6% per year after mitral valve 
replacement were achieved(l8). These results are not 
dissimilar to those of other noncloth-covered prostheses . The 
Smeloff-Cutter valve has the advantage over disc prostheses of 
a very low incidence of thrombotic stenosis(l8) . However, 
Smeloff et al . (29) in 1982 reported the development of a 
fibrous subvalvular pannus , which was the cause of mitral 
stenosis in 16 of 376 patients with this prosthesis . Although 
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the design has not been significantly altered in over 17 
years, this finding has prompted Smeloff et al. to examine 




Dwight Harken and co-workers successfully implanted a 
caged-ball prosthesis in the aortic root of human patients in 
the early 1960s, but the initial operative mortality was 
71%.(30,31). The early Harken valve incorporated both inner 
and outer cages with a total of eight struts. The outer cage 
had the function of preventing the aortic wall from 
interfering with movement of the poppet(18).The valve was 
constructed so that it could be firmly anchored by Surgaloy 
(American Cyanamid Co.) and covered by silk sutures in Ivalon 
(Clay-Adams Inc.) or Teflon backing. 
The modern model of the Harken caged-ball prosthesis has a 
hollow metal (Stellite) ball enclosed by three cloth-covered 
struts. A plastic (polyethylene) inner ring seats the poppet 
proximal to its equator. 
(iv)MAGOVERN-CROMIE VALVE. 
This sutureless heart valve(32) was developed by Dr George 
Magovern of the University of Pittsburgh School of Medicine 
and Mr Harry Cromie, a machinist. (This successful venture led 
Cromie to start a company called Surgitool,Inc. which produced 
the Magovern-Cromie, DeBakey, Beall and Harken 
prostheses)(18). 
The initial Magovern-Cromie valve had a stainless steel 
closed cage surrounding a silicone rubber ball. The valve base 
incorporated curved metal pins which were turned outward and 
through the aorta when the cage was rotated horizontally with 
a special instrument. 
When autopsy revealed thrombus at the apex of the cage of 
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this prototype valve , all subsequent valves were made with an 
open-ended cage. Model Al introduced in 1963 had 24 pins 
attached to an upper metal plate and 24 additional 
interdigitating pins projected from the lower rim. Model A2 of 
1964(33) had a silicone rubber flange over the outflow aspect 
of the ring to limit periprosthetic leaks . The poppet 
contained barium sulphate for radio-opacity . Model A3 was 
introduced in 1965 due to the problem of thromboembolism with 
the earlier model. Model A3 had the rubber flange replaced by 
a cuff of Dacron cloth and its inflow surface was partially 
covered with Teflon . Model A4 introduced in 1968 , had a Dacron 
fabric cover over most of the base of the titanium prosthesis , 
but the struts were bare . In this model only the aortic valve 
used the sutureless technique and the mitral prosthesis was 
abandoned . 
Although the sides and part of the base of the 
Magovern-Cromie prosthesis were covered by Dacron in 1968 , a 
large amount of bare metal remained in the sutureless 
prosthesis . Thus , the cloth did not extend to the edge of the 
inflow surface , but spared a metal rim and three metal 
projections(l8) . The rotating pin fixation mechanism resulted 
in a large amount of metal within the valve orifice. The 
establishment of safe techniques for cardiopulmonary bypass 
and myocardial protection rendered the rapidly implantable 
sutureless Magovern-Cromie valve redundant . Its use was 
discontinued in the late 1960s . 
(v)BRAUNWALD - CUTTER VALVE . 
As a result of Braunwald and Morrow ' s observations that 
fabric leaflet valves become covered by host tissue(34), 
Braunwald reasoned that porous cloth coverings could be 
beneficially applied to mechanical prostheses in order to 
combine the advantages of both devices . She and her colleagues 
modified several current noncloth-covered (Starr-Edwards, 
Cross-Jones, Kay-Shiley) prostheses by covering the struts 
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with loosely knit polypropylene and the metal ring with 
stretch-knit Dacron(35,36) Experimental work with these 
modified prostheses yielded the following 
information(18,37,38) 
1. The fabric covering the metal increases thrombogenicity of 
the prosthesis, but the more adherent thrombus gets covered by 
endothelial cells, thereby producing a non-thrombogenic 
autologous surface. 
2. Thicker thrombi take a longer time to undergo 
organization. 
3. The thrombus which forms is seldom more than twice as thick 
as the underlying cloth. 
4. A coarse fibre weave in the cloth favours a uniform 
fibroblast infiltration of the thrombotic layer and results in 
better adherence. 
5. Thicker tissue layers more often undergo degeneration and 
give rise to emboli.This may be related to the poor 
vascularization of this layer. 
6. Anticoagulants promote the formation of a thinner, more 
uniform thrombus-tissue layer. 
7. The cloth covering the struts had an abrasive action which 
led to wear of soft poppets (e.g., those made from silicone 
rubber), whereas hard poppets (made of Stellite) resulted 
instead in wear of the cloth(39). 
In 1967 Braunwald and co-workers started clinically to use 
standard, noncloth-covered Starr-Edwards prostheses which they 
had completely covered with cloth. An encouragingly low 
incidence of thromboembolism was noted, but the 
platelet-fibrin layer developed slowly in humans (unlike the 
experimental results in calves) and the human neo-intima was 
thin and delicate. An important additional disadvantage was 
that the cloth covering the ring rendered the smaller 
prostheses stenotic(40). In order to overcome the latter 
difficulty, the Braunwald-Cutter totally cloth-covered 
prosthetic heart valve was produced by Cutter Laboratories. 
The Braunwald-Cutter caged-ball valve(41) had a titanium frame 
with an open-ended cage. The ring was 
mesh and the struts with knitted 
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covered by polypropylene 
Dacron . The mild - cure 
silicone rubber poppet was similar to that used in 1966 in the 
Smeloff-Cutter valve . 
(vi)DEBAKEY-SURGITOOL AORTIC VALVE . 
This prosthesis was designed by Dr Michael E . DeBakey and 
associates of Baylor College of Medicine , Houston , Texas and 
Mr H . Cromie of Surgitool , Inc. The aim was to devise a 
prosthesis which would not be plagued by the problem of ball 
variance that was encountered with the early model 
Starr-Edwards aortic valves . Several different models were 
manufactured in the evolution of this prosthesis . 
The first DeBakey-Surgitool valve had a titanium poppet 
and the struts plus the ring were covered with Dacron velour . 
This totally cloth-covered design was unsuccessful due to 
severe haemolysis(42) . The second model of the valve had a 
pyrolytic carbon-silicone alloy coated ball with a bare 
titanium cage(43) . The poppet was rendered radio-opaque by an 
inner tungsten screen . The fabric sewing ring was designed for 
a ortic valve replacement only(l8). The third model of the 
DeBakey-Surgitool valve (introduced in 1969) had a primary 
orifice covered with a double layer of woven Dacron. Severe 
haemolysis prohibited its use . The fourth model introduced in 
1971 was characterized by a base ring made of ultrahigh 
molecular weight polyethylene. This substance was not ideal 
since it could only be sterilized by gaseous methods and steam 
autoclaving could not be used . The fifth valve design 
(available from 1972) had a base ring made of pyrolytic 
c arbon(l8) . 
There have been very few reports published of results 
using the DeBakey - Surgitool valve(44 , 45) . Embolism appears to 
have been on a par with other noncloth-covered prostheses . One 
problem peculiar to this prosthesis has been wear and/or 
f racture of the struts due to the combination of an extremely 
hard pyrolytic carbon ball and a 
Design alterations in the mid-1960s 
virtually eliminated ball variance 
poppets(l8). The long-term durability 
still to be proved . 
DEBAKEY-SURGITOOL MITRAL VALVE : 
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soft titanium cage(46) . 
by Cutter Laboratories 
with silicone rubber 
of such poppets has 
This prosthesis has been used at Baylor College by DeBakey 
and co - workers for several years , but it has not been made 
available for general use . Like the Beall-Surgitool valve it 
has a pyrolytic carbon disc and Dacron velour covers the 
orifice. The struts cross on the DeBakey valve, unlike the 
parrallel arrangement of the Beall valve . 
2 . CAGED-DISC VALVES . 
The caged-ball design gained worldwide acceptance 
following early successes with mitral valve replacement in 
1960(18,47) . In those early years there was difficulty in 
distinguishing between valve-related and patient-related 
complications . There was concern as to whether caged-ball 
valves could produce subaortic outflow tract obstruction (low 
cardiac output) or whether ventricular fibrillation might 
result from septal irritation by the cage . Pathological 
specimens at times gave support for such a possibility(48 , 49) . 
This concern regarding the suitability of caged-ball valves 
for mitral valve replacement in patients with non-dilated left 
ventricles led to the development of numerous low-profile 
prostheses in the mid-1960s . The chief advantage of this type 
of valve is that the retaining cage is much shorter, and thus 
lower in profile, than in the ball valve . These caged disc 
valves had a lateral flow design. 
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(i) HUFNAGEL-CONRAD VALVE(SO). 
Drs Hufnagel and Conrad of the Georgetown University 
Hospital described a polypropylene and silicone rubber 
caged-disc prosthesis . 
Hufnagel also evaluated a stemmed disc-type valve . Various 
shapes of disc were tried out , but this valve and its numerous 
modifications were not satisfactory in a blood medium . Its use 
was soon abandoned due to problems of wear and thrombosis . 
(ii) CROSS-JONES VALVE(Sl) . 
This prosthesis had an open-ended cage composed of 3 
struts and there was a radiolucent poppet which contained a 
radio-opaque ring. There were no feet within the valve 
orifice . Significant complications included thromboemboli, 
cocking of the disc and disc variance . 
(iii) KAY-SUZUKI VALVE(49) . 
This valve was designed by Drs Earle B . Kay and Akio 
Suzuki. It had a closed-ended cage composed of 4 struts . There 
were also 4 short, open base feet which projected into the 
orifice opposite the cage. The valve also had a double-ring 
valve base (metal inner ring) and a radiolucent poppet . Major 
problems were thromboemboli and disc variance . 
(iv) HARKEN-CROMIE VALVE(52) . 
This has a closed cage formed of 4 thin , crossing struts 
and a radio-opaque poppet . Thromboemboli and disc variance 
were recognized complications . 
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(v) UNIVERSITY OF CAPE TOWN VALVE(53 , 54) . 
This locally developed tethered-plunger prosthesis had 
flat (lenticular) and cone-shaped Silastic poppets . The U. C . T . 
mitral valve prosthesis initially had a plump lenticular disc 
suspended from a T-piece which moved up and down through a 
ring at the end of a suspension arm . In the mitral prosthesis 
the restraining mechanism was placed in the atrium and thus 
overcame the most important disadvantage of the ball-valve . 
The suspension arm was anchored to a larger steel ring which 
formed the valve seat. This seat ring was covered with Ivalon, 
and later with Teflon , which also acted as a sewing ring . 
Later the poppet was modified into . a slimmer lenticular 
outline . The U . C . T . (lancer) aortic valve(55) had two rings 
and two suspension arms to hold the I-pieces of the double 
cone-shaped poppet . Problems with thromboembolism later led to 
the use of the U . C . T . prosthesis being discontinued. 
(vi)KAY-SHILEY VALVE . (56,57). 
The Type I Kay-Shiley valve had 4 struts which projected 
vertically from the Stellite sewing ring to form 2 bars made 
of bare metal (Stellite) . The closed cage held a radiolucent 
silicone rubber disc. This valve was used for mitral and 
tricuspid valvular replacements(58 , 59). The Type II valve was 
produced in response to a high thromboembolic rate and the 
modification consisted of extending the knitted Teflon cloth 
to reduce the orificial bare metal(60) . The Type III 
Kay-Shiley valve had a muscle guard projecting from the ring 
of the valve to protect the excursion pathway of the disc from 
encroachment by adjacent myocardium . It has been pointed out 
that this modification nullifies the originally stated 
theoretical advantage of the low-profile valve , namely that it 
avoids contact with the myocardium(61). The addition of a 
second guard gave rise to the Type IV valve, which also 
substituted Delrin for silicone rubber as the disc 
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material(62) . 
Since low profile prostheses should produce less 
obstruction of the tertiary orifice (the space between the 
poppet and the aortic wall) , Bjork implanted the Kay-Shiley 
valve in the aortic position in 60 consecutive patients . 
Post-operatively the average systolic gradient was 
disappointing 27 mm Hg at rest and 38 mm Hg during 
exercise(63). 
Major complications encountered with the Kay-Shiley 
prosthesis included thromboembolism , sudden unexpected 
unexplained death , grooving and disc wear , restenosis with 
tissue ingrowth , perivalvular leaks , disc cocking and disc 
variance(6). According to Lefrak and Starr(l8) the established 
vulnerability of the Kay-Shiley prosthesis to catastrophic 
malfunction is typical of disc prostheses ; a small amount of 
thrombus may critically interfere with disc mobility, 
rendering it stenotic and susceptible to a vicious cycle of 
rapidly progressive thrombosis . Deaths from low cardiac output 
syndrome or arrythmias continue to occur despite the use of 
low-profile valves . 
(vii) BEALL-SURGITOOL VALVE. 
Dr Arthur Beall and the staff of Surgitool Inc . produced a 
partially cloth-covered, low-profile valve which they hoped 
would have a lower risk of thromboembolic complications . The 
disc consisted of extruded Teflon and the titanium struts were 
covered with solid Teflon(64) . Due to premature disc 
wear(65 , 66) the disc was changed to a thicker , 
compression-moulded Teflon disc in Model 103 . The next 
alteration to the prosthesis was in response to reports of 
poor hemodynamic responses during exercise(67) . In the Model 
104 Beall prosthesis the primary and secondary orifice areas 
of the paediatric and small-sized valves were enlarged . During 
the ensuing years it became apparent that disc wear, 
particularly of the edge of the disc , was still a significant 
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problem(68 - 71) . Disc wear manifested clinically as increased 
hemolysis and mitral incompetence or stenosis . Model 105 
introduced in 1971 no longer had a Teflon disc and there was 
no Teflon on the struts. A pyrolytic carbon-silicone alloy 
coated the new graphite disc and the titanium wire struts(43) . 
However , Model 105 was plagued by the problem of strut fracture 
due to cracking of the brittle carbon alloy(72 , 73). 
In Model 106 the diameter of the strut wire was increased 
from 0 . 030 to 0.045 inches and it was packaged more strongly 
for shipping and sterilization(l8) . The degree of hemolysis 
associated with the Beall-Surgitool valve is greater than that 
seen with the noncloth-covered caged-ball or tilting disc 
valves . The increased hemolysis is probably related to the 
Beall-Surgitool valve's combination of an overlapping disc 
with a Dacron velour cloth-covered orifice . The prosthesis has 
also failed to reduce the incidence of thromboembolism after 
mitral valve replacement . 
(viii) STARR-EDWARDS DISC VALVE . 
The first Starr-Edwards disc valve had a poppet made of 
hollow Stellite 21 and the cage was made from the same metal 
alloy(74) . The heat-tempered poppet was made harder than the 
cage legs , which were made thick enough to prevent problems 
due to wear. The sewing ring was made of Teflon cloth . While 
the problem of disc edge wear was eliminated by this valve 
model , it later became evident that thromboembolism , poor 
hydraulic function and thrombotic entrapment of the disc were 
significant problems(lS , 75 , 76). In the Model 6520 
Starr-Edwards disc prosthesis(77) the disc was made from Hifax 
(ultrahigh molecular weight polyethylene) . It contained a 
radio-opaque titanium ring . The hydraulics were improved by 
enlargement of both the primary and secondary orifices. The 
same closed cage design of Stellite 21 as the previous design 
was used in this new model. 
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Up till 1979 , Edwards Laboratories had not been notified 
of a single case of disc wear , strut fracture, or poppet 
embolization with either the 6500 or 6520 Models. In common 
with other disc valves it shares an haemodynamic effect 
inferior to caged-ball or tilting disc valves , and a tendency 
to disc immobilization by thrombus or endocardium . It also has 
a similar embolic rate to other noncloth-covered valves(l8). 
(ix) COOLEY-CUTTER VALVE . 
Dr Denton Cooley ' s experience with prosthetic valve 
construction began during his association with Dr D. Liotta at 
the Baylor College of Medicine in the mid-1960s(l8) . Liotta's 
eccentrically hinged disc valve closed too slowly allowing an 
unacceptable amount of incompetence(78) . This was followed by 
the Cooley-Liotta-Cromie prosthesis , which was a modification 
of the Starr-Edwards valve . It had a titanium ball and Dacron 
velour completely covered the ring and the struts(79) . Its use 
was soon discontinued due to cloth wear and haemolysis(SO) . 
The Cooley-Bloodwell-Cutter prosthesis introduced in 1966 had 
a silicone-rubber disc and bare titanium cage legs . The 
orifice of the valve was covered with Dacron cloth(81) . 
Thromboembolism(82) and disc wear soon led to its use being 
discontinued. 
The COOLEY-CUTTER VALVE(83) introduced in 1971 had a 
double cage made of titanium struts. It had a 
peripheral , self-washing regurgitant stream in the closed 
position and the knitted Teflon sewing ring was eccentric in 
order to reduce the danger of poppet entrapment by mural 
endocardium . Initially the valve was a mitral prosthesis only , 
but in 1973 an aortic prosthesis with a biconical occluder was 
introduced . In the same year the mitral poppet was changed to 
this type too . 
Like the DeBakey-Surgitool and the Lillehei-Kaster 
prostheses , the Cooley-Cutter valve has a hard pyrolytic 
carbon poppet and relatively soft titanium struts . Titanium 
102 
TYPES OF PROSTHESES 
strut wear has been reported with the DeBakey - Surgitool valve 
and the Cooley-Cutter valve may have the potential for similar 
wear . Strut fracture of the Cooley-Cutter prosthesis has been 
reported(84,85). 
(x) UNIVERSITY OF STELLENBOSCH VALVE . 
The University of Stellenbosch mitral valve prosthesis was 
developed by Dr Pieter M. Barnard and colleagues at the Karl 
Bremer Hospital and the University of Stellenbosch , South 
Africa . The Silastic (silicone rubber) disc (manufactured by 
the Dow-Corning Center for Aid to Medical Research , Michigan, 
U.S . A. ) was enclosed in an open-ended, stainless steel cage 
having 4 bare metal struts . The original disc incorporated a 
stainless steel ring which was later changed for a perforated 
nylon plate . Electron beam-welding of the prosthesis was 
performed by the Technical Department of the South African 
Council for Scientific and Industrial Research . The sewing 
ring of the prosthesis was covered with Dacron velour . 
Following on testing of the valve in baboons(86) , clinical use 
of the prosthesis started in July 1967 . In 1970 Barnard et 
al . (87) reported their clinical experience with 25 patients in 
whom the valve had been implanted . Thirty-percent of patients 
showed early thromboembolism (none fatal) and 9% had late 
embolism. In contrast to other reported series(40 , 88) , the 
cloth covering (Dacron velour) on the University of 
Stellenbosch mitral valve prosthesis did not reduce the 
incidence of early embolism . Due to the high rate of 
thromboembolism , this valve is no longer used . 
3 . HINGED-LEAFLET VALVE . 
In the mid-1960s Dr V.L . Gott and colleagues devised a 
hinged-leaflet, low-profile valve(89 , 90) for aortic valve 
replacement . The Gott-Daggett valve had a central cross strut 
with multiple prongs projecting from the inner aspect of the 
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ring. The leaflets were radiolucent. Major problems with this 
prosthesis were thromboembolism and haemolysis. The latter was 
associated with an increased incidence of gallstones(6,91). 
4.CAGELESS,CENTRAL FLOW,TILTING DISC,LOW-PROFILE VALVES. 
(i) PIERCE VALVE. 
This valve was the earliest tilting disc prosthesis 
devised(92). The standard sewing ring attached by Edwards 
Laboratories was cloth-covered and plastic composed the inner 
portion of the ring. The ends of the spindle supporting the 
tilting disc were retained by this plastic inner ring. The 
valve was used in experimental animals at the National Heart 
and Lung Institute, U.S.A. It was shown that laminar flow 
occurred through the larger orifice,but the lesser orifice had 
a turbulent flow pattern. In vivo it was found that a small 
amount of thrombus or granulation tissue could seriously 
interfere with valve function. 
(ii) WADA-CUTTER VALVE. 
This valve was jointly developed by Dr Juro Wada and 
Cutter Laboratories. The valve has no obvious cage. Two small 
metal feet project horizontally into the valve orifice, 
producing a hinge upon which the disc pivots. The titanium 
inner ring extends as a lip onto the outflow and inflow 
surfaces. The base ring has two notches. The radiolucent solid 
Teflon (polyethylene) disc is vaguely Z-shaped in profile and 
it occludes the orifice by having part of the disc seating on 
both surfaces. The larger portion of the disc seats on the 
outflow side of the titanium ring. The smaller portion of the 
disc overlaps onto the inflow side of the ring. The disc tilts 
open to an angle of 75 to 80 degrees. The valve was used in 
the mitral, tricuspid and aortic positions. Problems 
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encountered included early disc wear(93) , total valve 
thrombosis(94), thromboembolism and peribasilar leaks with 
notable regurgitation(6) . These complications , as well as 
instances of fatal poppet embolization, led to this prosthesis 
being abandoned . 
(iii) BJORK-SHILEY VALVE . 
Encouraged by the 
Wada-Cutter valves , Dr 
designs 
Viking 0 . 
of both 
Bjork 
the Pierce and the 
of the Karolinska 
Institute in Sweden combined with Mr Donald Shiley to develop 
the Bjork-Shiley prosthetic valve . (Shiley had previously 
worked with Mr Edwards on the Starr-Edwards valve before 
forming his own company , Shiley Laboratories , Inc ., in Santa 
Ana , California) . 
The valve devised by Shiley was tested experimentally in 
1968 and clinical usage was instituted in 1969(95,96) . The 
valve has 2 curved , roughly U-shaped , naked cast Stellite 
struts which are heat-fused to the ring . They are 
for insertion of the disc. The latter is held 
bent apart 
in place by 
fitting the outflow strut into a central depression on the 
disc . Delrin was initially used to construct the disc, but it 
absorbed moisture during steam autoclaving with resultant 
swelling of the poppet(97) . Thus, in 1971 the disc material 
was changed to graphite coated with pyrolytic carbon , and the 
edge was made thicker(98) . The disc tilts open to 60 degrees 
and does not overlap the valve ring on closure . This allows a 
degree of regurgitant flow through the closed valve (10% 
versus 3% for the Starr-Edwards valve) in order to prevent and 
to wash the valve free of thrombi. Such a construction permits 
an optimal orifice diameter and area for a given tissue 
diameter it provides a low resistance to blood flow and is 
less traumatic to erythrocytes with minimal incompetence(99) . 
Initially , in trye mitral prosthesis the disc was designed to 
open only to 50 degrees in order to avoid its touching the 
ventricular endocardium . Later the angle was changed to 60 
105 
TYPES OF PROSTHESES 
degrees to improve post-operative haemodynamics and to better 
wash the ventricular side of the disc during diastole(lOO) . 
Turning of the disc in vivo was expected to prolong the life 
of the disc . From late 1975 a radiopaque tantalum foil loop 
marker was incorporated into the disc to assist in diagnosis 
of thrombosis(lOOa , lOOb) . 
There is no fabric on the struts or on the primary 
orifice . The aortic prosthesis has a vertical , thin-walled 
base and a rectangular sewing ring , which serve to give a 
greater internal orifice in relation to the valve's external 
diameter. The mitral valve has a more horizontal , L-shaped 
sewing ring in profile . Despite the theoretical advantage of 
the absence of a central occluder in the Bjork-Shiley valve , 
it has been shown that the flow pattern through the valve is 
primarily through the major orifice and not through the entire 
internal orifice. Also the flow pattern is directed laterally 
and not centrally as in natural valves or with 
bioprostheses(lS , 101). 
The Bjork-Shiley valve may be easily implanted in the 
aortic root and its low profile makes coronary arterial 
re-implantation into a Dacron graft easier . Durability has 
been very good and strut fracture is rare . The thin , unpadded 
sewing ring makes peri-prosthetic leakage in a rigid aortic 
root more likely . The fundamental weakness of the tilting disc 
design is the close association between the mobile poppet and 
the thrombogenic valve ring(l8) . Thrombus on the ring can 
easily interfere with poppet motion . Such failure is often 
sudden and catastrophic . In an attempt to reduce the area of 
flow stagnation predisposing to thrombosis on the outflow side 
of the disc , the design was later altered so that the disc now 
had a convexo-concavo outline and the pivot point was moved 
2 . 5 mm downstream to reduce obstruction by thrombus which 
might form(l02). 
Later a Bjork-Shiley prosthesis which had a 70 degree 
opening angle was introduced . However , strut fracture led to 
this concavo-convex Bjork-Shiley 70 degree opening valve being 
withdrawn from the market ( F. C . 
africa , personal communication). 
monostrut Bjork-Shiley valve was 
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Marcus & Co . Ltd ., South 
In 1983 , a new type of 
introduced . No welding is 
present ; the inlet and outlet struts are all part of the same 
metal since the valve is machined from a solid piece of cobalt 
alloy. The product name "monostrut" refers to the valve ' s 
outlet strut which is now a single projecting finger of metal , 
rather than the U-shape associated with the concavo-convex 
valves . This new strut has a cross-sectional area 3.5 times 
greater than the old wire outlet strut . The disc occluder 
opens to 70 degrees and is made of pyrolytic carbon . 
(iv) LILLEHEI-KASTER VALVE. 
Dr C. Walton Lillehei and colleagues performed one of the 
first human heart valve replacements ever attempted using a 
bicuspid silicone rubber flap-valve aortic prosthesis(l03). An 
electrical engineer called Robert Kaster working in Lillehei ' s 
laboratory tried to design an improved heart valve prosthesis. 
He and Dr A. Cruz produced the CRUZ-KASTER pivoting disc valve 
which had a concavo-convex (meniscus) shaped disc that tilted 
open to up to 80-85 degrees . However , blood flowed only on one 
side of the disc, predisposing to thrombosis on the other 
side . It was tested experimentally from 1963 , but was never 
used clinically(l04) . In 1965, the pivotal axis was moved 
towards the centre, so allowing blood flow on both aspects of 
the disc . The struts were altered and then abolished , yielding 
a cageless design with lateral guides to hold the disc in 
place(l05) . The poppet was still a pivoting disc, but it was 
inclined at 18 degrees when closed to aid rapid opening and 
closing . 
The LILLEHEI-KASTER valve evolved from the above valve 
after evaluation of various materials . Delrin (acetal 
homopolymer) and various plastic discs were found to 
wear(l06) . The valve was used clinically for the first time in 
1970 by Dr Lillehei(l07) and was made commercially available 
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the following year . 
The Lillehei-Kaster(l , 6 , 18) valve prosthesis has a 
pivoting disc composed of a graphite centre covered by a thin 
layer (250 um) of a carbon-silicone alloy (Pyrolite Gulf 
General Atomic, Inc. , San Diego , California) . The pyrolytic 
carbon disc is retained by a titanium housing that allows the 
disc to open to a maximum angle of 80 degrees from its closed 
position of 18 degrees to the horizontal (62 degrees of 
movement). The disc seats in the prosthesis lumen at its 
equator . The metal housing can be rotated within the Teflon 
cloth sewing ring to permit optimal alignment of the disc 
after sewing ring fixation(l). The effective diameter of the 
valve orifice is smaller than the diameter of the disc. The 
inner ring consists of bare metal(9) . 
Two naked (titanium) metal struts , that are thicker at 
their base than their free margin (tear - drop shaped), project 
from the sewing ring at an angle of less than 90 degrees to 
form an open cage . Three tiny metal feet project into the 
valve orifice from the inner ring on the surface opposite the 
cage two act as hinges and the third functions as a disc 
stopper . The disc is free to distribute wear by moving around , 
and it is held in place within the housing by its own diameter 
during ventricular systole. The two long struts prevent the 
disc escaping through the outflow orifice. When closed the 
disc just barely overlaps the seat(18) . 
The valve has given good early results(18) , but cardiac 
catheterization has revealed no superior 
prosthesis compared to several other 
prostheses . Catastrophic thrombosis 
complication(108-110) . 
(v) LILLEHEI - MEDICAL VALVE . 
function of this 
types of valve 
was a common 
This valve was introduced by Lillehei et al.(111) in order 
to overcome the problems with the Lillehei-Kaster prosthesis . 
The titanium components which characterized the latter were 
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replaced by pyrolytic carbon layered over a graphite 
substrate. The base of the valve was made thinner to 
incorporate the advantage of the Bjork-Shiley valve regarding 
the inner-to-outer diameter ratio . The disc was also thinner 
than before. The design abolished struts and the cage was much 
shorter . 
(vi) HAMMERSMITH VALVE . 
The Hammersmith low-profile prosthetic valve(112-114) was 
introduced in 1964 by Melrose and his colleagues(112) . The 
valve had evolved from from an earlier design of a 
self-retaining ball-valve(113) . The Hammersmith mitral valve 
was designed to open so that most of the blood flow was 
directed to the area next to the left ventricular septum below 
the aortic outflow tract. This meant creating a mechanism 
similar in action to a hinged flap , but without the 
disadvantages of a hinge-joint. The initial tilting disc valve 
(J. B. Flege design) had steel retaining-pins loosely secured 
within a plastic ring for the hinge mechanism . Another 
arrangement (F. R. Alvarez Diaz design) repositioned the 
retaining elements. There were no steel pins and the ring was 
modified . This design was similar to the original ball-valve 
except that there were only 2, not three legs attached to the 
disc and 2 stops protruded from the inner aspect of the ring . 
Three types of Hammersmith mitral valve prosthesis have been 
manufactured . Each model aimed to improve the hydraulic 
function and reduce the tendency to thrombosis on the valve . 
The Mark I valve, (used in animal experiments) , had 3 legs 
of equal length supporting a large trapdoor . The Mark II valve 
used clinically had only two legs and a lighter trapdoor, 
which opened to one side only. Thus , the valve had to be very 
accurately placed in the heart so that it opened into the left 
ventricular outflow tract, because one side was completely 
occluded when the trapdoor was open. The Mark III valve has 3 
legs , two long and one short , so that the trapdoor opens all 
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around its circumference . Positioning of the valve is less 
critical with this version. An extension of the ring prevents 
rotation of the disc. The valves were manufactured and sold by 
Portland Plastics Ltd ., Kent , England. 
Shaw et al.(115) reported sudden mechanical malfunction of 
Hammersmith mitral valve prostheses due to wear of the 
polypropylene material at the site of contact between the 
short leg of the disc and the valve ring . Such malfunction 
resulted from detachment of the disc from the ring or sticking 
of the disc in the open position . These authors concluded that 
polypropylene has a low resistance to abrasion and it may not 
be suitable for prostheses, especially if the design 
predisposes to localized wear . 
Polypropylene is a synthetic polymer produced from the 
hydrocarbon gas propylene which is obtained by " cracking " 
oils . It was also used in the Model 6310 Starr-Edwards 
valve(ll6) . Polypropylene can exist in 3 spatial forms(l03) 
and the proportion of these forms helps determine the 
properties of a particular batch of the polymer. Prolonged 
high temperatures make the plastic brittle . Thus, not only the 
design of the valve , but the mode of production of the plastic 
itself are important in determining the durability of the 
prosthesis. 
(vii) HALL - KASTER (MEDTRONIC-HALL) VALVE . 
The primary goals of the Hall-Kaster prosthesis(ll7) 
design were to obtain the least possible obstruction to flow 
in the open position and to increase the size of the small 
orifice. All projections into the orifice, 
central disc guide strut , are open-ended 
including the 
to prevent 
thrombogenesis at these sites . The new pivotal disc mechanism 
was so designed that when open the disc split the total valve 
orifice into two nearly equal parts . The disc has a composite , 
two-part movement . There is a large range of movement and in 
the aortic position , the disc opens to 75 degrees . The disc is 
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less than 2 mm in thickness , with an aperture at the centre , 
and it is made of a graphite substrate containing tantalum 
which makes the disc radio-opaque . It is Pyrolite-coated for 
maximum wear , polishability , and has electronegativity . The 
valve housing consists of titanium and includes an annular 
valve base, a pair of inflow pivots , a single outflow pivot , 
and an S-shaped disc guide-strut with a disc stop . The disc is 
fitted to the guide-strut , which controls the movement of the 
disc throughout its travel . The valve housing with its 
open-ended structural members is low in profile and contains 
no welds or introduced bends(ll8) . The sewing ring is made of 
knitted Teflon . In the closed position , the disc is parallel 
to the plane of the valve base and rests within the orifice on 
the two inflow pivots and the disc stop . To open , the disc 
lifts slightly , then pivots about the curved end of the 
outflow pivot through an arc of 75 degrees in the aortic 
model . Soon after its clinical introduction in 1977 , two 
dimensional changes were made . Firstly , the clearance between 
the edge of the disc and the ring was reduced in order to 
lower the degree of regurgitation and theoretically reduce the 
amount of haemolysis(l06) . Secondly , the diameter of the 
sewing ring was reduced by 1 mm to allow insertion of a valve 
with a larger internal orifice in a given annulus . 
Semb et al.(119) reported the first in vivo haemodynamic 
observations with this prosthesis in both acute and chronic 
experiments following implantation of the valve in the mitral 
position in dogs . These studies showed a low transvalvular 
pressure gradient, an effective opening angle of about 70 
degrees and good diastolic flow through both the large and 
small orifices of the prosthesis. Aasen et al . (120) used 
anticoagulants and antibiotics to develop a long-term canine 
model for studying the Hall-Kaster valve in the mitral 
position. A recent study from South Africa(l21) reported the 
occurrence of intermittent aortic regurgitation in 4 of 160 
patients with Hall-Kaster aortic prostheses . In all 4 patients 
mechanical obstruction to free movement of the disc was 
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excluded . Wide opening of the occluder beyond the axis of 
blood flow appeared to be responsible for non-closure of the 
valve during diastole . The aortic incompetence was corrected 
by re-orientation of the major orifice of the prosthesis . It 
is disturbing that such incompetence may be impossible to 
detect prior to closure of the aorta and discontinuation of 
cardiopulmonary bypass . These authors believe that the major 
orifice should face the anterior commissure i . e ., between the 
left and right aortic cusps . 
(viii) OMNISCIENCE VALVE . 
This valve has four tiny metal struts with angled ends 
which project into the valve orifice(ll) . Closure of the 
orifice is achieved by a thin , curvilinear black pyrolytic 
carbon-coated disc which pivots between the metal struts . The 
struts on the inflow surface also angle upwards from the metal 
inner ring. The disc lies at an angle of 12 degrees when the 
prosthesis is closed. The sewing ring has 4 black marks on it 
to help the surgeon to orientate the valve . Despite a short 
follow-up period , Rabago et al.(12la) noted a significant 
incidence of valvular dysfunction , which led them to 
discontinue using the Omniscience prosthetic valve. 
(ix) OMNICARBON VALVE . 
This prosthesis is similar to the Omniscience valve 
described above . The difference is that all portions of the 
valve , including the sewing ring , are covered with black 
pyrolytic carbon. The dark-coloured sewing ring has 2 or 3 
white marks on it for assisting with the orientation of the 
valve at the time of implantation(ll) . 
(x) SORIN VALVE has been used in Italy . I have been unable to 
obtain information regarding its structure , but prosthetic 
thrombosis has been reported(l2lb) . 
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5. BILEAFLET HEART VALVE PROSTHESES. 
(i) KALKE-LILLEHEI DOUBLE LEAFLET VALVE. 
The first rigid,bi-leaflet prostheses were described by 
Kalke and Lillehei in the mid-1960s(122,123). This new design 
concept was well tested at that time in the pulse duplicator, 
by animal implantation studies and by cineradiography. The 
valve had excellent flow characteristics and haemodynamics 
were better than existing designs. The leaflets and housing 
were made of titanium and the sewing ring of Teflon. The 
leaflets opened to an angle of 60 degrees, permitting flow 
through both the central and lateral areas of the orifice. 
Each leaflet had two ball-like knobs laterally that pivoted 
within ovoid recesses in the titanium housing. Thus, while 
opening the leaflets slid laterally to increase the central 
orifice as they rotated. During closure the leaflets again 
moved to meet in the midline leaving only a narrow linear gap. 
This prosthetic design was further refined and the valve was 
made totally of pyrolytic carbon. The prosthesis, now called 
the St.Jude Medical Valve, was ready for in vitro and animal 
testing in 1976(124). 
(ii) St JUDE MEDICAL VALVE. 
At the time of writing, this is the newest, 'state of the 
art' mechanical prosthesis. It is a low profile, lightweight, 
bi-leaflet, central-flow device made entirely of pyrolytic 
carbon. It has two semi-circular (D-shaped) discs(125) that 
open to an angle of 85 degrees from a closed position in which 
the leaflets lie at 30-35 degrees to the valve housing. An 
ingenious pivot mechanism eliminates the need for any 
supporting struts. The two housings containing the pivoting 
ends of the discs protrude as smooth elevations on the inflow 
aspect of the valve(ll). All portions of the valve (except the 
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sewing ring) 
occluders lie 
are covered with black pyrolytic carbon . The 
at an angle to each other in the closed 
position . Controlled leakage aims to minimize thrombosis . 
There is a seamless , double velour Dacron sewing cuff . A 
pressure of only 0 . 8 mm Hg is needed to open or close the 
valve. The valve design allows for a high ratio of flow 
orifice to tissue annulus diameter . 
Before clinical use of the valve was instituted , an 
intensive programme of in vitro and in vivo evaluation was 
performed . The in vitro tests(l26) showed the St Jude Medical 
valve to be safe and effective with superior haemodynamic 
parameters compared to other clinically available cardiac 
valvular prostheses . In vivo testing of the valve in 
calves(l27) showed equally promising results . The St Jude 
Medical cardiac valve prosthesis is 
extensive world-wide clinical trials . 
presently undergoing 
Early postoperative 
catheterization studies at several centres showed excellent 
hydraulic function(l28) . 
B . TISSUE VALVES (BIOPROSTHESES) . 
1 . HOMOGRAFT (ALLOGRAFT) AORTIC VALVE . 
The varied methods for tissue valve preparation have 
resulted in some confusion , particularly over exact definitions 
of valves , which have not been chemically treated(l29) . This is 
not surprising , since homograft valves are a variable 
entity(l8) according to (i) the method and timing of 
collection , (ii) sterilization , (iii) methods of valve 
storage, (iv) technique of implantation, and (v) use of a free 
graft or one on a supporting stent. Pioneering work in 
introducing the clinical use of the viable aortic valve 
homograft was performed by Carrel(l30,131) , Gross(l32 , 133) , 
Lam(l34) , Murray(l35) , Duran and Gunning(l36) , Ross(l37) , and 
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Barrat-Boyes(138) . It was the latter two authors who were the 
first to (independently from each other) successfully perform 
orthotopic implantation of a homograft aortic valve . The work 
of Heimbecker et al.(139) also helped to verify the long-term 
durability of aortic valve homografts . 
(i) FRESH HOMOGRAFT AORTIC VALVE . 
Fresh valve is a relative term , not specifying the time 
period from time of death to procurement(129) . Such valves are 
usually obtained between 4 and 48 hours after death , commonly 
from males aged between 18 to 40 years . Patients dying with 
septicaemia (or hepatitis, tuberculosis, or syphilis) are 
excluded as donors . The adjective viable indicates that the 
cuspidal fibroblasts are kept alive in vitro and will 
theoretically be capable of replication and formation of 
collagen following implantation of the valve in a recipient. 
Fresh homograft aortic valves implanted in the sub-coronary 
position proved virtually free of thromboembolic complications 
without anticoagulant therapy(l40) . The fresh homograft valves 
were mounted on a stent to allow such valves to be implanted 
in other intra-cardiac (e.g . , atria-ventricular) 
positions(141) and to aid insertion of the graft in the aortic 
position(125). Angell et al . (142) first used a frame-mounted 
aortic homograft in 1967 . 
(ii) STERILIZED HOMOGRAFT AORTIC VALVE. 
At first, the valves were removed from cadavers using 
sterile precautions , but later because of logistical 
difficulties the method was changed to clean conditions . It 
thus became important to have a means of ensuring the 
sterility of the excised valve . 
Initially , severe methods(144) were used to sterilize the 
homograft aortic valves e . g ., exposure to ethylene oxide or 
beta-propiolactone sterilization , irradiation , freezing and 
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freeze - drying . Such treatment abolished valve viability . A 
method of sterilization and storage was sought which would 
maintain valve viability . Surface sterilization using 
formaldehyde vapour proved to be unsatisfactory(l45) . The use 
of in vitro antibiotics in high concentrations(l46 , 147) led to 
successful sterility , but also yielded a non-viable valve. 
order to overcome this problem Angell et al . (143) 
In 
used 
non-sterile procurement of the valve homograft and euthermic 
(37 degrees Centrigrade) incubation of the valves in tissue 
culture solutions containing physiological doses of selected 
antibiotics . After trying various combinations of antibiotics, 
these authors were able to achieve satisfactory sterilization 
with only a 15% reduction in cuspidal viability . Fungi were 
not affected by such treatment . Bakst et al . (148) reported 
good early haemodynamic results with antibiotic-treated 
homograft aortic valves . 
However , there are those who believe that donor cells do 
not survive after allotransplantation(l49). Experimental 
evidence for continued donor cell survival in valves following 
allotransplantation is conflicting. Some reports have shown 
continued donor cell survival in fresh allograft leaflets 
implanted into dogs(l47 , 150,151), whereas others have reported 
rapid depletion of cuspidal cellularity after 
implantation(l52-154) . 
The problem of ensuring viability is compounded by the 
need for having a means of storing aortic valve homografts of 
different sizes for more than just a few days. A variety of 
storage processes have been tried(l8 , 143) including 
hypothermic storage in tissue culture medium , glycerol or 
dimethylsulphoxide. Freeze-drying and storage at room 
temperature was widely used from 1962 to 1968 , but there was a 
high failure rate with such prostheses, since they were 
effectively composed of dead , acellular , easily degradable 
tissue . 
Homograft valves were not widely used due to the 
difficulties described above . This was fortunate , since those 
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subjected to the rigorous sterilization and storage techniques 
in use up to 1968 had a high failure rate(l8). Antibiotic 
sterilization has been applied more recently and about 50% of 
such patients have normal valve function 5 years after 
implantation(l8). However, the advantages to the patient with 
regard to freedom from embolism, anticoagulation, noise and 
haemolysis justify the use of aortic valve homografts. Due to 
logistical difficulties, these valves have not been formally 
utilized at Groote Schuur Hospital. 
As noted earlier, in order to use the aortic valve 
homograft in the mitral position, the valve has to be mounted 
on a supporting stent to maintain normal cuspidal 
relationships. The rigid stent leads to greater stresses on 
the valve with resultant accelerated leaflet 
degeneration(l42). Others are hoping that the use of a pliable 
stent will reduce the magnitude of this problem(lSS). 
Pulmonary valve homografts implanted in the mitral position 
have been most unsuccessful(l56,157). Several reports describe 
the pathology of the human aortic valve homograft(l58-161). 
Hudson(l58) noted thickening of the bases of the cusps of 
aortic valve homografts in addition to the usual complications 
that may follow cardiac surgery. Smith(l59) noted that 
calcification occurs as a late complication in the dead tissue 
of the homograft. Davies et 1.(160) noted "degenerative" 
changes in the cuspidal collagen of their homografts implanted 
in patients, as well as calcification and/or rupture or 
perforation of the cusps. Aparicio et al.(161) studied the 
microscopical changes in valvular homografts and pig aortic 
xenografts sterilized by various methods. The freeze-dried 
valves showed structural changes due to physico-chemical 
degradation of the collagen due to improper preservation of 
the graft prior to insertion. Calcification was observed in 
this group, but not in homografts treated with 
gamma-radiation. The latter valves showed fewer and less 
severe morphological alterations. 
117 
TYPES OF PROSTHESES 
2. XENOGRAFT AORTIC VALVES. 
(i) UNFIXED XENOGRAFT VALVES. 
In 1965, Duran and Gunning(l62) reported on the behaviour 
of freeze-dried pig aortic valves transplanted into the 
descending thoracic aorta of 17 dogs. Although no animal 
survived for more than 18 months, the xenograft cusps were all 
in good condition. Duran and Gunning (unpublished data) 
transplanted a xenograft aortic valve in a very ill patient in 
1964. This patient, cited by Binet et al.(163), died 24 hours 
later from causes unrelated to the xenograft. At necropsy the 
valve was competent and in good condition. Encouraged by this 
work, Binet et al.(163) treated xenograft aortic valves by 
three days immersion in a mercurial solution prior to 
implanting them into 5 patients. Four patients received pig 
aortic valves and one was given a calf aortic valve. All 5 
patients were doing well at the time of documentation less 
than 3 months later. 
A year later Halseth et al.(164) reported that fresh, 
sheep aortic valves stored in a lactate-Ringer antibiotic 
solution had been implanted into the descending aorta of 35 
dogs. Only 6 animals survived longer than 7 weeks. Problems 
encountered included graft thrombosis, cuspidal atrophy and 
fibrosis. Duran et al.(165) found that ficin-digested and 
fresh, untreated pig 
transplanted into the 
valves 
canine 
gave poor results when 
descending aorta. Freeze-dried 
valves were associated with a lower operative mortality and an 
improved mean survival time, but there was a marked tendency 
for the grafts to rupture through the heterologous aortic wall 
cuff. Sweatt et al.(166) transplanted aortic aortic valves of 
sheep and pigs into the descending thoracic aorta of dogs. The 
valves were fresh, freeze-dried, or treated with 
propiolactone . Half of the recipient dogs received 
azathioprine. The following conditions gave the best results : 
(a) transplantation of a minimum of aortic wall with the valve 
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(b) good initial alignment and movement of the cusps ; (c) 
administration of azathioprine for 8 weeks ; and (d) support 
of the graft by a Dacron tube , preventing rupture and 
separating the graft from ingrowing host tissue . Drury et 
al.(167) compared porcine aortic valves stored in various 
concentrations of sucrose (50-80%) for up to one year with 
others stored in a nutrient and antibiotic medium for 12 
weeks . They concluded that sucrose solution is acceptable for 
the long-term preservation of biological valves . 
(ii) FORMALDEHYDE-PRESERVED XENOGRAFT. 
Obtaining aortic valve grafts from animals overcomes the 
logistical problems encountered with procuring cadaveric human 
aortic valves. While fresh valves could be implanted , there is 
the potential problem of rejection. Also , since the viability 
of fresh allograft aortic valves was often questionable , 
attention began to shift from the viability of the cuspidal 
cells to factors affecting the connective (mainly collagenous) 
tissue which constitutes the valve substance . Various means of 
pre-treating the xenograft valve in order to render it less 
antigenic were evaluated e . g ., mercurial salts(l68) or 4% 
buffered formaldehyde solution(l69). In 1968 , Warren Hancock , 
an engineer with Hancock Laboratories, Anaheim, California and 
William Angell of Cutter Laboratories , Berkeley , California , 
produced the first commercially available prepared tissue 
valve . This was a formalin-tanned , stent-mounted porcine 
xenograft . Long-term follow-up in such patients was 
disappointing. As we shall see later (Chapter 9) the locally 
prepared University of Cape Town formalin-treated porcine 
xenografts yielded similar results . Formalin-fixation by 
cross-linking of valve collagen was found to be reversed in 
vivo , resulting in stretching, thinning and tearing of the 
leaflets when the cusp degenerated(l43 , 170) . 
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(iii) GLUTARALDEHYDE-TREATED PORCINE XENOGRAFT AORTIC VALVES. 
(a) CARPENTIER PROSTHESIS. 
Alain Carpentier(l71) showed that the durability of a 
preserved tissue valve depended upon its own structural 
integrity. The underlying concept of the porcine aortic valve 
was changed from that of a graft to that of a bioprosthesis 
i.e., the tissues used to construct the valves are pre-treated 
in such a way that they become non-antigenic and stable like a 
synthetic material. Thus, in contrast to a graft, the 
durability of the bioprosthesis depends upon the unfailing 
stability of the biological material and not upon regeneration 
by host cells. He used sodium metaperiodate oxidation of 
mucopolysaccharides and glycoproteins to reduce antigenicity 
and glutaraldehyde to prevent collagen denaturation. The new 
glutaraldehyde-treated porcine aortic valve was first 
implanted by Carpentier in 1968 using an asymmetrical stent to 
support the muscular component of the right coronary 
cusp(l72). Unfortunately, Carpentier's first glutaraldehyde 
xenograft implants were hampered by poor leaflet mobility and 
tissue fatigue due to the oxidation step in the tanning 
process(l73). 
(b) HANCOCK GLUTARALDEHYDE-PRESERVED PORCINE XENOGRAFT VALVE. 
















strength(l25). Following the promising 
by Carpentier's glutaraldehyde treated 
xenograft valve, Reis and Hancock(l74), working at the United 
States National Institutes of Health and Hancock Laboratories, 
and Angell first with Cutter and then with Shiley Laboratories 
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in California, changed from formaldehyde to glutaraldehyde 
fixation(l75). These valves were first used clinically in 1969 
and 1970 respectively. There are 3 commercially available 
glutaraldehyde-treated xenograft valves from Hancock, 
Edwards (Santa Ana,California) and Shiley Laboratories . 
While these three companies manufacture the porcine 
bioprosthesis in a very similar manner , specific techniques of 
tissue handling and valve mounting probably accounts for the 
main differences between these valve types(163) . In the case 
of the Hancock glutaraldehyde xenograft valve , the stent has a 
symmetrical and uniform design and the stent material consists 
of Stellite and polypropylene. The stent itself is covered 
with Dacron . A 0 . 2% glutaraldehyde solution is used for 
pressure fixation of the valve in the closed position prior to 
suturing of the valve (by continuous and interrupted sutures) 
to the cloth-covered , semi-flexible stent and for subsequent 
storage of the manufactured bioprosthesis . A silicone rubber 
(Silastic) insert within the Dacron cloth ring acts as a 
cushion to facilitate coaption of the bioprosthesis to the 
patient ' s valvular annulus . The prosthesis is radiolucent 
apart from the metallic ring in the base . The aortic 
prosthesis (Model 2 4 2) and the atrioventricular valve (Model 
342) differ only in the shape of their sewing margins . Due to 
the obstructive effect within the stent of the muscular 
component to 
Laboratories 
the porcine right coronary cusp , Hancock 
produced a valve (Model 250) in which this cusp 
was replaced by a non-muscular cusp . This yielded a composite 
prosthesis with a larger flow orifice . 
(c) CARPENTIER-EDWARDS GLUT AR ALDEHYDE-TREATED PORCINE 
XENOGRAFT AORTIC VALVE . 
The first series of xenograft valves produced by Edwards 
Laboratories incorporated an oxidation step with sodium 
metaperiodate before glutaraldehyde fixation(l73) . This step 
was abandoned in the mid-1970s(l76) . The second series of 
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valves was treated with glutaraldehyde alone . The first such 
valve was implanted by Dr Carpentier in March 1975 the 
commercially available prosthesis , named the 
Carpentier-Edwards valve , was generally available from 1976 . 
The Carpentier-Edwards valve(l8,163) is treated in a 
stronger glutaraldehyde solution (0 . 625 % glutaraldehyde in 
phosphate buffered saline , pH 7.4) than is the Hancock valve . 
The compliant metal stent consists of Elgiloy (an alloy of 
cobalt and nickel made by 
stent (i . e . ,the supporting 
The inflow orifice is 





Corporation). The entire 
base frame) is flexible. 
to support the partly 
cusp . The commissural 
supports are not equidistant and slant inwards at an angle to 
conform with the anatomical configuration of the porcine 
aortic valve . The asymmetry allows the use of a larger pig 
valve for a given stent diameter. The strength and flexibility 
of Elgiloy allows the use of a thinner metal frame , resulting 
in an improved orifice-to-annulus ratio(l8) of 0 . 91 
to 0 . 76 for the Hancock valve) . 
(compared 
The metal frame is covered with porous , knitted Teflon 
cloth to facilitate tissue invasion and encapsulation . The 
sewing ring has a Silastic (silicone sponge rubber) insert, 
which is covered by a porous , seamless Teflon cloth . As in the 
Hancock valve , the compliant sewing ring allows coaption 
between the valve and an often irregular or calcified tissue 
bed . The pig valve is attached to the stent by both 
interrupted and continuous sutures . 
The current Model 2625 Aortic and Model 6625 Mitral 
Carpentier-Edwards Bioprostheses have been used clinically 
since March 1975 in at least seven institutions world-wide . A 
data sheet issued by Edwards Laboratories in November 
1968(177) reported that 0.625 % glutaraldehyde is an effective 
sterilizing agent 
including E . coli , 
Candida albicans 





Streptococcus pyogenes , 
of mycobacteria. Only the 
mature spore of Chaetomium globosum was found to be resistant 
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to 0 . 625% glutaraldehyde . Glutaraldehyde in concentrations up 
to 10% proved to be ineffective against this organism ' s mature 
spore . Formaldehyde in a 4% concentration was found to be an 
effective sterilizant against this spore . Since studies showed 
that glutaraldehyde-induced leaflet tissue cross-linkage was 
not reversed after short-term exposure to 4% formaldehyde, 
this step was added to the valve preparation as an additional 
sterilization precaution. The recent Carpentier-Edwards valves 
are thus treated with both glutaraldehyde and formaldehyde . 
As noted earlier , the Carpentier - Edwards valve uses an 
asymmetric design for the base of the valve to give a more 
contoured inlet orifice . This design plus the thinner sewing 
ring provides better hydraulic function than the standard 
Hancock valve . However , 
in the small sizes , are 
valves . In 1981 , 
the transvalvular gradients , especially 
still higher than those of mechanical 
Bonchek(l25) reported that Edwards 
Laboratories were introducing a modified xenograft prosthesis 
with improved hydraulic performance in vitro due to further 
thinning of both the cloth and metal components of the frame . 
(d) ANGELL-SHILEY VALVE . 
Dr William W. Angell and his co-workers started making 
glutaraldehyde-treated porcine aortic valve xenografts in 
1970 , using the metal stent used earlier in 
In 1975 , an association was entered 
aortic homografts . 
into with Shiley 
Laboratories, and the Angell-Shiley xenograft valve was 
marketed(l8). These valves were treated with 0 . 5% 
glutaraldehyde and the flexible stent was made of Delrin and 
totally covered by Dacron cloth . The stent has an anatomic 
design derived from castings which were made from the most 
frequently occurring porcine aortic valve configurations(l75) . 
Each pig valve is matched to one of 70 different anatomic 
stent configurations , which vary in both shape and size . This 
provides a natural position and support for the valve . The 
resulting annular sewing rim is not circular in shape and thus 
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the orificial area of the bare stent is a 
quantity . 
(e) LOW PROFILE BIOPROSTHESIS. 
calculated 
This low-profile, glutaraldehyde-fixed porcine aortic 
valve is produced by Cientifica Argentina, Buenos Aires , 
Argentina. Navia et al . (178) report on the hydraulic and 
haemodynamic features of this valve in 316 patients . 
3. AUTOLOGOUS FASCIA LATA VALVE . 
Professor Ake Senning(l79) of Switzerland in 1962 first 
implanted an unstented aortic valve prosthesis fabricated from 
fascia lata. While the patient was on cardiopulmonary bypass , 
a strip of fascia was taken from the patient ' s thigh, cleaned 
and tailored to size . The strip was sutured into the aortic 
root using continuous sutures and the commissures were 
attached to the aortic wall by separate , Teflon-felt anchored 
sutures. Senning ' s favourable experience with such a valve 
stimulated Mr . Donald N. Ross and Mr . M. I . Ionescu of Britain to 
produce a series of fascia lata valvular prostheses for use in 
the aortic , mitral , tricuspid, and pulmonary positions. In 
their valves the fascia was mounted on a cloth-covered metal 
stent. The early results showed a low rate of 
thromboembolism(lS0 , 181). 
This encouraged many surgeons world-wide to implant 
home-made autologous fascia lata valves . Experimental 
data(l82 , 183) soon began to sound a cautionary note regarding 
the durability and lack of thrombogenicity of the fascia lata 
valve. Such valves gave disastrous results when used in the 
mitral and tricuspid positions(l84-187) due to severe 
regurgitation . Within 3 years after implantation , 90% of 
mitral valves and 20 % of aortic valves had failed(l8) . Removed 
valves often showed leaflet shrinkage , retraction and loss of 
mobility due to overgrowth by host tissue(l88,189) . A wide 
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literature documents the meteoric rise and fall in popularity 
of the fascia lata heart valve(l90-234) . 
4. DURA MATER HOMOGRAFT VALVE . 
Dura mater has been used previously to repair inguinal 
hernias(235) and experimentally to reconstruct the right 
ventricular outflow tract(236) . The external aspect of the 
dura mater has a smooth , shiny surface and the internal aspect 
is covered by a layer of arachnoidal endothelial cells(237) . 
At the easily detachable (temporal) area the dura mater is 
less vascular and it is of uniform thickness , resistance and 
flexibility. Since the dural double collagen layer has the 
collagen bundles arranged at right angles to each other, it 
should be stronger structurally than fascia lata in which 
there is only a single layer of parallely arranged collagen 
fibres . The failure of the fascia lata valve led to attempts 
to fashion a valve from dura mater . This form of prosthesis 
was pioneered by Professor E . J. Zerbini and colleagues in 
Brazil(237-239) starting in 1971. 
Dura mater was obtained within 20 hours after traumatic 
death from human cadavers aged between 10-50 years . Cases of 
infective or degenerative diseases , as well as neoplasia were 
excluded . The dura mater was removed at autopsy using sterile 
gloves and instruments. Thereafter it was washed for 1-2 hours 
in flowing water and then placed in a sterile container filled 
with 98 % glycerol at room temperature for 10-20 days . At the 
end of this time a sample of the dura was cultured 
bacteriologically. Zerbini and Puig found that 18 . 7 % of such 
samples were contaminated and the dura had to be 
discarded(237) . 
Before valve construction, the tissue is rehydrated in 
sterile physiological saline and the valves are then fashioned 
under operating theatre conditions. The leaflets are 
separately cut from the dura selecting areas with a similar 
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thickness and vascularity . The separate cusps are texture , 
mounted 
stent and 
on a Dacron velour-covered , rigid , stainless steel 
attached to each other by interrupted sutures 
augmented by Teflon strips. The dura mater is mounted on the 
outside of the struts , resulting in retention of the full 
central orifice . Completed prostheses are stored at 4 degrees 
Centigrade in an antibiotic solution(18) . The radio-opaque 
stent is readily recognizable on x-ray . 
The dura mater valve has a low incidence of 
thromboembolism without anticoagulation(18) . Procurement of 
dura mater is a problem outside large metropolitan areas where 
trauma victims are less plentiful. Sterility is another 
important problem , since the efficacy of glycerol in this 
regard is dubious . The valve has shown a moderately high rate 
of early and late re-operation . The 
development and clinical usage of 
bioprosthesis is reflected in 
prosthesis is no longer used. 
more recent history of the 
the dura mater valvular 
references 240-249. This 
5 . BOVINE PERICARDIAL XENOGRAFT BIOPROSTHESES. 
(i) IONESCU-SHILEY VALVE . 
In 1970 Dr Marian I . Ionescu began constructing and testing 
glutaraldehyde stabilized pericardial x enografts(250,251) . 
Between March 1971 and April 1976 the valves were constructed 
in limited numbers in his own laboratory in Leeds , England and 
used for single valve replacements only(252). Following on the 
good results obtained after 5 years of clinical testing(253) , 
from May 1976 the Ionescu-Shiley pericardial xenograft valve 
became available from Shiley Laboratories Inc ., Irvine , 
California , U.S . A. 
The Ionescu-Shiley valve(lS,252 , 254) consists of bovine 
pericardium mounted 
support stent . The 
on a Dacron cloth - covered pure titanium 
sewing ring consists of porous Dacron 
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fabric covered with a thin layer of Dacron cloth . All valve 
sizes have the same sewing ring configuration and there is no 
difference between valves used in the aortic or 
atrioventricular positions , either sub- or supra-annularly . 
The pericardium is o b tained fro m 6 - 18 months old calves 
which have been certified as being fit for human consumption 
by the United States Food and Drug Administration . Sterile 
procedures are used from the time the pericardium is 
harvested . The pericardium is first placed in a balanced 
electrolyte solution to remove soluble antigenic proteins . 
Thereafter it is stored at 4 degrees Centrigrade for 2 weeks 
in 0 . 5% glutaraldehyde buffered to pH 7 . 4 with 0 . 067 M 
phosphate(240). This treatment aims to reduce or eliminate 
antigenicity and prevent collagen denaturation by forming 
irreversible covalent cross-links between the amino groups of 
collagen and glutaraldehyde(l8) . A single strip of pericardium 
is used per prosthesis and the tissue is stitched to the 
outside of the stent to 







orifice - to-annulus ratios for various 23 mm prostheses are 
0 . 65 for the Starr-Edwards caged-ball valve , 0 . 70 for the 
Lillehei-Kaster pivoting disc valve , 0 . 78 for the Bjork-Shiley 
tilting disc valve and 0 . 84 for the Ionescu-Shiley valve(l8). 
Such an advantage is important in small aortic sizes . The 
strut posts of small valves (17 to 23 mm annulus diameter) are 
splayed 9 degrees outward to maintain the full central 
orifice . 
The valves manufactured in Ionescu ' s own laboratory 
between 1971 and 19 7 6 underwent little , if any , quality 
control(252) and no standardization of thickness and 
pliability of the cusps was attempted . Also these early valves 
were pre-treated with sodium metaperiodate and ethylene glycol 
prior to fixation in a simple dilution of commercially 
available , non-purified glutaraldehyde . The latter has an 
unknown and unstable proportion of monomers and polymers(251) . 
Aqueous solutions of glutaraldehyde are complex mixtures of 
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free glutaraldehyde, mono- and dihydrate glutaraldehyde, 
cyclic monomer and polymer glutaraldehyde and alpha, beta 
unsaturated glutaraldehyde polymers. The importance of 
glutaraldehyde polymerization has not been well understood. It 
would appear that monomeric glutaraldehyde is not an effective 
fixative because a longer chain polymer is necessary in order 
to bridge the gap between the collagen protein amino acid 
molecules(175). Solutions containing high concentrations of 
very long-chain glutaraldehyde polymers are poor fixatives due 
to the reduced number of active aldehyde groups available for 
cross-linking . Pure solutions of relatively short-chain 
polymers appear to provide optimal fixation(252,253). 
Since 1976 the pericardial xenografts produced by Shiley 
Laboratories have been treated with a solution of ' purified 
glutaraldehyde' containing the optimal proportion of monomers 
and polymers and an ideal cross-link density achieved by 
controlling the concentration and pH of the solution as well 
as its temperature and the exposure time. The completed 
bioprosthesis is transported and stored in 4% buffered 
formaldehyde to maintain sterility . 
Ionescu ' s data(250-252) showed that the pericardial valve 
had a low thrombogenicity without anticoagulants, an absence 
of catastrophic failure , good haemodynamic function and lack 
of haemolysis (if no paravalvular leak was present). However , 
the narrow unpadded sewing ring appeared to predispose to a 
high incidence of perivalvular leakage after aortic valve 
replacement(l8,252) . While the valve appears to give good 
service in the aortic position , the 3 year re-operation rate 
of nearly 12% after mitral valve replacement and the 
established poor durability record of other tissue valves(18) 
in this position leaves a question mark over this prosthesis 
for mitral valve replacement . Pathologic data on a few 
Ionescu-Shiley valves encountered in hearts received for 
examination from another hospital (see Chapter 13) as well as 
in experimental implants performed in baboons (Papio ursinus) 
in our institution (see Chapter 16) are recorded later in this 
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study. Published experience(254-267) with follow-up periods of 
up to 10 years(261) records a low incidence of valve-related 
complications. Calcification of the prosthesis militates 
against its use in children(265) . 
(ii) EDWARDS PERICARDIAL VALVE. 
valve produced The bovine pericardial 
Laboratories differs from the Ionescu - Shiley 
by Edwards 
valve in the 
following respects : (a) The frame is totally made of flexible 
Elgiloy wire rather than rigid titanium . Thus , both the 
orifice and the supports are flexible. (b) The pericardium is 
treated with 0.625% glutaraldehyde rather than a 0 . 5% 
concentration . (c) There are different sewing ring 
arrangements for the aortic and atrioventricular prostheses. 
(d) The valve is transported and stored in glutaraldehyde 
rather than formaldehyde. 
(iii) MITROFLOW BOVINE PERICARDIAL HEART VALVE . 
In 1982 Professor C . N. Barnard and his colleagues at Groote 
Schuur Hospital and the University of Cape Town , South Africa 
implanted in baboons (Papio ursinus) a series of bovine 
pericardial heart valve prostheses constructed by Mitral 
Medical International Inc ., of Wheat Ridge , Colorado , U . S.A . 
These valves have been made from glutaraldehyde-treated bovine 
pericardium . The valves have also been evaluated in a canine 
model in the United States of America . These results have not 
yet been published in any medical journal (see Chapter 16). 
The valves have been implanted in a large number of patients 
in Spain and in less than a dozen patients at Groote Schuur 
Hospital. 
(iv) MEDOX UNICUSPID BOVINE PERICARDIAL HEART VALVE. 
In a lecture to the Southern Africa Cardiac society on 
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March 7,1984 Professor R . W. M. Frater mentioned that the 
Albert Einstein College of Medicine would shortly be marketing 
a unicuspid pericardial heart valve . The single cusp is the 
only moving component of the valve and it closes against an 
immobile pericardial baffle . 
6. ABIOMED POLYMERIC PROSTHESIS. 
The Abiomed polymeric trileaflet heart valve prosthesis 
was originally designed for use in valved conduits . Flow 
studies indicate that overall it has improved leaflet motion 
and pressure drop characteristics compared to the 
Carpentier-Edwards porcine and Ionescu-Shiley pericardial 
tissue valves in current clinical use . The Abiomed valve is , 
however , more stenotic 
low-profile 
than the St Jude Medical and 
Medtronic-Hall 
outputs(268) . 
C . VALVE-CONTAINING CONDUITS . 
valves at 
1 . PULMONARY ARTERY AND VALVE SUBSTITUTES . 
normal cardiac 
Tubular conduits containing valvular prostheses have been 
used clinically as pulmonary artery and valve substitutes in 
complex congenital heart disease(l8) . In patients with 
transposition of the great arteries undergoing surgical 
correction, the finding of pulmonary obstruction too severe to 
be eliminated by excision is an indication for a Rastelli 
operation(269). In this procedure the left ventricular flow is 
diverted via an intra ventricular conduit through the 
ventricular septal defect into the aorta . The pulmonary artery 
is divided and the proximal (cardiac) stump is ligated . An 
extra-cardiac valved conduit restores continuity between the 
right ventricle and the distal pulmonary artery . 
Kirklin(270) used a composite conduit for repair of 
pulmonary valve and pulmonary artery atresia associated with a 
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defect . The conduit consists of 
inserted into a 
containing a homograft valve . The valve 




sutures proximally and distally . The knitted Dacron graft 
containing the homograft valve is then interposed between 2 
woven Dacron grafts . The distal end of this composite graft is 
then fashioned according to the pathological features of the 
pulmonary arteries and is sutured distally . The proximal end 
of the graft is sutured to an opening in the right ventricle . 
Artificial tube grafts containing valvular prostheses have 
also been used for the correction of other complex congenital 
cardiac diseases e . g . , a persistent truncus arteriosus (common 
aorticopulmonary trunk)(271) . 
2 . LEFT VENTRICLE-TO - AORTA BYPASS. 
Following upon the above described successful use of 
valved conduits to correct right-sided cardiac defects , 
attempts have recently been made to apply similar techniques 
to left-sided cardiac lesions(l8). The first fully reported 
clinical use of the double-outlet left ventricular concept for 
patients with severe aortic stenosis was that of Bernhard et 
al.(272). Their patient also had hypoplasia of the aortic ring 
and of the ascending aorta. 
Apico-aortic shunts are primarily used in persons with 
complex forms of supravalvular or subvalvular aortic stenosis 
in whom complex surgery in the aortic root may be avoided(l8) . 
The conduits may also have a potential role to play in 
patients with infective endocarditis where the infection has 
left insufficient tissue in the aortic ring for the suturing 
of a valve prosthesis . 
All of these apico-aortic shunts appear to need to have a 
rigid outlet connector in order to prevent occlusion of the 
apical outflow tract by myocardium . The conduits may differ 
with regard to the type of valve they incorporate and the 
location of the distal anastomosis . Tissue valves have been 
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the most popular , because most conduits have been used in 
children in whom freedom from anticoagulants is an advantage. 
However , lack of long-term durability may limit the use of 
such valves . Several firms manufacture conduits : 
(a) Thermo Electron Corporation , Waltham , Massachussetts make 
a rigid U-shaped stainless steel tube , which is coated 
externally with a layer of polyurethrane(261). The inner 
aspect is lined with Dacron fibrils and the distal end 
consists of tubular Dacron which may be connected to a 
valve-containing Dacron tube graft. 
(b) Texas Technology Transfer Laboratories , Inc . make a rigid 
ventricular tube made of bevelled pyrolytic carbon with a 
Teflon felt sewing margin and a woven Dacron tube graft is 
attached distally(273) . 
(c) Hancock Laboratories 
Stellite frame covered 
initially made a conduit with a 
by polyurethrane(l8), but the more 
recent device uses a semi-rigid polypropylene support and the 
internal surface is lined with Dacron fabric. 
3 . REPLACEMENT OF AORTIC VALVE AND ASCENDING AORTA. 
As a safer procedure in patients with ascending aortic 
aneurysms and severe aortic incompetence, Bentall and De 
Bono(273) used a conduit consisting of a Starr-Edwards valve 
in a Teflon tube graft to join the aortic valve ring to the 
distal non-aneurysmal aorta . This technique obviates placing 
sutures in the often diseased aortic root. The coronary ostia 
are sutured to holes made in the tube graft . Lefrak and 
Starr(l8) comment that this technique holds promise for 
patients with very small aortic valve rings who require aortic 
valve replacement . 
CONCEPTS AND ENGINEERING EVALUATION OF HEART VALVE 
SUBSTITUTES 
For additional information regarding biomaterials and 
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design of valvular prstheses references 266-288 should be 
consulted. A number of papers deal with the in vitro testing 
of heart valve prostheses(289-306) , whilst others give special 
consideration to tissue-derived prostheses(307-316) . The 
search for the ideal prosthesis is a continuing one and modern 
thoughts are again turning towards the concept of a synthetic 
valve (Mr G . Keith Gielding , Mitral Medical Inc. , personal 
communication) . A similar earlier concept , the synthetic 
Hufnagel trileaflet prosthesis(317) 
results. 
gave poor 
IDENTIFICATION OF PROSTHETIC HEART VALVES 
clinical 
Several articles outline the morphological(6 , 9-ll) and 
radiological(318 , 319) criteria for the identification of 
prosthetic heart valves. Such identification has been rendered 
important due to the continuing introduction of new prosthetic 
heart valves and the increasing awareness of 
prosthesis-related complications. The operation notes are 
often not available to the pathologist performing an autopsy 
on such patients . 
Firstly , one has to decide if the valve in question is a 
mechanical prosthesis (made of artificial materials) or a 
xenograft prosthesis (made of biological tissue) . With regard 
to the mechanical prostheses , there are high-profile valves 
which have a ball as the mobile portion (Starr-Edwards , 
Smeloff - Cutter, DeBakey-Surgitool , Braunwald-Cutter , 
Magovern - Cromie, Harken , and Surgitool 200 prostheses) and the 
low-profile valves which have a mobile disc. The latter 
include the following prostheses Lillehei-Kaster , 
Wada-Cutter , Bjork-Shiley , Cooley-Cutter , Kay-Suzuki , Harken , 
Starr-Edwards model 6520 , Cross-Jones , Beall model 103, 
Beall-Surgitool model 105 , and the Kay-Shiley (T series , K 
series , MGCD series and TGCD series) prostheses . 
Next the number of struts should be examined . With the 
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low profile valves it is important to note whether the struts 
have an acute angle to the base ring plane (Lillehei-Kaster) , 
emerge into the valve orifice (Wada-Cutter, Bjork-Shiley) , or 
arise at right angles to the base ring plane (Cooley-Cutter , 
Kay-Suzuki , Starr-Edwards models 6500 and 6520 disc valves , 
Harken disc valve , Cross-Jones , Beall model 103 , 
Beall-Surgitool model 105 , and Kay-Shiley (series T , K, MGCD , 
TGCD) prostheses . 
Note whether the cage is single (Starr-Edwards) or double 
(Smeloff-Cutter) and whether the cage is open 
(Braunwald-Cutter , Magovern-Cromie , and Starr-Edwards models 
2300, 2310, 6300, 6310) . In the latter Starr-Edwards models 
the cloth covering the struts obscures the opening, which is 
easily identified only by radiography . The Magovern-Cromie 
valve has a large cage opening , whereas the above - named 
Starr-Edwards models have a small cage opening . The other 
models of the Starr-Edwards prostheses have a closed cage. 
References numbers 6 , 9 - 11,183 , 184 should be consulted for 
further details regarding such distinguishing features as the 
strut-ring junction, the shape of the base ring edge , the site 
at which the poppet seats (e . g., near its equator or 
otherwise) , radiolucency of the ball or of the disc occluder . 
Radiography of the prosthesis at postmortem may help the 
pathologist identify the type of heart valve prosthesis he is 
dealing with. This is especially helpful in the case of the 
currently available xenograft prostheses . Whereas the x-ray of 
the Hancock porcine aortic valve prosthesis , like that of the 
Hancock pericardial heart valve , reveals only a narrow 
wire-like base ring (please see Fig . 12 . 2 of Chapter 12) , the 
Carpentier-Edwards xenograft valve has a radiolucent base ring 
and only the serpentine - like wire stent is radiopaque (Fig. 
2 . 4). Mehlman(319) has recently reviewed the radiographic 
features of ten of the newer valvular prostheses marketed in 
the United States of America since 1978 . This updates an 
earlier report(318) . The base ring and stent of the Hancock II 
porcine xenograft valve are radiolucent. Three tiny circular 
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rings mark the distal external aspects of the 3 supporting 
posts . Although superficially similar to the radiographic 
silhouette of the Carpentier-Edwards Bioprosthesis , in the 
Carpentier-Edwards Supra - Annular Bioprosthesis the change of 
shape of the wireform as it shifts from base ring to stent is 
more gradual, giving the wire a gently curving instead of a 
right-angle appearance. 
In the Carpentier-Edwards pericardial valve prosthesis 
the base ring is marked radiographically by a flattened 
circular ring with three holes . The flattened ring does not 
extend into the stent as is the case with the Ionescu-Shiley 
xenograft (Fig . 2 . 4) . In addition , a narrow wireform outlines 
each of the 3 stent posts and the base ring. In the case of 
the Ionescu-Shiley xenograft valve the base ring and stent 
form a single radiopaque structure which appears flattened 
with many perforations in both. By contrast the Ionescu-Shiley 
Low Profile Pericardial Xenograft has a base ring consisting 
of 3 narrow wireform arcs , each length being approximately 
one-third of the circumference of the base ring . Adjoining 
arcs are separated by small radiolucent areas. The stent posts 
are radiolucent. 
The St Jude Medical valve , which has 2 leaflets that open 
to right-angles to the base ring , is radiolucent . When viewed 
on edge, the discs may be weakly radiopaque. The Bjork-Shiley 
heart valve prosthesis with the convexo-concave disc has the 
same x-ray appearance as the Bjork-Shiley valve with the 
straight disc and incorporated disc marker . Emerging from the 
base ring towards its centre are 2 eccentrically located 
U-shaped structures of unequal size. The radiolucent disc 
contains a narrow , circular radiopaque disc marker. The 
Bjork-Shiley Integral Monostrut cardiac valve prosthesis has 
only one U-shaped structure . Perpendicular to the flattened 
portion of the U is a short straight projection with a very 
small hook or bulge on its end . The radiolucent disc also has 
a radiopaque circular disc marker . Due to strut fractures , 
this prosthesis has been removed from the market . 
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Figure 2 . 4 : Postmortem radiograph of a heart containing two 
xenograft bioprostheses. The Ionescu-Shiley aortic valve 
prosthesis has a solid continuous base ring and stent (with 
circular perforations) , whereas the Carpentier-Edwards porcine 
aortic valve prosthesis has a radiolucent base ring and a 
radiopaque , serpentine-like wire stent . 
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CHAPTER 3 . 
PATHOLOGY OF NATURAL HEART VALVES AND INDICATIONS FOR HEART 
VALVE REPLACEMENT 
In this chapter I shall pay attention to pathological 
conditions warranting replacement of heart valves, and discuss 
the clinical indications for heart valve replacement , the 
problem of matching prosthesis to patient, and trends in 
cardiac surgery at the University of Cape Town. One hundred 
consecutive valve replacement operations will be analysed with 
regard to the aetiology of the native valvular disease and the 
incidence of Aschoff bodies in surgically resected atrial 
appendages . 
A. PATHOLOGY OF CARDIAC VALVES WARRANTING REPLACEMENT BY VALVE 
PROSTHESES . 
Before reviewing the clinical indications for heart valve 
replacement , I would like to examine the various types of 
valvular diseases which may necessitate heart valve 
replacement . This survey of valvular pathology covers 18,132 
autopsies performed in the University of Cape Town Pathology 
Department during the 30 year period 1950-1979 . 
l . ACQUIRED VALVULAR HEART DISEASE IN 1225 AUTOPSY PATIENTS 
ENCOUNTERED OVER A 30 YEAR PERIOD : 
Table 3 . 1 gives the functional classification of the 
clinically significant acquired valvular heart diseases 
encountered in 1225 autopsy patients (6.8%) during this 
period . Table 3 . 2 indicates associated involvement of other 
valves . In Cape Town the mitral valve (Figs . 3 . 1 and 3 . 2) is 
the most commonly diseased heart valve (52 . 1% of acquired 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































PATHOLOGY & INDICATIONS 
TABLE 3.3 RATES OF RHEUMATIC MITRAL STENOSIS (MS) PER 100 
AUTOPSIES 
1950-1959 1960-1969 1970-1979 
PTS·. WITH 
MS 132 148 124 
No. OF 
AUTOPSIES 5428 4915 4120 
RATE/100 
AUTOPSIES 2.43 3.01 3.01 
Figure 3.1 : Severe rheumatic stenosis of mitral valve orifice 
due to commissural and chordal fusion. The cusps and chordae 
are also shortened. 
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Figure 3.2 (clockwise from top left) : left atrial view of 
floppy mitral valve ; appearance of opened floppy valve 
ruptured mycotic aneurysm of infected anterior mitral leaflet 
; ruptured head of infarcted postero-medial papillary muscle. 
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TABLE 3 . 4 : TYPES OF CONGENITAL HEART DISEASE IN 358 AUTOPSY 
PATIENTS COMPRISING 2 . 0% OF 18 , 132 AUTOPSIES ENCOUNTERED 
OVER THE 30 YEAR PERIOD 1950 - 1979 . 
MITRAL VALVE 
STENOSIS 5 ( 1. 4%) 
INCOMPETENCE 4 (1 . 1%) 29 
ATRESIA 20 (5.6%) 
AORTIC VALVE 
STENOSIS 7 (2 . 0%) 
ATRESIA 12 (3 . 4%) 31 
CALCIFIED BICUSPID 12 (3 . 4%) 
INCOMPETENCE 0 
TRICUSPID VALVE 
STENOSIS 10 (2 . 3%) 
ATRESIA 12 (3 . 4%) 30 
STRADDLING 3 (0 . 8%) 
EBSTEIN ' S ANOMALY 5 (1 . 4%) 
INCOMPETENCE 0 
PULMONARY VALVE 
STENOSIS 24 (6 . 7%) 
FALLOT'S TETRA LOGY 82 (22.9%) 146 
ATRESIA 40 (11 . 2%) 
COMMON ATRIOVENTRICULAR CANAL 14 (3 . 9%) 
SUBAORTIC STENOSIS 9 (2 . 5%) 
DOUBLE OUTLET RIGHT VENTRICLE 15 (4 . 2%) 
PERSISTENT TRUNCUS ARTERIOSUS 22 (6.2%) 
COMPLETE TRANSPOSITION 62 (1 7 . 3%) 
TOTAL 358 
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Figure 3.3 : Aortic nodular sclerosis (top left) 
congenital bicuspid aortic valve (top right) 
transversely sectioned congenital bicuspid 
(below). 
calcified 
histology of a 
aortic valve 
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(39 .4%) , and the tricuspid (8 . 3%) and pulmonary valves (0 . 3%) . 
In none of our patients was tricuspid valvular disease the 
most significant functional lesion ; usually it was associated 
with more severe disease of the mitral and aortic valves . 
Rheumatic-type valvular disease accounted for 99 . 8% of the 
cases of mitral stenosis and 68 . 9% of 
incompetence . This overall pattern 
patients with mitral 
of descending order of 
disease involvement of the mitral , aortic , tricuspid and 
pulmonary valves is similar to that seen in other developing 
countries e . g., India and in the countries of South America . 
In the more developed countries of Europe and North America 
the frequency and severity of rheumatic fever have 
diminished(l-4) . In the United States , Roberts et al.(S) found 
at necropsy that aortic stenosis was twice as frequent as 
mitral stenosis . My data show that mitral stenosis , (usually 
attributed aetiologically to rheumatic fever) , is 
approximately a third more common than aortic stenosis ( Table 
3 . 1 ). Table 3 . 3 shows that our autopsy incidence of mitral 
stenosis has not diminished over the 30 year period 1950 to 
1979 . Thus , Cape Town still has a relatively high autopsy 
incidence of rheumatic-type heart disease . My findings confirm 
a recently published analysis(Sa) of the incidence of 
rheumatic fever in children in South Africa and abroad. In the 
United Kingdom and Japan , the incidence rate of rheumatic 
fever is 0 . 06/1,000 inhabitants and in America it is 0.7/1000. 
A conservative estimate(Sa) of the incidence of rheumatic 
fever in South Africa is 
Indians it is 11/1000 . 
7/1 , 000 inhabitants and in Natal 
Whereas rheumatic fever was the apparent cause of 
virtually all of our cases of mitral stenosis , only 46 . 3% of 
acquired aortic stenosis was due to chronic rheumatic - type 
deformity . In 81 out of the 87 
unclassified aortic stenosis the aortic 
diseased heart valve . According to 
isolated valvular aortic stenosis 
patients (93%) with 
valve was the only 
Roberts et al . (S) such 
is nearly always 
non-rheumatic in origin and most commonly represents a 
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congenital malformation of this valve(6,7). Davies(8) states 
that the predominant cause of isolated aortic valve stenosis 
is premature calcification of a congenitally bicuspid valve. 
Many pathologists are apt to wrongly diagnose such valves as 
aortic nodular sclerosis (tricuspid senile calcific stenosis). 
Indeed, a calcified bicuspid aortic valve was found in our 
pathology museum wrongly labelled as an example of aortic 
nodular sclerosis. This diagnostic pitfall is facilitated by 
the fact that the congenitally bicuspid aortic valve only 
develops stenosis as cuspidal calcification commences from 
middle age onwards. 
Aortic nodular sclerosis (Fig. 
than a quarter of our cases of 
3.3) accounted for less 
aortic stenosis. Healed 
infective endocarditis was regarded as the cause of aortic 
valve stenosis in 3.3% of patients. Rheumatic fever, infective 
endocarditis, syphilis (Fig. 3.4) and aortic medionecrosis 
were the commonest cause of aortic regurgitation (Table 3.1). 
Tricuspid valve disease (incompetence and/or stenosis) was 
mainly due to rheumatic-type involvement, with smaller 
contributions made by infective endocarditis and myxomatous 
degeneration (floppy valve). The latter two conditions were 
more commonly noted in the mitral valve. The floppy valve was 
only recognized as an entity in the mid-1960s. The floppy 
valve was first diagnosed at autopsy in our Pathology 
Department in 1973. Thus, our earlier autopsy data do not give 
its true incidence and this means that our overall incidence 
figure for floppy valves over the 30 year study period is too 
low. 
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Figure 3 . 4 : Aortic incompetence due to healed syphilitic 
aortitis (top picture) . Bottom picture shows aortic stenosis 
due to calcification of a congenital, unicuspid , 
unicommissural aortic valve . 
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2 . CONGENITAL HEART DISEASE IN 358 AUTOPSY PATIENTS WITH 
EMPHASIS ON CONDITIONS THAT MAY REQUIRE TREATMENT BY VALVE 
REPLACEMENT OR USE OF A (VALVED) CONDUIT . 
Congenital heart diseases , which may require treatment by 
valve replacement or use of a valved conduit , are indicated in 
Table 3 . 4 . These data are derived from 358 autopsy patients 
with congenital cardiac disease who comprised 2% of 18 , 132 
autopsies performed over the 30 year period 1950-1979 . Data on 
diseases not necessarily treated by valve replacement or use 
of a conduit are included for comparative purposes . Even if 
cases of Tetralogy are excluded , congenital pulmonary valve 
disease was twice as common as other congenital valvular 
disease . 
Closed valvotomy in congenital mitral stenosis has not 
yielded good results, and open operation is advocated(9) . Both 
medical and surgical treatment for mitral atresia give poor 
results . Congenital mitral incompetence may require mitral 
valve replacement . Aortic stenosis may be present from birth 
or it may develop as a result of cuspidal calcification in 
later life e . g. , in a unicommissural aortic valve (Fig . 3 .4 ) . 
B . CLINICAL INDICATIONS FOR HEART VALVE REPLACEMENT . 
Several reports deal with the pathophysiological and 
clinical aspects of diseases of the natural heart 
valves(l0-18) and others consider the general aspects of heart 
valve surgery(l9-27) . There is no clinically applicable test 
for accurately measuring the functional capacity of the heart . 
In general , the best index is provided by the classification 
of the New York Heart Association , which is based on the 
patient ' s history of past and present disability and is 
uninfluenced by the presence or absence of physical signs : 
CLASS I. Patients with cardiac disease and no limitation 
of physical activity. Patients in this class do not have 
symptoms of cardiac insufficiency, nor do they experience 
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anginal pain. 
CLASS II. Patients with cardiac disease and slight 
limitation of physical activity. They are comfortable at rest, 
but if ordinary physical activity is undertaken, discomfort 
results in the form of excessive fatigue, palpitations, 
dyspnoea, or anginal pain. 
CLASS III. Patients with cardiac disease and marked 
limitation of physical activity. They are comfortable at rest, 
but less than ordinary activity causes discomfort in the form 
of excessive fatigue, 
pain. 
palpitations, dyspnoea, or anginal 
CLASS IV. Patients with cardiac disease and inability to 
perform any physical activity without discomfort. Symptoms of 
cardiac insufficiency or of the anginal syndrome may occur 
even at rest, and if any physical activity is undertaken, 
discomfort is increased. 
l.ACQUIRED VALVULAR HEART DISEASE. 
All surgery for acquired valvular disease is palliative 
only. Working together, the cardiologist and cardiac surgeon 
must select for operation those patients in whom heart valve 
replacement (with its attendant operative and long-term risks) 
offers a better prognosis for health and longevity than 
continued medical therapy. 
MITRAL VALVULAR DISEASE 
Mitral valvotomy is usually 
severe mitral stenos is and 
class III of cardiac function 
performed on patients with 
an aggravation of symptoms (in 
by the New York Association 
Classification.) not due to medically remediable causes. Some 
patients are only referred for surgery once they are totally 
disabled (class IV of cardiac function). All closed operations 
should be performed with the immediate availability of 
cardiopulmonary bypass, so that valve replacement may be 
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performed if valvotomy is unsuccessful . If severe cuspidal 
calcification accompanies the stenosis, then mitral valve 
replacement is usually indicated(28) . Patients with similarly 
severe disability due to severe mitral regurgitation resulting 
from a badly damaged valve may also require valve replacement . 
Fortunately patients with both mitral stenosis and mitral 
insufficiency run protracted courses even after symptoms 
develop . Thus the timing of the surgery can be selected 
deliberately by both the patient and his doctors . 
AORTIC VALVULAR DISEASE 
Critical aortic valve stenosis, and mild stenosis 
associated with severe coronary arterial atherosclerotic 
narrowing may both give identical symptoms . The first requires 
aortic valve replacement and the other does not . The clinical 
and angiographic means of distinguishing between these two 
conditions is beyond the scope of this review . The combination 
of severe coronary artery disease and severe aortic stenosis 
(or incompetence) is usually an indication for surgery in 
symptomatic patients 
ominous(28) . 
since the medical prognosis is 
Unlike mitral valve disease, patients with aortic valve 
disease often do well for a long time , but their condition 
deteriorates rapidly once symptoms appear. Accentuated angina 
pectoris or angina at rest , syncope ( especially on effort ) , 
and accelerated dyspnoea or pulmonary oedema indicate a grave 
prognosis. Such patients are at risk for sudden death . The 
decision to operate must be made expeditiously soon after the 
onset of symptoms in these patients. 
MULTIVALVULAR DISEASE 
The combination of aortic and mitral disease is usually 
due to rheumatic fever . Usually bivalvular disease has a long 
course similar to that of isolated mitral valve disease. 
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Indications for surgery are similar to those for isolated 
mitral or aortic valve disease. 
TRICUSPID VALVULAR DISEASE 
This is usually overshadowed by 





valves . Functional tricuspid incompetence is more common than 
organic disease of this valve, but the distinction can usually 
only be made at operation . Functional insufficiency is treated 
by annuloplasty rather than by valve replacement . Tricuspid 
valve replacement is nearly always performed in conjunction 
with replacement of left-sided heart valves . 
INDICATIONS FOR HEART VALVE REPLACEMENT AT GROOTE SCHUUR 
HOSPITAL 
The following are the indications for heart valve 
replacement for rheumatic valvular disease at Groote Schuur 
Hospital(29) (a) Aortic stenosis and/or aortic incompetence 
plus symptoms. (b) Mitral stenosis is suitable for closed 
valvotomy if there are class III symptoms and the valve is 
suitable . The valve should be replaced if there are class III 
symptoms and the valve is not suitable for valvotomy e . g ., if 
it is severely calcified. (c) Mitral incompetence with class 
III symptoms on medical treatment . (d) Asymptomatic patients 
with aortic incompetence and mitral incompetence may need 
valve replacement if there are signs of increasing left 
ventricular dilatation . Most valve replacements at Groote 
Schuur Hospital are done because of rheumatic heart disease . 
Table 3 . 5 indicates the numbers of patients who had prosthetic 
heart valves implanted at Groote Schuur Hospital between 
1962-1982 , the types of prostheses inserted and the autopsy 
rate . 
Numerous reports deal with the indications for heart valve 
replacement in valvular heart disease. While some papers 
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consider the general indications for surgery in 
acquired valvular heart disease (28,30-41) , 
patients with 
others report 
miscellaneous diseases necessitating valve replacement e . g . , 












such as syphilitic 
aneurysm(48) , aortic 
incompetence(S0 , 51) 
lupus valvulitis(S4) ; Whipple's 
disease(SS) ochronosis of the aortic valve(S6) and 
endomyocardial fibrosis(S7,58) . Other reports deal with valve 
replacement in special groups of patients e . g ., 
children(59-75) , the elderly(76-82) , patients with infective 
endocarditis(83-97) , and patients with valve prostheses who 
need re-operation(98-100). 
2 . CONGENITAL HEART DISEASE . 
Decisions as to why , when , how and where to operate on 
children with congenital heart disease have to be handled on 
an individual basis by the physician in consultation with the 
parents(lOl) . The doctor has to make a firm recommendation 
which the parents may accept or reject. The clearest 
indication for operation is a matter of life or death e.g ., a 
newborn child with transposition of the great arteries and an 
intact ventricular septum . Without operation there is a 90 % 
mortality rate in a few months ; with surgery the survival 
rate is 90% over the same period. Some cases of transposition 
with associated hypoplastic pulmonary valve and infundibulum 
may require use of a valved conduit to link the right 
ventricle to the distal pulmonary artery. This is usually done 
as part of a Rastelli operation(102) . 
Severely symptomatic heart disease treated by a safe 
surgical procedure is also a fairly straight-forward decision 
which yields gratifying results . Surgery may also be performed 
i n order to prevent complications e.g . , pulmonary vascular 
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obstructive disease associated 
and central nervous system 
with pulmonary hypertension , 
complications in infants with 
cyanotic heart disease. Of lesser importance in the antibiotic 
era is the reduction of the risk of infective endocarditis . 
Following on these general comments , I would like to 
consider some of the specific indications for valve 
replacement or use of a valved conduit . Although stenosis and 
infective endocarditis are commonly appreciated complications 
of the congenitally bicuspid aortic valve , pure severe aortic 
regurgitation complicating this congenital malformation, 
unassociated with 
recognized . Roberts 
required aortic 
either stenosis or infection, is not well 
et al . (103) reported 13 patients who 
valve replacement due to this type of 
incompetence . Severe mitral incompetence in symptomatic 
patients with ostium primum atrial septal defects may require 
very complex surgical techniques or mitral valve replacement . 
Attempts have been made to correct complete atrioventricular 
canal defects by closure of the defect and reconstruction of 
the atrioventricular valve. Prosthetic valve replacement can 
be avoided in the overwhelming majority of such patients , but 
it is sometimes performed(l04) . Total correction of a truncus 
arteriosus in infancy(l05) involves separation of the 
pulmonary arteries from the truncus , closure of the resulting 
defect in the truncus , patch closure of the ventricular septal 
defect , and reconstitution of right ventricular-pulmonary 
artery continuity with an external valved conduit . Some 
patients have required replacement of their truncal valve at 
the same time as total correction . 
Valve replacement is necessary in 10-15% of the cases of 
congenital mitral valve malformation(l06) . However, valve 
replacement is associated with a higher morbidity and 
mortality compared to valve repairs. Schwarze and 
Bernhard(l07)describe the special pathology of reconstructable 
or only prosthetically correctable congenital malformations of 
the mitral valve. The hammock valve describes a situation in 
which the mitral valve orifice is obstructed by intermixed 
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chordae and abnormal papillary muscles implanted just 
underneath the mural leaflet(l08). This condition has been 
described in the literature under a variety of names(l06) 




obstructive papillary muscles, 
mitral stenosis. This 
muscles, 
condition 
and 'typical' congenital 
is difficult to correct by 
reconstructive techniques and valve 
necessary. Absent papillary muscles 
replacement is often 
rarely gives rise to 
mitral stenosis. In such a case there are numerous intermixed 
chordae attached to the ventricular wall with imperforated 
interchordal spaces. Valve replacement is again often 
necessary. A parachute mitral valve is one of the commonest 
causes of congenital mitral stenosis, but it can be corrected 
by splitting the papillary muscle and fenestrating the 
interchordal spaces(l06). Congenital mitral valve incompetence 
is usually treatable by reconstructive surgical techniques. 
The primary lesion may be one of three types (i) annulus 
dilatation and deformation, (ii) cleft leaflet or (iii) 
leaflet defect. Valve replacement is hardly ever necessary. 
Tricuspid valve replacement may be performed in patients with 
Ebstein's anomaly(llO). 
Patients with tricuspid atresia (and normal 
ventriculo-arterial connections) usually need some form of 
systemic to pulmonary artery or cavo-pulmonary artery 
anastomosis in the first few years of life to alleviate 
' progressive hypoxia. In the Fontan procedure(lll), the atrial 
septal defect is closed and the right atrium is 
the outlet chamber, either directly or by 
anastomosed to 
an external 
conduit(l06). As the outlet chamber is expected to act as a 
ventricle, there is a theoretical advantage in inserting a 
valve between the right atrium and the outlet chamber. A 
Fontan-like surgical approach is also applicable to patients 
with tricuspid atresia, transposition of the great arteries 
and pulmonary stenosis(lOS). 
An extracardiac valved conduit has been used to treat 
pulmonary atresia. The conduit is anastomosed to the distal 
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main pulmonary artery or to its branches and to a right 
ventriculotomy incision. Double outlet left ventricle and 
double outlet right ventricle have similar indications for 
operation:early repair or pulmonary artery banding in infants 
with high pulmonary blood flow, aorta-pulmonary shunt and 
subsequent repair using external valved conduit in patients 
with associated pulmonary or sub-pulmonary stenosis(106) . 
Transannular outflow tract patches may be used to 
overcome right ventricular outflow tract obstruction. If such 
patients have haemodynamically significant pulmonary 
insufficiency in association with residual pulmonary artery 
stenosis, pulmonary hypertension from other causes, or 
associated tricuspid regurgitation, a prosthetic valve can be 
implanted at the level of the annulus under the outflow patch 
or a valved conduit may be used(l06). 
With regard to univentricular hearts, most centres have 
abandoned the approach of septation of such hearts plus use of 
a valved conduit to establish continuity between the newly 
created "right" ventricle and the pulmonary artery. However, 
this technique may still be applied in the patient with single 
left ventricle, left-sided infundibular chamber supporting a 
discordantly connected and laevopositioned aorta, naturally 
occurring pulmonary outflow tract obstruction, or two 
functionally normal atrioventricular valves. The likelihood of 
damage to and the need to replace the abnormal 
atrioventricular valves , contributed to the high initial 
mortality of the procedure and to the post-operative 
morbidity. 
C.MATCHING PROSTHESIS TO PATIENT(112-118). 
Consideration should be given to the unique concerns of 
any given patient before a particular 
Roberts(l12) discusses the choice 
valve with reference to type, size and 
prosthesis is chosen. 
of a substitute cardiac 
surgeon. He regarded 
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the caged disc prosthesis as the least desirable since it 
obstructs, it thromboses and disintegrates. The other three 
types of valve prostheses had more favourable characteristics. 
Because of its large size , the caged-ball prosthesis might be 
limited to patients with mainly regurgitant lesions. The 
tilting disc has favourable haemodynamics and is durable , but 
long - term anticoagulant therapy is necessary (as with all of 
the other mechanical valves). The glutaraldehyde-treated 
porcine xenograft valve lacks the latter disadvantage, but its 
later durability is suspect and it is unsuitable for use in 
young patients due to early cuspidal calcification ( see 
Chapter 12 ). Roberts believes that if the valve replacement 
is performed in a large , well - equipped medical centre by an 
experienced surgical team , the operative result is more 
dependent on the type and size of substitute valve inserted 
than on the surgeon who inserts the valve . 
l . GUIDELINES FOR THE USE OF TISSUE VALVES (BIOPROSTHESES) 
Chung(ll3) has proposed the following guidelines for use 
of tissue valves for heart valve replacement 
(i) Patients unable to have adequate control of 
anticoagulation. 
(ii) Patients with less than 10 years life 
expectancy , especially if the patient is older than 60 years of 
age . 
(iii) Women wanting to have children or patients engaged in 
potentially traumatic activity . 
They should not be used in children or in patients receiving 
dialysis for renal failure(29) . 
McClung et al . (114) state that although few anatomic 
complications have been described, the Ionescu-Shiley 
pericardial bioprosthesis may be more suitable for aortic 
valve replacement due to its greater flow capacity , whilst the 
porcine xenograft(ll6-118) may be more suitable in the mitral 
position because of anatomical considerations . 
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2.GUIDELINES FOR THE USE OF MECHANICAL PROSTHETIC VALVES 
(i) Patients aged 35 years or younger. 
(ii) Patients on renal dialysis or having disorders of calcium 
metabolism(ll3,115,116). 
(iii) Patients needing long-term anticoagulation for other 
indications e.g., atrial fibrillation or past 
thromboembolism. 
The operative mortality rate at Groote Schuur Hospital 
for implantation of mechanical prostheses is 5% and the 10 
year survival figure is 60%(29). The main problems encountered 
clinically are thromboembolism, acute mechanical failure and 
anticoagulant-induced haemorrhage. 
D.TRENDS IN CARDIAC SURGERY AT THE UNIVERSITY OF CAPE TOWN. 
Three reports(ll9-121) analyse the trends in cardiac 
surgery at the University of Cape Town for the years 1951-1965 
and 1971-1981 : 
(i) OPERATIONS FOR ACQUIRED VALVULAR HEART DISEASE BETWEEN 
APRIL 1951-APRIL 1965(119) 
Closed mitral valvotomy was performed upon 525 
patients,with a hospital mortality rate of 6%. Ten percent of 
patients died up to 12 years after surgery, mainly due to 
mitral valve disease related heart failure. Restenosis 
occurred in about 15% of operated patients. Heart valve 
replacement was still in its infancy at that time and heart 
valve replacement was carried out on 85 patients using the 
University of Cape Town prosthesis. There were 15 hospital 
deaths (18%) and 10 late deaths. Four patients developed 
infective endocarditis. The main problem was a high incidence 
of thromboembolism. In those early years valve replacement was 
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often pre-terminal 
(ii) CONGENITAL HEART DISEASE NEEDING OPEN HEART VALVE SURGERY 
APRIL 1951-APRIL 1965(120) : 
Open heart valve surgery was performed on 53 patients 
with a 26% hospital mortality rate . During the same period 
complete correction was attempted in 113 patients with 
Tetralogy of Fallot (12% mortality rate) and 62 patients had 
ventricular septal defects repaired (10% mortality rate) . 
No published data are available for the years 1966-1970 . 
(iii) TRENDS IN CARDIAC SURGERY AT THE UNIVERSITY OF CAPE TOWN 
1971-1981 : 
Parry et al.(121) reported that a yearly average of 560 
cardiac operations was performed (75% for acquired and 25% for 
congenital heart disease) during this period. The average 
mortality rate was 6.1% between 1971-1975 and 5.0% between 
1976-1981 . Although it was the policy of the cardiac surgical 
unit to perform closed mitral valvotomy whenever the clinical 
indication is suitable, there was a fall in the number of such 
operations performed in the later part of the study period. A 
maximum of 59 closed mitral valvotomies in 1972 fell to a 
minimum of 7 in 1978. This may reflect more stringent criteria 
for patient selection for closed valvotomy or greater surgical 
confidence in obtaining a better result by an open procedure. 
During the first 5 years of this period mitral valvotomies 
comprised 20 . 5% of the total valve operations, but in the 
second 6-year period it had dropped to 10.2% . The high 
incidence of rheumatic fever in the Cape Province was 
reflected in a steady stream of new patients . Patients with 
malfunctioning heart valve prostheses also contributed to the 
operating load. A substantial reduction of the hospital 
mortality associated with valve surgery, from a maximum of 
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8 . 3% in 1972 to 2 . 2% in 1980 was noted . This reduction in 
mortality is probably related in part to improved methods of 
myocardial protection (cardioplegia) during valve replacement . 
Causes of operative and postoperative deaths were not analysed 
in detail , but Parry et al . (121) believed that there were no 
significant change in factors relating to mortality throughout 
the 11 - year period . Post-operative myocardial failure remained 
a significant problem in patients who presented late in the 
course of their valvular disease for surgery . 
During this same period Parry et al . (121) noted that the 
majority of cardiac surgery performed in children was for 
correction or palliation of congenital lesions ; operations 
for valve disease formed only 7-15 % of the yearly total . 
In our institution , patients who have cardiac valvular 
prostheses implanted receive anticoagulation (Warfarin) from 
the evening of the second post-operative day . Those with 
tissue valves are treated for only 3 months , but with 
mechanical prosthetic valves indefinite anticoagulant 
administration is practised with regular assessment of the 
prothrombin index. 
E.TYPES OF PROSTHETIC HEART VALVES IMPLANTED IN PATIENTS AT 
THE UNIVERSITY OF CAPE TOWN BETWEEN 1962-1982 ( see Table 3 . 5 
) . 
(i) TISSUE VALVES . 
A total of 33 patients had University of Cape Town 
formaldehyde-treated , porcine aortic valve xenografts 
implanted in the mitral position (see Chapter 9 ) . No accurate 
data regarding post-operative deaths are available, but two of 
these patients were autopsied at the University of Cape Town 
(U . C . T.) Pathology Department . According to Schrire and 
Barnard(ll9) most of the patients underwent re-operation . One 
hundred and sixty-three patients received Hancock 
159 
PATHOLOGY & INDICATIONS 
bioprostheses ; there were 36 deaths (22 . 1%) and 9 patients 
(25% of the fatalities) were autopsied . Carpentier-Edwards 
bioprostheses were inserted in 704 patients ; there were 101 
(14 . 3%) post-operative deaths and 38 patients (37 . 6%) were 
autopsied. 
(ii) MECHANICAL VALVES . 
Cape 
Five hundred and twenty patients received University of 
Town lenticular prostheses . No published data are 
available regarding the high late post-operative death rate. 
Ninety - eight of these patients came to necropsy in the U . C . T . 
Pathology Department . Four hundred and thirty-four patients 
had Starr-Edwards prostheses implanted there were 145 
post-operative deaths (33 . 4%) and 44 of the latter patients 
(30 . 3%) were autopsied . One hundred and nineteen patients 
received Lillehei-Kaster prostheses. Fifty-two patients 
(43 . 7%) died post-operatively and 16 (30 . 8%) were autopsied . 
Bjork-Shiley prosthetic heart valves were implanted in 126 
patients and there were 29 deaths (23%) . Fourteen of these 
patients (48 . 3%) were autopsied . Three hundred and sixty-five 
patients received St Jude prosthetic valves and there were 33 
post-operative deaths (9 . 0%) , of whom 29 were autopsied 
(87 . 9%) . 
(iii) MIXED PROSTHESES . 
Twenty-four patients came to autopsy with more than one 
different type of prosthetic heart valve implanted in the same 
heart. These 24 patients had 52 prostheses in situ ; the types 
of prostheses that were inserted are listed in Tables 14.1 and 
14.2 of Chapter 14 . 
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TABLE 3 . 5 : PATIENTS WITH PROSTHETIC HEART VALVES AT THE 




























KNOWN POST-OP . 
DEATHS (%) 
36(22 . 1) 
101(14 . 3) 
145(33 . 4) 
52(43 . 7) 
29(23 . 0) 





38(37 . 6) 
98 
44(30 . 3) 
16(30 . 8) 
14(48 . 3) 
29(87.9) 
- indicates no data available . A few fresh aortic homografts 
and fascia lata valves were also inserted - no data 
available. 
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F. AETIOLOGICAL DATA ON 100 CONSECUTIVE VALVE REPLACEMENT 
OPERATIONS. 
One hundred randomly selected patients, who underwent 
heart valve replacement consecutively at Groote Schuur 
Hospital in 1973 were analysed with regard to the aetiology of 
their native valvular disease as recorded in the surgical 
operation notes, the information on the pathology request 
form,which accompanied the excised valve, and the 
pathologist's report after macroscopical and histological 
examination of the excised valve. These data were compared 
with one another and I then reviewed the pathological 
diagnosis of the likely aetiology of the native heart valve 
disease in the light of the operation note details. The latter 
information had in most instances not been supplied to the 
original pathologist who first examined the valve. 
Table 3.6 summarizes the results of this investigation. A 
notable feature was that in 62% of patients the surgeon gave 
no indication on the pathology request form as to the 
suspected aetiology of the valvular disease necessitating the 
operation. In only 15% of patients did the operation notes and 
the request form agree on the aetiological diagnosis. However, 
in 13% of cases the request form was more informative than the 
operation notes. 
The pathologist was able to 
diagnosis in only 35% of the excised 
make an aetiological 
valves. This is not 
surprising since fibrous thickening, distortion or destruction 
of the normal architecture, and superimposition of thrombus 
are non-specific findings, which may occur in both congenital 
and acquired valve lesions. The only feature identifying the 
acquired lesions histologically is the increased 
vascularity(9). Since some rheumatic-type valves are very 
sparsely vascularised, even this histological feature is of 
dubious specificity(8). On reviewing the operation notes in 
conjunction with the macroscopical description of the excised 
valve and the cuspidal histology, I was able retrospectively 
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to make an aetiological diagnosis in 81% of the excised valves 
( Table 3 . 7 ) . The crucial information that enables one to 
improve the aetiopathological diagnosis from 35% to 81% is 
that which is contained in the surgical operation notes and 
pertains to the appearance of the intact valve prior to 
excision . This information is seldom transmitted to the 
pathologist who has to examine the valve . 
The mitral valve is usually excised in toto and thus its 
macroscopical morphology may be interpreted by the pathologist 
and most often it takes the form of a chronic rheumatic-type 
of deformity. The present study found that very few 
pathologists were prepared to label severe mitral valve 
stenosis as a chronic rheumatic-type of deformity usually 
only a description was given without any reference being made 
as to the likely aetiology . Although there are other rare 
causes of mitral stenosis e . g ., Whipple's disease(l23 , 124), 
carcinoid syndrome(lOS) , treatment with methysergide(l25) , 
Fabry's disease (126) , Hurler-Schei syndrome(lOS) , familial 
pseudoxanthoma elasticum (105) , the presence of this lesion 
pathognomonic of previous rheumatic fever(l27) . 
However , in the case of the aortic valve it is even more 
important that the pathologist be given a guide as to the 
app~arance of the valve at operation and/or the clinically 
suspected aetiology of the valvular disease , since the aortic 
valve is usually removed in a fragmented fashion and it is 
often not possible for the pathologist to reconstruct the 
appearance of the 
encountered in this 
intact 
series 






replacement operations were received as multiple tissue 
fragments ranging in number from 1 to 11 pieces per valve. As 
Davies(8) points out , it is not possible to report 
meaningfully on one cusp. Each report should note the number 
of cusps, their shape, the presence of fibrosis or 
calcification , and whether commissural fusion is present. This 
is usually easily recognizable , even in a surgically excised 
valve. 
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In several instances in which infective endocarditis was 
the clinical diagnosis, this information was not transmitted 
to the pathologist. Since there is some evidence(l28) that 
infection of the native heart valve at the time of heart valve 
replacement may predispose to infection of the prosthetic 
valve , it is important to alert the pathologist to this 
possibility, since antibiotics may have muted the inflammation 
and appropriate stains for micro-organisms may consequently 
not be performed. 
TABLE 3.6 : AETIOLOGICAL DATA ON 100 CONSECUTIVE HEART 
VALVE REPLACEMENT OPERATIONS 
OPERATION NOTES AND REQUEST FORM AGREE 
REQUEST FORM & PATHOLOGY REPORT AGREE 
OPERATION NOTES DIFFER FROM REQUEST FORM 
15 
12 
REQUEST FORM MORE HELPFUL 13 
REQUEST FORM LESS HELPFUL 4 
NO OPERATION NOTE FOUND 6 
NO AETIOLOGY ON REQUEST FORM 62 
PATHOLOGIST DIAGNOSED AETIOLOGY 35 
AETIOLOGY AFTER REVIEW OF OP. NOTES & HISTOLOGY 81 
164 
PATHOLOGY & INDICATIONS 
TABLE 3.7 : AETIOLOGICAL DIAGNOSES MADE IN 100 CONSECUTIVE 
HEART VALVE · REPLACEMENT OPERATIONS BY REVIEW OF THE 
OPERATION NOTES IN CONJUNCTION WITH THE 
MACROSCOPICAL AND MICROSCOPICAL 
PATHOLOGY. 
l.SPECIFIC DIAGNOSIS MADE : 
CHRONIC RHEUMATIC-TYPE DEFORMITY 















(*=senile calcific tricuspid aortic stenosis) 
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G. INCIDENCE OF ASCHOFF BODIES IN SURGICALLY REMOVED CARDIAC 
TISSUE. 
The Aschoff body (nodule) in its granulomatous 
(proliferative) phase is the pathognomonic myocardial lesion 
of rheumatic fever(129). However, many authorities disagree 
over what constitutes a typical Aschoff body. Rich and 
Gregory(l30) observed nodular collections of monocytes and a 
predominance of "Aschoff cells". The latter name was applied 
to the large cell which may be mono- or multinucleated and has 
a basophilic cytoplasm. While most observers regarded the 
Aschoff cell as originating from the cardiac histiocyte 
(Anitschkow cell)(131,132), others believed that the Aschoff 
cell was derived from damaged myocardial fibres(133,134). In 
the 1960 second edition of Gould's Pathology of the Heart(135) 
it is stated that proliferating connective tissue cells are 
the dominant feature of the Aschoff body and that Aschoff 
cells are scanty. In the 1968 third edition of the same 
book(136) it is recommended that the term 00 Aschoff cell" 
should be discarded because of the differing views on its 
histogenesis. In the same writing the cardiac histiocyte 
(Anitschkow myocyte) is recognized as the chief component of 
the Aschoff body(137). As Ward(138) points out, other 
definitions reveal further differences of opinion regarding 
the Aschoff body's characteristic features(139-142). Several 
of these authors, while agreeing that the Aschoff body is 
specific to rheumatic carditis, also claim that it should only 
be diagnosed with strict adherence to their own (differing) 
histological criteria. 
Fassbender(l43) stresses the perivascular situation of 
the classical Aschoff body and states that the adventitial 
cells swell and become separated and participate in the 
formation of the granuloma. He states that there are three 
evolutionary patterns of rheumatic carditis : 
(i) The "exudative" variety of the rheumatic process may run a 
fulminating clinical course, especially in children, with 
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death from heart failure within 3 weeks . Not a single Aschoff 
body may be present , only an interstitial fibrinous exudate 
with large numbers of neutrophiles and occasional lymphocytes . 
This form may represent a type of Arthus phenomenon . 
(ii) The granulomatous (proliferative) form of rheumatic 
carditis is the classical Aschoff body , the features of 
will be described below . Fassbender(l43) suggests 
which 
that 
fibrinoid is the result of pathologically increased capillary 
permeability, which may result from the deposition of immune 
complexes (streptococcal antigens and antibodies which bind 
complement). The Aschoff body (granuloma) is the morphological 
expression of a local inflammation associated with a limited 
exudate . The Aschoff body passes through 4 phases : (a) 
exudative, (b) granulomatous (proliferative), (c) resolving 
and (d) healed phases . It is only the granulomatous phase 
which is diagnostic of rheumatic fever . This phase is noted 
one month or more after an acute attack of rheumatic fever and 
may persist in the tissue for 3-6 months or even longer after 
the symptoms of the acute attack have abated(lOS) . 
A small area of fibrinoid necrosis may be present at the 
centre of the nodule in the early granulomatous phase. It 
becomes surrounded and finally replaced by histiocytes , giant 
cells , lymphocytes , plasma cells and fibroblasts arranged in 
roughly parallel rows. The histiocytes (so-called Anitschkow 
" myocytes " ) have a characteristic owl ' s eye appearance to the 
nucleus due to a bar-like arrangement of the chromatin. These 
cells give rise to giant cells (Aschoff cells) which are 
usually found towards the centre of the nodule . 
(iii) The muscle-associated ( " myo-aggressive granuloma " ) 
spares the connective tissue , is usually not seen in 
association with typical Aschoff nodes and is found in the 
myocardium itself or in the loose sub-endothelial tissues in 
juxtaposition to necrotic myofibres . No fibrinoid is seen, 
only small fragments of necrotic muscle . Auto - antibodies 
directed against cardiac muscle may cause the necrosis, which 
may be a late complication of long-continued rheumatic 
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carditis. The granulomata produced experimentally in rabbit 
hearts by Murphy(l44,145) who repeatedly injected the animals 
with killed group A Streptococci appear to be of a similar 
nature to the muscle-associated granuloma and are unlike the 
Aschoff body . No experimental model of a connective tissue 
lesion related to small myocardial vessels has yet been 
produced . 
Since rheumatic fever is such an important cause of 
valvular heart disease in Cape Town , I decided to investigate 
the incidence of the granulomatous phase Aschoff bodies (as 
described above) in atrial appendages removed during heart 
valve surgery . Two groups of patients were studied 
1. One hundred consecutive patients who underwent heart valve 
replacement comprised the first group . Their atrial 
appendages, papillary muscles and valves were examined 
histologically for granulomatous phase Aschoff bodies . 
2. The second group consisted of 468 patients who had atrial 
appendages excised between the years 1973-1982 inclusive at 
the time of surgery for mitral stenosis or mixed mitral valve 
disease in which stenosis predominated . The incidence of 
Aschoff bodies as diagnosed by a variety of pathologists in 
this group of patients was recorded . I then reviewed the 
histology of those patients in whom Aschoff bodies had been 
diagnosed . (See Methodology , section 3 G ) . 
Table 3.8 summarizes the findings in the first group of 
patients . Atrial appendages were sent for pathological 
examination in 58% of these patients and proliferative phase 
Aschoff bodies were seen in 10.3% of the atrial appendages 
(and in 11 . 3% of patients with a suspected rheumatic aetiology 
for the valvular disease) . The papillary muscles had been 
removed as part of the mitral valve excision and examined 
histologically in 34 patients, only one of whom showed an 
Aschoff body in this situation(2.9%) . In only one out of the 
100 patients did a valve cusp contain Aschoff bodies . This 
accords with the experience of Edwards et al.(146) who found 
no Aschoff bodies in 34 valves with active valvulitis of 
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patients who had active rheumatic carditis (myocardial Aschoff 
bodies perivascularly) . These authors believe that 
non - specific oedema , leukocytic infiltration and fibrinous 
vegetations are the usual changes of 
valvulitis . 
active rheumatic 
TABLE 3 . 8 : INCIDENCE OF PROLIFERATIVE PHASE ASCHOFF 
BODIES IN 100 CONSECUTIVE VALVE REPLACEMENT OPERATIONS 
TOTAL No. OF ATRIAL APPENDAGES 58 
APPENDAGES OF CLINICALLY RHEUMATIC PATIENTS 53 
APPENDAGES OF NON-RHEUMATIC PATIENTS 5 
APPENDAGES CONTAINING ASCHOFF BODIES 6 
VALVES CONTAINING ASCHOFF BODIES 1 
PAPILLARY MUSCLES CONTAINING ASCHOFF BODIES 1 
One hundred and sixteen out of the 468 atrial appendages 
of patients with mitral valve stenosis (with or without mild 
incompetence) were recorded as containing Aschoff bodies 
(24 . 8%) . These diagnoses had been made by several different 
pathologists, all of whom had ostensibly been looking for 
granulomatous (proliferative) phase Aschoff bodies. Table 3 . 9 
summarizes my findings after reviewing the atrial appendicular 
histology of these 116 patients . 
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TABLE 3.9 : REVIEW OF 116 SURGICALLY REMOVED ATRIAL 
APPENDAGES (FROM PATIENTS WITH MITRAL STENOSIS) DIAGNOSED 
BY A VARIETY OF PATHOLOGISTS AS CONTAINING ASCHOFF BODIES 
No . OF GRANULOMATOUS 
PTS. PHASE ASCHOFF 
BODIES 
REVIEW NEGATIVE FOR ASCHOFF BODIES 
MONONUCLEAR NON-SPECIFIC ORGANIZING 
CELLS GRANULOMA THROMBUS 
116 82 25 4 5 
I found that if strict criteria were applied and if only 
granulomatous phase Aschoff bodies as described earlier above 
were accepted , then only 82 out of the 116 patients had 
acceptable Aschoff bodies ; this corresponds to 17.5% of the 
total group of 468 patients . The commonest error appeared to 
be the labelling of focal collections of mononuclear cells 
(mainly lymphocytes) as Aschoff bodies . Four patients had 
of the type described by muscle-associated granulomata 
Fassbender(l43) without typical Aschoff bodies . Organizing 
endocardial thrombi were misinterpreted as Aschoff bodies in 5 
other patients . 
The reported incidence of active Aschoff bodies in atrial 
appendages removed from patients with mitral stenosis varies 
from centre to centre (Table 3.10) . While all record the 
incidence of "Aschoff nodules " , there are some differences in 
the histological criteria . Another factor is the variation 
from centre to centre of the types of patient selected for 
operation . Most series give little information in this regard . 
The present study found an 
when diagnosed by a variety 
incidence of 17 . 5% on review 
Town incidence correlates best 
reported by Waaler(l48) and 
Virmani(l27). 
Aschoff body incidence of 24 . 5% 
of pathologists and a lower 
by the present author . The Cape 
with the incidences of 25% 
the 21% noted by Roberts and 
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TABLE 3 . 10 : INCIDENCE OF ASCHOFF BODIES IN ATRIAL 
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INCIDENCE OF ASCHOFF BODIES IN AUTOPSIED PATIENTS 
IMPLANTED VALVULAR PROSTHESES. 
WITH 
In the present study, only 23 out of 272 patients (0 . 9%) 
with implanted prosthetic heart valves showed Aschoff bodies 
histologically in the myocardium . This figure is unduly low 
since the 272 patients includes some who were operated upon 
for non-rheumatic valvular heart disease . Since 198 out of the 
272 patients (73%) had their valves replaced because of 
chronic rheumatic valvular deformities , the true incidence is 
11 . 6% . The latter figure is in agreement with the incidence of 
Aschoff bodies in 10 . 3% of surgically resected right atrial 
appendages of such patients. The slightly higher incidence at 
autopsy compared to biopsy may be related to the more 
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PATHOLOGY OF HEART VALVE REPLACEMENT WITH THE UNIVERSITY OF 
CAPE TOWN CARDIAC VALVE PROSTHESIS. 
The clinical and haemodynamic findings in patients with 
University of Cape Town (UCT) valvular prostheses have been 
previously reported from our institution(l-6) and the 
pathology of aortic valve replacement with this prosthesis has 
also been described(7). Details regarding the structure of the 
UCT aortic and mitral valve prostheses are given in Chapter 
2 . 
AORTIC VALVE REPLACEMENT 
The present study reviews the autopsy findings in 41 
patients with UCT aortic valve prostheses. There were 34 men 
and 7 women, with a mean age of 44.5 years (range 16-66 
years). Post-operative survival ranged from 7 hours to 141 
months. Pre-operatively all patients had been in functional 
classes III or IV of the New York Heart Association 
classification. Twenty patients died 30 days or less after 
operation (group l,early deaths), and 21 patients died more 
than 30 days after surgery (group 2,late deaths). 
The following diseases (Table 4.1) necessitated aortic 
valve replacement : 30 patients had a chronic rheumatic-type 
deformity of the aortic valve and in 16 patients this could be 
ascribed to rheumatic fever on the basis of either a previous 
history of rheumatic fever, associated mitral stenosis or 
Aschoff bodies in the myocardium. The aetiology was uncertain 
in the other 14 patients. The remaining 11 patients had the 
following native aortic valve diseases infective 
endocarditis 1, calcified congenital bicuspid aortic valve 3, 
syphilitic aortitis 2, aortic incompetence associated with 
aortic medionecrosis 3, and 2 had aortic nodular sclerosis 
(tricuspid senile calcific aortic stenosis). All patients 
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received anticoagulation (Coumadin) post-operatively. 
TABLE 4 . 1 : NATIVE AORTIC VALVE DISEASE LEADING TO AORTIC 
VALVE REPLACEMENT WITH UNIVERSITY OF CAPE TOWN AORTIC 
VALVE PROSTHESIS IN 41 PATIENTS 
CHRONIC RHEUMATIC-TYPE DEFORMITY 30 
INFECTIVE ENDOCARDITIS 1 
CALCIFIED CONGENITAL BICUSPID VALVE 3 
SYPHILITIC AORTITIS 2 
AORTIC MEDIONECROSIS 3 
AORTIC NODULAR SCLEROSIS 2 
TABLE 4 . 2 : PRINCIPAL CAUSES OF DEATH (1 PER PATIENT)IN 41 







MYOCARDIAL PERFUSION ERROR 
. PNEUMONIA 








MYOCARDIAL FAILURE 3 
INFECTED PROSTHESIS 3 
UNKNOWN 3 
ANTICOAGULANT EXCESS,BLEEDING 1 
AIR EMBOLISM 3 
AORTIC RUPTURE (MEDIONECROSIS) 1 




Table 4.2 lists the principal causes of death in the 
short-time survivors with U.C.T. aortic valve prosthesis and 
Table 4.3 gives the non-fatal complications/associated 
conditions. There were no complications due to an error in 
pre-operative diagnosis or 
cardio-pulmonary bypass 
operative technique relative to 
or insertion of the prosthesis. 
However, myocardial damage was encountered in 4 patients. This 
took the form of left ventricular contraction band necrosis 
(coagulative myocytolysis)(8) in a patient who died 20 hours 
post-operatively,and focal left ventricular colliquative 
myocytolysis(8) in 2 patients (who survived 7 and 8 hours 
after surgery). The fourth patient showed subendocardial 
coagulative necrosis of the left ventricle. None of these 4 
patients had significant coronary arterial disease and there 
was no evidence that the myocardial injury was caused by 
emboli,iatrogenic damage to the coronary arteries,or due to 
direct surgical trauma . The myocardial injury appeared to be 
attributable to poor myocardial perfusion during 
cardiopulmonary bypass, since there was no history of 
post-operative hypotension in these patients. The first three 
of these patients died suddenly and unexpectedly. 
Another patient died 5 days post-operatively because of 
regional transmural coagulative necrosis of the left 
ventricle. This patient had an unsuspected congenital 
abnormality of the left coronary artery, which divided almost 
immediately after its origin into the anterior descending and 
the left circumflex branches.The result of this unrecognized 
abnormality was that the coronary perfusion cannula was 
directed solely into the circumflex branch during surgery and 
there was no flow of perfusant into the occluded anterior 
descending branch . At autopsy a reperfusion type of 
haemorrhagic infarction of the left ventricle was found , which 
corresponded to the territory of supply of the underperfused 
anterior descending coronary artery. 
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Three patients developed infection of their prosthetic 
valves this was due to fungi in two instances (Candida 
albicans and an unidentified fungal species) and Diphtheroids 
in the third patient . Massive intracerebral haemorrhage (due 
to ruptured mycotic aneurysm or embolism) was the terminal 
event in all 3 patients . Apart from one patient with a 
coronary thrombo-embolus , post-operative systemic embolism was 
not encountered in the group 1 patients. No patient in this 
group had non-infected prosthetic valve thrombi at autopsy. 
Serious post-operative complications were encountered in 8 
patients : 7 had severe myocardial failure , and 1 patient 
developed bilateral confluent bronchopneumonia. 
One complication unique to cardiac surgery was 
encountered in a patient who underwent aortic valve 
replacement for annulo-aortic ectasia due to aortic 
medionecrosis. A corrugated Dacron tube graft was inserted in 
place of the ascending aorta. Death occurred on the 22nd 
post-operative day when the distal anchoring sutures of the 
tube graft tore out of the fragile aortic tissue. Seven 
patients died suddenly and unexpectedly of unknown causes in 
the early post-operative period , possibly as a result of a 
serious cardiac arrhythmia . Changes in the 7 patients who died 
of unknown cause included the following : serum potassium 
excess (1 patient) , subendocardial ventricular necrosis (4 
patients), and interruption of a fascicle of the left bundle 
branch by a surgical suture (1 patient). Two patients showed 
no abnormality likely to cause arrhythmia . All 7 patients who 
died of myocardial failure had only grades 1-2 coronary 
arterial luminal narrowing. The myocardium showed focal 
fibrosis in 3 cases and confluent fibrosis in 4 . One patient 
had numerous myocardial Aschoff bodies. The latter were found 
in the heart of only one other patient in group 1. 
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Figure 4 . 1 : Partial dehiscence of a UCT mitral valve 
prosthesis . There is an unusual lack of host tissue over-
growth on the sewing ring despite the 12 year implantation 
period . 
Figure 4 . 2 : Non-infected thrombus rests upon upper retaining 
ring of a UCT aortic valve prosthesis . Thromboembolus lies 
within the left coronary artery (top left). 
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GROUP 2 . 
The principal causes of death (1 per patient) in patients 
who survived more than one month following insertion of a 
U . C . T. aortic valve prosthesis are listed in Table 4 . 2 . Two of 
the patients who died in this later period succumbed to 
complications following intra-operative air embolism and one 
patient died of air embolism during cardiac catheterization 30 
months post-operatively . Three patients developed infection of 
the prosthesis an Actinobacillus and Diphtheroids were 
cultured in 2 patients , but no growth was obtained from the 
third case. Dehiscence of the prosthesis (Fig . 4 . 1) 
unassociated with infection caused the death of one 
(Mild prosthetic dehiscence in another patient 
patient . 
played no 
significant role in the fatal outcome) . Both of these patients 
were noted to show significant haemolysis . Poor 
anticoagulation control caused fatal cerebral haemorrhage in 
one patient . 
Thromboembolism , myocardial failure , infection and sudden 
death(? arrhythmia) were the commonest principal causes of 
death . None of the 3 patients who died of myocardial failure 
had acute myocardial lesions detectable by light microscopy . 
One patient had syphilitic coronary ostial stenosis plus focal 
myocardial fibrosis. A second patient had Marfan's syndrome 
with poor pre-operative myocardial function . He was treated 
successfully for post-operative infective endocarditis , but 
died of myocardial failure 30 months post-operatively. His 
myocardium showed confluent fibrosis , and the small coronary 
arteries 






had also been 
The third 
treated 
post-operatively for infective endocarditis . Focal myocardial 
fibrosis was present and some small coronary arteries 
contained atheromatous emboli . 
Non-fatal complications/associated conditions observed in 
this group of patients are indicated in Table 4 . 3 . The 
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silicone emboli appeared to result from inadequate filtration 
of the silicone, which was used as an antifoam agent in the 
bubble oxygenator of the cardio-pulmonary bypass machine. 
Although only 12 patients showed thrombi on their prostheses, 
there was autopsy evidence of systemic thromboembolism in 15 
patients (please see Table 4.4). 
TABLE 4.3 : NON-FATAL COMPLICATIONS/ASSOCIATED CONDITIONS 
IN 41 PATIENTS WITH U.C.T. AORTIC VALVE PROSTHESIS 
GROUP 1 
ACUTE RHEUMATIC FEVER 2 
ACUTE TUBULAR NECROSIS 1 
SUBARACHNOID HAEMORRHAGE 1 
HAEMORRHAGE IN RIGHT BUNDLE BRANCH 1 
GROUP 2 
MITRAL STENOSIS 3 
JEJUNAL CARCINOID TUMOUR 1 
PROSTHETIC DEHISCENCE 1 
CLINICALLY APPARENT HAEMOLYSIS 2 
75%+ CORONARY ARTERY NARROWING 1 
SILICONE & ATHEROMATOUS EMBOLI 1 
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TABLE 4.4 : SITES OF THROMBUS DEPOSITION UPON UCT 
AORTIC AND MITRAL VALVULAR PROSTHESES 
AORTIC MITRAL 
NO. PATIENTS WITH UCT VALVES 41 36 
NO.UCT VALVES WITH THROMBI 13(32%) 12(33%) 
SEWING RING : INFLOW ASPECT 2(5 %) 6(17 %) 
OUTFLOW ASPECT 7 (1 7%) 1(3%) 
BOTH ASPECTS 6 (15 %) 2(6%) 
METAL GUIDES FOR BOBBIN 5 (12 %) 2(6 %) 
BOBBIN 3(7 %) 3(8%) 
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COMBINED FINDINGS IN THE 41 PATIENTS WITH UCT AORTIC VALVULAR 
PROSTHESIS 
HEART WEIGHTS 
Table 4 . 5 gives the heart weights in three groups of 
operated patients with UCT aortic valvular prostheses . The 
heaviest hearts were those belonging to patients who had 
pre-operative aortic valve incompetence . 
TABLE 4 . 5 : MEAN HEART WEIGHTS IN THREE GROUPS OF PATIENTS 
WITH U . C . T . AORTIC VALVE PROSTHESES 
PRE-OPERATIVE LESION MEAN HEART WT . (G) + /-S . D. 
AORTIC INCOMPETENCE (N = 6) 
AORTIC STENOSIS (N=l6) 
AORTIC STENOSIS/INCOMPETENCE (N=l2) 
a= p less than 0 . 05 
b = p less than 0 . 05 
817 + /-188 a , b 
604+/-121 a 
654 + /-192 b 
The mean heart weight of all patients with UCT prostheses 
was 710 g (range 343-1124 g) . There was no significant 
difference in heart weight between patients and controls with 
aortic stenosis . Patients with pre-operative aortic 
incompetence 











post-operatively of myocardial failure had a mean heart weight 
of 766 g (range 561-940g). Twenty-nine patients who died of 
other causes had a mean heart weight of 690 g (range 343-1124 
g) . The difference in heart weight was not significant between 
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these 2 groups . 
ASCHOFF BODIES : Only 4 of the 30 patients (13%) with chronic 
rheumatic-type valvular deformity who underwent aortic valve 
replacement showed Aschoff bodies , while 8 of 44 non-operated 
controls with rheumatic-type aortic valve deformity had 
Aschoff bodies (18%) . ( See too Chapter 3 ) . 
SMALL CORONARY ARTERY DISEASE 
patients showed abnormalities of 








thickening , medial 
thrombo-embolism were the commonest 
alterations. Two patients had particles of silicone antifoam 
from the heart-lung machine in small coronary arteries . 
Control subjects had fewer abnormalities . ( See too Chapter 17 
) . 
AORTIC ROOT AND PROXIMAL CORONARY ARTERIES : One patient had 
slight intimal thickening of the aortic root , but the latter 
was normal in all of the other patients. No significant 
difference was found in the degree of narrowing of the 
proximal portions of the two major coronary arteries between 
patients with UCT aortic valve prostheses and unoperated 
controls with aortic valve disease . Coronary cannulation 
injury was thus not demonstrated in the operated patients . 
STRUCTURAL ALTERATIONS WITHIN THE PROSTHESIS : The bobbin of 
the early-model UCT prosthesis accumulated lipid (Fig . 4 . 3) 
and acquired an opaque , yellow appearance (variance) . This was 
not noted in prostheses which had been in situ for less than 2 
years . Subsequent alterations in the curing technique of the 
Silastic bobbin during manufacture prevented this change . 
Noticeable wear of the contact surface of the bobbin was 
encountered in 2 patients . 
significant cloth wear . 
None of the prostheses showed 
ORGAN INFARCTS The distribution of organ infarcts in 
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patients and controls is indicated in Table 4.6. Organs most 
commonly bearing infarcts were the kidneys, spleen, heart and 
brain ; pulmonary infarction was more common in controls, due 
to associated congestive heart failure. In controls with 
uncorrected aortic valve disease, systemic emboli (organ 
infarcts) were found in 36% and pulmonary emboli in 16%. No 
source of systemic embolism was found in 10 out of the 27 
patients (37%) with organ infarcts. The likely source of the 
emboli in the 17 control patients in whom a potential source 
was discovered was as follows infective endocarditis 7 
patients, left ventricular thrombi 5, and left atrial thrombi 
4 ; one patient had both a left atrial thrombus and left-sided 
infective endocarditis. The distribution of thrombi on the 
various portions of the UCT aortic valve prosthesis in the 41 
patients studied is given in Table 4.4. 
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Fig. 4.3 : Early model UCT atrioventricular prosthesis shows 
bobbin wear and lipid accumulation (variance). The crack in 





















































































































































































































































































MITRAL VALVE REPLACEMENT 
Thirty-six patients who each had isolated mitral valve 
replacement with a University of Cape Town (UCT) mitral valve 
prosthesis were studied. As will be seen from Table 4 . 7 , 
chronic rheumatic-type deformity of the mitral valve was by 
far the commonest indication for mitral valve replacement in 
these 36 patients. However, only 3 out of the 36 hearts 
contained Aschoff bodies at autopsy. Three patients had 
non-rheumatic valvular disease . 
TABLE 4.7 : NATIVE MITRAL VALVE DISEASE IN 36 PATIENTS 
LEADING TO VALVE REPLACEMENT WITH A U . C.T . PROSTHESIS 
CHRONIC RHEUMATIC-TYPE DEFORMITY 






The 12 patients in group 1 (who died 30 days or less 
after valve replacement) had a mean age of 49 years (S.D.= 9), 
with a range of 28-60 years . There were 7 females and 5 males . 
The mean post-operative survival period was 7.2 days (S.D . = 
8.5),with a range of from a few hours to 21 days . The mean 
heart weight was 648 grams (S . D.= 265). The principal causes 
of death in the group 1 patients are given in Table 4 . 8 . Four 
patients had complications attributable to an error in 
operative technique ; air embolism occurred in 2 , one patient 
had two sewing ring sutures which penetrated the circumflex 
branch of the left coronary artery and the fourth patient had 
severe limitation of prosthetic bobbin movement by the 
proximity of the 
disproportion due to a 
inter-ventricular 




) . Three 
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patients developed embolic cerebral infarction. One patient 
had an infection on the prosthesis (Klebsiella species). Four 
patients died of unknown causes . Few non-fatal complications 
or associated conditions were observed (Table 4.9) . 
TABLE 4 . 8 : PRINCIPAL CAUSES OF DEATH (1 PER PATIENT) 














ANTICOAGULANT EXCESS , BLEEDING 
PROSTHETIC DEHISCENCE 
UNRELATED TO CARDIAC SURGERY 
CATHETERIZATION ACCIDENT 
GROUP 2 
















than 30 days 
post-operatively) numbered 24 persons and their mean age was 
49 years (S . D.= 14) . Fourteen of the patients were females . 
Mean post-operative survival was 951 days (S.D.= 1314) with a 
range of 30-6120 days . The mean heart weight in group 2 was 
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650 grams (S.D . = 232) . The principal causes of death in the 
group 2 patients are listed in Table 4.8. Thromboembolism was 
the commonest complication encountered . Infection of the 
prosthesis was encountered in 4 patients. ( Staphylococci were 
involved in 3 cases and no organism was identified in the 
fourth patient ) . One patient had a complication related to 
post-operative cardiac catheterization the catheter 
perforated an iliac artery, which necessitated a laparotomy . 
The patient then developed severe bilateral bronchopneumonia 
and died . One patient developed a fatal cerebral haemorrhage 
due to poor anticoagulation control. Other fatal complications 
included thrombotic immobilization of the prosthesis , 
myocardial failure, death unrelated to 
(complications following cholecystectomy) and 
cardiac surgery 
dehiscence of 
the prosthesis. Cause of death was unknown in 2 patients. The 
sites of thrombus deposition on the various portions of the 
UCT mitral prosthesis in the 36 patients (combined groups 1 
and 2) are indicated in Table 4 . 4. Table 4 . 10 gives the 
pattern of organ infarcts in the same patients. 
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TABLE 4 . 9 : NON-FATAL COMPLICATIONS/ASSOCIATED 
CONDITIONS IN 36 PATIENTS WITH U. C. T . MITRAL 
PROSTHESIS 
GROUP 1 
ACUTE GASTRIC EROSIONS 
AORTIC VALVE DISEASE 








75 %+ CORONARY ARTERY NARROWING 
AORTIC VALVE DISEASE 















TABLE 4.10 : ORGAN INFARCTS ENCOUNTERED IN 36 PATIENTS 


































Two patients had isolated tricuspid valves replacement 
with a University of Cape Town prosthesis. The first patient, 
a 23-year-old white male, had Ebstein's anomaly of the 
tricuspid valve plus an atrial septal defect. The patient died 
of an arrhythmia 24 hours post-operatively and at autopsy the 
heart weighed 460 grams. No thrombi were seen on the UCT 
prosthesis which had been well inserted. The second patient 
was a 19-year-old white female who had had two previous mitral 
valvotomies because of rheumatic mitral stenosis. She 
underwent a third mitral valvotomy and her tricuspid valve was 
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day . Silicone emboli were present in the renal 
pancreas . The UCT prosthesis showed no 
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MULTIPLE UNIVERSITY OF CAPE TOWN VALVULAR PROSTHESES IN THE 
SAME HEART 
A total of 41 University of Cape Town (UCT) valvular 
prostheses was implanted i n the hearts of 19 patients, who 
received no other additional kind of heart valve. The sites of 
implantation of the 41 valves in these 19 patients are 
indicated in Table 4.11. 
TABLE 4.11 : SITES OF IMPLANTATION OF 41 U.C.T. 
PROSTHETIC HEART VALVES IN 19 PATIENTS 
A,M A,M,T M,T 
GROUP 1 2 2 2 
GROUP 2 10 1 2 
TOTAL 12 3 4 
A=AORTIC VALVE M=MITRAL VALVE 
T=TRICUSPID VALVE 
Eighteen of the 
prostheses had rheumatic 
19 patients with multiple U.C.T. 





The remaining patient had a 
and developed infective 
endocarditis, which ca used severe destruction of his aortic 
and mitral valves. 
GROUP 1 
These 6 patients comprised 4 females, 2 males 3 were 
coloureds and 3 were whites. Their mean age was 30 years 
(S.D.= 12) with a range of 16-44 years. The mean 
post-operative survival period was 5.3 days (S.D.= 11) with a 
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range of 8 hours to 27 days. The heart weights ranged from 
540-1150 grams with a mean of 830 grams (S.D.= 222). Scanty 
thrombi were present on the sewing ring (inflow aspect) of 
only 1 out of the 14 prostheses implanted in this group of 
short post-operative survivors. Infarcts were noted in the 
following organs : spleen 2 patients, kidneys 4, lung 1, ileum 
1, and left ventricle 2. Neither of the latter two patients 
had significant coronary arterial disease, and the myocardial 
infarcts were considered to be embolic in origin. The 
principal causes of death in these patients are indicated in 
Table 4.12. One is uncertain whether the patient with the 
aortic dissecting aneurysm developed it at surgery,but death 
was due to extension of the dissection into both coronary 
arteries on the 27th post-operative day. One patient had very 
severe pulmonary 
pre-operatively. 
stenosis which had been underestimated 
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TABLE 4 . 12 : PRINCIPAL CAUSES OF DEATH (1 PER PATIENT) 
IN 19 PATIENTS WITH MULTIPLE U. C. T. VALVULAR PROSTHESES 
GROUP 1 
MYOCARDIAL FAILURE 2 
AIR EMBOLISM 1 
DISSECTING ANEURYSM 1 




MYOCARDIAL FAILURE 3 
UNRELATED TO OPERATION (catheterization) 1 
THROMBOEMBOLISM 1 
THROMBOSED MITRAL & TRICUSPID PROSTHESES 1 





TABLE 4.13 NON-FATAL COMPLICATIONS/ASSOCIATED 
CONDITIONS IN 19 PATIENTS WITH MULTIPLE U.C.T. 
PROSTHESES 
GROUP 1 









SUTURE IN BUNDLE OF HIS 
WOUND INFECTION 
BOBBIN WEAR 




ACUTE TUBULAR NECROSIS 
PNEUMOTHORAX 



















These 13 patients comprised 7 males, 6 females and there 
were 8 whites, 4 coloureds and 1 black patient. Their mean age 
was 36 years (S.D.= 8) with a range of 21-52 years. The mean 
post-operative survival period was 895 days (S.D.= 1066) and 
the range was 42-3285 days. The mean heart weight was 757 
grams (S.D.= 294) with a range of 522-1200 grams. Only three 
out of the 27 prostheses implanted in these 13 patients showed 
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any evidence of thrombosis : one patient had abundant base 
ring thrombus obstructing her U.C.T. mitral and tricuspid 
prostheses , and another had scanty thrombus on the strut of a 
mitral prosthesis. Seven prostheses in this group of 
longer-surviving patients bore infected vegetations. The 
following organisms were cultured from these 5 patients with 
infected prostheses Candida albicans 1 , Candida parasilosis 
1 , Staphylococcus albus 2 and Staphylococcus aureus 1 . The 
following organ infarcts were encountered in these 13 patients 
kidneys 9, spleen 7, heart 5, brain 4 , lungs 3 , liver 1 and 
ileum 1. Non-fatal associated conditions in the 19 patients 
with multiple UCT prosthetic valves are listed in Table 4 . 13 . 
SUMMARY OF THE PRINCIPAL CAUSES OF DEATH IN THE 98 PATIENTS 
WITH UNIVERSITY OF CAPE TOWN CARDIAC VALVULAR PROSTHESES 
The following groups of principal causes of death were 
encountered (a) due to an error in pre-operative diagnosis , 
1 ; (b) due to an error in operative technique , 10 (10%) ; due 
to problems inherent in the cardiac valve prosthesis , 42 ( 4 3%) 
; (c) post-operative complications , 22 (23%) ; (d) unrelated 
to the valve replacement operation , 4 (4%) ; and unknown 
causes , 19 (19%) . 
COMMENT 
The fact that 43% of the deaths were due to problems 
inherent in the UCT prosthetic valve indicates that the valve 
is an unsatisfactory prosthesis. With regard to the early 
deaths following aortic valve replacement it should be noted 
that the commonest principal causes of death were unknown 
causes (? arrhythmia) and myocardial failure . The high 
incidence of myocardial failure in these patients with UCT 
aortic valve prostheses is probably influenced by poor patient 
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selection for cardiac surgery. In those early days in which 
this valve prosthesis was used , cardiac surgery was regarded 
as a last resort to be used when medical treatment had failed . 
Many patients were operated upon who would in modern times 
have either been operated upon earlier in the course of their 
disease, or they would have been refused surgery because of 
severe myocardial dysfunction. Less than adequate myocardial 
protection during cardiopulmonary bypass may also have played 
a role in the high incidence of myocardial failure 
post-operatively , since these operations were performed prior 
to the institution of cardioplegic myocardial protection . The 
group 2 patients with isolated aortic valve replacement had 
thromboembolism , myocardial failure , infection and death due 
to unknown causes as the commonest causes of demise . Although 
thrombus deposition was slightly less common on the UCT aortic 
valves compared to the UCT mitral prosthesis , thromboembolism 
was still an important complication with the UCT aortic 
prosthesis. Two of the patients in group 2 died of the late 
effects of operative air embolism . 
In patients with an implanted UCT mitral prosthesis the 
most important causes of death early post-operatively (group 
1) were unknown causes , thromboembolism and operative air 
embolism . Later deaths (group 2) were most often due to 
systemic thromboembolism , infection of the prosthesis or 
massive thrombotic occlusion of 
failure probably favoured the 
complication in some instances. 
the prosthesis . Myocardial 
development of the latter 
The frequent incidence of 
thrombus deposition in relation to the UCT prosthesis is 
reflected in the numerous organ infarcts which were observed 
at autopsy in these patients . The high thromboembolic rate led 
to clinical use of the UCT prosthetic being discontinued . 
Patients with UCT prostheses had a higher incidence of small 
coronary arterial thromboembolism compared to other prostheses 
( see Chapter 17 , part E ) . 
CHAPTER 5. 





PATHOLOGY OF CARDIAC VALVE REPLACEMENT WITH THE STARR-EDWARDS 
BALL-VALVE PROSTHESIS 
STARR-EDWARDS MITRAL VALVE PROSTHESIS 
Between January 1970 and June 1976, 332 adult patients 
underwent isolated mitral valve replacement (with or without 
tricuspid valve annuloplasty) with a Starr-Edwards 
prosthesis(l). The operative, in-hospital, or post-operative 
mortality rate within 30 days of the operation was 8.0%. 
Twenty-eight percent of these patients had been lost to 
follow-up by 1975. Thromboembolism was encountered clinically 
in 15 late survivors, among whom there was fatal embolism in 
5, transient embolic symptoms in 4 and minor embolic effects 
in another 4 (Dr R. Forman, personal communication). The 
yearly survival and embolism events in all patients with 
implanted Starr-Edwards cardiac valvular prostheses listed in 
the computerized records of Groote Schuur Hospital are 
indicated in Tables 5.1 and 5.2. 
Thirty-four patients came to autopsy following mitral 
valve replacement with a Starr-Edwards 
Fifteen patients died 30 days or less after 
1) and 19 died later (group 2). The mean 
was 35.1 years ( S.D. = 15.2 ). There were 
prosthetic valve. 
operation (group 
age of the patients 
13 males and 21 
females. Twelve patients were whites and there were 14 
coloureds, 7 blacks and 1 asiatic patient. The mean period of 
post-operative survival in group 1 was 10 days ( S.D.= 9 ) and 
that for group 2 was 37.9 months ( S.D.= 35.6 ). Table 5.3 
indicates the models of Starr-Edwards prostheses used in these 
34 patients. Only cloth-covered valves had been implanted. 
(For structural differences between the different models of 
the Starr-Edwards prosthesis please see Chapter 2 and Table 
2.2). Few of the autopsied patients had models 6300 and 6310 














































































































































































































































































































































































































































































































































































































































































































































































TABLE 5.3 : MODELS OF STARR-EDWARDS MITRAL VALVE 
PROSTHESES IN 34 AUTOPSY PATIENTS 






TABLE 5.4 : PRINCIPAL CAUSES OF DEATH (1 PER PATIENT) 






UNRELATED TO CARDIAC OPERATION 
INCORRECT PRE-OPERATIVE DIAGNOSIS 
GROUP 2 
SYSTEMIC THROMBOEMBOLISM 
THROMBOSED PROSTHESIS (CLOTH WEAR) 
MYOCARDIAL FAILURE 














the 34 patients was 59 4 grams (S . D. = 126) . Thirty-three out of 
the 34 patients had mitral valve replacement for chronic 
rheumatic-type deformities of their native mitral valves . The 
remaining patient had developed mitral incompetence with 
minimal stenosis following infective endocarditis . 
GROUP 1 
From the principal causes of death in the group 1 
patients listed in Table 5 . 4 it is apparent that most often 
the cause of death was unknown(? arrhythmia) , followed in 
order of frequency by myocardial failure and thromboembolism . 
One patient , who died due to an error in pre-operative 
diagnosis, had been treated elsewhere for a few weeks with an 
erroneous diagnosis of broncho-pneumonia and no cardiac 
treatment had been given . She was finally admitted to Groote 
Schuur Hospital in a moribund state 
suspected cardiac myxoma. The patient 
operation in which the mitral valve was 
for operation on 





the operative finding of severe chronic rheumatic-type mixed 
valvular disease . 
One-third of the group 1 patients had antemortem thrombi 
on their Starr-Edwards prostheses and 3 patients had evidence 
of cerebral thromboembolism. Minor complications observed 
included a small para-prosthetic leak between the sewing ring 
of the Starr-Edwards valve and the native mitral valve ring in 
one patient and peripheral silicone emboli from the bubble 
oxygenator in 
post-operative 
five patients . Four patients had severe 
myocardial failure and a few had pulmonary 
diseases , including pneumonia , incidental lung cancer and 
persistent severe passive venous pulmonary hypertension . One 
patient had myocardial infarction due to coronary arterial 
atherosclerosis . Table 5.5 shows the non-fatal complications 
encountered in the group 1 patients . Three patients had 
inadequate anticoagulant control ; this led to bleeding in 2 
and widespread thrombosis in the third patient . A patient with 
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severe , persistent post-operative pulmonary hypertension 
showed changes of severe passive venous pulmonary hypertension 
at autopsy . 
GROUP 2 
In the group 2 patients (long survivors) it is evident 
that thrombus formation in relation to the Starr - Edwards 
prosthesis ( Table 5.6 ) and resultant thromboembolism were 
the most important complications . In three patients abundant 
thrombus had led to virtual immobilization of the prosthetic 
ball . The commonest organs showing infarcts (in descending 
order of frequency) were the kidneys , brain , spleen , heart and 
the limbs . Poor anticoagulant control led to a small 
subarachnoid haemorrhage in one patient . Severe cloth wear 
(Figure 5 . 1) over the sewing ring of the prosthesis was 
recorded in 5 patients with post-operative survival periods 
varying from 26 . 5 to 96 months . Myocardial failure occurred in 
only 2 of the 19 patients.One patient was found to have a 
fistula between the oesophagus and the left atrium , which was 
sealed by thrombus . A likely cause of the fistula is that it 
was caused during the operation by a cautery electrode 
touching the lead of the intra-oesophageal 
temperature-monitoring device. One patient developed pneumonia 
and 2 patients had serious diseases unrelated to the cardiac 
surgery ( endometrial carcinoma , miliary tuberculosis ) . 
The principal causes of death in the 19 group 2 patients 
are indicated in Table 5 . 4. Thromboembolism ( coronary or 
cerebral ) killed 11 patients and three died of thrombotic 
obstruction of their prostheses . 
the late deaths were related to 
Thus , seventy - five percent of 
thrombus deposition on the 
prosthesis . Other miscellaneous causes of death are listed in 
the same Table . 
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TABLE 5.5 : NON-FATAL COMPLICATIONS/ASSOCIATED 
CONDITIONS IN 34 PATIENTS WITH STARR-EDWARDS 
MITRAL VALVE PROSTHESES 
GROUP 1 
INADEQUATE ANTICOAGULATION CONTROL 
SILICONE EMBOLI 
MILD PROSTHETIC DEHISCENCE 
LUNG CARCINOMA 
BRONCHOPNEUMONIA 
SEVERE PULMONARY HYPERTENSION 









ENDOMETRIAL CARCINOMA 1 
TUBERCULOSIS 1 
SUBAORTIC STENOSIS DUE TO PROSTHESIS 1 
POST-OPERATIVE SUBMITRAL FALSE ANEURYSM 1 
TABLE 5.6 : SITES OF THROMBUS DEPOSITION ON 
STARR-EDWARDS MITRAL VALVE PROSTHESES 
No. OF PATIENTS WITH STARR-EDWARDS PROSTHESES 
No. OF PROSTHESES BEARING THROMBI 














TABLE 5 . 7 : ORGANS WITH INFARCTS IN 34 AUTOPSY 


























The sites of thrombus deposition on the 18 Starr-Edwards 
mitral prostheses bearing thrombi are detailed in Table 5.6 . 
The commonest sites were the inflow aspect of the sewing ring 
and the inner aspect of the cage . The pattern of organ 
infarcts is indicated in Table 5.7 . None of the patients had 
more than 75 % luminal narrowing of a major coronary artery and 





Removal of abundant thrombus from this 
mitral valve prosthesis revealed cloth wear and 
loss over much of the base ring due to wear of the protective 
metal studs on the contact zone of the ring . 
Figure 5.2 Disproportion between the bulky Starr-Edwards 
tricuspid prosthesis and a mildly dilated right ventricle has 
led to incorporation of part of the cage into the right 




STARR-EDWARDS AORTIC VALVE PROSTHESIS 
Only seven patients with isolated Starr-Edwards aortic 
valve prostheses were autopsied . These patients had a mean age 
of 46 years ( S . D . = 10 . 1 ) and a range of 34 to 62 years . 
There were 6 whites and 1 colcured patient . The pre-operative 
aortic valvular lesions were as follows aortic nodular 
sclerosis (tricuspid senile calcific aortic stenosis) 1 , 
stenotic calcified congenital bicuspid aortic valve 3, 
rheumatic fever 1 and aortic incompetence secondary to 
dissecting aneurysm of ascending aorta 1 , and unknown 1 . The 
mean post-operative survival period of these 7 patients was 
482.4 days ( S.D . = 935 ) , with a range of from Oto 2520 days. 
Three patients died one month or less following the valve 
replacement operation. The mean heart weight in the seven 
patients was 785 grams ( S . D. = 359 ). Six patients received 
model 2400 Starr-Edwards aortic valve prostheses and one 
received a model 2320 prosthesis . Three patients had very 
severe coronary atherosclerosis and 2 of these patients had 
undergone saphenous vein aorta - coronary arterial bypass grafts 
at the same time as the valve replacement operation . The 
coronary arterial narrowing in the third patient was not so 
severe as to warrant such grafting at the time of operation 7 
years before death, but the coronary atherosclerosis had 
progressed markedly since then and had caused 2 separate 
myocardial infarcts . 
GROUP 1 
The principal causes of death ( Table 5 . 8) in 3 patients 
consisted of who survived 30 days or less post-operatively 
irreversible , anoxic brain damage 
separated from the pump for 4 minutes 




bypass when the lines became disconnected due to a build- u p of 
pressure in the arterial line ; a ruptured aortotomy wound in 
a patient with aortic medionecrosis and sticking of the 
prosthetic ball in a patient with a too narrow aortic root. 
The latter complication had been recognized at surgery , but 
the aortic patch which had been inserted failed to fully 
correct the problem. Only one of these 3 group 1 patients had 
scanty thrombus on the struts of the prosthesis . One cannot 
comment on systemic embolization, since in two out of the 3 
autopsies only the heart was examined (partial postmortems). 
Other complications noted in these 3 early deaths included 
acute gastric erosions , excessive anticoagulation, and a 
pseudomonas gastroenteritis. 
TABLE 5.8 : PRINCIPAL CAUSES OF DEATH (1 PER PATIENT) 
IN 7 PATIENTS WITH STARR-EDWARDS AORTIC VALVE PROSTHESES 
GROUP 2 
GROUP 1 
BYPASS ACCIDENT-INDUCED CEREBRAL ANOXIA 1 
RUPTURED AORTOTOMY WOUND (MEDIONECROSIS) 1 






The 4 patients comprising group 2 all had thrombotic 
material on their prostheses (rings and cages) this was 
infected in 3 and bland in one patient. Two out of the 3 
patients with infective endocarditis had aortic ring abscesses 
and in only one was there involvement of a natural (mitral) 
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valve . One patient was i n fected by Bacillus cereus and another 
by Staphylococcus aureus . Whilst no organism was cultured from 
the third patient , gram positive cocci were seen on a smear of 
the vegetations. Two of the patients with infective 
endocarditis showed recent septic organ infarcts cardiac , 
splenic and renal in one patient and splenic and renal in the 
other. Silicone emboli from the bubble oxygenator were seen in 
the glomeruli of one patient . The principal causes of death in 
these 4 patients ( Table 5 . 8) were infective endocarditis (3 
patients) and thrombotic obstruction of the prosthesis in one 
patient . The development of thrombosis in the latter patient 
may have been favoured by the ischaemic heart disease - induced 
myocardial failure from which this patient also suffered . None 
of these 7 patients showed Aschoff bodies histologically in 
their hearts . 
TWO STARR-EDWARDS PROSTHESES IN THE SAME HEART 
Autopsies were performed upon 3 patients who each had 2 
Starr-Edwards valve prostheses implanted in their hearts . The 
salient clinicopathological features in these patients are 
given in Table 5 . 9 . Patient 1 died of a Pseudomonas pneumonia 
and lung abscesses . The prostheses of these 3 patients 
exhibited tissue ingrowth into the cloth covering the sewing 
ring and base rings . Patient 2 showed a unique form of host 
tissue ingrowth , whereby portion of the cage of the tricuspid 
prosthesis became attached to and incorporated into the wall 
of the ventricle (Fig . 5 . 2 ) . This complication appeared to 
result from endocardial trauma produced by the bulky 
prosthetic cage and organization of thrombus . Ball movement 
was severely limited by the host pannus and this 
prosthetic-related complication appeared to have played a 
significant role in the production of the 
of heart failure . 
patient ' s symptoms 
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TABLE 5.9 : CLINICOPATHOLOGICAL DATA ON 3 PATIENTS WITH 
DOUBLE STARR-EDWARDS PROSTHETIC VALVE REPLACEMENTS 
PT .1 PT.2 PT.3 
AGE,RACE,SEX 32,W,F 23,C,F 54,W,M 
AETIOL.PRE-OP.LESIONS RHEUM. RHEUM. RHEUM. 
VALVES REPLACED M,T M,T A,M 
POST-OP.SURVIVAL (DAYS) 3 1095 510 
CAUSE OF DEATH PNEUMONIA AS C.C.F. 
PROSTHETIC THROMBI M-,T- M+,T- A-,M-
TISSUE INGROWTH M-,T- M-,T+ A-,M-
STASIS THROMBI NIL NIL LA,LV 
HEART WT.(G) 498 680 1208 
ASCHOFF BODIES NIL + NIL 
A=aortic valve,M=mitral valve,T=tricuspid valve 
LA=left atrium,LV=left ventricle,W=white,C=coloured 
M=male,F=female,RHEUM=rheumatic fever,AS=aortic stenosis 
CCF=congestive cardiac failure,+=scanty,-=absent. 
PRINCIPAL CAUSES OF DEATH IN ALL 44 PATIENTS WITH 
STARR-EDWARDS PROSTHESES 
The principal causes of death in the 44 patients with 
Starr-Edwards valvular prostheses was as follows : (a) due to 
error in pre-operative diagnosis, 1 ; (b) due to error in 
operative technique, 2 ; (c) due to problems inherent in the 
prosthetic valve, 23 ; (d) post-operative complications, 9 
(e) unrelated to the valve replacement operation, 4 ; and (f) 




Starr et al.(2) reported a 10-year follow-up of 290 
patients with isolated mitral valve replacement with noncloth-
and cloth-covered Starr-Edwards prostheses . The 10- year 
projection of the percentage of patients alive and free of 
emboli (disregarding transient ischaemic attacks) for the 
Model 6310-6320 (50%) was similar to that actually observed 
for the model 6120 (46%) . Salomon et al.(3) compared the 
long-term results of isolated mitral valve replacement in 897 
patients with Starr-Edwards Model numbers 6000 and (49 cases) 
and 6120 (519 cases) ; aortic allografts (115 patients) and 
214 porcine xenograft valves. Thromboemboli were more common 
with the Starr-Edwards than with either of the tissue valves . 
Patients with Starr-Edwards Models 6120 and 6000 valves 
sustained an incidence of fatal thromboemboli of 1 . 0% and 0 . 6% 
per patient-year respectively . Patients with allograft valves 
suffered an incidence of 0 . 4% per patient-year . In contrast, 
no fatal thromboembolism occurred in patients with porcine 
xenograft valves . 
Fraser and Waddell(4) studied 47 patients with isolated 
aortic valve replacement and found a statistically significant 
lower incidence of emboli in those who were on 
00 well-controlled " antocoagulant therapy compared to others 
who received no anticoagulants . However , Lewis et al . (5) found 
in their study of the results of aortic valve replacement with 
the Starr-Edwards prosthesis in 86 patients , that 
thromboembolism was a major problem. It was noted in 15 
patients and was fatal in 5% of patients followed up for 3 
years. Herr et al . (6) encountered fatal prosthetic infection 
in 5 out of 266 patients who had Starr-Edwards valves 
implanted over a 4 - year period. Six patients developed a 
peri-prosthetic leak , 7 patients had severe anaemia due to 
haemolysis , and embolism was noted in 27 of 65 patients who 
had been followed for a minimum of 3 months . Twenty-two out of 
the 27 patients with emboli had atrial fibrillation. 
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Roberts and Morrow(7) reported on autopsies performed 
upon 98 patients with Starr - Edwards valves. In the 65 early 
deaths (less than 1 month post-operatively) major causes of 
death included mechanical interference to proper functioning 
of the prosthesis in 22 patients, uncontrolled bleeding (22 
patients) , and acute myocardial infarction (16 patients). Less 
frequent early fatal complications were associated uncorrected 
valvular disease, pulmonary complications, arrhythmia , and 
infection. Causes of the 33 late deaths included prosthetic 
valve infection (in 5 patients) , congestive heart failure (8 
patients) sometimes due to prosthetic thrombosis , and sudden 
unexpected death. 
Prosthetic 
the 33 patients 
thickening of 
valve thrombi were found at autopsy in 27 of 
and other complications included intimal 
the aortic root and proximal portions of the 
major coronary arteries , traumatic intra-vascular haemolysis , 
and ball variance. The latter problem is reviewed by Laforet 
et al . (8) who described a patient whose death resulted from 
ball variance . They state that 29 out of 1400 Starr-Edwards 
valves returned to Edwards Laboratories Inc . for examination 
showed ball variance of some degree . This consisted of change 
in colour, mass, hardness, shape or surface appearance . 
Magovern(9) has described a case in which the ball of an 
aortic valve prosthesis had increased in size to the point 
where it became stuck in the open position . Similar cases have 
also been reported by others(l0,11) . Ball variance has not 
been encountered at Groote Schuur Hospital since only 
Starr-Edwards prostheses with metal (Stellite) balls have been 
used . Hameed et al.(12) described a patient whose 
Starr-Edwards aortic valve prosthesis suffered ball fracture 
with extrusion and dissemination of the plastic ball material 
into the systemic circulation. Gobel et al . (13) reported a 
patient with fatal coronary arterial embolism resulting from a 
similar complication.Others have reported similar cases of 
ball fracture leading to systemic embolism(l4) . 
Cloth wear , as seen in some of my patients and recorded 
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in the literature(lS-18) , may be a significant problem. Cloth 
wear was seen in 5 out of 47 Starr-Edwards prosthetic valves 
implanted in 44 patients in the present study . All 5 were 
Model 6310-6320 mitral prostheses in which wearing away of the 
metal studs had led to subsequent cloth wear . Bonchek and 
Starr(lS) reported cloth wear in 10 patients with 
Starr-Edwards valves and expressed the hope that the newer 
model 2400 aortic and 6 4 00 mitral composite track valves would 
overcome this problem . Shah et al . (16) suggest that the 
following clinical findings should arouse suspicion of cloth 
wear : (a) recurrent transient cerebral ischaemic attacks or 
other systemic emboli despite adequate anticoagulation (b) 
systemic arterial embolization more than 4 years after valve 
replacement with cloth-covered prostheses (c) increase in 
loudness of the prosthetic valve clicks on auscultation , 
particularly with a metallic pitch ; (d) persistent severe 
haemolytic anaemia with or without regurgitation across the 
prosthesis and (e) incomplete seating of the poppet on the 
valve orifice seen on cinefluorography 
regurgitation seen on angiography . 
The true incidence of cloth wear 
or intra-valvular 
in general , and of 
clinically significant cloth wear in particular , is unknown. 
Starr et al . (17) reported that 12 out of 18 patients with 
cloth-covered aortic valve valves (Models 2310-2320) who were 
re-operated upon for a variety of reasons showed cloth wear . 
Four of these 12 patients were re-operated upon for haemolytic 
anaemia and all 4 had strut cloth wear . Isom et al . (18) stated 
that clinically significant cloth wear was present in 1% of 
their patients . Shah et al . (16) observed an overall incidence 
of 2 . 5% (aortic valve prostheses 3 . 3% and mitral valve 1 . 2%). 
Teflon fibre embolism resulting from cloth wear has been 
observed at autopsy(l9) . Sudden death due to fatal coronary 
arterial obstruction due to Starr-Edwards aortic valve cloth 
wear has also been reported(20). The composite strut valves do 
not develop strut cloth wear but , as was observed in my 
patients, the metal studs that protrude through the sewing 
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ring cloth may wear away and lead to cloth wear(21). 
Ringel et al . (22) reported a unique form of structural 
failure of a Starr-Edwards aortic track valve , which has not 
been observed in my study . Fractures of the 3 struts and their 
liners had occurred above their insertion into the valve ring. 
At operation the ball was found in the aortic root and the 
cage was lodged in the descending aorta at the level of the 
diaphragm . Complete detachment of the entire prosthesis may 
also occur occasionally(23) . 
There are numerous reports(S , 24-56),including one from 
our own institution(l) , detailing the haemodynamic and 
clinical findings in patients with Starr-Edwards prostheses. 
Other papers address more specifically the problems of valve 
obstruction due to thrombosis(57-62) , infection(SS , 63 , 64), 
mitral valve remnants(65) and encroachment by pannus(66 , 67) . 
Relatively few reports(68-72) give detailed data on the 
valvular or general autopsy findings in patients with 
Starr-Edwards valves . Vasconez(73) studied healing around the 
Starr-Edwards aortic valve replacement in patients and 
concluded that the Starr-Edwards prosthesis with a Teflon 
sewing ring is held in place predominantly by sutures and host 
tissue ingrowth is minimal. This explains why peri-prosthetic 
leakage has not been uncommon . These authors welcomed the 
change of the sewing ring of 
Teflon to Dacron . 
the Starr-Edwards valve from 
Seningen et al.(74) drew attention to the problem of 
disproportion between 
prosthesis and a too 
the bulky Starr - Edwards ball - valve 
narrow aortic root, which may lead to 
prosthetic aortic stenosis and death due to too low a cardiac 
output . Prosthetic stenosis was observed in one of my patients 
with a tricuspid valvular prosthesis in which a strut had 
become fused to the ventricular wall by fibrous tissue , 
probably due to organized thrombus . Engagement of a papillary 
muscle or the wall of a ventricle by a strut of an open-cage 
(Cutter) ball-valve prosthesis has also been reported(75) . 
In 1983 , Starr(76) reviewed ball valve prostheses from a 
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perspective of 22 years . He suggests that the Starr-Edwards 
mitral Silastic ball-valve , which has been in use for 17 years , 
is the valve of choice except in very elderly patients and 
those in whom anticoagulant therapy poses a big risk. Starr 
also concluded that , overall , there are no major differences 
in the incidence of thromboembolism between currently 
available tissue valves and the ball valve during the same 
time frame (from 1973 onwards) . He also claims that the St 
Jude Medical valve(77,cited reference) has a 




stenosis in aortic valve replacement , 
to that of the 
Regarding thrombotic 
he cited evidence to 
show that the Bjork-Shiley valve was 97% free of this 
complication at 5 years , whereas the Starr-Edwards ball-valve 
was 99 . 5% free. In a recent study(78) , in vitro velocity , 
shear stress , and pressure drop measurements were made under 
steady-flow conditions and used to interprete some of the 
failure modes of the Starr-Edwards prostheses as observed at 
autopsy(79-83) . 
For further discussion on the pathological findings in my 
44 patients with Starr-Edwards prosthetic heart valves please 
see Chapter 18 (OVERALL REVIEW). 
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CHAPTER 6 . 
PATHOLOGY OF CARDIAC VALVE REPLACEMENT WITH THE BJORK-SHILEY 
TILTING-DISC VALVE PROSTHESIS . 
Table 6 . 1 gives the yearly survival for patients who had 
Bjork-Shiley valvular prostheses implanted at Groote Schuur 
Hospital . The post-implantation embolism events are summarized 
in Table 6.2. 
AORTIC VALVE REPLACEMENT 
Autopsies were performed upon 12 patients with 
Bjork-Shiley aortic valve prostheses . Seven of the 12 patients 
were males and there were 7 whites, 4 coloureds and one black 
patient . The mean age of the 12 patients was 35 . 2 ( S . D . = 15 . 2 
) years with a range of 2-60 years . ( One patient was 2 years 
old and the remainder were all older than 25 years ). The 
aetiology of the native aortic valvular disease necessitating 
valve replacement is given in Table 6 . 3 congenital 
abnormalities of the aortic valve and rheumatic fever were the 
commonest underlying pathology . The mean post-operative 
survival period was 110 ( S . D . = 203 ) days with a range of 
0-720 days . The mean heart weight was 579 ( S . D . = 192) grams . 
The 2-year-old child had a heart weight of 115 grams . The 
heart weights of the other 11 adult patients ranged from 
448-907 grams. Only one out of the 12 patients had scanty 
platelet and fibrin thrombus on the edge of the sewing ring 
(outflow aspect) of the Bjork-Shiley prosthesis. All patients 
received an anticoagulant (Warfarin) post-operatively . 
Seven of the 12 patients had a forensic autopsy and only 
the hearts were referred to me for examination.No data are 
available regarding organ infarcts in these 7 patients . Two 
out of the 5 patients who had full postmortems showed organ 
infarcts viz . renal infarcts in 2 and embolic left ventricular 
myocardial infarction in one. Table 6 . 4 gives the principal 
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causes of death (1 per patient) in the patients 
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The 6 patients in this group consisted of 5 whites and 1 
black patient ; there were 3 males and 3 females . The mean age 
was 34 years ( S . D . = 19 . 3 ) with a range of from 2-60 years . 
Pre - operative native valvular disease is listed in Table 6 . 3 
and the principal causes of death are given in Table 6.4. The 
mean post-operative survival period was 2 . 6 days ( S . D.= 3.8) 
with a range of 0-9 days. The mean heart weight in this group 
of patients was 566 grams ( S . D . = 266) with a range of from 
115 to 907 grams . Two group 1 patients died due to an error in 
pre-operative diagnosis , namely unrecognized very severe ( 
Heath-Edwards grade 6 ) pulmonary hypertension in one and 
congenital stb - aortic stenosis in another . Problems with 
regard to operative technique led to the demise of 2 patients 
: 1 had severe myocardial damage, so-called 00 stone heart " (1) 
and the other had a shock lung syndrome . There were two 
general post-operative complications in this group ( pneumonia 
and intrathoracic bleeding ). 
The non-fatal complications/associated conditions in this 
group of 12 patients with Bjork-Shiley aortic prostheses are 
listed in Table 6 . 5 . 
GROUP 2 
There were also 6 patients in group 2 ( who survived more 
than 30 days post-operatively ) . They consisted of 4 coloureds 
and 2 whites 4 out of the 6 were males . The mean age was 
36.5 years ( S.D . = 11 . 4) with a range of from 25-50 years. 
The mean post-operative survival was 218 days (S . D . =251) and 
the range was from 90 to 720 days . The mean heart weight in 
this group of patients was 595 grams ( S . D . = 62 ) with a range 
of 540-648 grams . The principal causes of death and associated 
conditions are given in Tables 6 . 4 and 6.5 . Problems with 
regard to operative myocardial protection led to one patient 
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developing the "stone heart" syndrome, (see Chapter 17 ). An 
heterotopic heart transplant was attempted using a donor heart 
from a baboon in order to try and save the patient's life, but 
the graft functioned for only 4 hours. Another patient 
suffered dehiscence of the prosthesis. Only one patient had an 
infected prosthesis (no organism cultured). One patient 
developed a complication which is unique to open heart 
surgery, namely post-perfusion coronary ostial stenosis. Two 
deaths unrelated to operation were rupture of a pre-existing 
cerebral mycotic aneurysm and a fatal motor vehicle accident. 
None of the hearts showed Aschoff bodies . 
TABLE 6.3 : AETIOLOGY OF THE NATIVE VALVULAR DISEASE 












*=AORTIC STENOSIS,TRUNCUS ARTERIOSUS. 












TABLE 6.4 : PRINCIPAL CAUSES OF DEATH (1 PER PATIENT) 
IN 12 PATIENTS WITH BJORK-SHILEY AORTIC VALVE 
PROSTHESES 
GROUP 1 
PULMONARY HYPERTENSION 1 
STONE HEART 1 
UNRECOGNIZED SUBAORTIC STENOSIS 1 
BLEEDING 1 
SHOCK LUNG SYNDROME 1 
PNEUMONIA 1 
GROUP 2 
STONE HEART 1 
DEHISCENCE OF PROSTHESIS 1 
RUPTURED MYCOTIC ANEURYSM 1 
INFECTED PROSTHESIS 1 
POST-PERFUSION OSTIAL STENOSIS 1 
MOTOR VEHICLE ACCIDENT 1 
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TABLE 6.5 NON-FATAL COMPLICATIONS/ASSOCIATED 
CONDITIONS IN 12 PATIENTS WITH BJORK-SHILEY 
AORTIC VALVE PROSTHESES 
GROUP 1 
PUMP LUNG 1 
MEDIASTINAL SURGICAL EMPHYSEMA 1 
75%+ CORONARY ARTERIAL NARROWING 1 
GROUP 2 
EXTRA-DURAL ABSCESS (OTITIS MEDIA) 1 
SEVERE HAEMOLYSIS 1 
75%+ CORONARY ARTERIAL NARROWING 1 
HETEROTOPIC HEART TRANSPLANT (4HRS)l 
MITRAL VALVE REPLACEMENT 
1. Only one patient with a Bjork-Shiley mitral valve 
prosthesis was autopsied. The patient was a 13-year-old black 
female with rheumatic mitral stenosis and incompetence. In 
1978 her mitral valve was replaced with a Carpentier-Edwards 
bioprosthesis. Cuspidal calcification led to functional 
stenosis of the latter prosthesis, which necessitated its 
replacement by a Bjork-Shiley prosthesis. Free-floating 
thrombus was noted in the left atrium at operation. The 
patient died at the end of the operation. Autopsy revealed 
occlusion of the left main coronary artery by a 
thromboembolus. This patient's death is attributable to the 
calcification-induced stenosis of the Carpentier-Edwards 




2. I have had the opportunity of examining Bjork-Shiley mitral 
valve prostheses which were surgically removed from 3 
patients : 
(a) The first patient , a 30-year-old white 
cardiac catheterization because of a 
female, underwent 
para-valvular leak. 
During the catheterization procedure the disc was dislodged 
due to the catheter passing through the lesser instead of the 
greater orifice as had been intended . Emergency mitral valve 
replacement was performed and the dislodged disc was recovered 
from the aorta. 
(b) The second patient was a 44-year-old coloured female who 
had a Bjork-Shiley mitral prosthesis inserted 3 . 5 years 
before. She then underwent re-operation because of severe 
aortic stenosis and at surgery it was noted that host pannus 
had grown over the base ring and narrowed the effective 
orifice of the Bjork-Shiley prosthesis . Maximal encroachment 
was present in the vicinity of the lesser orifice. The 
prosthesis was also replaced at the same operation . Calcified , 
vascularized fragments of the aortic valve were received, 
together with the excised Bjork-Shiley prosthesis and multiple 
fragments of the host tissue overgrowth . The latter had the 
histological appearance of compacted fibrin and fibrous 
tissue . The cloth of the sewing ring of the prosthesis 
appeared to have been damaged during surgical removal. 
(c) The third patient , (no clinical data available), had the 
disc of the Bjork-Shiley prosthesis totally immobilized by an 
overgrowth of host pannus tissue ( see Figure 7.1). 
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Only a single patient was autopsied with Bjork-Shiley 
prostheses replacing both the mitral and tricuspid valves . The 
patient was a 44-year-old coloured female with chronic 
rheumatic heart disease and insulin-dependent diabetes 
mellitus . In addition to her mitral and tricuspid valvular 
disease , the patient had mild aortic stenosis and 
incompetence . The patient died 4 hours post-operatively due to 
a massive haemorrhage from numerous acute gastric erosions. No 
organ infarcts were noted at autopsy . An incidental colloid 
goitre of the thyroid gland was present. No heart weight was 
available , but both prosthetic valves were securely inserted . 
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Scanty fibrin thrombus was noted on the atrial aspect of the 
sewing ring of the tricupid prosthesis. 
PRINCIPAL CAUSES OF DEATH IN 13(*) AUTOPSIED PATIENTS WITH 
BJORK-SHILEY VALVE PROSTHESES. 
The principal causes of death were as follows (a) due 
to error in pre-operative diagnosis, 2 ; (b) due to error in 
operative technique, 5 ; (c) due to problems inherent in the 
Bjork-Shiley valve, 1 (d) due to post-operative 
complications, 2 ; (e) unrelated to the cardiac operation, 2 ; 
(f) unknown causes, 1. 
(* The death of the 14th 
re-operation, is attributable 
previous xenograft valve). 
patient, who did not survive 




The Bjork - Shiley prosthesis has not been used very often 
as a valve substitute in our institution since no policy for 
its systemic use 
used when batches 
evaluation by the 
has been applied. The prosthesis has been 
of the valves have been provided for 
manufacturers or at times of transition 
between the formal use of other valve prostheses or in special 
circumstances where the use of other currently available valve 
prostheses was contraindicated e . g ., heterograft valves in 
young persons , or in patients with narrow aortic roots . 
The number of my autopsy patients with Bjork-Shiley valve 
prostheses is too small for any definite conclusions to be 
drawn regarding the frequency of fatal complications. One fact 
that does emerge is that systemic thromboembolism was not a 
prominent feature . None of the prostheses examined showed 
evidence of significant wear or variance . Errors in operative 
technique accounted for 39 % of the deaths and valve-related 
problems were responsible for only 8 % of the deaths . 
Thromboembolic events are the most 
complication of cardiac valves(2) 
Bjork-Shiley(3-35) , despite the neglible 
common and dreaded 
the including 
incidence of this 
complication in my small series of necropsy patients. 
Thrombosis of the Bjork-Shiley prosthetic cardiac valve may 
occur in any valve position and regardless of anticoagulant 
status(22) . Review of cases reported in the literature 
suggests that the cumulative incidence of thrombosis of 
Bjork-Shiley prostheses is about 2 % in the aortic position and 
about 4 % in the mitral position . Prevention of this 
complication is dependent upon continuous anticoagulation with 
warfarin even temporary interruption or alteration of 
anticoagulation regimen may be detrimental . Although changes 
in anticoagulant therapy may rarely precipitate sudden 
thrombosis , in most cases a period averaging 10 months is 
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required for pannus of organized thrombus to build up enough 
to cause acute thrombosis and valve malfunction(22) . Operation 
to remove the thrombus or to replace the prosthesis is usually 
needed for left-sided cardiac prostheses , but thrombosed 
valves in the tricuspid position may be successfully treated 
with fibrinolytic medical therapy. Peterffy et al . (18) suggest 
that red thrombus on Bjork-Shiley valves may be amenable to 
such therapy , which should not be prolonged for more tha n 24 
hours and, if unsuccessful , the patient should undergo valve 
replacement . Others(S) stress that, as soon as obstruction of 
the prosthesis is recognized , the patient should undergo 
immediate surgery. Copans et al . (5) recommend that the 
Bjork-Shiley valve should only be used in the mitral area if 
excellent control of anticoagulation can be guaranteed . 
Bjork and Henze( 4 ) report an experience with 300 
Bjork-Shiley aortic valvular implants and state that they 
encountered no cases of encapsulation or massive thrombosis in 
patients who were adequately anticoagulated . Two of their 
patients who developed massive thrombosis on their 
Bjork-Shiley aortic valves had received no anticoagulants . One 
patient underwent valve replacement and the other had 
operative removal of the thrombus only . This was facilitated 
by temporary removal of the disc . These authors stress that 
this method cannot be recommended for general use as an 
inexperienced surgeon may bend the struts so that the disc 
will not function properly after re-insertion . A decade later , 
Alvarez et al . (36) propose that thrombectomy should be the 
treatment of choice for a thrombosed Bjork-Shiley prosthesis , 
since no deaths in the literature have been attributed to the 
procedure. Moulton(37) questions whether thrombectomy is 
really a proven procedure . 
Thrombosis has been a particular problem with 
Bjork-Shiley valves implanted in the tricuspid position(38) 
and in patients with multiple Bjork-Shiley prostheses(39) . The 
latter study shows that the cumulative incidence of thrombosis 
in patients with multiple prostheses is 26 . 8 % at six years. 
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Coumarin anticoagulation in pregnancy may result in foetal 
malformation and haemorrhagic complications(40). McLeod et 
al.(40) reported the case of a young woman who was given low 
dose heparin from the 17th week of pregnancy. Though there was 
a successful foetal outcome, heparin did not prevent 
thrombosis on the prosthesis and its continuation into the 
puerperium proved nearly fatal. Wong et al.(41) described a 
patient with a Bjork-Shiley aortic prosthesis who had received 
no anticoagulants for 28 months. Sudden, severe intravascular 
haemolysis developed as a result of thrombosis of her aortic 
prosthesis. Several papers discuss the early diagnosis of 
thrombosis of the Bjork-Shiley valve prosthesis(42-44). 
Yoganathan et al.(45) report on their findings in 
recovered Bjork-Shiley aortic valve prostheses and in vitro 
measurements of velocities in the near vicinity of a normally 
functioning and a parially occluded Bjork-Shiley valve. The 
amounts of thrombus formation varied from nearly total 
thrombotic occlusion, similar to that shown by Bjork et 
al.(46) and Fernandez et al.(47), to a thin layer of thrombus. 
Yoganathan et al.(45) attributed the thrombus formation and 
tissue overgrowth to the stagnation zone and the low shear in 
the minor outflow region. A ring-shaped radiopaque marker was 
incorporated into the disc in 1977 to assist in diagnosing 
massive thrombosis of this type of prosthesis(46). Dale(48) 
found that the Bjork-Shiley and Lillehei-Kaster disc valves 
were equally thrombogenic and that the rate was not lower than 
that in patients with Starr-Edwards aortic ball-valves. As we 
shall see later below, others have noted a lower rate of 
prosthetic thrombi in the Bjork-Shiley valves compared to the 
Starr-Edwards ball-valves. 
A large number of articles deal with the clinical and 
haemodynamic features of clinically implanted standard and 
convexo-concave models of the Bjork-Shiley tilting disc valve 
prosthesis(49-67). Other authors deal with specific problems 
e.g., immediate post-operative 
Bjork-Shiley aortic valve due to 
regurgitant malfunction of a 
interfering Teflon of a 
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ventricular septal defect repair(68) retrograde left 
ventricular catheterization in patients with a Bjork-Shiley 
aortic valve prosthesis(69 , 70) ; prosthetic dehiscence(71) ; 
haemolysis due to para-prosthetic regurgitation(72 , 73) or 
death due to complete prosthetic detachment(74). Koops and 
Puschel(75) describe a rare fatal complication in a patient 
who died of acute malfunction of her Bjork-Shiley aortic valve 
prosthesis caused by a large thromboembolus which originated 
in her left atrium . Silver(76) describes wear in Bjork-Shiley 
prostheses recovered at autopsy or at operation . 
Strut fractures have occurred with the new type of 
concavo - convex Bjork-Shiley prosthesis which opens to 70 
degrees(77) and 14 such fractures have occurred worldwide(78) . 
The fractures have all occurred less than 14 months after 
valve implantation - most have been in the mitral position , 
but some were aortic implants. The basic problem is a fault in 
strut design(78) and the prosthesis has been withdrawn from 
the market . Strut fracture may have disastrous clinical 
consequences, but some patients have been saved by emergency 
valve replacement(79 , 80) . 
Obstruction of the Bjork-Shiley valve by chordal 
tissue(81) , 
ingrowth(85) , 
sutures(82-84), early post-operative pannus 
tissue detached from the aortic intima(86) , and 
septal interference of mitral Bjork-Shiley prosthesis(83 , 87) 
have been documented . Echocardiography has been used to detect 
dehiscence(88) and thrombosis(23) of Bjork-Shiley prostheses . 
Verdel et al . (89) developed a method in which cineradiography 
is used for the assessment of the opening angle of implanted 
Bjork-Shiley valves . 
Henze et al . (90) describe the cause of death and the main 
pathological findings in 20 patients following 161 
Bjork - Shiley aortic valve implant operations . Myocardial 
failure (9 patients) was the predominant cause of death. The 
remainder died of cerebral haemorrhage (3 patients), 
malignancy (3 patients) , infection (2 patients) , dissecting 
aortic aneurysm ( 1 patient), hepato-renal syndrome ( 1 
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patient) and thromboembolism (1 patient) . All 20 hearts showed 
gross cardiomegaly . Coronary perfusion during aortic valve 
replacement was considered to be of great importance in 
reducing the incidence of massive sub-endocardial myocardial 
necrosis . 
Roberts and Hammer(91) describe the clinical and autopsy 
findings in 46 patients who had one or more cardiac valves 
replaced with Bjork-Shiley prostheses and compared the latter 
with the findings in patients with caged-ball , caged-disc , and 
trileaflet prostheses . The Bjork-Shiley valves gave less 
problems with regard to disproportion , haemolysis (as judged 
by renal haemosiderosis) , and prosthetic thrombi . No instance 
of prosthetic wear or variance was noted over the relatively 
short 3 to 30 months (mean = 11) follow-up period . Forty 
percent of their early deaths (less than 2 months 
post-operation) were due to unknown causes , 18% were due to 
bleeding, coronary heart disease accounted for 15% , 
uncorrected associated valvular disease 12% , infection 9%, and 
prosthetic dysfunction was encountered in 6% . The latter 
figure is similar to the 8% incidence of valve-related deaths 
in my series. Principal causes of the 13 late deaths reported 
by these authors(91) was as follows (my percentages) 
prosthetic valve endocarditis, 31% ; unknown , 23% ; prosthetic 
valve thrombosis , 23% aortic regurgitation , 15% and 
coronary heart disease , 8% . A variety of clinical 
reports(92-102) indicate an overall similar experience to that 
discussed above . Roberts and Hammer(91) and others(103-105) 
caution that even mild aortic incompetence may cause cocking 
of the mitral disc of a caged disc prosthesis. Roberts and 
Hammer(91) further suggest that aortic incompetence may 
prevent proper opening of a mitral tilting disc prosthesis and 
lead to mitral prosthetic dysfunction, as was illustrated by 
one of their patients . 
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PATHOLOGY OF VALVE REPLACEMENT WITH THE LILLEHEI-KASTER 
PIVOTING-DISC CARDIAC VALVE PROSTHESIS 
The yearly survival of patients 
Lillehei-Kaster prostheses and the 
events are listed in Tables 7 . 1 
after implantation of 
incidence of embolism 
and 7 . 2 . The actuarial 
survival rate at 5 years was 63.5% and 72.4% of patients were 
free of embolic events . 
AORTIC VALVE REPLACEMENT 
Nine patients with Lillehei-Kaster aortic valve 
prostheses were autopsied there were 4 whites, 4 coloureds 
and one black patient . Five of the 9 patients were females and 
the 9 patients had a mean age of 43.3 years (S . D.= 16 . 4) . The 
mean postoperative survival period of the whole group was 
366 . 8 (S . D.= 596.7) days with a range of from 1 to 1800 days . 
The nature of the native aortic valvular disease leading to 
aortic valve replacement with Lillehei-Kaster aortic valve 
prostheses in the 9 patients was as follows chronic 
rheumatic-type deformity 3 , aortic ring distortion due to an 
aortic dissecting aneurysm 1 , senile tricuspid calcific aortic 
stenosis 1 , calcified congenital bicuspid aortic valve 2 , and 
other congenital anomalies of the aortic valve 2 . The mean 
heart weight of these 9 patients was 555 grams (S . D . = 83) . The 
principal causes of death (one each per patient) are indicated 





Regarding the principal causes of death , errors in 
operative technique led to the deaths of 2 patients. In one 
there was obstruction of a small right coronary arterial 
ostium by the sewing ring of the prosthesis ; a patient with a 
pacemaker had unrecognized ventricular fibrillat i on during 
anaesthesia leading to irreversible anoxic cerebral damage . No 
cause of death was found in one patient (? arrythmia) and one 
had fatal myocardial failure . Lesser complications encountered 

































































































































































































































































































































































































































































































































































































































































































































































TABLE 7.3 : PRINCIPAL CAUSES OF DEATH IN 9 PATIENTS 
WITH LILLEHEI-KASTER AORTIC VALVE PROSTHESES 
GROUP 1 
ANAESTHETIC MISHAP 1 
OPERATIVE TECHNIQUE ERROR 1 
MYOCARDIAL FAILURE 1 
UNKNOWN CAUSE 1 
GROUP 2 
ERROR PRE-OPERATIVE DIAGNOSIS 1 
OPERATIVE ERROR 1 
THROMBOSED PROSTHESIS 1 
INFECTED PROSTHESIS 1 
CORONARY THROMBOSIS 1 
TABLE 7.4 : NON-FATAL COMPLICATIONS/ASSOCIATED 
CONDITIONS IN 9 PATIENTS WITH LILLEHEI-KASTER 
AORTIC VALVE PROSTHESES 
GROUP 1 
SUTURES NEXT TO SINO-ATRIAL 
INFECTED CHEST WOUND 




SEVERE CORONARY ATHEROSCLEROSIS 1 
GROUP 2 
AORTIC DISSECTION 1 
SEVERE CORONARY ATHEROSCLEROSIS 2 
MID-ZONAL LIVER NECROSIS 1 
ANTICOAGULANT EXCESS BLEEDING 1 
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to calcification of the central fibrous body. Infarcts were 
most commonly encountered in the heart (2 cases), brain (2 
cases) and kidneys (2 cases), spleen (1 case) and bowel (1 
case). One patient had greater than 75% narrowing of the major 
coronary arteries. 
Two of the 4 patients had bland thrombus on their 
Lillehei-Kaster prosthesis. In both the thrombus involved the 
sewing ring and extended variably into the lesser orifice of 
the prosthesis. Proliferative phase Aschoff bodies were noted 
in the heart of one of the 4 patients. 
GROUP 2 
The 5 group 2 patients died of the following causes (see 
Table 7.3) error in pre-operative diagnosis (unrecognized 
subaortic stenosis) operative trauma led to bowel 
perforation which was followed by infective pericarditii and a 
mediastinitis ; thrombosed prosthesis ; infective endocarditis 
and myocardial infarction due to coronary thrombosis. The 
patient with the thrombosed prosthesis had received no 
anticoagulants. 
Lesser complications included ischaemic heart disease in 
2 patients (greater than 75% narrowing of one or more of the 
major coronary arteries), a dissecting aneurysm, and mid-zonal 
liver necrosis of unknown cause and a subdural haematoma due 
to bleeding induced by excessive anticoagulant therapy. 
Infarcts were noted in the kidneys of 2 different patients, in 
the hearts of 3 and in the brains of 2 cases as well as the 
lungs of another patient. Two out of the 5 patients had bland 
thrombus on their Lillehei prosthesis. This filled the lesser 
orifice of one valve and totally immobilised the other 
prosthesis. A patient with infected vegetations on the 
prosthesis had pyaemic abscesses 
myocardium. 
in the kidneys and 
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PRINCIPAL CAUSES OF DEATH AND COMMENT 














Figure 7.1 : Massive thrombus in lesser orifice has led to 
immobilization of this Lillehei-Kaster mitral valve 
prosthesis . 
Figure 7 . 2 : Infected Lillehei-Kaster prosthesis 210 days 
after implantation. Staphylococcus albus was cultured from the 




MITRAL VALVE REPLACEMENT 
Seven patients with Lillehei - Kaster mitral valve 
prostheses were autopsied. There were 4 blacks , 2 whites and 1 
coloured patient . Their mean age was 27.4 years (S . D. = 15.2) 
and the range was from 18-59 years. All seven patients 
underwent heart valve replacement for post-rheumatic mixed 
mitral valve disease . The mean post-operative survival was 453 
days (S . D.= 552) with a range of 4-1350 days . Two patients 
survived 7 days or less and the other 5 survived 38 days or 
longer post-operatively . The mean heart weight was 577 grams 
(S . D.=139) and the range was 450-808 grams . 
Principal causes of death (one per patient) are given in 
Table 7.5 and lesser complications are listed in Table 7 . 6 . No 
patients died due to an error in pre-operative diagnosis or 
due to error in operative technique. Three patients died 
because of problems with the prosthetic valve (Figs. 7 . 1 and 
7.2) and another 2 died of post-operative complications unique 
to open-heart surgery . No morphological cause of death was 
noted in 2 patients . Lesser complications (Table 7 . 6) included 
cardiac catheterization-induced dissecting aneurysm of the 
aorta in one patient and massive thrombosis on the atrial 
suture line in another patient . Lung and spleen were 
organs with the most infarcts . No data regarding 
infarcts were available in 2 of the seven patients since 




Thrombus was noted on two of the Lillehei-Kaster mitral 
valve prostheses. In both instances abundant thrombus filled 
the lesser orifice and led to almost total immotilization of 
the prosthesis . Scantier thrombus was present on both aspects 
of the sewing ring and within the greater orifice. Aschoff 
bodies were seen histologically in 2 out of the 7 hearts. 
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TABLE 7 . 5 : PRINCIPAL CAUSES OF DEATH IN 
7 PATIENTS WITH LILLEHEI-KASTER MITRAL 
VALVE PROSTHESES 
UNKNOWN 2 
ANTICOAGULANT EXCESS BLEEDING 2 
THROMBOSED PROSTHESIS 2 
INFECTED PROSTHESIS 1 
TABLE 7 . 6 : NON-FATAL COMPLICATIONS/ASSOCIATED 
CONDITIONS IN 7 PATIENTS WITH LILLEHEI-KASTER 
MITRAL VALVE PROSTHESES 
CATHETER-INDUCED AORTIC DISSECTION 1 
MASSIVE ATRIAL SUTURE LINE THROMBUS 1 
SUBARACHNOID HAEMORRHAGE 1 
THROMBOEMBOLUS S-A NODE ARTERY 1 








DOUBLE VALVE REPLACEMENT WITH THE LILLEHEI-KASTER PROSTHESIS 
Two patients came to autopsy with Lillehei-Kaster 
prostheses in both the aortic and mitral positions. The first 
patient, a 39-year-old black female, was operated upon as an 
emergency because of acute aortic incompetence 
infective endocarditis. The patient had only 
antibiotics for 3 days pre-operatively. A 





post-operatively due to 




grams, showed focal 
myocarditis. Both Lillehei prostheses bore abundant antemortem 
thrombi on the sewing ring and 'horns' of the prosthesis, but 
there was no histological evidence of infection. Thrombus was 
more plentiful on the mitral prosthesis. No organ infarcts 
were detected, but acute gastric erosions were seen. 
The second patient, a 15-year-old black female with 
chronic rheumatic heart disease, died of cardiac failure 6.5 
months after cardiac surgery. Immediately prior to death her 
serum potassium had been abnormally elevated. Both aspects of 
the Lillehei mitral prosthesis were covered by large amounts 
of antemortem thrombus,which was also continuous with left 
atrial thrombi. These combined thrombi, which appeared to be 
of several weeks duration, produced severe orificial 
obstruction of the mitral prosthesis. Scanty antemortem 
thrombus was detected on the inferior aspect of the Lillehei 
aortic valve prosthesis. A small pulmonary infarct was also 
present, together with evidence of a rheumatic pneumonitis. 




PRINCIPAL CAUSES OF DEATH IN PATIENTS WITH MITRAL AND DOUBLE 
VALVE REPLACEMENT 
Five out of the 7 patients' deaths were due to problems 
directly related to the Lillehei-Kaster mitral valve 
prosthesis itself. 
COMMENT 
Lillehei and Kaster(l , 2) introduced the concept of a 
pivoting disc prosthetic valve in an attempt to improve on the 
haemodynamic performance of the caged-ball prosthetic valves . 
The present studied has shown that prosthesis-related 
principal causes of death were more commonly encountered in 
patients with mitral valve prostheses and in group 2 patients 
with Lillehei-Kaster aortic valve prostheses. Myocardial 
failure may have favoured the development of thrombi on some 
of the valvular prostheses. Conversely, thrombosis upon the 
prosthesis may have produced sufficient obstruction in some 
cases to account for the cardiac failure. Non-infected 
thrombus on the Lillehei-Kaster prosthesis was primarily 
situated within and around the lesser orifice of the valve. My 
patient with massive left atrial suture line thrombus is 
similar to the cases decribed by Ben-Shachar et al.(3), in 
which the mural thrombi were attributed to operative trauma . 
Such thrombus may also be a source of late post-operative 
thromboembolism . 
Gibson et al.(4) have delineated the phonocardiographic 
and echocardiographic characteristics of the Lillehei-Kaster 
eccentric monocusp central flow valve prosthesis . Clinical and 
haemodynamic assessments of the valve have also been 
published(4-16) . Rao et al.(17) compared the incidence of 
chronic haemolysis following mitral valve replacement with the 
Lillehei-Kaster valve and with some other cardiac valvular 
prostheses . In isolated mitral valve replacement 66% showed 
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compensated haemolysis compared to 42% in Bjork-Shiley valves , 
85% in composite seat Starr-Edwards valves and none in 
frame - mounted homograft valves . Poppet jamming of a 
Lillehei-Kaster prosthesis due to impaction of a left atrial 
monitoring line during mitral valve replacement has been 
described(l8) . Behle and Brown(l9) described a case with late 
snaring of a Lillehei-Kaster prosthesis by a fragment of left 
atrial monitoring catheter . The catheter had snapped at its 
point of fixation and the retained fragment caused 
immobilization of the disc . Jamming of a disc prosthesis may 
thus be due to factors other than thrombosis or entrapped 
sutures. 
Nitter-Hauge(4) reported favourable results after a 
relatively short follow-up period of 1 year in 68 patients 
with single aortic valve replacement with either a 
Lillehei-Kaster pivoting disc valve or a Bjork-Shiley tilting 
disc valve . Lillehei-Kaster valves implanted in the mitral 
position(6) gave similarly good results after 12 to 24 months 
follow-up and compared well with the Bjork - Shiley prosthetic 
valve(7). Intra - operative haemodynamic evaluation of the 
Lillehei-Kaster valve by Starek et al.(8) showed it to have 
improved haemodynamics compared to the various models of 
caged-ball valves. In vivo evaluation of the Lillehei-Kaster 
valve by Sigwart et al . (9) showed that the maximum opening 
angle of 80 degrees was never reached in this group of 
patients opening angles ranged from 57 to 74 degrees without 
evidence of disc malfunction . They concluded that incomplete 
opening of the disc occluder is not necessarily a sign of disc 
malfunction , since there was no correlation between the ratio 
of effective to geometric valve area . 
Starek et al . (10) reported on the clinical evaluation of 
133 patients with Lillehei-Kaster valves who had been followed 
for 4 years . Patients with aortic valve replacement had 
remained free of valve-related problems. Patients with mitral 
valve implants had a 10% incidence of valve thrombosis, which 
was attributed to inadequate anticoagulation or to the use of 
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an inappropriate suturing technique , or both . In a discussion 
appended to the same paper(lO) , Lillehei warned against 
inserting too large a Lillehei-Kaster prosthesis in the mitral 
area the danger being that a small left ventricle may lead 
to one of the struts becoming embedded in the mural 
myocardium. This may provoke scar tissue growth that may 
slowly impede disc motion . 
From Durban , South Africa , Mitha et al . (11) reported a 
disturbing incidence of thrombosis in their patients with 
Lillehei-Kaster valves involving at least 10% of the mitral 
implants and 5% of the aortic , which led them in 1974 to stop 
using the prosthesis. They attributed the thrombosis to late 
prosthetic disproportion following shrinkage in size of the 
heart post-operatively. Minimal impingement and cocking of the 
disc on the ventricular endocardium results in thrombosis of 
the prosthesis and of the left atrium. Mitha et al . (11) 
postulate that insertion of smaller mitral prostheses may have 
obviated the thrombotic complications. Roberts et al.(20) drew 
attention to the fact that the regurgitant jet of blood of 
unsuspected severe aortic incompetence may interfere with the 
opening of disc valves. Forman et al . (12) from our institution 
catheterized 26 patients with Lillehei-Kaster valves and 
showed no advantage over other types of prosthetic valves . 
Dale(l3) reported that arterial thromboembolic complications 
are a considerable problem with both the Lillehei-Kaster and 
Bjork-Shiley disc valves , including those in the aortic 
position . Zwart(l4) found an incidence of thromboembolism of 
5 . 0 per 100 patient-years and the actuarial survival was 81% 
at 5 years with the Lillehei-Kaster prosthesis. Christo et 
al . (15) found that thrombosis was an important late 
complication of heart valve replacement with this prosthesis. 
Uhrenholdt et al . (16) discussed the cardiac catheterization 
findings in patients after insertion of a Lillehei-Kaster 
prosthesis and explained how to distinguish clinically between 
myocardial failure and valve dysfunction. 
Despite the adequate number of clinical reports on the 
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Lillehei-Kaster valve prosthesis, I am not aware of any report 
that specifically addresses the pathology associated with the 
implantation of this prosthesis. Roberts et al.(20) have 
reported the pathology of 61 autopsied patients with a discoid 
prosthesis of the Hufnagel type. The latter type of prosthesis 
was found not to be an ideal substitute cardiac valve. It 
thromboses despite adequate anticoagulant therapy, it is 
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CHAPTER 8 . 
PATHOLOGY OF CARDIAC VALVE REPLACEMENT WITH THE St JUDE 
MEDICAL VALVE PROSTHESIS 
Stevens(l) from our institution reported that in a 40 
month period (February 1979 to August 1981) 333 patients 
received 399 St Jude Medical ( SJM) valves (118 aortic , 149 
mitral , 59 aortic and mitral, 3 tricuspid plus mitral , 2 
tricuspid, mitral and aortic, and 2 isolated tricuspid) . The 
age range was 1.5 to 75 years ( mean 34 ) . There were 177 
males and 156 females (181 coloured , 87 white , and 65 black 
patients) . The operative mortality was 4 . 8% and 306 patients 
were followed from 1 to 39 months (mean 15 . 4). Seventeen valve 
failures occurred 13 obstructed acutely, 3 had haemolysis 
immediately post-operatively and 1 had a late para-valvular 
leak needing re-operation . Of the 13 obstructed valves , 7 had 
emergency re-operation with 1 death . Five died suddenly in 
pulmonary oedema , and 1 had echocardiographic and aucultatory 
evidence of an obstructed tricuspid valve. None of these 
patients was on anticoagulants . Fifty embolic events occurred 
in 42 patients within the first 30 days, and 26 when 
anticoagulation was unsatisfactory. Seventeen patients had 
severe anticoagulant-induced bleeding . Re-study of 33 patients 
showed small mean gradients across the SJM prostheses (mitral 
0-6 mm Hg , aortic 0-26 mm Hg) . Stevens(l) concluded that the 
SJM valve has good haemodynamics , a low incidence of emboli , 
but the sudden thrombosis of the valve in the 
non-anticoagulated patients stresses the need for 
anticoagulant therapy . 
Tables 8.1 and 8 . 2 give the yearly survival and embolism 
events respectively in patients with SJM prosthetic heart 



























































































































































































































































































































































































































































































































































































































































































































































































St JUDE PROSTHESIS 
St JUDE MEDICAL AORTIC VALVE PROSTHESIS 
Ten patients with St Jude medical prostheses replacing 
the aortic valve were autopsied . There were 6 males and 4 
females , and 3 whites , 5 coloureds and 2 blacks . The 
pre-operative native aortic valvular diseases were as follows 
: syphilitic aortitis 2 , chronic rheumatic heart disease 3 , 
infective endocarditis 1 , aortic nodular sclerosis 1 , 
calcified bicuspid aortic valve 2 and unknown 1. 
GROUP 1 
Seven patients who died less than 30 days 
post-operatively had a mean age of 47 . 4 years (S . D .= 18) with 
a range of 19-66 years . The mean post-operative survival 
period was 9 . 5 days (S . D . = 9 . 9) with a range of from 17 hours 
to 25 days . The mean hegrt weight was 773 grams (S.D . =250) , 
and the range was from 466 to 1065 grams . Only one of the 7 
prostheses showed scanty antemortem thrombi on the sewing ring 
all of the other prostheses appeared normal in this regard. 
One heart , which was referred for examination from my forensic 
colleagues , contained a St Jude prosthesis in which one of the 
pyrolytic carbon leaflets had been broken into two fragments. 
One fragment remained in situ within the prosthesis , whilst 
the other lay free within the left ventricle . The problem was 
to decide whether the fragmentation had occurred during life 
or if it was artefactual in nature. There was a scratch mark 
at the edge of the fractured leaflet and the forensic 
pathologist who had performed the original autopsy later 
recollected that he had opened the left ventricle with a large 
pair of scissors and had inadvertently tried to cut across the 
prosthesis . The pyrolytic carbon discs of this prosthesis are 
evidently rather brittle . 
The 7 patients showed infarcts in the following organs 
brain (bilateral) 1 , and left ventricle 1 . It should be noted 
that in 4 of the 7 patients , only the heart was received for 
examination and few details were available regarding the 
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general autopsy findings. In addition , the patient with the 
bilateral cerebral infarcts had developed one of these 
infarcts pre - operatively due to 
myocardial infarct listed 
infective 
above was 
endocarditis . The 
due to coronary 
atherosclerosis . This patient plus another had saphenous vein 
coronary arterial bypass grafts inserted at the time of the 
valve surgery . The principal causes of death in the group 1 
patients are indicated in Table 8.3 . A Klebsiella species was 
cultured at postmortem from the one patient ' s infected 
pulmonary infarcts. Associated conditions in group 1 included 
a small pulmonary embolus in 1 patient , and hereditary 
spherocytosis in another . A third patient had systemic 
hypertension, atheromato u s emboli in small renal arteries and 
haemorrhages in the atrioventricular node and bundle of His . 
TABLE 8 . 3 : PRINCIPAL CAUSES OF DEATH (1 PER PATIENT) 
IN 10 PATIENTS WITH St JUDE MEDICAL AORTIC VALVE PROSTHESES 
GROUP 1 
UNKNOWN 





RUPTURED MYCOTIC ANEURYSM (PRESENT PRE-OPERATIVELY) 1 
INFECTED PULMONARY INFARCTS (PRESENT PRE-OPERATIVELY) 1 
GROUP 2 
INFECTIVE ENDOCARDITIS 3 
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Figure 8.1 : Infected (Staphylococcus albus) St Jude Medical 
aortic valve prosthesis viewed from the left ventricle . 
GROUP 2 
The 3 patients who survived longer than one month 
post-operatively (Table 8 . 3) were two coloured woman aged 67 
and 71 years and a 33 year old black woman. Post-operative 
survival had been 32 , 120 and 42 days respectively . Heart 
weights were 563 , 650 and 370 grams . All three patients died 
of infective endocarditis (Fig . 8 . 1) . Pre - disposing factors 
for infection were the presence (1 each) of the following 
diseases in these 3 patients : diverticulitis , septic abortion 
with infective endocarditis pre-operatively , and 
post-operative wound infection. The bacteria inculpated in 
these 3 patients with infected prostheses consisted of 
Staphylococcus aureus , Pseudomonas and coliforms . Two patients 
had ring abscesses and the patient with the Staphylococcal 
infection had two mycotic aneurysms in the aortic root . 
Associated conditions observed in the 3 patients included 
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bronchopneumonia 1 , gallstones 1 , subarachnoid haemorrhage 1 , 
and focal segmental glomerulonephritis 1 . Only one of the 3 
patients showed signs of embolism (to the hand , leg and 
heart). 
MITRAL VALVE REPLACEMENT 
Nine patients with St Jude prostheses in the mitral 
position were autopsied . The native mitral valvular diseases 
leading to operation were as follows : chronic rheumatic heart 
disease 5 , congenital mitral valve disease 2 (parachute mitral 
valve ; ostium primum defect with cleft mitral valve), floppy 
mitral valve 1 and unknown 1 . 
GROUP 1 
The 6 patients who died less than 30 days 
post-operatively had a mean age of 23.5 years (S . D . = 18 . 2) and 
a range of 6 to 59 years . There were 3 coloureds , 2 blacks and 
1 white patient . Four of the 6 subjects were females . The mean 
post-operative survival period was 7.7 days (S . D . = 10 . 2) with 
a range of 36 hours to 28 days . The mean heart weight was 468 
grams (S.D . = 134) with a range of 232-610 grams . Scanty 
thrombi were present on the left atrial (inflow) aspect of the 
sewing ring in 2 out of the 6 prostheses . These 6 patients 
showed the following organ infarcts spleen 1 , kidney 1 , 
pituitary 1 . Table 8 . 4 gives the principal cause of death for 
each of the 6 patients . Non-fatal complications/associated 
conditions included the following (i) dehiscence of the 
prosthesis from the patch used to close an ostium primum 
defect. This may possibly have been artefactually produced by 
pre-terminal external cardiac massage . (ii) Subarachnoid 
haemorrhage , (iii) Takayasu ' s aortitis and acute renal tubular 
necrosis , and (iv) shock lung . 
GROUP 2 
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TABLE 8.4 : PRINCIPAL CAUSE OF DEATH (1 PER PATIENT) 
















Three patients (a SO-year-old coloured female, a 
56-year-old white female and an 18-year-old black female) died 
more than 30 days post-operatively. Post-operative survival 
was 38, 59 and 180 days respectively. The respective heart 
weights were 462, 593 and 400 grams. Principal causes of death 
are indicated in Table 8.4. The patient who died of myocardial 
failure showed very extensive thrombus lining most of the left 
atrium, as well as upon both aspects of the St Jude mitral 
valve prosthesis and the septal and inferior walls of the left 
ventricle. The primary abnormality is interpreted to be the 
myocardial failure with the formation of stasis thrombi at 
these sites, rather than primary thrombotic occlusion of the 
St Jude prosthesis. 
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AORTIC AND MITRAL VALVE REPLACEMENT WITH St JUDE MEDICAL 
PROSTHESES 
Autopsies were performed upon 8 patients with St Jude 
Medical prostheses in both the aortic and the mitral 
positions . Five of the 8 patients were females. There were 3 
blacks and 4 coloureds . The aetiology of the native heart 
valvular diseases leading to double valve replacement were as 
follows : chronic rheumatic heart disease 5 , floppy mitral 
valve with superimposed infective endocarditis 1 and unknown 
2 • 
GROUP 1 
The five patients who died early post-operatively had a 
mean age of 29 . 3 years (S . D . = 14 . 3) with a range of 15-46 
years . Mean post-operative survival was 15 days (S . D . = 13) 
with a range of 20 hours to 30 days . The heart weights ranged 
from 298 grams (in a 15-year-old) to 644 grams, with a mean of 
505 grams (S . D . = 135). All 5 St Jude mitral valve prostheses 
were free of thrombi, but one out of the 5 St Jude aortic 
prostheses bore infected vegetations . The 5 patients showed 
the following organ infarcts : brain 3, heart 2 , kidney 2, 
spleen 2 and limbs 2 . It should be noted that in one patient 
with infarcts of the brain , heart , spleen and kidney , the 
infarcts were old and appeared to antedate the double valve 
replacement operation . Table 8 . 5 lists the principal cause of 
death in these patients. Non-fatal complications/associated 
conditions observed in group 1 included a pulmonary primary 
tuberculous complex, an erroneous surgically created 
communication between the left ventricle and the right atrium 
sealed by a suture in the right atrium 1 , acute renal tubular 
necrosis 1, disseminated intravascular coagulopathy 1 and pump 
lung 1 . 
GROUP 2 
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TABLE 8 . 5 : PRINCIPAL CAUSES OF DEATH (1 PER PATIENT) 
IN 8 PATIENTS WITH St JUDE MEDICAL PROSTHESES IN THE 








THROMBOSED MITRAL PROSTHESIS 








The three patients who died more than 30 days 
the 3 post-operatively were aged 30 , 34 and 28 years . Two of 
were females , and all 3 were coloureds who had been operated 
upon for chronic rheumatic valvular heart disease . Only one 
out of the 3 heart weights was available (452 grams) . Two of 
the 3 mitral valve prostheses in this group of patients were 
immobilized by thrombosis on both aspects of the prosthesis . 
The third patient had a low prothrombin index (13 %) and bled 
spontaneously into her brain and vulva . The principal causes 
of death of these 3 patients are also included in Table 8 . 5 . 
Both patients who died of thrombosed prostheses had inadequate 
anticoagulant control. One of these patients had attended the 
Casualty Department of Groote Schuur Hospital several times 
pre-terminally and had been reassured and sent home without 
seeing a cardiologist . She was finally admitted to hospital 
and did not survive re-operation . All of the deaths in this 
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group were attributable to problems inherent in the design and 
structure of the St Jude prosthesis . 
St JUDE MEDICAL PROSTHETIC VALVE REPLACEMENT OF THE MITRAL AND 
TRICUSPID VALVES 
Only one autopsy patient fell into this category. She was 
a 16-year-old black female with Marfan ' s syndrome and 
incompetence of both the mitral and tricuspid valves . Both 
valves were replaced by St Jude Medical prosthetic heart 
valves . At the time of the initial surgery the right upper 
pulmonary vein was inadvertently damaged and repaired . Two 
weeks post-operatively the patient the underwent re-operation 
because of severe thrombotic obstruction of the St Jude valve 
in the tricuspid position . The previously surgically repaired 
right upper pulmonary vein was totally occluded by thrombus . 
The patient did not survive the re-operation . Both ventricles 
showed myocytolysis , but no Aschoff bodies were seen . The left 
anterior descending coronary artery contained some calcified 
material, which appeared to be embolic in origin. The only 
infarct encountered was that seen in the lung. 
TRICUSPID VALVE REPLACEMENT WITH A St JUDE MEDICAL VALVULAR 
PROSTHESIS 
One patient , an 18-month-old white female , underwent 
isolated tricuspid valve replacement with a St Jude prosthesis 
due to severe tricuspid valve incompetence , which followed an 
episode of infective endocarditis. She also had had a previous 
exomphalos repaired . Sudden death occurred on the second 
post-operative day. Autopsy revealed an hypertrophied and 
fibrosed right ventricle and evidence of severe thromboembolic 
pulmonary hypertension . The St Jude prosthesis appeared 
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normal. Death was attributed to 
hypertension . 
the severe pulmonary 
ASSOCIATED NON-FATAL CONDITIONS IN PATIENTS WITH St JUDE 
MEDICAL PROSTHESES 
Non-fatal, associated conditions are listed in Table 
8 . 6 . 
TABLE 8.6 : ASSOCIATED NON-FATAL COMPLICATIONS IN 
PATIENTS WITH St JUDE MEDICAL CARDIAC PROSTHESES 
AORTIC VALVE REPLACEMENT 
LUETIC CORONARY OSTIAL STENOSIS 
SPHEROCYTOSIS 
GALLSTONES 




AORTIC & MITRAL VALVE REPLACEMENT 
TUBERCULOSIS 
PUMP LUNG 
RENAL TUBULAR NECROSIS 
VULVAL HAEMATOMA 





RENAL TUBULAR NECROSIS 



















St JUDE PROSTHESIS 
SUMMARY OF PRINCIPAL CAUSES OF DEATH IN 29 PATIENTS WITH St 
JUDE MEDICAL VALVES 
There were no deaths due to an error in pre-operative 
diagnosis . Three patients died due to an error in operative 
technique and the deaths of 9 were due to problems directly 
related to the St Jude Medical valve . Six patients died of 
post-operative complications , 4 died of complications 
unrelated to the cardiac operation and the causes of death 
were unknown in 7 patients. 
COMMENT 
The St Jude Medical (SJM) prosthetic heart valve is a 
rigid , bi-leaflet , central orifice , all pyrolytic carbon 
device that has gained widespread acceptance since its 
clinical introduction in 1977(2-5). Lillehei(6 , 7) has 
summarized the worldwide experience regarding the clinical and 
haemodynamic results with the SJM prosthetic valve . The 
prosthesis is being evaluated in 4 primary centres in the 
United States of America and by 13 other centres worldwide , 
including our institution. In vitro haemodynamic studies(S-11) 
show that , in general , the SJM valve represents a clear 
improvement in valve design with a low level of stenosis and a 
low regurgitant fraction . Catheterization data after SJM 
implantations in 
institution(l2), 
patients , including a report 





haemodynamics are claimed to be superior to those reported for 
any other valve. Colman et al . (13) stated that the SJM valve 
is the prosthesis of choice over a bioprosthesis for mitral 
valve replacement under the following conditions : (a) a small 
valve ring , i . e. all that would accept only a prosthesis below 
27 mm diameter (b) elevated left ventricular end-diastolic 
pressure , including all forms of cardiomyopathies 
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primary/secondary (ischaemic or rheumatic) ; or (c) giant left 
atrium . Gray and colleagues(l4-16) and Dalichau et al . (17) 
came to similar conclusions . Kinsley(ll) inserted a SJM aortic 
valve obliquely in 6 patients as a simple method for aortic 
root enhancement . 
Starek et al . (18) found in vitro that the SJM valve was 
less vulnerable to leaflet entrapment than other mechanical 
valves e.g . , the Lillehei-Kaster , Bjork-Shiley , Omniscience or 
Hall-Kaster disc valves . Whilst the disc · of the latter 4 types 
of valves can be totally immobilised by a single interference 
anywhere around their circumference , the SJM valve proved to 
be vulnerable only at the areas immediately adjacent to the 
two pivot guards . Salvatore et al.(19) reported a case wherein 
a chordal remnant had immobilised one leaflet of a SJM mitral 
valve prosthesis in a closed position and the patient was in 
no distress. When fully open to 85 degrees , the large 
effective orifice area of the SJM valve , free of any struts , 
is separated into approximate thirds , with complete washing of 
each leaflet during the cardiac cycle. A slow cardiac rate or 
rhythm disturbance may produce occasional slight leaflet 
asynchrony, which is detectable by high-speed cinefilm or 
echocardiography(20 , 21) . Since tissue valves are 
contra - indicated in children and young persons , especially due 
to their propensity to undergo calcification ( see Chapter 12 
) , the SJM valve may have an important role to play in this 
group of patients(l2 , 22-26) . 
Thrombotic occlusion of a SJM prosthesis in the mitral 
position has been reported from our institution(27) and in the 
tricuspid position from elsewhere(28) . In the present study, 4 
patients had thrombotic obstruction of St Jude Medical 
prostheses one tricuspid and 3 mitral prostheses were 
thrombosed. One of the patients with a thrombosed SJM mitral 
prosthesis had suffered from severe myocardial failure. From 
Australia , Hunt et al . (29) 
complications occurred less 
Jude valves than in reports of 
reported that thromboembolic 
frequently in patients with St 
similar patients with other 
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material accumulating at critical points may cause failure of 
this prosthesis . Baudet et al . (31) reported a patient , who was 
not on anticoagulant therapy and thrombosed a SJM mitral valve 
prosthesis . Moulton et al . (32) reported a case of fatal 
thrombosis of a SJM valve in the aortic position despite 
documented "therapeutic " levels of warfarin anticoagulation . 
They suggest that special attention should be paid to valve 
orientation at the time of surgery and possible septal 
impingement on the prosthetic leaflets. It is apparent that 
the SJM valve shares the propensity of other mechanical valves 
to initiate thrombosis . 
Ziemer et al. (33) reported an intrinsic manufacturing 
fault in a SJM valve . Minimal disproportion between the 
leaflets and the valve ring caused intermittent inhibition of 
leaflet motion and the patient required re-operation . 
Guttierez et al.(34) reported a patient with a peri - prosthetic 
leak , which mimicked entrapment of a leaflet in a SJM mitral 
valve prosthesis . Other reported complications include partial 
detachment of a SJM aortic valve(35) and escape of a leaflet 
from a SJM mitral prosthesis due to a fracture in the pivot 
area(36) . Kafka et al . (38) attributed the malfunction of their 
patient's SJM mitral prosthesis to lack of adequate 
anticoagulation plus impingement by a piece of papillary 
muscle on the prosthesis . Joyce et al . (39) successfully 
dissolved thrombus on a thrombosed SJM tricuspid valve in a 





al . (40) found 
significantly 
that thromboembolic 
more frequent after 
Bjork-Shiley mitral , aortic and double valve replacements than 
after St Jude valve implantations . Wada and Kasagi(41) 
reported 3.7 thromboembolic episodes per 100 patient-years in 
their experience with 132 implanted SJM prostheses . Three of 
the 5 thromboembolic episodes were considered to be due to 
poor anticoagulation control and the cause was unknown in 2 
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instances . Duncan et al . (42) implanted 261 SJM valves in 253 
patients over a 25 month period . There were 4 non-fatal 
thromboembolic episodes during the follow-up period , resulting 
in a risk of thromboembolism for aortic and mitral valves of 
2.1% and 2 . 1% per patient-year respectively. 
The Proceedings of the Third International Symposium on 
the St Jude Heart Valve held in November 1982 in Scottsdale, 
Arizona have recently been published(43). In this Symposium 
DeBakey et al . (44) stated that the principal disadvantages of 
the SJM valve are firstly , the poor design of the valve 
holder, and secondly the need for long-term anticoagulation. 
Nicolo££ et al.(45) noted a low incidence of bacterial 
endocarditis and thromboemboli and an absence of mechanical 
failure . D ' Alessandro et al . (46) established that the SJM 
valve is durable for at least 4 years . Sauvage(47) found that 
there are no significant differences regarding hospital 
mortality for the old-style Bjork-Shiley , the St Jude , or the 
Hancock valves . However , valve-related deaths within 2 years 
are higher in the patients with Hancock valves compared to 
those with Bjork-Shiley or SJM valves . Jones et al . (48) 
reported that the complication rate with the St Jude valve is 
as low or lower than that for any other mechanical prosthetic 
cardiac valve available in the world today. 
For further discussion regarding the pathology of heart 
valve replacement with the St Jude Medical prosthetic cardiac 
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CHAPTER 9. 
PATHOLOGY OF THE UNIVERSITY OF CAPE TOWN FORMALDEHYDE-TREATED 
PORCINE XENOGRAFT BIOPROSTHESIS 
The mitral valve was replaced by a formaldehyde 
preserved, stent-mounted 
at Groote Schuur Hospital. 
porcine aortic valve in 33 patients 
No accurate data are available 
regarding the period of implantation of these xenografts, but 
the majority had been implanted for less than 18 months. 
Usually, there was a gradual onset of dysfunction of the 
prosthesis, which allowed for timeous replacement of the 
failed xenografts by another valve substitute(l). Eleven of 
the failed xenograft prosthetic valves were submitted for 
pathological examination. Since there were only two autopsies 
on such patients with malfunctioning xenograft valves, the 
standard approach used in the present study of the major 
complications relating to prosthetic valve replacement could 
not be applied. The nature of the dysfunction of the xenograft 
valves which necessitated their removal will be described 
below. 
The eleven patients ranged in age from 18 to 59 years. The 
valves had been in situ for a mean period of 9.9 months (S.D.= 
8.6) and the range was from 2 to 32 months. Table 9.1 
summarizes the main clinical and pathological details of the 
11 patients. The most important macroscopical finding was that 
all of the cusps of the implanted xenograft prostheses showed 
varying degrees of stretching and deformation with resultant 
valvular incompetence. No cusp had perforated and no thrombi 
were seen with the naked eye. A prosthesis which had been 
implanted for 32 months showed a torn commissure (Fig. 9.1). 
However, microscopically 8 of the 11 valves had a thin layer 
of platelet-fibrin thrombus on the arterialis (concave) 
surface of the cusps. Histologically, all of the grafted 
valves showed an absence of the original cells of the cusp. 
Several cusps had a few isolated mononuclear cells scattered 
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on their surface, often entrapped within the fibrinous 
deposit. 
A variable reduction in amount of the cuspidal collagen 
was noted in each of the 11 valves. The collagen acquired an 
amorphous, hyaline or fibrinoid appearance and stained less 
intensely with the van Gieson stain. The fibrosa was often no 
longer distinguishable as a 
Figure 9.1 : UCT formaldehyde-preserved porcine aortic valve 
xenograft prosthesis shows shortened, downward prolapsing 




































































































































































































































































































































































































































UCT XENOGRAFT VALVE 
distinct layer withi n the cusp . An immune-mediated cellular 
response to the graft was noted in two valves only (cases 2 
and 11) . The pathology of valves which failed early ( four 
~onths or less after insertion) was the same as those failing 
later ( after nine months ) . 
Striking differences were noted when the failed xenograft 
valves were compared macroscopically and microscopically with 
the control pig valves . The cusps of the control valves meet 
together in a triradiate fashion with a fairly wide area of 
apposition and have clearly discernible valve pockets . The 
contact areas of the cusps lie in a vertical plane at a level 
superior to that of the sewing ring . The failed xenograft 
valves had stretched cusps , which hanged down below the level 
of the sewing ring and rendered the valve incompetent. In a 
few of the xenografts one cusp (often the one with muscle in 
its base) showed a greater degree of prolapse than did the 
other two . The pig aortic valve has an essentially similar 
histology to that of the human aortic valve (2) . The anatomy 
of the pig aortic valve differs from that of the normal human 
aortic valve in that one-third of the porcine aortic ring is 
formed by cartilage and the base of the right coronary cusp is 
muscular(3) . The 0 backbone ' of the normal pig aortic valve 
cusp consists of a layer of compacted collagen fibres called 
the fibrosa . The remainder of the cusp is composed of loosely 
arranged collagen and elastic fibres . Moderate numbers of 
fibroblasts are present . 
The host cellular response in 9 of the 11 cases was that 
of a mild mononuclear cellular infiltration at the base of the 
cusp where it had been in proximity to the host tissue . There 
was no sign of an host immune response to the acellular , 
denatured collagen of the cusp in these 9 valves. In the 
remaining two xenografts the cellular response was ,more florid 
and there were indications of a possible host immune response 
as evidenced by the presence of plasma cells and other 
pyroninophilic cells of lymphoid type . These cells were most 
numerous at the base of the cusp and appeared to be migrating 
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out along the cusp surface in diminishing numbers towards its 
free margin. The cellular infiltrate was associated with 
erosion of the cuspidal substance in areas . Apart from this 
response by what appear to be immunologically competent cells , 
the cusps of these two patients did not appear to show any 
signicant differences from the other nine cases which failed 
to evoke a similar response. 
There was no sign of infection of any of the grafted 
valves. In contrast to the collagen, the elastic tissue of the 
heterograft valve cusps had a relatively normal appearance. No 
abnormality of acid mucopolysaccharide production was noted . 
None of the valves showed any evidence of calcification . 
Electron microscopy of the control pig valves revealed that 
the collagen fibres were poorly preserved , but their 
structural integrity appeared to be intact and a regular 
periodicity was still discernible in most of the fibres 
(Figure 9 . 2) . The collagen fibres of the xenograft valve of 
patient 10 had an ultrastructural appearance similar to that 
of the controls. However, electron microscopy of the collagen 
present in the valve of patient 2 ( one of the two valves 
eliciting an immune response ) revealed that the poorly 
preserved collagen fibres in many areas seemed to 0 fade out ' 
and merge with amorphous , finely granular material lying 
between still intact collagen fibres (Figure 9.3) . Periodicity 
was discernible in very few of the fibres . It is likely that 
the amorphous , finely granular material is derived from the 
destruction of collagen fibres . Electron microscopy of areas 
of total loss of collagen revealed finely granular material in 
the region normally occupied by well-orientated bundles of 
collagen fibres . 
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Figure 9 . 2 : Regular periodicity is discernible within some of 
the collagen fibres of an unused formaldehyde-preserved UCT 
xenograft valve. (Electron photomicrograph , X 127000) . 
Figure 9.3 : Poorly preserved collagen fibres of the xenograft 
which had been implanted in patient 2 for 2 months . 
Periodicity is lacking and the fibres appear to be 
disintegrating into amorphous, finely granular material . 
(Electron photomicrograph , X 190000) . 
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COMMENT 
Stretching of the valve cusps was the cause of the 
incompetence in all 11 failed aortic valve xenografts , with a 
torn commissure contributing to the regurgitation in one 
patient . Tearing of the substance of the cusps was not noted. 
The changes observed in the collagen seem to be the most 
significant . The denatured collagen of the xenograft has a low 
antigenicity and limited durability . Progressive weakening of 
a valve subjected to an abnormal degree of stress is the 
likely cause of the observed changes . A similar problem of 
stretching of aortic valve homograft cusps was encountered by 
Davies et al . (4) . In the discussion of a paper by Carpentier 
et al . (S) , Kay states that " all transplant valves in patients 
six months or more who come to autopsy ... demonstrated varying 
degrees of stretching of the leaflets , attenuation of the 
tissues , fragmentation and laceration regardless of the method 
of preservation or whether it was a homograft or heterograft . 
One of the factors responsible for failure may well be the 
inability of the aortic valve to withstand the greater 
ventricular closing pressures over a prolonged period without 
becoming stretched. " Our experience in these 11 patients(6) is 
similar to that of Wright et al . (7) and Stimmel et al.(8) who 
reported that implanted formalin-preserved porcine xenograft 
valves showed valvular insufficiency in 35% of cases within 
one year of operation because of tissue disruption . 
While there are many instances, both physiological and 
pathological , in which collagen is rapidly destroyed(9-ll) , it 
appears unnecessary to postulate active collagenolysis of the 
cuspidal collagen of the failed xenografts . The inert and 
denatured collagen in the transplanted pig valve does not have 
an infinite durability . No living cells are present within the 
valve substance , thus no new collagen can be produced . The 
destruction of the valvular collagen , which is not prevented 
by the formaldehyde treatment , is a function of time , 
augmented perhaps by the increased mechanical stress that the 
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valve is subjected to in the mitral position. Treatment of the 
pig aortic valve in formaldehyde renders the cusps more rigid 
than they are in the fresh state . Gunning and Meade(l2) feel 
that once the valve cusps are thickened or changed by 
preservation then turbulence ensues . If turbulent flow is 
present , the natural deterioration that occurs in preserved 
valve cusps may well be accelerated . 
The use of formalin (4% formal-saline) is an easy means 
of attaining bacteriological sterility as well as attenuation 
of antigenicity of the valvular collagen . None of the 
University of Cape Town formaldehyde-treated porcine valves 
were complicated by infective endocarditis . This contrasts 
with 7 instances of infection among 30 orthotopically 
transplanted human homograft 
betapropiolactone reported by 
aortic valves sterilized with 
Reichenbach et al . (13) and 
infection of some of the early aortic homografts treated with 
steroids by Davies et al.(4) . Thrombus was detectable only 
microscopically on the cusps of our patients ' xenografts . The 
latter finding contrasts with the experimental work in dogs of 
Gunning and Meade(l2) , who noted that pig valves preserved in 
formaldehyde showed a tendency for thrombus formation in the 
sinuses of Valsalva . 
Ionescu et al . (14) postulated that calcification would be 
less prone to occur due to the low pH inside the 
formaldehyde-treated transplant. The present results would 
appear to confirm this , as the absence of calcification was a 
constant finding in each of the 11 xenografts examined . This 
contrasts with the relative frequency with which calcification 
has been observed in aortic homograft valves transplanted in 
the fresh state(4 , 15) . Mohri et al . (16) found foci of 
apparently reversible mineralization in fibrin deposits on 
homograft aortic cusps in the dog the valves had been 
transplanted fresh and still contained viable donor cells. It 
is doubtful that the pH within the formalin-treated xenograft 
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aortic valve cusps would remain low for many months , since the 
valve is in intimate contact with the circulating blood . Our 
11 xenografts had been in situ for a mean period of only 9 . 9 
months ; this short period may also be a factor in the lack of 
calcification of these valves . 
Another possible explanation for the absence of 
calcification may be that formaldehyde acts as a tanning 
substance by combining readily with the epsilon-amino group of 
the lysine residues in collagen with the formation of a 
methylol compound(l7) . These groups , which are important in 
tissue mineralization such as calcification , may thus be 
blocked by the action of the formaldehyde . As we shall see 
later (Chapter 12) , cuspidal calcification is a serious 
complication limiting the use of glutaraldehyde-treated 
porcine aortic valve xenografts in young persons . 
Manufacturers of glutaraldehyde-preserved porcine 
bioprostheses are currently trying to devise means of lowering 
the calcification-promoting effects of the glutaraldehyde 
fixation procedure . The latter has proved superior to 
formaldehyde 
durability . 
treatment with regard to bioprosthetic 
The absence of any significant immune response in 9 of 
the 11 transplanted valves agrees with the suggestion of 
others(l8) that the reason for this lies in the nature of the 
cuspidal tissue , which is low in cell membrane elements , 
contains denatured protein and is a non-living graft. Collagen 
possesses a low antigenicity 
has been borne out by cardiac 
even if untreated . This premise 
transplantation in which the 
donor myocardium readily evokes a rejection response on the 
part of the host , whilst the donor heart valves seldom 
stimulate rejection . Hirsch(l9) suggested that autograft , 
homograft and xenograft valves should all behave similarly in 
failing to evoke a destructive immunological or inflammatory 
response in the host. My findings in 9 of the 11 valves 
confirm this with regard to porcine xenograft valves . The 
reason for the plasma cell response in two of the valves is 
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unexplained . 
The microscopical and ultrastructural findings suggest 
that the cuspidal stretching results from a depletion of 
collagen fibres which disintegrate into amorphous , gran u lar 
debris. Similar appearing material was described in 
extracellular collagen resorption in carrageenin granulomas(9) 
and in a report on connective tissue abnormalities in 
spontaneous rupture of chordae tendineae(20) . Apart from the 
lack of durability , the formaldehyde-treated porcine xenograft 
aortic valve has several advantages over mechanical prosthetic 
heart valves , especially with regard to thromboembolism , even 
if no anticoagulation is given. It was hoped that a living 
autologous fascia lata valve would retain the advantages of 
the pig valve , while possessing a greater inherent durability 
by virtue of its living fibroblasts. However , in practice the 
fascia lata valve became depleted of fibroblasts and the 
collagen degenerated(21 , 22) . Insufficiency of the implanted 
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CHAPTER 10 . 
PATHOLOGY OF VALVE REPLACEMENT WITH THE HANCOCK PORCINE 
XENOGRAFT BIOPROSTHESIS 
The yearly survival rates for patients who had Hancock 
cardiac valvular prostheses implanted at Groote Schuur 
Hospital are indicated in Table 10 . 1 . The post-implantation 
embolism events are given in Table 10 . 2 . 
MITRAL VALVE REPLACEMENT 
Only eight patients with Hancock mitral valve 
bioprostheses were autopsied . Their mean age was 38 . 9 years 
(S . D . = 19 . 4 years) with a range of 16-63 years . There were 5 
coloureds , 2 blacks and 1 white patient . Four patients were 
males and 4 were females . The mean post-operative survival 
period was 95 . 4 days (S . D.= 171.1 days) with a range of 0-318 
days. The mean heart weight was 583 grams (S . D . = 152 grams) 
with a range of 371-826 grams . In 7 of the 8 patients the 
pre-operative valvular disease had a rheumatic aetiology ; one 
patient had mitral incompetence due to rupture of an infarcted 
papillary muscle. The principal causes of death in these 
patients are indicated in Table 10 . 3 . 
One death was attributable to an error in pre-operative 
diagnosis the patient was found to have severe , unrelieved 
aortic stenosis at autopsy 2 weeks after mitral valve 
replacement . Another patient died because of an error in 
operative technique , whereby excision of a calcified mitral 
valve had led to loss of atrio-ventricular continuity when 
portion of the mitral valve ring was also excised . Death was 
due to cardiac tamponade, which followed massive bleeding 
through the resultant defect. Initially the haemorrhage was 
retained by the epicardium and the patient died 3 hours after 
the operation(l). The role which loss of atrio-ventricular 
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continuity may play in the development of submitral aneurysms 
is discussed in Chapter 17 . A death occurred due to a problem 
inherent in the Hancock bioprosthesis ; severe mitral stenosis 


























































































































































































































































































































































































































































































































































































































































































































































TABLE 10.3 : PRINCIPAL CAUSES OF DEATH (1 PER PATIENT) 
IN 8 PATIENTS WITH HANCOCK MITRAL VALVE PROSTHESES. 
NO CAUSE FOUND 3 
CALCIFIED HANCOCK XENOGRAFT 1 
POOR PRE-OPERATIVE CONDITION 1 
UNOPERATED SEVERE AORTIC STENOSIS 1 
MYOCARDIAL NECROSIS 1 
SURGICAL DISRUPTION OF VALVE RING 1 
TABLE 10 . 4 : NON-FATAL COMPLICATIONS/ASSOCIATED DISEASES 
IN 8 PATIENTS WITH HANCOCK MITRAL VALVE PROSTHESES. 
SMALL HAEMOPERICARDIUM 1 
SUBAORTIC STENOSIS DUE TO PROSTHESIS 1 
TORN LEFT ATRIAL APPENDAGE 1 
MASSIVE LEFT ATRIAL THROMBUS 
SUTURE IN CORONARY ARTERY 
XENOGRAFT CUSPIDAL PROLAPSE 












No recognizable direct post-operative complications were 
encountered . Two deaths were due to complications which were 
unrelated to the cardiac operation : one suffered a myocardial 
infarction due to atherosclerosis, and the other was in a very 
poor general condition before being operated upon as an 
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emergency . No morphological cause of death was found in the 
remaining 3 patients (arrythmia cannot be excluded) . Non-fatal 
complications are listed in Table 10 . 4 . Only one of the 8 
Hancock prosthetic valves had thrombus on it . The thrombus was 
situated on the atrial side of the sewing ring and between one 
stent of the prosthesis and the left ventricular wall . 
AORTIC VALVE REPLACEMENT 
A solitary patient was encountered at autopsy with a 
Hancock valve prosthesis in the aortic position . The patient , 
a 68-year-old white male with medionecrosis of the aorta , 
developed aortic incompetence due to dilatation of the aortic 
ring . The aortic valve was replaced by a No . 27 Hancock 
prosthesis . The post - operative course was uneventful . Seven 
and a half months after the surgery he was re - admitted with 
severe chest pain and died of a ruptured dissecting aneurysm 
of the aorta . The Hancock prosthesis showed no abnormality . 
The heart weighed 670 grams and showed sub-endocardial 
fibrosis plus focal myocytolysis . 
DOUBLE VALVE REPLACEMENT 
Three patients had Hancock prostheses inserted in both the 
aortic and the mitral position for rheumatic valvular disease . 
The first patient was a 22-year-old black male with aortic 
incompetence, mitral incompetence (mild mitral stenosis) and 
functional tricuspid incompetence . The patient did not survive 
the operation during which surgically produced complete heart 
block followed insertion of the mitral prosthesis . At autopsy 
the heart weighed 665 grams and the Hancock valves showed no 
significant abnormality . No principal cause of death was 
identified. Numerous proliferative phase Aschoff bodies were 
seen histologically . No organ infarcts were noted . 
The second patient , a 37-year-old male with aortic 
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incompetence and mixed mitral valve disease, survived 13 days 
after mitral and aortic valve replacement. His heart weighed 
824 grams and the Hancock aortic valve appeared normal. The 
mitral prosthesis was covered with abundant infected 
(Staphylococcus aureus) 
effective orifice of the 
vegetations, 
prosthesis by 
which narrowed the 
as much as 60%. 
Dehiscence had occurred at one side of the prosthesis, where 
sewing ring sutures had torn free from the infected host 
tissue. No organ infarcts were present. 
The third patient, a 21-year-old male, with mixed aortic 
and mixed mitral valve disease, suffered severe acute 
myocardial ischaemic damage during cardiopulmonary bypass with 
coronary perfusion and survived only 3 hours post-operatively. 
Autopsy revealed extensive coagulative necrosis and 
coagulative myocytolysis (contraction band 
necrosis/myofibrillar degeneration) 
myocardium. No significant coronary 







prostheses appeared normal. No organs showed infarcts. 
The principal causes of death in the 12 patients with 
Hancock valve prostheses described above fell into the 
following categories due to error in pre-operative 
diagnosis,l due to error in operative technique,2 ; due to 
problems related to the prosthetic valve,2 due to 
post-operative complications,nil unrelated to the cardiac 
operation,3 and 
complications were the 
cause unknown,4. Prosthesis-related 
cause of only 17% of the 12 deaths, but 
the mean post-operative duration of the patients with 
implanted prostheses was only 83.5 days (S.D.= 149.2). 
COMMENT 
Many of the complications and comments which will be 
made in this section will be equally applicable to other 
tissue valves, especially the Carpentier-Edwards porcine 
aortic valve bioprosthesis (see Chapter 11). Cohn et al.(2) 
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compared the Hancock porcine valve prosthesis with a 
prosthetic Harken discoid valve for isolated mitral valve 
replacement . They concluded that there is a significant 
reduction in morbidity and mortality , primarily from reduced 
thromboembolism , if a porcine valve is used for mitral 
replacement . They recommend that anticoagulants should be used 
in patients with atrial fibrillation and enlarged left atria 
regardless of the type of valve used . In an editorial co mment 
on a later report by from the same group(3) , Kirklin(4) 
wondered whether elderly patients with bioprostheses should 
not also receive anticoagulants . Stahmann et al.(5) reported a 
patient with 
release of 
transient cerebral ischaemic attacks due to 
thrombi formed on the worn cloth covering of the 
supporting valve stent . 
Unexplained primary thrombosis of a 
has occasionally been encountered(6 , 7) . 
reported that only one of 6 late deaths 
Hancock prosthesis 
Pipkin et al.(8) 
of patients with 
Hancock prostheses was due to a valve-related problem . Their 
actuarial analysis predicted 84% survival at 3 years . 
Following on the favourable preliminary experience regarding 
the clinical course , thrombogenicity and durability of the 
glutaraldehyde-preserved porcine aortic valve(9-16) , Lurie et 
al.(17) performed post-operative cardiac catheterization on 26 
patients who had Hancock prostheses implanted for a mean 
period of 19 weeks . They concluded that these prostheses give 
generally 
function . 
satisfactory post-operative haemodynamic valvular 
Cevese et al . (18) reported on 564 patients who had 
received Hancock cardiac valves for observation periods 
extending up to a maximum of 6.5 years. They concluded that 
the valve was durable for at least that period . Cohn et 
al . (19) and Casarotto et al . (20) came to similar conclusions 
after follow-up periods in excess of 5 years in large groups 
of patients. Gallo et al . (21) followed up 632 patients with 
Hancock valves, which had been implanted for periods of 
between 1 and 6 years and were encouraged by its durability 
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over that medium period . The same group again expressed 
optimism in a similar report 2 years later(22) . Bolooki et al . 
(23) , in evaluating failures of Hancock xenograft valves , 
presented data to show that valve position was an important 
determinant as to whether structural failure occurred or not . 
failure was not observed after aortic valve Structural 
replacement, whereas 8 mitral valve prostheses were removed 
for structural failure (calcification, leaflet perforation , or 
torn cusp) at a mean follow-up period of 42 months . Hannah and 
Reis(lO) reported on 234 porcine xenograft valves implanted 
for up to 5 years . Twelve patients , all with mitral 
prostheses, had systemic arterial thromboembolism . 
In an attempt to ameliorate the problem of residual 
systolic gradients and small effective orifice areas in the 
aortic position , Hancock Laboratories introduced a modified 
bioprosthesis , constructed by the removal of the muscular 
right coronary leaflet and replacing it with the non-coronary 
cusp from a second porcine aortic valve. Zusman et al . (24) 
found that the Hancock modified orifice valve has good 
hydraulic performance and a low embolic rate without the need 
for anticoagulation and it is acceptable for the elderly 
patient with a small aortic root. 
Several reports document structural changes in Hancock 
valve prostheses(23 , 25-36). Spray and Roberts(25) observed the 
following histological changes in 44 bioprostheses (i) 
fibrin deposits on the inflow and outflow surfaces of the 
cusps (ii) inflammatory cellular infiltrates (iii) 
histiocyte deposition (iv) giant cell formation and (v) 
focal disruption of the fibrocollagenous structure of the 
cusps . Their observations indicate that porcine bioprostheses 
are not biologically inert in the human circulation . Valve 
failure was rare up to the period of 72 months studied . 
Dysfunction of Hancock prosthetic valves due to degeneration , 
disruption and/or thrombosis has been documented by Hetzer et 
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al . (26) , Brown et al . (27) and Thiene et al.(30) . Bortolotti et 
al . (29) reported 2 cases of late Hancock prosthetic stenosis 
due to fibrous tissue overgrowth on the atrial aspect of the 
cusps. Schoen et al . (31) described a patient with the 
carcinoid syndrome who had his mitral and tricuspid valves 
replaced by Hancock valve prostheses. He died 8 months later 
of tumour-related complications and it was observed that 
carcinoid plaques had extended onto both prostheses from the 
atria . 
Infective endocarditis of Hancock prostheses was 
described by Magilligan et al . (34) and Bortolotti et al . (35) . 
Magilligan et al . reported 11 patients with 
endocarditis of their Hancock valves . There 
infective 
were 3 
valve-related deaths 2 from valve incompetence and 1 from 
mitral and aortic xenograft stenosis . These authors concluded 
that the Hancock porcine xenograft is (i) as resistant to 
infection as are rigid prostheses in active infective 
endocarditis (ii) resistant to early post-operative 
bacteraemias and (iii) easier to sterilize than rigid 
prostheses and more durable than other tissue valves (e . g. , 
fascia lata , homograft or pericardial valves) in the face of 
prosthetic valve endocarditis. Bortolotti et al . studied 10 
infected Hancock valves removed from 9 patients . The devices 
had been in place from 2 87 months (mean= 37 . 5) and the 
causative organisms included gram negative bacteria in 3 
patients (Klebsiella , Enterobacter and Serratia) , gram 
positive organisms in 2 patients (Staphylococcuc aureus and 
Streptococcus viridans) and fungi in 4 (Candida in 3 and an 
Aspergillus species in one). Prosthetic incompetence was the 
commonest type of dysfunction resulting from the infection . 
The mortality 
high(37-39) and 
of prosthetic valve endocarditis is very 
a high incidence of infection-related deaths 
has been reported when endocarditis involves porcine 
xenografts(35 , 40 , 41) . This poor outcome might be due to a high 
incidence of associated septic complications. Only one out of 
my 12 autopsied patients with Hancock prostheses had infective 
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endocarditis and this led to partial dehiscence of the mitral 
prosthesis. 
Left ventricular rupture, which may complicate mitral 
valve replacement, may result from excessive mitral valve 
excision, as was demonstrated by one of my patients. A second 
type of rupture that may occur with mitral valve replacement 
is illustrated by the 2 patients reported by Bortolotti et 





which evolved into a cardiac rupture in one of 
laceration is ascribed to friction between a 
prosthetic strut and the endomyocardium. A disproportion 
between ° 0 high-profile" device and the left ventricular 
chamber is the likely cause of this complication. 
Salomon et al.(28) reported an unusual complication of 
the Hancock valve, namely strut compression by a too small 
aortic root resulting in the struts being angled centrally 
into the aortic lumen. Impedance of central flow had led to 
subsequent valve thrombosis. In a similar case reported by 
Magilligan et al.(43) the inward bending of the stents was 
associated with severe haemolysis. I have encountered one 
surgically excised Hancock aortic valve prosthesis which 
showed similar strut deformation. The prosthesis was free of 
thrombus, having been removed due to a cuspidal tear four 
years after implantation and the patient had no overt 
haemolysis. Borkon et al.(32) noted similar inward stent-post 
bending of a mitral Hancock porcine bioprosthesis 9 years 
post-operatively, which they attributed to "polymer creep." 
The latter is an aging characteristic of polypropylene(44). 
Spray and Roberts(25) observed stent-post deformity associated 
with bioprosthetic failure due to leaflet degeneration, but 
they did not discuss its significance. 
Arbustini et al.(33) described a case in which lipid 
infiltration of the cusps of a Hancock mitral valve prosthesis 
8 years after implantation was so diffuse and severe that it, 
by itself, led to commissural detachment and significant valve 
incompetence. Histology revealed cholesterol clefts in the 
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spongiosa and fibrosa , interspersed with amorphous material. 
Scanning electron microscopy showed erythrocytes, platelets 
and macrophages on the cuspidal surface which was partially 
devoid of endothelial cells . Transmission electron microscopy 
revealed large lipid droplets between bundles of collagen 
fibres . 
Pre- and post-implantation ultrastructural changes in 
Hancock porcine valvular xenografts were described by Ferrans 
et al.(36) . Unimplanted , commercially available valves showed 
loss of endothelium and acid mucopolysaccharides. Short - term 
post-implantation changes included insudation of plasma 
proteins , penetration of erythrocytes into surface crevices , 
formation of a thin surface fibrin layer and deposition of 
macrophages , giant 
changes consisted 
erosion of the 
cells and a 
of progressive 
valvular 
few platelets . Longer-term 
disruption of collagen , 




They concluded that 
progressive breakdown of collagen is a critical factor in the 
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PATHOLOGY OF CARDIAC VALVE REPLACEMENT WITH THE 
CARPENTIER-EDWARDS PORCINE XENOGRAFT BIOPROSTHESIS . 
The yearly survival rates and embolism events in Groote 
Schuur Hospital patients with Carpentier - Edwards bioprostheses 
are listed in Tables 11.1 and 11.2 respectively . 
AORTIC VALVE REPLACEMENT 
Fifteen patients with isolated replacement of the aortic 
valve with a Carpentier-Edwards bioprosthesis were autopsied . 
Eleven patients died 30 days or less after operation (group 1) 
and only 4 died later (group 2) 
GROUP 1 
These 11 patients had a mean age of 57.8 years (S . D.= 
11.9) and their ages ranged from 39 - 82 years . There were 6 
whites, 3 coloureds and 2 blacks . The pre-operative aortic 
valve lesions were as follows aortic nodular sclerosis 
(senile calcific tricuspid aortic stenosis) 5 cases , aortic 
ring dilatation due to aortic aneurysm 4 cases , and 1 patient 
with Fallot ' s tetralogy had aortic valvular incompetence due 
to lack of cuspidal support associated with a peri-membranous 
ventricular septal defect. No information was available 
regarding the aetiology of the valvular disease in one 
patient. Post-operative survival ranged from 0 . 8 to 15 days, 
with a mean of 4 . 3 days (S.D . = 5 . 5) . The mean heart weight was 
644 grams (S . D .= 165) with a range of 463-940 grams . None of 
the 11 Carpentier-Edwards prostheses showed naked eye thrombus 
on the cusps or sewing ring . This group of patients exhibited 
the following organ infarcts : heart 3 , renal 1 , pulmonary 1 , 




































































































































































































































































































































































































































































































































































































































































































































































































































These four patients had a mean age of 43.7 
14.2) and the range was 31-59 years . There were 
years (S . D. = 
2 whites and 2 
coloureds ; all four were males. The aortic valvular disease 
necessitating operation was as follows : unknown 1 , rheumatic 
fever 2 , and aortic nodular sclerosis 1 . The mean 
post-operative survival period was 106 . 8 days (S . D. = 119.2) 
with a range of 35-285 days . The mean heart weight was 728 
(S.D . = 303) grams and the range was 460-1057 grams. Only 2 
infarcts were encountered (lung 1 , spleen 1). The prostheses 
were all free of macroscopical thrombotic deposits . 
Tables 11 . 3 and 11 . 4 list the principal causes of death 
and major non-fatal complications/associated conditions in the 
14 patients with Carpentier-Edwards aortic prostheses . 
Associated valvular disease took the form of mitral stenosis 
(2 patients) , mitral incompetence (1 patient) and mixed mitral 
valve disease plus tricuspid incompetence (1 patient) . 
TABLE 11 . 3 : PRINCIPAL CAUSES OF DEATH 
(1 PER PATIENT) IN 5 PATIENTS WITH CARPENTIER-
EDWARDS AORTIC VALVE PROSTHESES . 
UNKNOWN 3 
PROSTHESIS BLOCKS CORONARY OSTIUM 1 
OPERATIVELY INDUCED MYOCARDIAL DAMAGE 2 
IATROGENIC CORONARY DISSECTION 1 
RUPTURED AORTOTOMY WOUND 3 
CEREBRAL HAEMORRHAGE 1 
MEDIASTINAL ABSCESS 1 
MYOCARDIAL FAILURE 1 
MYOCARDIAL INFARCTION (ATHEROSCLEROSIS) 1 
TRAUMATIC DEATH 1 
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TABLE 11.4 : NON-FATAL COMPLICATIONS/ASSOCIATED 
CONDITIONS IN 15 PATIENTS WITH CARPENTIER-EDWARDS 
AORTIC PROSTHESES. 
PATIENTS WITH CORONARY BYPASS VEIN GRAFTS 4 
AORTIC MEDIONECROSIS 2 
ACUTE PANCREATITIS 1 
SUBARACHNOID HAEMORRHAGE 1 
RENAL TUBULAR NECROSIS 1 
WOUND SEPSIS 2 
ACUTE GASTRIC EROSIONS 1 
MALIGNANT HYPERTENSION 1 
ASSOCIATED VALVULAR DISEASE 4 












All of the valve cusps of the prostheses implanted in the 
group 1 patients showed histologically well preserved cuspidal 
collagen with ghost outlines of the pre-existing fibroblasts 
and scanty fibrin deposits on both aspects of the cusps. No 
host immune assault was noted, but an occasional host monocyte 
or lymphocyte was attached to the cuspidal surface in at least 
one section of every valve examined. The 4 prostheses 
implanted in the group 2 patients who survived longer also 
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showed a well preserved collagenous fibrosa , but the cuspidal 
collagen in the prosthesis of the longest survivor (who was 
murdered 285 days post-operatively) stained less intensely 
with the van Gieson stain . A few valve cusps contained scanty 
interstitial fibrin deposits , but there was no sign of 
calcification or of infection . All valves were devoid of 
endothelial cells and only an isolated host cell was attached 
here and there to the cuspidal surfaces . No intra-cuspidal 
haematomas were seen . 
MITRAL VALVE REPLACEMENT 
Sixteen patients came to autopsy with Carpentier-Edwards 
mitral valve prostheses. Twelve patients died 30 days or 
earlier post - operatively (group 1) and 4 survived longer 
(group 2). 
GROUP 1 
The 12 patients comprising this group had a mean age of 
36.2 years (S . D . = 13.7) and an age range of 16-62 years . There 
were 5 males and 7 females ; 6 were coloureds , 3 white and 3 
were black . The pre-operative natural mitral valve lesions 
were as follows unknown 2 , rheumatic fever 9 and mitral 
incompetence due to myocardial infarction 1. Their mean 
post-operative survival was 7 . 7 days (S . D.= 8.4) with a range 
of 0 . 42-30 days. The mean heart weight was 526 grams (S . D.= 
79) and the range was 386-640 grams . Four of the 12 
Carpentier-Edwards mitral prostheses had macroscopical surface 
thrombi (2 on the sewing ring and 2 on the concave aspects of 
the cusps). The thrombus was scanty in both amount and extent 
and did not cause significant obstruction to the prosthetic 
orifice . 
The following infarcts were exhibited by the 12 patients 
left ventricle 2' brain 7 , lung 1, and kidney 2. Five 
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patients had associated disease of the aortic valve 
(incompetence in 2 and stenosis in 3) and 5 showed tricuspid 
valvular disease . The latter took the form of incompetence in 
3 and stenosis in two . Histologically , all of the prosthetic 
cusps showed well preserved collagen in the fibrosa , with no 
living cells within the cusp. Scanty acid mucopolysaccharide 
was demonstrable in the spongiosa of the porcine cusps. Scanty 
surface fibrin deposits were detectable focally on nearly all 
of the valves examined . No calcification was detected and none 
of the valves had elicited a foreign body giant cell response . 
Electron microscopy of 3 randomly selected prostheses which 
had been implanted for periods of 1 day , 8 days and 30 days 
respectively revealed normal-looking collagen fibres. 
GROUP 2 
The four group 2 patients had a mean age of 33 years 
(S . D . = 32) with a range of 13- 7 0 years . There were 2 blacks , 1 
coloured and 1 white patient . All 4 had undergone aortic valve 
replacement for rheumatic valvular disease . The mean 
post-operative survival was 1725 days (S . D . = 430) with a range 
of from 1170-2220 days . Two of the 4 prostheses showed surface 
thrombotic deposits ; scanty fibrin-platelet deposits on the 
sewing ring in one patient and abundant similar thrombus 
filled the concavities of the three cusps in another . Only one 
infarct was noted in the 4 patients and this involved the 
brain . All four porcine valves had poorly preserved cuspidal 
collagen which stained weakly or not at all with the van 
Gieson stain . Focal fibrin deposits permeated the interstitium 
of the cusps and there appeared to be a total loss of acid 
mucopolysaccharide . No intra-cuspidal haematomas were seen . 
Electron microscopy performed upon a porcine valve which had 
been implanted for 1740 days revealed evidence of focal 
dissolution of collagen fibres into granular, amorphous , 
electron dense material . 
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Tables 11.5 and 11 . 6 list the principal causes of death 
and major non-fatal complications/associated conditions in the 
16 patients with Carpentier-Edwards mitral prostheses. 
TABLE 11.5 : PRINCIPAL CAUSES OF DEATH 
(1 PER PATIENT) IN 16 PATIENTS WITH CARPENTIER-
EDWARDS MITRAL VALVE PROSTHESES 
UNKNOWN 6 
OPERATIVE AIR EMBOLISM 1 
INFECTION 1 
CALCIFIED XENOGRAFT 1 
CEREBRAL THROMBOEMBOLISM 3 
CEREBRAL HAEMORRHAGE 1 
MEDIASTINITIS,SEPTICAEMIA 1 




TABLE 11.6 : NON-FATAL COMPLICATIONS/ASSOCIATED 
CONDITIONS IN 16 PATIENTS WITH CARPENTIER-EDWARDS 
MITRAL PROSTHESES 
DIGITALIS TOXICITY 1 
CORONARY ARTERIAL THROMBOEMBOLUS 1 
SUBAORTIC STENOSIS DUE TO PROSTHESIS 1 
HAEMATOMA DISRUPTS THE BUNDLE OF HIS 1 
ACUTE GASTRIC EROSIONS 1 
SEPTUM PRIMUM ANEURYSM 1 
ABDOMINAL ATHEROSCLEROTIC AORTIC ANEURYSM 1 
VENOUS MALFORMATION OF RIGHT ATRIUM 1 
CORONARY SAPHENOUS VEIN BYPASS GRAFT 1 
BRONCHOPNEUMONIA 1 
MARKED PASSIVE VENOUS PULMONARY HYPERTENSION 3 












MORE THAN ONE CARPENTIER-EDWARDS VALVE PROSTHESIS IN THE SAME 
HEART. 
Only seven patients with more than one Carpentier-Edwards 
prosthetic heart valve in the same heart were autopsied. 
GROUP 1 
Six of the patients fell into group 1 (death occurring 
one month or less post-operatively). They consisted of 4 males 
and 2 females (3 coloureds, 2 blacks and 1 white subject). 
Their mean age was 29 years (S.D.= 14.3) and the range was 
14-51 years. The mean heart weight was 652 grams (S.D.= 165) 
with a range of 330-790 grams. The mean post-operative 
survival of the 6 patients was 2.2 days (S.D.= 2.4) and the 
range was 0.2-6.0 days. One patient had both the aortic and 
the mitral valves replaced ; three patients had their aortic, 
mitral and tricuspid valves replaced, and the remaining 2 
patients had both their mitral and tricuspid valves replaced. 
The aetiology of the native heart valve disease necessitating 
operation was rheumatic fever in 5 instances and the sixth 
patient had myxomatous degeneration of the aortic and mitral 
valves. None of the 15 prostheses examined showed 
macroscopically detectable thrombi on the surface of the 
prosthesis. 
Histological examination 




group 1 patients with 
Carpentier-Edwards aortic and mitral prostheses described 
above. The principal cause of death in the 6 group 1 patients 
with more than one Carpentier-Edwards bioprosthesis in the 
same heart was as follows : the cause of death was unknown in 
5 patients, and one other patient died of a fungal infection 
superimposed upon bilateral pulmonary infarcts. The infected 
infarcts had developed prior to open heart surgery. There was 
no sign of infective endocarditis. No other organ infarcts 
were noted in these patients. Non-fatal 
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complications/associated conditions observed in the group 1 
patients included the following marked passive venous 
pulmonary hypertension in 2, pre-operative multiple lung 
abscesses in 1 patient, localised dissection of the aortic 
root below the aortotomy wound 1 patient, and one patient had 
focal deep oesophageal ulceration which may have resulted from 
a cautery electrode touching the lead of the intra-oesophageal 
temperature-monitoring device during surgery. 
GROUP 2 
Only one patient with more than one implanted 
Carpentier-Edwards prosthesis fell into the longer surviving 
group. The patient was a 14-year-old coloured female who died 
suddenly while at school 391 days after replacement of her 
aortic and mitral valves by Carpentier-Edwards prostheses for 
chronic rheumatic heart disease. At autopsy her heart weighed 
380 grams and the most significant finding was that the mitral 
bioprosthesis had undergone extensive calcification resulting 
in severe mitral stenosis. Scanty fibrin-platelet thrombi were 
noted on the concave (non-contact) aspects of both 
bioprostheses, but there was no evidence of calcification of 
the aortic prosthesis, which had been implanted at the same 
time as the calcified mitral prosthesis. 
PATHOLOGY OF SURGICALLY RESECTED CARPENTIER-EDWARDS VALVULAR 
PROSTHESES 





pathological evaluation following surgical 
prosthetic dysfunction. Eight valves had been 
implanted in the mitral position, and two in the aortic 
position. The patients' ages ranged from 13 to 56 years at the 
time of initial operation, with 
Half of the patients were 
implanted for periods ranging 
a mean of 
males. The 
from 2-60 
36 years (S.D.= 
prostheses had 
months (mean= 





months) . Five of the prost h etic valves were removed because of 
pure incompetence , one showed stenosis only , and 2 showed both 
stenosis and incompetence . Three of the 5 incompetent valves 
had tears near the commissures (type I lesion of Ishihara et 
al . (l) ) , and the other 2 had tears and/or holes in the 
cuspidal substance (types III and IV lesions of Ishihara et 
al.(l) ) . Three valves showed cuspidal calcification , (Fig . 
11 . 1 and see Chapter 12 too) . These three patients were aged 
13 , 14 , and 16 at the time of their initial operation . Three 
valves showed scanty surface fibrin deposits and one aortic 
prosthesis (Fig . 11 . 2) was removed 3 years after implantation , 
because of massive thrombosis(2) . The latter patient had 
received no anticoagulants post-operatively . One valve showed 
resolving infection of the cusps . In valves implanted for up 
to 36 months the collagen appeared histologically normal , but 
by 60 months there was a uniformly severe depletion of 
cuspidal collagen . 
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Figure 11 . 1 : Surgically excised calcified Carpentier-Edwards 
prosthesis 23 months after implantation . One cusp has two 
tears in its substance . 
Figure 11 . 2 Massive thrombotic deposits fill the cuspidal 
pockets of this Carpentier-Edwards aortic valve prosthesis . 
Contrary to the usual policy , the patient was given no 
anticoagulant in the initial post - operative period . 
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SUMMARY OF PRINCIPAL CAUSES OF DEATH IN ALL PATIENTS WITH 
CARPENTIER-EDWARDS PORCINE XENOGRAFT BIOPROSTHESES. 
The principal causes of death in my 38 patients with 
Carpentier-Edwards porcine aortic valve xenograft prostheses 
fell into the following categories : 
(i) error in pre-operative diagnosis,nil (ii) error in 
operative technique,5 ; (iii) prosthesis-related problems,9 
(iv) general post-operative complications,6 ; (v) unrelated to 
cardiac operation,4 ; and (vi) unknown causes,14. 
COMMENT 
Between March 1975 and January 1978, an estimated 8,000 
Carpentier-Edwards bioprostheses had been implanted 
world-wide(3) and the following complications had been 
reported to the manufacturers, Edwards Laboratories 
endocarditis 5, high gradient 5, thromboembolism 5, thrombosis 
5, prosthetic calcification by the 17th post-operative day 1, 
peri-prosthetic leak 1, leaflet perforation 6 (related to 
handling with surgical instruments), haemolysis 1, 
regurgitation 2 (due to stent distortion produced by sutures, 
which spanned distances greater than 5mm), miscellaneous 9 
(e.g.,sewing ring disruptions and loosening of tissue-to-stent 
suture line). In November 1978, Edwards Laboratories reported 
that 0.625% glutaraldehyde was an effective sterilizing agent 
against the following organisms Eschericia coli, 
Staphylococcus aureus, Streptococcus pyogenes, Candida 
albicans, Propionibacterium acnes, Bacillus subtilis, five 
species of Mycobacterium and Aspergillus species. It was 
concluded that 0.625% glutaraldehyde is effective against most 
organisms and only the mature spore of Chaetomium globosum was 
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resistant to such treatment(4) . Formaldehyde in a 4% 
concentration was found to be an effective sterilizant against 
Chaetomium globosum in its mature spore form . Experiments with 
C14-labelled formaldehyde showed that formaldehyde was not 
incorporated into the protein structure of the 
glutaraldehyde-treated valve . 
Haemodynamic studies(S) comparing Hancock and 
Carpentier-Edwards bioprostheses revealed that 
Carpentier-Edwards prostheses had significantly lower 
trans-valvular gradients than the Hancock valves(6) and the 
differences in the design of bioprosthetic valves and that of 
natural valves are probably major factors in increasing the 
stress in the bioprostheses(7). Echocardiography(8 , 9) has been 
useful in evaluating porcine aortic bioprostheses and 
detecting degeneration of such valves(l0 , 11) , 
vegetations(12,13) , dehiscence(14 , 15) and flail porcine valve 
leaflets(l6) . 
Clinical experience with the Carpentier-Edwards xenograft 
valve prosthesis indicated that it was a valid heart valve 
substitute(17 - 20). Carpentier et al . (21) suggested that 
variations in histologic structure and durability resulted in 
part from inadequate preservation of the valve during the 
shipping process and large variations in the intervals between 
harvesting and glutaraldehyde treatment and in part too from 
high-pressure glutaraldehyde fixation . These authors expressed 
the hope that reduction of turbulence by the supra-annular 
concept and improved preservation of the valve would minimize 
the incidence of calcification. 
In view of the low incidence of thrombo-embolic events in 
patients with tissue valves , it is surprising that there are 
reports of massive thrombosis in relation to 
Carpentier-Edwards prostheses(2 , 22) . Phillips et al . (23) 
described subvalvular thrombotic obstruction of an aortic 
porcine xenograft. The thrombus appeared to have arisen at the 
junction of the aortic and mitral valve annuli. Bornstein and 
Sandroni(24) reported a patient in whom left atrial thrombosis 
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occurred after mitral valve replacement with an unspecified 
type of glutaraldehyde-treated bioprosthesis . In our 
patient(2) , the thrombosis involved the aortic valve 
prosthesis , but spared an identical type of prosthesis in the 
mitral position . The patient with uninfected prosthetic valve 
thrombus described by Cohen et al . (22) also involved an aortic 
valve prosthesis . 
Angell and Angell(35) , while reviewing porcine xenograft 
heart valves , commented upon an apparent trend for current 
porcine valves to undergo sterile valvular degeneration at 5-7 
years post-implantation . Many of the degenerative changes are 
related to host reactivity e . g ., calcium deposition and host 
phagocytic activity. Because of similarities in the 
manufacturing process and complications of Hancock and 
Carpentier-Edwards xenograft prosthetic valves , several 
reports do not separate their results regarding groups of 
patients including both types of prostheses(36 - 43). Hatcher et 
al . (38) reported that the highest incidence of tissue failure 
occurred in young patients after six years of implantation . 
Their data suggest that use of the valve should be restricted 
to older patients in whom anticoagulation is contraindicated . 
In their report dealing with the long-term failure rate and 
morphological correlations in porcine valvular bioprostheses , 
Schoen et al . (44) noted that causes of valve failure included 
calcification-related cuspidal tears , tears without calcium 
deposits , cuspidal stiffening without any tears , but with 
calcium deposits and thrombosis . Late primary dysfunction was 
most often due to degenerative processes , especially 
calcification , often with secondary tears. However , cuspidal 
tears (without associated calcification or thrombosis) 
predominated at shorter intervals . 
Several papers give an overall view of the subject of 
porcine bioprosthetic heart valve replacement(45 - 49) . Geha et 
al . (39 , 50) and Magilligan et al . (51) noted a high incidence of 
early failure of porcine xenograft heart valves in children 
and young adults , but excellent medium and long-term results 
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in older adults , in whom severe dysfunction occurred mainly 
with recurrent infective endocarditis . Thromboem bolism 
occurred only in patients with mitral valve replacement , 
especially in those with atrial fibrillation and if no 
anticoagulation was given . Sarabu and Parker(52) have recorded 
an unusual functional abnormality of a porcine xenograft 
cardiac valve that may be difficult for a pathologist to 
detect on morphological examination alone . Two of their 
patients required re-operation because in each patient it was 
discovered that one of the cusps of the mitral prosthesis was 
in the fixed-open position with no evidence of a peri-valvular 
leak. These authors assumed that the failure of the leaflet to 
close properly had been present from the operation. 
Structural alterations in porcine xenografts described by 
Ashraf and Bloor(S3) included fibrin deposits , erythrocyte 
trapping , disruption of the valve matrix, and interstitial 
oedema 2 years and 2 months after implantation . Scanning 
electron microscopy demonstrated an absence of endothelial 
cells . Camilleri et al . (54) observed no significant evidence 
of tissue rejection in 29 xenograft bioprostheses which had 
been implanted for periods of up to 115 months. They 
emphasized three factors (i) disruption of the endothelial 
cell barrier and lack of significant host endothelialization ; 
(ii) increased cuspidal permeability, which favours 
calcification and lipid accumulation ; (iii) biodegradation of 
the collagen framework . Contrary to this experience with 
commercially available bioprostheses , Bodnar et al.(55) stated 
that porcine aortic valves may be processed in glutaraldehyde 
without loss of integrity of the endothelium and with the 
development of optimal collagen fibre structure . However , 
their valves were evaluated after only up to 6 months 
experimental implantation and their illustrations did not 
demonstrate endothelial cell persistence . The findings in my 
patients with Carpentier-Edwards prostheses mirrors the 
experience of Ashraf and Bloor(S3) . 
Ishihara et al . (l) classified and described the structure 
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of cuspidal tears and perforations in porcine bioprost h etic 
cardiac valves implanted in patients . Such lesions were more 
frequent in the left and non-coronary cusps , than in the right 
coronary cusp (which in the prostheses studied had a muscular 
shelf at its base). These authors concluded that cuspidal 
tears and perforations develope in bioprostheses as a res u lt 
of structural failure of the connective tissue components. 
Types I , III and IV tears/perforations were observed i n some 
of the bioprostheses of patients in my study . Early leaflet 
perforation as a cause of bioprosthetic dysfunction has also 
been described by Nunez et al . (56) . In two of their patients , 
the cut ends of the sutures used for valve insertion were 
believed to be the cause of the cuspidal perforations . This 
situation may be prevented by inserting the sutures in the 
periphery of the sewing ring and cutting the sutures flush 
with the knots. Their third case showed massive collagen 
breakdown due to inadequate collagen fixation by the 
glutaraldehyde treatment . Torn xenograft leaflets may produce 
unusual auscultatory findings(57 , 58) . A high-resolution method 
of spectral analysis ( " maximum entropy method " ) , which has 
been used to study aortic porcine valve closing sounds , may be 
useful for the detection of intrinsic xenograft 
dysfunction(58) . 
Experimental evidence(59) indicates that glutaraldehyde 
preserved porcine heart valves are vulnerable to compressive 
flexure, which produces fatigue-induced damage and this may 
limit long-term durability . Degenerative changes are more 
severe in the mitral than in the aortic valve position(60). 
This is probably related to the greater closing pressure that 
the mitral valve is subjected to . Spontaneous xenograft 
failure usually occurs in a progressive and gradual fashion , 
but occasionally acute , catastrophic , spontaneous xenograft 
failure has been encountered(61) . Biodegradation of collagen 
is the commonest cause of failure , but occasionally 
manufacturing faults may be responsible e . g . , the case of 
Grehl et al . (62) in which 2 leaflets of a Carpentier-Edwards 
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porcine xenograft valve tore away from the aortic wall . This 
probably resulted from thinning of the aortic wall beyond a 
critical point of maintenance of wall strength during the 
process of mounting the xenograft on the stent . 
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CHAPTER 12 . 
CALCIFICATION OF GLUTARALDEHYDE-PRESERVED PORCINE XENOGRAFTS 
IN YOUNG PATIENTS 
It is estimated that stent-mounted glutaraldehyde 
preserved porcine aortic valves (GPVs) have been used in over 
500 , 000 cardiac valve replacements since 1971(1-12 , 53). Late 
calcific degeneration of GPV occurs commonly in long-term 
valve replacements and often results in bioprosthetic 
failure(3-18) . One of the earliest reports of calcification of 
a glutaraldehyde-preserved porcine xenograft came from Cape 
Town(l9) . There are numerous isolated case reports of valve 
dysfunction resulting from calcification(20-24) and several 
larger studies reveal that calcification may be more common in 
the younger age group(8-12 , 26-29) . At Groote Schuur Hospital 
between 1975-1980, 670 glutaraldehyde-preserved porcine 
xenografts have been inserted in 568 patients in the aortic 
and mitral positions(30) . Of these, 81 were Hancock and 589 
were Carpentier-Edwards prostheses . Fifty-four of the Groote 
Schuur Hospital patients were under 16 years of age at the 
time of implantation . Seven of these patients have required 
re-operation to replace nine prostheses (7 mitral and 2 
aortic) for calcification and severe stenosis. In addition , 
another young patient had a xenograft inserted elsewhere and 
presented with severe stenosis . A further 3 young patients 
died and postmortem revealed severely calcified , stenotic 
prostheses . The latter 3 patients have been included in 
Chapters 10 (Hancock prosthesis) and 11 (Carpentier-Edwards 





The clinical features at the time of presentation , 
catheterization findings , and outcome in the 11 patients are 
listed in Table 12 . 1 . All patients were 16 years of age or 
younger at the time of initial operation (mean age 13 
years , S . D . = 1 . 5) . There were 6 girls and 5 boys all had been 
operated upon for rheumatic valvular disease with remission of 
symptoms post-operatively . Seven patients had isolated mitral 
valve replacement , 3 had combined aortic and mitral valve 
replacement , and one patient had isolated aortic valve 
replacement. There were 12 Carpentier-Edwards prostheses and 2 
Hancock prostheses. All of the 11 patients presented with 
prosthetic malfunction less than 33 months after the initial 
operation (range 12 to 33 months, mean 22 months) . Two 
patients (numbers 8 and 10) died suddenly and unexpectedly. 
Both showed heavily calcified and stenosed xenografts at 
autopsy . One patient (number 9) presented with sudden 
pulmonary oedema and died before re-operation could be 
performed. Autopsy again revealed severely calcified xenograft 
leaflets(19) . One patient (number 3) presented with syncope 
and increasing dyspnoea . The remaining 7 patients (numbers 1 , 
2, 4 , 5, 6 , 7 and 11) all had a relatively short history of 
symptoms of dyspnoea or had severe pulmonary oedema when first 
seen . One of these patients (number 2) was operated upon 
twice, once for a disrupted , calcified mitral prosthesis and a 
second time 11 months later for disruption and calcification 
of the aortic prosthesis . At operation in all cases the 
prosthesis was heavily calcified and stenosed . 
Seven of the 8 patients who underwent replacement of the 
calcified xenografts are alive and well following 
re-operation . One patient (number 11) died 3 months after his 
second operation . Poor left ventricular function had been 
demonstrated at cardiac catheterization prior to operation . 
Before the clinicians became aware of the extent of the 
problem of xenograft calcification in young persons, a few of 
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TABLE 12.1 PRESSURE GRADIENT BEFORE REOPERATION AND OUTCOME 
IN PATIENTS WITH CALCIFIED XENOGRAFTS 
PT. AGE AT VALVE, TIME TO PRESS. PROSTHETIC OUTCOME 



























RE-OP GRAD(mmHg) AREA(cm2) 
(months) 
21 26 0.3 A & W 
16 63 0.5 A & W 
27 27 1. 0 A & W 
33 25 0.6 A & W 
23 20 0.5 A & W 
23 18 0.7 A & W 




20 12 0.5 DIED 
CE=Carpentier-Edwards. H=Hancock. A & W=Alive and well after 
re-operation.M=Mitral,A=Aortic,Press.Grad.=Mean Pressure 
Gradient,M.V.A.=Mean Valve Orifice Area,Re-op.=Re-operation, 




Pathological examination of the calcified xenografts (3 
obtained at autopsy and the rest as surgical specimens) 
revealed essentially similar features in each . By way of 
avoiding repetition , the pathological changes observed will be 
described together and differences between individual cases 
will be mentioned . 
Calcification (Figures 12 . 1 - 12.4) involved all 3 cusps 
in each xenograft. In most instances the calcified area was 
enclosed by a 
tissue (Figure 
superficial layer 







calcification showed well-preserved collagen and the ghost 
outlines of pre-existing cuspidal fibroblasts . Calcification 
mostly spared the portions of the cusps near the free margins. 
In a few areas , especially near the commissures , the 
calcification was present as calcified excrescences , which 
deformed the otherwise smooth cusp surface . Calcified areas 
still stained positively with the von Kossa and alizarin red 
stains after mild decalcification prior to routine tissue 
processing . Calcified zones also stained positively with 
empirical histological stains for fibrin (Martius scarlet blue 
and picro-Mallory methods) . However, immunoperoxidase staining 
of the sections for fibrinogen often revealed scanty fibrin 
thrombus on the outflow portion of the cusps , but the 
calcified zones as well as the remainder of the cuspidal 
substance were negative for fibrinogen . The results with the 
empiric stains are interpreted as non-specific, false-positive 
staining . Stains for micro-organisms were uniformly negative . 
One prosthesis showed additional calcification of 
myocardial fibres in the base of a cusp in another 
prosthesis two of the calcified cusps were torn . Only one 
prosthesis exhibited an histiocytic and foreign body giant 
cell reaction to the xenograft cusps . The cellular aggregation 
appeared unrelated to the cuspidal calcification . Light 
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microscopy of the xenograft valves revealed an appearance of 
dystrophic cuspidal calcification in a patchy, unpredicatable 
fashion. Apart from the calcification , the xenografts appeared 
no different from other xenografts that I have examined at 
various periods after implantation . 
Electron microscopy was performed upon 7 of the 
xenografts . The tissue examined was taken from macroscopically 
non-calcified portions of the xenograft valves. 
Ultrastructural evidence of very early calcification was 
observed in 3 of the seven valves . In 2 of the three valves 
the earliest sign of calcification was observed in the 
interstitium (Figure 12.4) adjacent to collagen fibres and 
fibroblast-like cells . One valve had very early calcification 
within the cytoplasm of a fibroblast-like cell . 
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Figure 12.1 : Left atrial view of the severely calcified, 
stenotic Hancock bioprosthesis of case 9. Left atrial thrombus 
is present. 
Figure 12.2 : Radiograph of a surgically excised calcified 
Hancock valve. Calcification is present in all 3 cusps. The 
prosthesis has a narrow, wire-like base ring. 
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Figure 12.3 : Histological section of a cusp of the calcified 
Hancock valve shown in Figure 12 . 1 shows calcification to 
involve the core of the cusp with sparing of the superficial 
portions of the cusp . (Haematoxylin-eosin , X 150) . 
Figure 12 . 4 Early calcification within Hancock cuspidal 
interstitial tissue is seen as a central , densely stained 
nidus within an aggregate of hydroxyapatite crystals . (Uranyl 




The significant feature of the calcification in these 
cases is that it occurred in patients under the age of 16 
years. A total of 54 patients less than 16 years of age who 
have had xenografts inserted for chronic rheumatic heart 
disease was followed up at Groote Schuur Hospital(30). Of 
these, 7 developed severe stenosis requiring re-operation and 
3 patients died. During the same period of follow-up no 
calcification causing valve dysfunction was observed in any of 
the 514 patients over the age of 16 years with similar 
prostheses. Others have reported a similar 
experience(S,26,27). Calcification of xenografts in adults has 
sometimes been reported(27-29) and more recently a few such 
cases have been encountered at our institution. 
The reason for the discrepancy between the two age groups 
is not clear, as all of our patients had been managed 
similarly and all had received the usual anticoagulation 
regimen. None had evidence of infective endocarditis or of an 
abnormal calcium metabolism, although all had an elevated 
alkaline phosphatase level in keeping with their age. Most of 
the earlier reports of calcification have been in patients 
with Hancock prostheses. At our institution, the 
Carpentier-Edwards prosthesis has been more frequently 
implanted. It is not surprising that a similar pattern of 
calcification may involve this prosthesis, as there are only 
minor differences in preparation between the two valves. 
In addition to the age distribution, another unusual 
feature is the fact that the calcification mainly involves the 
central core of the cusps and often spares the superficial 
portions. Although calcification is a common complication of 
aortic valve homografts(31,32), it was not a significant 
complication of formaldehyde-treated porcine xenografts(33). 
The limited durability of the latter prostheses may also have 
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played a role in the lack of calcification, since most failed 
early and thus may not have been left in situ long enough for 
calcification to occur . A variety of possible reasons for 
calcification of glutaraldehyde-preserved porcine xenografts 
has been proposed , incl u ding the different calcium metabolism 
of young persons(26) , infection of the xenograft(34) , the 
presence within the cusp of a calcium-binding amino acid(9) , 
and the repeated flexing of the cusps(35). Glutaraldehyde is a 
notoriously poorly penetrating fixative(30) . Cross-linking of 
the surface layers makes it progressively harder for 
glutaraldehyde to penetrate the tissue bulk in conventional 
reactions carried out at pH 7 and this can lead to incomplete 
fixation of the tissue(36) . The superficial zones of the 
cusps, which are usually free of calcification , are the sites 
of the cusp that are fixed earliest and best by the 
glutaraldehyde solution. It is theoretically possible that 
alterations favouring subsequent calcification may develop in 
the core of the xenograft cusps in the period between valve 
excision and penetration of glutaraldehyde into the centre of 
the cusps . More recently , for sterilization purposes , the 
Carpentier-Edwards prostheses have been treated with 
formaldehyde during their manufacture(37). It is uncertain 
whether such treatment will have any effect on the propensity 
of these prostheses to calcify . 
It is apparent from our data and other reports in the 
literature(8,9 , 13 , 17 , 26 , 27 , 38-47) that glutaraldehyde 
preserved porcine xenografts are not suitable for insertion in 
children and adolescents . In addition to the Hancock and 
Carpentier-Edwards prostheses , other glutaraldehyde-preserved 
porcine aortic valve prostheses e . g ., the Angell - Shiley 
bioprosthesis appear to suffer from a similar problem of 
calcification in young hosts(48). Bovine pericardial 
prosthetic valves develop calcific obstruction significantly 
earlier than do the porcine valves(39). It is likely that all 
young persons with glutaraldehyde-treated bioprostheses will 
require early re-operation because of calcification . The 
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policy at Groote Schuur Hospital(30) is to follow all these 
young patients at 3 monthly intervals and to perform cardiac 
catheterization if they exhibit any symptoms of reduced effort 
tolerance , auscultatory features of prosthetic stenosis or 
pulmonary hypertension , electrocardiographic signs of 
progressive rightward axis deviation , or radiological evidence 
of pulmonary congestion . The cause of the bioprosthetic 
cuspidal calcification observed in young persons still awaits 
final elucidation . 
Experimental models in animals will hopefully provide 
more information in this regard(49 - 52) . Levy et al . (53) found 
in a study of subcutaneous implants of GPVs in rats that 
glutaraldehyde fixation of porcine aortic leaflets was a 
prerequisite for the calcification of GPV implants . These 
authors point out that while the specific steps in the 
glutaraldehyde treatment that promote the calcification are 
not known , the specific types of cross-links formed may be 
responsible . The pyridinium cross-link , which is one of the 
major types of glutaraldehyde induced cross-links(54-56) is 
directly analogous to similar compounds found in bone derived 
collagen and the desmosine residues of elastin(53) . The 
pyridinium cross-link 
theoretically cause an 
is a quartenary amine 
influx of phosphate 
inter-fibrillary spaces of 
leading to hydroxy-apatite 
the collagen helices 





rich in native cross-links , such as elastin or collagen , may 
promote calcification solely on the basis of the extent of 
cross-linking(53) . New observations portray calcification 
processes as similar whether occurring normally or 
pathologically(57) . Most forms of calcification are initiated 
by membranous organelles, i . e . extra-cellular, calcifying 
"matrix vesicles " or intra-cellular mitochondria . Matrix 
vesicles promote calcification through calcium-binding 
phospholipids and phosphatase activity . Mitochondria use a 
forceful , inwardly directed calcium and phosphate transport 
mechanism . After mineral initiation , the proliferation of 
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mineral crystals is dependent on regulatory factors such as 
extra-cellular calcium and phosphate and other mineral 
inhibitors and promoters. 
The unsolved problem for the manufacturers of xenograft 
bioprostheses is how such calcification may be prevented on a 
long-term basis. Most chemical methods used to date in the 
preparation procedure of GPVs have included materials to 
prevent precipitation or to compete with calcium for active 
sites. Most of these approaches show good short-term results 
which diminish as the anti-calcific agent leaches from the 
tissues(21). Others 
dodecyl sulphate(SO), 
special buffers or 





natural or synthetic polyelectrolytes. 
use adsorbed sodium 
borohydride(58), 
tissue matrix by 
Porcine mitral valve calcification has been identified as 
a cause of intra-vascular haemolysis in children and the 
presence of haemolysis may be taken as an indication of such 
dysfunction(46). It has been suggested that some systemic 
emboli in porcine valve recipients may not be due to 
intra-cardiac or prosthetic thrombosis, but to detachment and 








CHAPTER 13 . 
PATHOLOGY OF CARDIAC VALVE REPLACEMENT WITH MISCELLANEOUS 
TISSUE VALVES. 
l.AUTOLOGOUS FASCIA LATA HEART VALVE PROSTHESIS 
Only one patient with such a prosthesis was encountered, 
a 17-year-old coloured female, who had undergone a previous 
mitral valvotomy for chronic rheumatic valvular heart disease 
(mitral stenosis) . Her mitral valve was replaced by an 
autologous fascia lata prosthesis. She remained well for 8 
months . Two weeks before her death she was admitted to Groote 
Schuur Hospital because of a skin rash and congestive cardiac 
failure . The latter was thought to be due to infective 
endocarditis and , although no organisms were cultured , she was 
given Penicillin and Gentamycin . The drug rash was attributed 
to Lasix , which was stopped, but she died soon afterwards . 
At autopsy her heart weighed 680 grams and showed 
generalized hypertrophy and chamber dilatation . Infected 
vegetations were present on the fascia lata prosthesis and one 
of the cusps had torn , rendering the valve severely 
incompetent . Histologically the vegetations contained 
Gram-positive cocci . The aortic valve showed early aortic 
stenosis . Healed infarcts were present in the kidneys , the 
lungs showed a bronchiolitis, and the skin showed features of 
an allergic vasculitis . 
References for the fascia lata valve prosthesis are 
given in Chapter 2 (references 179 to 234 inclusive) . 
2.IONESCU-SHILEY BOVINE PERICARDIAL XENOGRAFT HEART VALVE 
PROSTHESIS 
I have had three hearts 




to me for 
examination . All three patients had chronic rheumatic valvular 
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heart disease and all three had undergone heart 
replacement at another institution . 
valve 
CASE 1 
This 23-year-old coloured female had severe stenosis 
plus incompetence of both her aortic and mitral valves . Her 
mitral valve was replaced by a 27 mm diameter Hancock 
prosthesis and the aortic valve was replaced by a 23 mm 
diameter Ionescu-Shiley bioprosthesis ; her aortic root was 
widened using a Gortex sheet . Despite repeated attempts , she 
could not be weaned off the heart - lung machine . Autopsy 
revealed that the Ionescu-Shiley bioprosthesis had been 
positioned in such a way that the prosthesis produced 
significant obstruction of both of the coronary arterial 
ostia . Grade 4 (75% + ) luminal narrowing by atherosclerosis was 
noted in the right coronary artery and in a diagonal branch of 
the left anterior descending coronary artery. Histology of the 
left ventricle revealed healed sub-endocardial infarction plus 
recent contraction band necrosis (myofibrillar degeneration/ 
coagulative myocytolysis) . Numerous Aschoff bodies were 
present in the myocardium . The patient ' s death appeared to be 
due to a deficiency in operative technique . 
CASE 2 
This 48-year-old white female had suffered from mitral 
stenosis and incompetence for 18 years . Three years before her 
death she had undergone a mitral valvotomy. On 23rd 
December , 1981 her mitral valve was replaced by a 27 mm 
Ionescu-Shiley bioprosthesis and the aortic valve by a 21 mm 
Bjork-Shiley prosthesis and a tricuspid annuloplasty was also 
performed . However, intra-operative air embolism occurred , 
resulting in permanent brain death. The ventilator was 
switched off on the morning of the third post-operative day . 
Morphological examination of the 492 gram heart revealed 
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mild subaortic obstruction produced by the Ionescu-Shiley 
mitral prosthesis . One of the sewing ring sutures of the 
latter prosthesis was looped around one of the commissural 
posts (Fig . 13.1). This led to tethering down of the 2 cusps 
which were attached to this post , with the production of 
minimal to mild valvular incompetence and possibly some 
stenosis . The supporting post at this site indented the septal 
endomyocardium . The Bjork-Shiley prosthesis showed no 
intrinsic abnormality , but the disc appeared to impinge 
against the aortic wall in the fully open position . The latter 
is difficult to assess in the formalin-fixed state and may be 
a fixation artefact. Scanty thrombus was present on the 
tricuspid annuloplasty sutures. The latter appeared to be 
unusually long and hanged down into the right ventricle . The 
left atrium contained fresh and organized thrombi . The right 
lower pulmonary vein was thrombosed . Grade 4 (75%+) 
atherosclerotic luminal narrowing was observed in the 2 major 
branches of the left coronary artery and the right coronary 
artery showed an old complete occlusion . 
Histology of the left ventricle showed focal coagulative 
necrosis , which was evoking an early neutrophile response . Some 
of the small coronary arteries were thick-walled and one 
contained a thrombo-embolus . The Ionescu-Shiley prosthesis 
showed no significant microscopical abnormality. Operative air 
embolism was the principal cause of death. 
CASE 3 
This 14-year-old black female with chronic heart failure 
due to mitral incompetence and aortic stenosis , had her mitral 
valve replaced by a 25 mm Ionescu-Shiley bioprosthesis and the 
aortic valve was replaced by a 19 mmm St Jude Medical 
prosthesis. The patient was weaned off the heart-lung machine 
with difficulty at the end of the operation and survived 4 
hours with a low blood pressure . The prostheses appeared 
normal naked eye and the Ionescu-Shiley valve cusps showed no 
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abnormality histologically . The left ventricle showed 
widespread contraction band necrosis , raising the possibility 
of inadequate intra-operative myocardial protection . Some 
small coronary arteries contained recent thrombo-emboli , b ut 
it is uncertain as to whether there is any relationship 
between the emboli and the myocardial damage . 
Figure 13 . 1 : Ionescu-Shiley mitral bioprosthesis of patient 2 
has a sewing ring suture looped around the supporting post , 
which is indenting the inter-ventricular septal endocardium . 
The suture has slightly reduced the amount of free margin of 
the 2 cusps attached at this site . 
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3.EXPERIMENTALLY IMPLANTED IONESCU-SHILEY BIOPROSTHESES 
Four Ionescu-Shiley bioprostheses were implanted into 4 
Chacma baboons as controls for similarly implanted Mitroflow 
Medical bioprostheses . Results are given in Chapter 16 . 
COMMENT 
There are too few patients with Ionescu-Shiley 
bioprostheses in the present study for any conclusions to be 
drawn regarding the efficacy of this valve substitute. Several 
published reports attest to its durability and low 
thromboembolic rate(l-6) . However , others have reported 
complications with this prosthesis e . g ., accelerated cuspidal 
calcification(7 - 9) , collagenous overgrowth(lO) and cuspidal 
disruption(ll , 12). Thubrikar et al . (13) have analysed the 
design and dynamics of various aortic bioprostheses in vivo . 
The configurations in the radial direction indicated that 
Carpentier - Edwards and Hancock valves have leaflets that are 
cylindrical, whereas the leaflets of Ionescu-Shiley valves are 
roughly spherical . Ishihara et al . (14) examined the structure 
of bovine parietal pericardium and of unimplanted 
Ionescu-Shiley pericardial valvular bioprostheses . They found 
that pericardial bioprosthetic cusps differ from normal 
pericardium by being denuded of mesothelium , but they have 
normal degrees of waviness in their collagen . In 
Ionescu-Shiley valves , the inflow and outflow surfaces of each 
cusp correspond to the epipericardial and serosal surfaces of 
parietal pericardium, respectively . The inflow surfaces have a 
coarse texture , chraracterized by large bundles of collagen , 
and the outflow surfaces have numerous grooves , which probably 
result from pressure exerted on the cuspidal surfaces by 
cotton material either during manufacture or packing of the 
valves. 
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CHAPTER 14. 
PATHOLOGY OF CARDIAC VALVE REPLACEMENT WITH MORE THAN ONE TYPE 
OF PROSTHESIS IN EACH HEART 
The 24 patients studied had 52 prostheses of various 
types implanted, i.e., each heart contained more than one kind 
of prosthetic heart valve (see Tables 14.1 and 14.2). The 
aetiology of the native heart valve disease in these patients 
was as follows : rheumatic heart disease 21, primary infective 
endocarditis (normal pre-existing valves) 2, and congenital 
heart disease 1. 
GROUP 1 
The 14 patients in this group had a mean age of 35 years 
(S.D.= 14) and a range of from 18 to 63 years. There were 9 
whites and 5 coloureds ; eight were females and 6 were males. 
Eleven patients had chronic rheumatic-type deformities of 
their native heart valves prior to surgery, 2 had infective 
endocarditis and one patient had congenital heart disease 
(mitral stenosis, double outlet right ventricle, ventricular 
septal defect and aortic incompetence). Their mean survival 
period was 4 days (S.D.= 7) with a 
mean heart weight was 682 grams 
from 420-1172 grams. Only one 










a range of 
prostheses 
of thrombus 
deposition at postmortem. This was observed on the sewing ring 
and on the cage of a Starr-Edwards prosthesis which had been 
implanted for 5 days. The Bjork-Shiley aortic valve prosthesis 
in the same patient was free of thrombus. The 14 patients 
were observed to have the following organ infarcts : heart 2, 
lung 1, spleen 1, kidney 1, and limb 1. However, as 9 out of 
the 14 patients had only partial postmortems performed and the 
heart only was referred to me from elsewhere for examination, 
the incidence of infarction may be underestimated in this 
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group. In the majority of these patients I was able to obtain 
only a verbal report regarding the presence or absence of 
organ infarcts at autopsy . Table 14.3 lists the principal 
causes of death in the group 1 and group 2 patients. 
TABLE 14. 1 : TYPES OF PROSTHETIC VALVES IMPLANTED IN 24 
PATIENTS WITH MORE THAN ONE KIND OF PROSTHESIS IN 
EACH HEART 
SITE GROUP UCT LILL B-S SJM HAN S-E C-E I-S TOTALS ----- -- -- -- -- --
AV 1 4 1 4 2 0 0 0 1 13 
AV 2 3 1 6 0 0 0 0 0 10 
AV TOTAL 7 2 10 2 0 0 0 1 22 
MV 1 0 1 1 2 1 7 2 0 14 
MV 2 1 1 0 0 0 6 1 1 10 
MV TOTAL 1 2 1 2 1 13 3 1 24 
TV 1 0 1 0 1 0 1 1 0 3 
TV 2 0 0 0 0 0 1 0 0 1 
TV TOTAL 0 1 0 1 0 2 1 0 5 
PV 1 0 0 0 0 1 0 0 0 1 
PV 2 0 0 0 0 0 0 0 0 0 
PV TOTAL 0 0 0 0 1 0 0 0 1 
TOTALS 8 5 11 5 2 15 4 2 
GRAND TOTAL = 52 
Code for types of prostheses: UCT=University of Cape 
Town, LILL=Lillehei,B-S=Bjork-Shiley,SJM=St Jude 
Medical, HAN=Hancock,S-E=Starr-Edwards,C-E=Carpentier-
Edwards, I-S=Ionescu-Shiley.AV=aortic valve , MV=mitral 
valve, TV=tricus2id valve, PV=2ulmonary valve. 
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TABLE 14.2 COMBINATIONS OF THE DIFFERENT TYPES OF VALVES 
INSERTED IN 24 PATIENTS 
No.of 
AV MV TV PV Patients 
GROUP 1 
SJM SJM C-E 1 
UCT SJM SJM 1 
B-S C-E 1 
I-S C-E 1 
B-S S-E 2 
UCT S-E S-E 1 
UCT S-E 2 
LILL S-E 1 
SJM LILL 1 
B-S HAN 1 
S-E LILL 1 
B-S B-S HAN 1 
GROUP 2 
B-S I-S 1 
UCT S-E 1 
UCT S-E 2 
B-S S-E 4 
UCT LILL 1 
LILL C-E 1 
Same code for abbreviations as used in Table 14. 1. 
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GROUP 2 
The 10 patients who survived longer than 30 days 
post-operatively had a mean age of 34 years (S.D . = 17) and a 
range of 14-57 years . There were 5 whites , 3 blacks and 2 
coloured patients . Six of the patients were females . Mean 
post-operative survival period was 355 days (S . D . = 341) with a 
range of 34 - 11 4 7 days . The mean heart weight was 873 grams 
(S . D . = 192) with a range of from 492-1138 grams . Eight out of 
the 22 prostheses present in the ten group 2 patients bore 
bland antemortem thrombi . One U.C . T . prosthesis had abundant 
thrombi on the bobbin and sewing ring , 4 Starr - Edwards mitral 
prostheses had moderate amounts of thrombus on the cage struts 
near to or at the apex , 2 Bjork-Shiley aortic valve prostheses 
had scanty sewing ring thrombi and 1 Lillehei mitral 
prosthesis was extensively covered on both aspects by thrombus 
which severely narrowed the major orifice and totally occluded 
the lesser orifice . The following organ infarcts were observed 
in these 10 patients kidneys 3 , brain 3 , spleen 2, heart 2 , 
and lung 1 . Only 2 out of the 10 patients were partial 
postmortems . For lists of the principal causes of death and 
non - fatal complications in these patients please see Tables 
14 . 3 and 14 . 4 . 
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TABLE 14.3 : PRINCIPAL CAUSES OF DEATH (1 PER PATIENT) 

































TABLE 14.4 : NON-FATAL COMPLICATIONS/ASSOCIATED 




PULMONARY VALVE MARANTIC THROMBUS 1 
SEVERE HAEMOLYSIS 1 
GROUP 2 
75%+ CORONARY ARTERIAL NARROWING 2 
PARTIAL PROSTHETIC DEHISCENCE 2 
DIGITALIS TOXICITY 1 
332 
MULTIPLE DIFFERENT PROSTHESES 
COMMENT 
GROUP 1 
The 4 patients with unknown cause of death may have died 
of early post-operative arrhythmia . Three of the patients did 
not survive the operation , and one lived for only 3 hours . The 
patient who died because of prosthetic disproportion had had 
pre-operative infective endocarditis of the aortic and mitral 
valves with aortic ring abscesses . Following excision of as 
much of the infected tissue as possible, there was a 
deficiency of aortic valve ring tissue . A patch was inserted 
in the aortic root and the latter plus the aortic root were 
angled obliquely across the summit of the Bjork-Shiley aortic 
valve prosthesis . The disc of the prosthesis appeared to have 
a limited opening motion as a result of this. A patient with 
an Ionescu-Shiley aortic valve prosthesis , who had both 
coronary ostia partially obstructed by the commissural 
supports of the prosthesis , did not survive the operation . Two 
patients with so-called ' stone heart ' (see chapter 17) showed 
global subendocardial haemorrhagic infarction due to 
inadequate myocardial protection during cardiopulmonary 
bypass . Candida albicans was cultured bacteriologically from 
the infected prosthesis of the one patient with infective 
endocarditis . 
GROUP 2 
Myocardial failure was the commonest cause of death in 
these patients . Staphylococcus albus was cultured from the 
blood of both of the patients with infected prostheses in this 
group of patients . The patient with the thrombosed U. C.T . 
mitral valve prosthesis also had had a U.C.T . tricuspid 
prosthesis replaced surgically 2 months before because of 
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thrombosis . The fatal thromboembolism observed in 2 patients 
involved the heart and brain respectively . The patient who 
suffered operative cerebral air embolism lived on a respirator 
for 34 days with evidence of brain death before it was decided 
to switch off the machine . Partial prosthetic dehiscence was 
observed in relation to 2 Starr-Edwards mitral valve 
prostheses in the absence of signs of infection . 
These data on patients with more than one type of 
implanted cardiac prosthetic valve in their heart are included 
here for completeness sake . Most articles dealing with 
prosthetic heart valves focus on one type of valve substitute 
only . Because of the application of a similar policy with 
respect to the computer programme used to maintain statistics 
on patients with valvular prostheses at Groote Schuur 
Hospital , no data are available on the yearly survival results 
or embolism events in this category of patient. 
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CHAPTER 15 . 
PATHOLOGY OF CARDIAC VALVULAR PROSTHESES SITUATED WITHIN TUBE 
GRAFTS 
Nine patients were encountered who had a variety of heart 
valve substitutes secured within tube conduit grafts made of 
woven Dacron. The clinicopathological information on these 
patients is summarized in Table 15.1. Seven patients were 
whites and there was 1 coloured and 1 black patient . This 
autopsy group included no late survivors . 
TABLE 15 . 1 AUTOPSIED PATIENTS WITH VALVED CONDUIT TUBE 
GRAFTS 
PATIENT AGE , SEX PRE-OP . 
LESION 
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C. A. STITCH 
BLEEDING 
P . HYPT . 
Ao=aortic , ANEU=aneurysm,COARCTN=coarctation , M=male , 
F=female,TGA=transposition of the great arteries , 
P=pulmonary,HYPT=hypertension , DORV=double outlet right 
ventricle , CA=right coronary artery,C- E=Carpentier-
Edwards,B-S=Bjork-Shiley , LILL=Lillehei , S-E=Starr-Edwards . 
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It will be observed from Table 15.1 , that 3 patients were 
aged 7 years or less and six out of the 9 patients had their 
operations because of congenital heart disease . The 3 patients 
with acquired heart disease all had aortic aneurysms . This 
took the form of a dissecting aneurysm in patient 1 and 
saccular aneurysms of the ascending aorta in patients 3 and 8' 
both of whom had aortic medionecrosis . The tube graft linked 
the right ventricle to the main pulmonary artery in 4 
patients , the right ventricle to the right pulmonary artery in 
1, and the aortic root to the more distal aorta in 4 
patients. 
COMMENT 
The 2 patients who died because of severe pulmonary 
hypertension , should in retrospect rather have undergone 
pre-operative lung biopsy prior to attempts at corrective 
surgery . Both deaths were attributable to errors in 
pre-operative diagnosis . 
truncus arteriosus , did not 
Patient 2 ' who had a persistent 
survive the 
revealed grade 6 pulmonary arterial 







pulmonary arteries. Patient 9 had advanced grade 3 pulmonary 
arterial lesions with severe luminal narrowing . 
Both patients who died of bleeding suffered loss of blood 
from the proximal anastomosis of the tube graft to the aorta . 
Whilst erroneous operative technique cannot be altogether 
excluded , the main problem in these 2 patients was probably 
the delicate , friable nature of the medionecrotic aortic 
tissue . The cause of death was unknown in 2 patients . In 
patient 5 the tube graft and Bjork - Shiley prosthesis underwent 
thrombosis resulting in severe luminal narrowing and severe 
limitation of movement of the disc of the valve prosthesis . 
Two patients died due to errors in operative technique . 
In patient 6 the Gortex patch used to seal the ventricular 
septal defect became partially detached as a result of several 
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sutures tearing free from the septal myocardium . In patient 7 
surgery was made difficult by the numerous fibrous adhesions 
which had developed following a Brock procedure a few years 
before . One of the sutures securing the tube graft to the 
right ventriculotomy wound passed through the right coronary 
artery and severely narrowed its lumen . 
Fiore et al . (2) compared valved and non-valved right 
ventricular-pulmonary arterial extra-cardiac conduits in a 
canine experimental model. They showed that after one year , 
the thickness of the neo-intimal lining was threefold greater 
in the valved conduits . Duran et al . (3) implanted homologous 
and heterologous aortic valves in prosthetic vascular tubes in 
experimental animals . Semb et al.(4) reported good clinical 
results with the use of valved xenograft conduits to correct 
tricuspid atresia. Nath et al . (S) discuss the radiological 
evaluation of composite aortic grafts used to treat aneurysm 
of the ascending aorta with aortic regurgitation caused by 
cystic medionecrosis . They found haemorrhage from the 
anastomotic sites to be the most important complication . (This 
complication was observed in 2 out of my 9 patients with 
external conduits and was the cause of death in 2 of the 3 
patients who received conduits for acquired aortic 
aneurysms) . 
There are several clinical reports of intra-conduit 
obstruction due to pannus formation(6-8). Infection has also 
been a problem(9 , 10) in some cases , and so too has coronary 
artery compression produced by the conduit(ll , 12) . Proper 
conduit placement and intra - operative recognition of possible 
coronary artery compression by the conduit are important in 
preventing significant ischaemic problems . Such fatal coronary 
compression is a rare complication and was only encountered in 
0 . 35% of the 860 conduit operations performed at the Mayo 
Clinic(l2). Porcine xenograft valves in conduits implanted in 
children have experienced the same problem with 
calcification(l3 , 14) that was noted in valves implanted 
orthotopically in children . Geha et al . (13) reported a 12% 
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failure rate of extra-cardiac conduits, whilst Bisset et 
al.(15) encountered a 30% incidence of xenograft conduit 
failure over a shorter follow-up period. The latter authors 
concluded that, although valved external conduits continue to 
play an important role in the treatment of complex congenital 
heart disease , a valved conduit with greater longevity is 
needed for use in children . 
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CHAPTER 16 . 
EXPERIMENTAL EVALUATION OF THE MITROFLOW BOVINE PERICARDIAL 
HEART VALVE BIOPROSTHESIS 
INTRODUCTION 
The Mitroflow pericardial heart valve (Mitral Medical 
International , Inc . ) was conceived at a time when major 
problems of calcification were beginning to occur with porcine 
valves that had been implanted for 5 to 10 years. At that time 
the Ionescu-Shiley pericardial valve had demonstrated clinical 
success for an extended period(l) . The Mitroflow bovine 
pericardial heart valve has undergone a series of animal 
tests . Attempts to develop a calf model were unsuccessful , but 
tests in dogs and baboons have been completed . The latter work 
has not yet been published . The canine animal model was tested 
at the University of California, Davis , California , U . S . A. as 
well as at St Luke ' s Hospital, Cleveland , Ohio , U . S . A. The 
primate model using the Chacma baboon was evaluated at the 
University of Cape Town , Cape Town, South Africa . These in 
vivo tests culminated in the first Mitroflow human implant in 
Spain on 23rd March, 1982. Each of the manufactured 
bioprostheses is subjected to pulsatile function testing prior 
to being marketed for clinical use . 
STRUCTURE OF THE MITROFLOW VALVE(l) 
STENT 
The stent is constructed of Delrin 500 , an acetal 
homopolymer with " low creep " properties(2). Delrin , which is a 
registered trademark of E . I . du Pont de Nemours & Co . (Inc . ) , 
is a highly crystalline polymer whose crystallinity is derived 
from the high degree of symmetry in the polymer chain . The 
crystallinity of Delrin is about 80% whereas polypropylene , 
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the other material used for some competitive stents , is of the 
order of 60-65% . Delrin has not only a higher and more 
predictable crystallinity than polypropylene, but it also has 
a narrower range of crystallite sizes(l) . According to Mitral 
Medical International Inc . of Wheat Ridge , Colorado , who 
manufacture the valve , Delrin has a molecular structure with 
adequate flex and shock absorbance . Consequently , it is 
claimed that the stent design has the lowest profile 
consistent with natural leaflet action , generous leaflet 
coaption, no prolapse and maximum movement of the leaflets . 
The stent is designed to have the maximum working orifice 
while having adequate structural strength at the top of the 
commissural posts. The shape of the scallop on the stent 
provides smooth action of the whole leaflet , which aims to 
produce optimal washing of the leaflet surfaces , combined with 
minimal abrasion . 
SEWING RING 
The sewing ring is moulded from Dow Corning medical grade 
silicone . Recently all the sewing rings of this prosthesis 
have been made to be radiopaque by loading the silicone with 
40% tungsten powder. This colours the ring black, but leaves 
it sufficiently soft to allow the ring to adapt to the cardiac 
valve annulus. 
STENT AND SEWING RING COVER 
Medical grade Dacron fabric , manufactured by E . I. du Pont 
de Nemours & Co . (Inc . ) , covers the stent and sewing ring in 
such a manner so that there is a single seam and no exposed 
knots in order to minimize microturbulence on the valve 
surface and lower the chance of thrombus formation . The stent 





The valve leaflets are constructed from a single piece of 
bovine pericardium. Tissue thickness is calculated 
corresponding to each valve size and the larger size valves 
have a thicker tissue. A major design feature of the Mitroflow 
valve is that the tissue is mounted on the external surface of 
the covered stent . There are no sutures at the top of the 
commissure posts to reduce leaflet movement and the leaflets 
are able to open to essentially a full cylinder . (The bovine 
pericardium of the other commercially available bioprosthesis 
is situated inside the stent and opens as a truncated cone . 
This gives rise to more eddies and vortices distally) . The 
bovine pericardium is mounted so that its inner surface (i . e ., 
the side adjacent to the heart) forms the outflow surface of 
the valve to minimize the possibility of thrombus formation . 
This is done because during production the adipose tissue is 
dissected off the parietal side of the pericardium , resulting 
in exposure of the cut ends of the collagen fibres . 
The valve is designed to have a small triangular hole at 
the central point of coaption which closes completely with 2- 3 
mm Hg of back pressure . This feature ensures synchronous 
leaflet action . When the valve is packaged in aqueous 
formaldehyde or saline , this hole may appear as a gap or as 
multiple gaps between the leaflets , because of the effect of 
the surface tension of the liquid(l). Tests have shown that 
total regurgitation (backflow) is insignificant(3) . The 
manufacturers claim that the ' perfect ' leaflet action of the 
Mitroflow valve will significantly reduce the thrombus 
formation on the leaflets which leads to tissue overgrowth . 
The latter immobilises the leaflets and may favour 
calcification(l). Unlike the Ionescu - Shiley prosthesis , there 
are no sutures tethering the leaflets at the commissures. 
Careful operative technique is recommended for use of the 
Mitroflow valve. This includes rinsing of the prosthesis prior 
to implantation to prevent the aldehydes producing tissue 
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necrosis and para-valvular leaks. The prosthesis should also 
be washed frequently during the operation to protect the 
bioprosthetic tissue. 
EXPERIMENTAL IMPLANTATION OF THE MITROFLOW PERICARDIAL 
VALVE(l). 
The in vivo testing of the Mitroflow pericardial valve 
was conducted at three study centres in two different animal 
models : 
(i) Animal Model : Canine (dogs). 
The valvular replacements in dogs were carried out at 2 
study centres involving two distinct surgical techniques under 
sterile conditions (a) Using 
Luke's Hospital, Cleveland). 
without cardiopulmonary 
California-Davis). 
cardiopulmonary bypass (St 
(b) Under profound hypothermia 
bypass (University of 
The number and duration of valvular implants is given in 
Table 16.1. 
Table 16.1 NUMBER AND DURATION OF VALVULAR IMPLANTS IN 
DOGS AT 2 STUDY CENTRES 
CENTRE POSITION No. OF IMPLANTS & DURATION 
(RANGE) DAYS 
MITROFLOW CONTROLS 
St Luke's Hospital, 
Ohio MITRAL 26(1-168) 5(1-35) 
Univ.California TRICUSPID 9(27-69) 3(24-64) 
Totals 35 8 
(Reproduced from Monograph on Mitroflow Pericardial Heart 
Valve, reference 1 of this chapter). 
344 
MITROFLOW VALVES 
The overall evaluation of valves implanted in the 
tricuspid position using profound hypothermia (University of 
California) suggested that the Mitroflow valves exhibit 
comparable morphology and histological characteristics to 
those of control valves(l). According to Mitral Medical Inc ., 
the St Luke ' s Hospital study showed that the gross appearance 
of the Mitroflow and the control valves were essentially 
equivalent for comparable implant duration , but in some cases 
the Mitroflow valves were free of thrombus and had a better 
appearance than the control valves (Ionescu-Shiley 
prostheses) . Both test and control valves showed similar 
changes in regard to leaflet integrity and extent of thrombus 
formation . 
(ii) Animal Model Primate (baboons) 
Baboons were chosen as the second animal model since 
their cardiovascular and physiological systems are almost 
identical to those of humans. Valvular implants were carried 
out at the University of Cape Town , South Africa under the 
direction of Professor C . N. Barnard and the hearts and lungs of 
the sacrificed baboons were submitted to the present author 
for pathological examination . 
Thirty-five Mitroflow valves and 4 control Ionescu-Shiley 
bioprostheses were implanted . The prostheses were divided into 
the following groups : 
(i) Seven pericardial bioprostheses had been treated and 
manufactured by " the original pilot process ", the details of 
which are known only to Mitral Medical Inc . All were implanted 
in the mitral position . 
(ii) Twelve Mitroflow pericardial valvular prostheses 
which had been treated and manufactured by " process G" , which 
is based on a simple glutaraldehyde fixation with no attempt 
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to enhance the pericardial tissue for anticalcific or 
antithrombogenic characteristics. All of these 
valves were implanted in the mitral position. Details 
Mitroflow 
of the 
"G" process are given in the Methods section. 
(iii) Sixteen baboons received Mitroflow valves treated 
by "process F", which relies 
glutaraldehyde cross-linking of 
epsilon-amino groups of lysine 
on tissue fixation by 
collagen molecules via the 
after biological species 
designed to inhibit calcification have been attached through 
pendant carboxyl groups of aspartic and glutamic acid 
residues. 
(iv) Nine valves comprised the "pre-human" series of 
Mitroflow valves which consisted of the latest model of this 
valve that had been developed prior to clinical trials in 
human patients. No details are available regarding its method 
of preparation. One of these valves was implanted in the 
tricuspid position and the remainder were placed in the mitral 
position. 
(v) Four commercially available Ionescu-Shiley 
pericardial heart valves 
controls. It should be 
Rl700.00 each. Three were 
were implanted in baboons as 
noted that these valves cost about 
placed in the mitral position and 
one in the tricuspid position. 
Kindly see the Methods section further data regarding the 




Table 16 . 2 lists the mean gradients across the Mitroflow 
valves at surgery immediately after implantation . 
TABLE 16 . 2 : GRADIENTS ACROSS MITROFLOW VALVES AND 
CONTROLS AT SURGERY IMMEDIATELY AFTER IMPLANTATION 
(mm Hg + /-S . D . ) 
MITROFLOW VALVES 
PILOT SERIES 
II G II PROCESS 




5.62 + /- 2 . 31 
6 . 09 +/- 1. 39 
5 . 20 +/- 2 . 48 
5 . 08 +/- 1. 95 
5 . 33 + /- 0 . 15 
(i) MITROFLOW VALVES PREPARED BY THE " ORIGINAL PILOT PROCESS " 
The mean post-operative survival of the 7 baboons which 
were sacrificed at various periods following implantation of 
Mitroflow prosthetic valves was 81 days (S.D . = 68) with a 
range of from 5 to 192 days . One animal died suddenly and 
unexpectedly of unknown cause 1 day post-operatively. Autopsy 
revealed evidence of recent myocardial necrosis , the cause of 
which is uncertain. Pre-sacrificial cardiac catheterization of 
this group of primates with implanted valves revealed a mean 
percentage valve orifice reduction of the Mitroflow prostheses 
of 53 . 0% (S.D.= 11 . 5%) with a range of from 29 - 65% . It will be 
observed from Table 16.3 that 6 out of the 7 prostheses had 
some thrombus on the surface , and usually this was on the 
inflow surface of the cusps (Figs . 16 . 1 and 16.2) . Some degree 
of host tissue overgrowth of the proximal portions of the 
cusps of the prosthesis was present in just over half of the 
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prostheses and a marked host immune assault with erosion of 
cuspidal substance was observed in only one of these valves . 
Only one prosthesis in this group showed attachment to the 
ventricular endomyocardium . 
(ii) MITROFLOW VALVES PREPARED BY " PROCESS G" 
The 12 baboons which received implants of the Mitroflow 
pericardia! valves treated by " process G" were sacrificed 
between 100 and 380 days post-operatively , with a mean 
survival of 247 days (S . D . = 98.8) . Pre-sacrificial cardiac 
catheterization revealed a mean percentage prosthetic valvular 
orifice reduction of 63.1% (S.D .= 11.5%) and a range of 
46-73% . Ten out of the 12 valves showed thrombus deposition on 
the inflow surface of the cusps just proximal to the contact 
area (Figs . 16 . 1 and 16 . 2). Host tissue overgrowth of the 
cusps was seen in 11 of the 12 valves , and it was 
instances . One valve was attached to 
severe in 9 
the host ' s 
endomyocardium . Another valve showed minimal cuspidal 
calcification which was quantitated at 5 . 5 , 0 . 7 and 3 . 3 µg/mg 
per cusp respectively . 
(iii) MITROFLOW VALVES PREPARED BY " PROCESS F " 
The seven baboons which received implants of Mitroflow 
valves prepared by " process F" were sacrificed between 99 and 
289 days post-operatively . Two baboons died suddenly and 
unexpectedly of unknown cause on days 2 and 5 
post-operatively . The mean post-implantation period for the 
valves was 167 . 7 days (S . D . = 128 . 3). Pre-sacrificial cardiac 
catheterization (N =4) revealed a mean percentage prosthetic 
valvular orifice reduction of 38 . 0% (S.D . = 18 . 8%) with a range 
of 18-54% . Six of the 7 valves showed scanty or moderate 
thrombotic deposits on the inflow aspects of the cusps and a 
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severe host tissue overgrowth resulting in erosion of the 
and 
the 
original cuspidal collagen 




2 patients. None of 
valves were attached to endocardium . One valve showed scanty , 
spotty cuspidal calcification and one of its cusps contained 
5 . 5 µg calcium per mg (the other 2 cusps contained only 0 . 1 














































































































































































































































































































































































































































































































































































































(iv) " PRE-HUMAN " SERIES OF MITROFLOW VALVES 
There were 9 valves in this group ; 8 were implanted in 
the mitral position and one in the tricuspid position . The 
mean post-operative implantation period prior to sacrifice was 
120 days (S . D . = 78) and the range was 28-220 days . The mean 
percentage valve area reduction was 39.8% (S . D. = 23.9%) , with 
a range of 8-57%. Only two valves showed no thrombus on the 
inflow aspect (see Table 16 . 3) . Two out of the 9 valves were 
rendered adherent to the left ventricular endomyocardium by 
organized thrombus. Two valves showed a significant host 
tissue overgrowth on the valve cusps . 
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Figure 16 . 1 : Left atrial view of a Mitroflow valve implanted 
in the mitral annulus of a baboon 6 . 5 months prior to 
sacrifice . Abundant thrombus on the inflow aspect of the cusps 
gives a characteristic tri-radiate ("Mercedes - Benz sign " ) 
pattern of thrombus deposition . Such a pattern was commonly 
seen on Mitroflow valves bearing thrombi. 
Figure 16.2 Histological appearance of thrombus on convex 
(inflow) surface of Mitroflow valvular cusp . The acellular 
thrombus shows no evidence of organization . (Elastic van 
Gieson, X 150) . 
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Figure 16 . 3 Extensive host tissue overgrowth onto the 
Mitroflow valvular cusps has led to cuspidal thickening and 
shortening . The latter is most apparent in the cusp with 
thrombus on its orificial aspect . 
Figure 16 . 4 Host tissue (myofibroblasts and collage n ) has 
grown over both aspects of this Mitroflow valve , which had 
been implanted for 4 7 days . (Elastic van Gieson , X 150). 
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TRANSMISSION ELECTRON MICROSCOPY 
Table 16.4 indicates the ultrastructural appearance of 
the state of preservation of the collagen fibres in the 5 
Mitroflow valves and the one Ionescu-Shiley control valve 
examined by electron microscopy. The control valve (Fig. 16.5) 
and the Mitroflow valves all showed good preservation of their 
collagen fibres. However, one "pilot study" valve (Fig.12.6) 
showed loss of periodicity in many of its collagen fibres. 
TABLE 16.4 : ULTRASTRUCTURAL ASSESSMENT OF COLLAGEN FIBRE 
PRESERVATION OF BOVINE PERICARDIAL BIOPROSTHESES IMPLANTED 
IN BABOONS 
GROUP VALVE PERIOD STATE OF 
INSERTED (DAYS) COLLAGEN PRESERVATION 
MITROFLOW 
PILOT 1010 71 LOST PERIODICITY 
PILOT 1417 44 GOOD 
F PROCESS 1017 240 GOOD 
PRE-HUMAN 1052 41 GOOD 
PRE-HUMAN 1109 28 GOOD 
CONTROL 
IONESCU-
SHILEY 4427 31 GOOD 
Figure 16 . 5 
to a control 
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Ultrastructural appearance of a cusp belonging 
Ionescu-Shiley bioprosthesis 31 days after 
implantation. Collagen fibres still show a regular 
periodicity . (Uranyl acetate and lead citrate , X 75000) . 
Figure 16 . 6 : Ultrastructural appearance of a cusp belonging 
to a Mitroflow valve ( " pilot study ", valve 1010) 71 days 
post-implantation. The collagen fibres appear less well 
preserved than in the control valve and many have lost their 
periodicity . (Uranyl acetate and lead citrate , X 75000) . 
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SCANNING ELECTRON MICROSCOPY 
Scanning electron microscopy was performed upon 3 
Mitroflow valves which had been implanted for 6 , 36 and 122 
days . These valves came from the " original pilot" series , the 
"F process " group and the " pre-human " series respectively . The 
contact surface of all three valves showed minimal fibrin and 
platelet deposition in the areas examined. The surface of the 
cusps consisted of bare collagen fibre bundles without any 
mesothelial cell covering . The scanty cells present on the 
surface of the cusps (see Frontispiece) included erythrocytes , 
histiocytes and lymphocytes . 
CALCIFICATION ANALYSIS 
Quantitative analysis (method unknown) of the amount of 
calcium within xenograft cusps was performed by Mitral Medical 
Inc . and the results were made available to me (please see 
Table 16 . 5). 
TABLE 16 . 5 : CALCIFICATION ANALYSIS OF MITROFLOW 
AND CONTROL VALVES(+/- S . D . ) 
DURATION (DAYS) µg/mg 
PRE - HUMAN VALVES(N=5) 96 +/- 82 . 2 0 . 81 +/-
" F PROCESS " VALVES(N =7) 209 +/- 107 . 9 0 . 93 + /-
" G PROCESS " VALVES(N=l2) 277 +/- 101 . 1 1. 30 + /-
IONESCU-SHILEY VALVES(N=4) 106 +/- 65.6 2 . 50 +/ -
COMBINED MITROFLOW BIOPROSTHESES 
0 . 70 
1. 5 
1. 6 
0 . 7 
All 35 Mitroflow xenograft valves combined gave a mean 
percentage reduction of valve orifice area of 47 . 6% (S . D. = 
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20 . 8) , which differed significantly from the 4 control valves 
(p less than 0 . 01) . The Mitroflow valves had a mean 
pre-sacrificial trans - valvular gradient of 11 . 3 mm Hg (S.D . = 
6 . 6) ; this did not differ significantly from the controls . 
(v)IONESCU - SHILEY PERICARDIAL VALVES USED AS CONTROLS 
The 4 Ionescu-Shiley valves were implanted in the 4 host 
baboons for a mean period of 128 days (S . D . = 71) , with a range 
of 31 - 181 days. Three of the valves were placed in the mitral 
position and one in the tricuspid position . One valve had 
abundant fibrin thromb u s on the convex surface of the cusps , 
especially at the contact zone and the remaining 3 valves 
showed only scanty thrombus with a similar distribution . An 
erosive host tissue overgrowth was noted in only one of the 
bioprostheses . Two of the valves showed attachment to the 
host ' s endomyocardium . Pre-sacrificial cardiac catheterization 
data in this group showed a mean percentage valve orifice 
reduction of 21 . 3% (S . D.= 12 . 6%) with a range of 8-33% . 
COMMENT 
The present study shows that the Mitroflow valves give 
poorer results in the baboon than those purported in the 
dog(l) . The 4 Ionescu-Shiley xenograft valves (an admittedly 
small control group) gave better results than did the various 
groups of Mitroflow valves either singly or in combination 
(Table 16 . 3). It will be observed that the various categories 
of Mitroflow valves gave an improved performance with each new 
process of preparation that was introduced . The only exception 
to this trend is provided by the second group (prepared by " 
process G" ) and this is probably due to the fact that this 







groups. This allowed more time for the progression 
valve-related 
organization of thrombus 
latest ("pre-human") model 
complications as thrombosis, 
and host tissue overgrowth. The 
of the Mitroflow valve tested 
showed no significant differences from the control valves with 
respect to percentage reduction in valve orifice area or in 
trans-valvular gradient immediately prior to sacrifice. 
However,it should be noted that the Ionescu-Shiley valves used 
were all size 19 mm diameter, whereas the Mitroflow valves 
were all size 21 mmm in diameter. The control valves were thus 
more stenotic ab initio. 
With regard to percentage valve orifice area reduction, 
significant differences were found when the following groups 
of animals were compared (Table 16.3) pilot study valves 
versus Ionescu-Shiley control valves "G" process valves 
versus "F" process, pre-human and control valves. Groups of 
baboons showing significant differences with regard to valve 
gradients were as follows pilot study versus "F" process, 
pre-human and control groups "G process" versus "F process", 
"pre-human" and controls. 
Fifteen out of the 35 Mitroflow valves (43%) had moderate 
or abundant non-infected thrombotic deposits on the 
prosthesis. This bulky thrombus appeared to play a role in the 
reduction of prosthetic valve orificial area and the 
development of increased trans-prosthetic gradients. The 
thrombus was virtually always confined to the inflow aspect of 
the xenograft cusps and was situated at and immediately 
proximal to the contact zones of the cusps. The thrombus 
usually involved all 3 cusps equally and presented a 
characteristic tri-radiate pattern ("Mercedes-Benz sign") when 
the prosthesis was viewed on the inflow aspect. Host tissue 
overgrowth appeared to be the second important mechanism 
leading to increased trans-valvular gradients. 
Another factor which may influence the results of valve 
replacement is the experience of the operating surgeon. In the 
"pre-human" series of Mitroflow valves several of the valves 
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were implanted by a less experienced surgeon than was the case 
with the other valves . This resulted in a number of 
technical-related problems e . g ., poor positioning of the 
prosthesis in the mitral valve ring (2 cases) , and snaring of 
a suture over a stent post with deformation of the 
juxta-commissural portions of the 2 attached cusps . 
The scanty calcification observed in 2 of the Mitroflow 
valves may serve to indicate that this prosthesis shares the 
tendency for cuspidal calcification of other 
glutaraldehyde-treated xenograft valves(3-S) . 
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MISCELLANEOUS ASPECTS OF THE PATHOLOGY OF HEART VALVE 
REPLACEMENT 
A. PATHOLOGY OF THE ATRIO-VENTRICULAR· SYSTEM OF HIS-TAWARA IN 
PROSTHETIC HEART VALVE REPLACEMENT 
This study of the His-Tawara system was undertaken in an 
attempt to find a pathological cause for the unexplained 
sudden deaths which occur following heart valve replacement . 
In many such patients no cause is found , even at autopsy . Such 
deaths are commonly attributed to arrhythmia. 
An haematoma in the inter-atrial septum is a not 
infrequent finding in hearts with recently inserted mitral 
valve prostheses. In some instances the haematoma (Fig . 17 . 1) 
may reach a diameter of several centimetres and even extend 
downwards to the vicinity of the atria-ventricular node 
(A . V.N.) and bundle of His . The bundle(l) is also at risk 
during valve replacement , as it penetrates the central fibrous 
body,which unites the contiguous fibrous rings of the 
tricuspid, mitral and aortic valves(2,3) . In the light of 
this, it was decided to examine the vulnerable proximal 
portion of the His-Tawara system of a series of 36 patients 
who died following heart valve replacement to see if any 
lesion could be found to explain their demise . Twenty-seven of 
these 36 patients have been previously reported(4). The 
methods used in this study are described in the Methodology 
section. A further series of 14 control hearts from routine 
autopsies was examined in an identical manner. 
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Figure 17 . 1 : Darkly-stained inter-atrial septal haematoma has 
extended downwards to reach the upper portion of the 
atria-ventricular node . (Haematoxylin-eosin , X 60) . 
RESULTS 
The main clinical and pathological findings in the 36 
patients who came to autopsy following heart valve 
replacement , are summarized in Tables 17 . 1 , 17.2 and 17 . 3 . The 
patients who died after valve replacement and whose conduction 
system was studied, ranged in age from 9 to 66 years , with a 
mean age of 41 years (S.D. = 16 . 9) . The patients in group A 
(Table 17 . 1) all died less than 14 days post-operatively. 
Conduction system haemorrhage was observed in 12 out of these 
22 patients , mainly within the bundle of His . In 11 out of the 
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12 patients the blood tracked along the connective tissue 
within and around the conducting tissue in a manner similar to 
that described by Hudson(2) . The earliest death in the group B 
patients (Table 17 . 2) occurred 14 days after valve replacement 
and the latest at 8 years . None of the group B patients showed 
evidence of recent conduction system haemorrhage. However , the 
haemosiderin deposits within the bundle branches of patients 
23 and 24 probably indicates previous haemorrhage . 
Haemosiderin was also observed within the His bundle of 
patient 27 , but this appeared to be related to trauma by a 
surgical suture, which passed through the A. V. N. In most of 
the patients in group B the cause of death was readily 
apparent at autopsy , apart from 3 patients (numbers 2 7, 29 and 
34) in whom the cause of death was unknown . In group A the 
cause of death was unknown in 11 out of the 22 patients . 
Haemorrhage into the conducting tissue was present in only 6 
out of these 11 patients for whom no cause of death had been 
found at autopsy . 
There was no sign of conduction tissue haemorrhage , past 
or present , in the 14 control hearts. The conducting tissue 
haemorrhage noted in gro u p A patients , appeared separate in 
most instances from the larger and more obtrusive haemorrhage 
frequently observed in the inter - atrial septum following 
mitral valve replacement . In most hearts the conduction system 
haemorrhage was limited in extent , whereas in others it was 
more extensive and appeared to disrupt the conducting tissues . 
In some of these latter cases the haemorrhage was visible to 
the naked eye . Haemorrhages were noted within the His bundle 
in 9 out of the 22 group A patients and in the A. V. N . in 5 of 
the same 22 patients . Four patients had haemorrhages within 
the left bundle branch and 6 had right bundle branch 
haemorrhages . In only 2 of the group A patients did the 
ventricular myocardial histology show any signs of acute 
myocardial damage, which might have led to death due to 
dysrhythmia. Overall , twelve out of the 22 group A patients 















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































It is significant that recent haemorrhage within the 
conduction system was only found in patients who died less 
than 2 weeks after heart valve replacement (Tables 17 . 1 and 
17 . 2) . Such haemorrhage is likely to be related to the 
operation. Although one is dealing with a small number of 
patients , there appears to be no significant difference in the 
incidence of conduction tissue haemorrhage when one compares 
the mitral and aortic prostheses. 
The central fibrous body and membranous septum constitute 
a continuous structure and are formed by the contiguous 
tricuspid , mitral and aortic valve rings(2) . The bundle of His 
penetrates the central fibrous body , and is thus at risk in 
operations on these valves . The bundle is said to be at 
greatest risk during aortic valve replacement(2) . Haemorrhage 
into the conducting tissues may come about either as a result 
of direct surgical trauma , or as a result of anoxia . In 
patient 27, a suture passed through the centre of the 
conduction tissue in the region where the A. V . N. becomes the 
bundle of , His . One can only speculate as to whether the 
haemosiderin and suture material within the conducting tissue 
may have caused electrical instability , leading to fatal 
arrhythmia . In patient 9 , a suture was observed to divide the 
left bundle branch and to run close to the bundle of His, 
which showed haemorrhage . 
Anoxia seems the likeliest cause of the conduction system 
haemorrhages noted in the other 11 patients in group A. Thung 
et al.(6) state that the conduction tissue is the most heavily 
vascularized portion of the heart, and hypoxia produces 
capillary wall changes , thereby increasing capillary 
permeability . Thus , hypoxia may be expected to produce 
selective haemorrhage into this area. An analysis of the 
clinical course of their patients , indicated that in each 
patient with haemorrhage not related to direct injury , a 
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significant period of hypoxia was a common denominator . They 
furnished experimental data to implicate hypoxia as a cause of 
haemorrhage into the cardiac conduction system , and emphasized 
the importance of adequate oxygenation in the post-thoracotomy 
patient . They also postulated that deposits of haemosiderin 
may remain within the conduction system , elicit scarring and 
produce arrhythmia . 
My three patients (numbers 23 , 24 and 27) of group B who 
had haemosiderin deposits (without fibrosis) within their 
conduction tissues had survived 2 weeks, 6 weeks and 6 months 
respectively . Patients 23 and 24 died of infective 
endocarditis . Patient 27 showed no cause of death at autopsy 
and the only significant finding was a suture passing through 
the A. V . N. 
Niles and Sandilands(7), found haemorrhage in the 
atrio-ventricular conduction system in 18 out of 26 early 
deaths after valve replacement with a Starr-Edwards 
prosthesis . Such haemorrhage was also present in 6 out of 
their 36 late deaths . Most of their 24 cases of conduction 
tissue haemorrhage had shown an inadequate post-operative 
cardiac output, and they regarded the haemorrhages as a 
possible cause of fatal post-operative heart failure . My 
findings confirm their impression that haemorrhage commonly 
occurs in the atrio-ventricular conduction tissue after valve 
replacement. 
It is possible that a more detailed (serial section) 
examination of the conduction system in my 50 patients might 
have revealed other pathological changes, including further 
instances of haemorrhage . A preliminary investigation of the 
His-Tawara system in several patients who died after cardiac 
surgery for lesions not necessitating valve replacement (e . g. , 
saphenous vein grafting of coronary arteries), but involving 
similar periods of time on cardio-pulmonary bypass, also 
showed instances of haemorrhage into the His-Tawara system . 
This may indicate that the relative hypoxia of the bypass 
procedure is of greater significance than direct surgical 
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trauma in the aetiology of such haemorrhage . A recent 
monograph for cardiac surgeons describes the anatomy of the 
conduction system in a variety of cardiac abnormalities(8) . 
It is apparent that haemorrhage into the conduction 
tissue is a not uncommon finding in patients dying 12 days or 
less after heart valve replacement, and hypoxia is the likely 
cause . Such haemorrhage cannot be blamed for causing sudden , 
unxpected death in the early post-operative period , since it 
was only present in about half of such sudden death patients. 
According to Froysaker et al.(9) the clinical manifestation of 
haemorrhage in the atria-ventricular conduction system is left 
bundle branch block followed by A-V block and ventricular 
arrhythmia in the early post-operative period . 
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B . RENAL HAEMOSIDEROSIS IN PATIENTS WITH PROSTHETIC HEART 
VALVES 
Haemolytic anaemia associated with an intra-cardiac 
prosthetic valve was reported for the first time by Rose et 
al.(l) in 1954 . This complication was confirmed experimentally 
in dogs by Stahlman et al . (2) in 1956. While many subsequent 
reports dealing with the clinical and haematological aspects 
of haemolysis associated with intra-cardiac valve prostheses 
have been published(3-22) , few refer to concomitant renal 
haemosiderosis(23 - 25). Renal siderosis is the anatomical 
indicator of intra-vascular haemolysis(23) . When an excessive 
amount of iron is liberated into the blood by intra-vascular 
haemolysis, it is deposited exclusively in the kidneys and 
none is evident in the liver or spleen . In the rare instance 
where the anaemia becomes severe and requires repeated blood 
transfusions, haemosiderosis may be observed in many 
organs(26). Needle biopsy of the kidney has been used to 
diagnose renal siderosis in the haemolytic anaemias(27) . 
Haemolytic anaemia on a mechanical basis has been a 
problem , particularly in patients with cloth-covered 
non-tissue, cardiac valve prostheses(26) . Haemolysis is 
believed to result from two major factors the 
"hammer-and - anvil " effect resulting from damage to the 
erythrocytes by closing of the occluder upon the metallic ring 
; and the abrasion or friction effect of a jet stream of blood 
against an irregular fabric surface , especially in 
cloth-covered valves. The first of these can be eliminated by 
having the occluder rest on small metallic struts rather than 
on a circular metal ring . The second may be reduced by having 
all parts of the valve except the sewing ring made of smooth 
highly polished material. Studies on patients with native 
valvular heart disease(6 , 28-31), especially aortic 
stenosis(30) and incompetence(32) , has revealed the presence 
of intra-vascular haemolysis . Mechanical 
has also been reported after repair 
haemolytic anaemia 
of ruptured chordae 
370 
SIDEROSIS 
tendineae of the mitral valve apparatus(33) . Haemolysis 
resulted from the whiplash motion of the loose ends of the 
ruptured chordae and the disrupted suture material attached to 
the mitral valve apparatus. Since the incidence of renal 
haemosiderosis in our patients with valve prostheses was 
unknown , I decided 
renal siderosis in 
prostheses, as well 
to examine the incidence and severity of 
autopsied patients with heart valve 
as in a group of patients with severe 
deformities and a routine autopsy rheumatic - type valvular 
control group. The iron content of ' normal' kidneys appears to 
be a neglected topic , and a standard reference on the 
histology and chemistry of tissue iron(34) gives no 
information regarding the iron content of ' normal ' 
kidneys.Deatils of the methods used in this study of 
prosthesis-related renal haemosiderosis are 
Methodology section. 
RESULTS 
PATIENTS WITH IMPLANTED HEART VALVE PROSTHESES 
given in the 
The incidence and severity of renal haemosiderosis in the 
autopsied 105 patients with implanted prosthetic valves is 
given in Tables 17 . 4 and 17.5 . Large (+++) amounts of iron 
(Figs. 17 . 2 and 17.3) were present in the kidneys of 9 out of 
the 105 patients,(8 . 6%) . The haemosiderin granules were 
usually seen within the cells of the proximal convoluted 
tubules (Fig . 17 . 3) , but in in some instances the iron was 
also present in the epithelial cells of the 
distribution is similar to that observed 
Morrow(23). Rarely, iron was seen lying free 
glomeruli . This 
by Roberts and 
within Bowman ' s 
space or in the interstitium . No significant amount of iron 
was seen in the liver or spleen of any of these 105 patients. 
Table 17 . 6 gives details of the 9 patients with abundant 
renal siderosis. The 2 patients with a U . C.T. aortic 
prosthesis both survived one month after operation . One died 
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of cardiac failure and the other had an unidentified fungal 
Figure 17.2 Abundant (+++) renal cortical siderosis in 
patient 1 with multiple UCT prostheses. (Perl's potassium 
ferrocyanide reaction, X 5). 
Figure 17.3 Prominent iron deposits are seen within the 
epithelial cells of the proximal convoluted tubules. (Perl's 
potassium ferrocyanide reaction, X 150). 
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infection of the prosthesis . A third patient had infected 
vegetations on her U . C.T . aortic and mitral prostheses and 
bacteriological culture grew Candida parasilosis. Death was 
due to a cerebral embolus . One patient with a U . C.T . mitral 
prosthesis had a 0 . 2 cm . wide endothelial-lined para - valvular 
defect , which would have caused mild incompetence . Death was 
again due to a cerebral thromboembolus . No thrombi were found 
on the prosthesis or anywhere else within the heart . A fifth 
patient with normal U . C . T . aortic , mitral and tricuspid 
prostheses , died of bilateral lobar pneumonia . Her prothrombin 
index had been very low (less than 10%) and intra-pulmonary 
haemorrhage was also present . Both patients with Starr-Edwards 
mitral prostheses had severe wear of the cloth covering the 
base ring of their prostheses . Extensive areas of both base 
rings showed bare metal where the cloth had been worn away . 
Abundant thrombus covered the bare metal , which was only 
revealed once the thromb u s had been removed . Both patients 
died of thromboembolism . Patient 4 (Table 17 . 6) with abundant 
renal siderosis had a U . C . T aortic and a Starr-Edwards mitral 
valve prosthesis inserted at the same time . Death occurred 150 
days post - operatively due to a fulminating rheumatic 
myocarditis and pneumonitis . 
Haematological data were obtainable retrospectively in 5 
out of the 9 patients with prominent renal siderosis (patients 
numbers 2,3 , 5 , 6 , and 7) . If the normal haematocrit f or males is 
39-45 % and that for females 35-40%, then 3 out of these 5 
patients (Nos . 3,6 , and 7 in Table 17 . 6) were anaemic shortly 
before death . Two of these anaemic patients had normal 
pre-operative haematocrits, while no haematocrit was available 
in the third patient (No . 7) . Patients 3 and 7 had fragmented 
red blood cells in their peripheral smears 2 months 
post-operatively . 
Moderate amounts of renal iron ( ++) were demonstrated in 
17 out of the 105 patients with prostheses . One of these 
patients was a 28-year-old female with a Starr-Edwards mitral 
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prosthesis who died only 2 days after operation . It is 
possible that her renal siderosis antedated the valve 
replacement operation. The other 16 patients had their 
prostheses implanted from 27 to 1440 days . Scanty amounts of 
iron (+) were noted in the kidney sections of 26 patients and 
53 showed no evidence of renal siderosis (Table 17 . 4) . 
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TABLE 17.4 : INCIDENCE AND SEVERITY OF RENAL SIDEROSIS IN 
105 AUTOPSY PATIENTS WITH HEART VALVE PROSTHESES 
RENAL IRON CONTENT 
PROSTHESES NIL SCANTY MODERATE ABUNDANT 
(+) (++) (+++) 
UCT-A 14 7 2 2 
UCT-M 5 9 5 1 
UCT-MULTIPLE 3 1 0 1 
TOTALS 22 17 7 4 
MIXED 8 2 4 3 
S-E-M 4 3 4 2 
S-E-A 0 1 0 0 
TOTALS 4 4 4 2 
LILL-M 3 0 0 0 
LILL-A 4 0 0 0 
TOTALS 7 0 0 0 
B-S-A 2 1 0 0 
HANC-M 3 0 0 0 
C-E-A 1 1 0 0 
C-E-M 2 1 0 0 
TOTALS 3 2 0 0 
SJM-A 2 0 0 0 
SJM-M 1 0 1 0 
SJM-A+M 1 0 1 0 
TOTALS 4 0 2 0 
No. PATIENTS 53 26 17 9 
GRAND TOTAL= 105 






TABLE 17.5 INCIDENCE AND SEVERITY OF RENAL SIDEROSIS IN 105 AUTOPSY PATIENTS WITH PROSTHETIC HEART VALVES 
RENAL IRON CONTENT 
NIL SCANTY MODERATE ABUNDANT 
(+) (++) (+++) 
PROSTHESIS 
UCT (N=50) 22 17 7 4 
MIXED(N=l7) 8 2 4 3 
S-E (N=l4) 4 4 4 2 
LILL (N=7) 7 0 0 0 
B-S (N=3) 2 1 0 0 
HANC (N=3) 3 0 0 0 
C-E (N=5) 3 2 0 0 
SJM (N=6) 4 0 2 0 
TOTALS 53 26 17 9 
GRAND TOTAL =105 
TABLE 17.6 : DATA ON PATIENTS WITH VALVE PROSTHESES AND 
ABUNDANT RENAL HAEMOSIDEROSIS 
PT. AGE(yr), PROSTHESIS POST-OP. 
SEX TYPE SURVIVAL(DAYS) 
1. 41,M UCT-MULTIPLE 27 
2. 20,F UCT-A 30 
3. 48,M UCT-A 30 
4. 14 ,M MIXED 150 
5. 39,F UCT-A+M 180 
6. 22,F UCT-M 330 
7. 43,F UCT-MULTIPLE 720 
8. 24,F S-E-M 795 























M=MALE,F=FEMALE,UCT=UNIVERSITY OF CAPE TOWN,A=AORTIC,M=MITRAL, 
S-E-M=STARR-EDWARDS,P-V=PARA-VALVULAR,C.A.=CORONARY ARTERY, 
CCF=CARDIAC FAILURE,INF=INFARCT,RH F=RHEUMATIC FEVER. 
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TABLE 17 . 7 AUTOPSY INCIDENCE OF RENAL SIDEROSIS 




ROUTINE AUTOPSIES (NORMAL VALVES) 
CONTROL PATIENTS 





Renal haemosiderosis was absent in 31 of the 32 control 
patients who died with advanced rheumatic-type valvular 
deformities (Table 17 . 7). The only control patient showing 
renal siderosis was a 57-year-old white male who had mitral 
stenosis , trivial aortic stenosis and functional tricuspid 
incompetence . Cardiac symptoms had been present for 10 years. 
This same patient had large amounts of iron in his liver and 
spleen too , and as no blood transfusions had been given , this 
suggested that he had a generalized haemosiderosis and that 
the renal siderosis was not due to intra - vascular haemolysis . 
None of the 21 routine adult autopsy cases (Table 17 . 6) showed 
renal siderosis . 
COMMENT 
Significant (i.e . of moderate or severe degree) renal 
haemosiderosis was present in 26 of the 105 autopsy patients 
(25%) with valvular prostheses. The nine patients with +++ 
renal siderosis included 2 patients with severe sewing ring 
cloth wear and one patient with a small para-valvular leak . 
Three patients had thrombi on the prosthesis (infected in 
two). The remaining 2 patients showed no abnormality related 
to the prosthesis . Ten out of the 17 patients with ++ renal 
siderosis showed no abnormality of their prosthetic valves . 
Five others had abundant thrombi on the prostheses (infected 
in one case). One patient had a small para-valvular leak 
alongside a St Jude Medical mitral valve prosthesis . The 
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remaining patient had normal St Jude Medical mitral and aortic 
valve prostheses . During surgery the knife had made a small 
communication between the left ventricle and the right atrium 
(acquired Gerbode defect) . This had been closed during the 
operation by a single suture with a pledget placed on the 
right atrial side. It is doubtful whether the latter event 
played any role in the patient ' s subsequent development of 
renal siderosis . 
Thus , in 12 patients , significant renal haemosiderosis 
was observed in the absence of any abnormality of the 
prosthesis . All 7 of Roberts and Morrow ' s(23) cases with renal 
siderosis had malfunctioning flexible Teflon aortic valves and 
haemolytic anaemia . Niles and Sandilands(24) encountered renal 
siderosis in 4 out of 26 early deaths and in 17 of 36 late 
deaths following heart valve replacement with Starr-Edwards 
prostheses . The latter authors did not indicate the degree of 
the renal haemosiderosis nor did they specify the state of the 
prosthetic valves in such patients . Both groups of authors 
agree that renal haemosiderosis does not impair renal 
function. Crexells et al . (35), however, point out that the 
long-term effects of haemosiderinuria have not yet been 
adequately documented . Others also comment on haemolysis in 
patients with Starr-Edwards prostheses(36 , 37) . Previous 
studies(6,7 , 38) have revealed haemolysis in patients whose 
prosthetic valves have shown no clinical evidence of 
incompetence . Postmortem renal siderosis may show clinically 
unapparent intra-vascular haemolysis . 
Davies(39) states that slight amounts of haemolysis are 
common with all mechanical valves . Mechanical valves appear to 
produce more severe haemolysis than xenograft valves with a 
similar degree of clinical incompetence(40) . Significant 
haemosiderosis (i . e. ++ or +++) was only observed in 
mechanical valves in my study and none of the cases with 
xenograft valyes examined showed such a degree of siderosis. 
Several authors discuss haemolysis associated with xenograft 
replacement of cardiac valves(40-47) . Rao et al . (44) conclude 
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that porcine xenograft valves do not seem to be associated 
with haemolysis unless complicated by a para-valvular leak . 
Intra-vascular haemolysis may be associated with porcine 
mitral valve calcification in children(47) . 
The present autopsy study showed renal haemosiderosis in 
56% of patients with University of Cape Town prostheses, (in 
44% with aortic prostheses and in 75% of those with mitral 
prostheses), 53% of patients with multiple mixed prostheses , 
71% of patients with Starr-Edwards prostheses , 33% of patients 
with Bjork-Shiley prostheses , 67% of patients with St Jude 
Medical prostheses , and 40% of patients with Carpentier-Edwards 
prostheses . None of the small number of patients examined with 
Lillehei-Kaster or Hancock prostheses showed renal 
siderosis . Crexells et al.(35) detected subclinical haemolysis 
in 67% of their 208 patients with valvular prostheses. Rao et 
al.(45) reported that in isolated mitral valve replacement 66% 
of Lillehei-Kaster valves showed associated compensated 
haemolysis compared with 42% in Bjork-Shiley valves , 85% in 
Starr-Edwards valves and none in frame-mounted homografts . 
Only one of the 290 patients with prostheses studied in 
this work had gallstones . The patient was a 67-year-old female 
with a St . Jude Medical aortic valve prosthesis . Surprisingly , 
her kidneys showed no evidence of siderosis . Harrison et 
al . (48) have shown that the prevalence of gallstones in 
patients with heart valve prostheses is significantly greater 
than in patients with mild or severe valvular heart disease 
without valve replacement . Apparently the formation of 
gallstones may result from even mild mechanical haemolysis . 
These authors suggest that valve prosthesis recipients should 
be evaluated carefully for symptoms of gall-bladder disease at 
periodic intervals, especially late after valve replacement . 
They also recommend that gallstones removed from prosthetic 
heart valve patients at surgery or at autopsy be analysed for 
chemical composition , especially to determine the existence of 
higher than average bilirubin content . The present autopsy 
study does not support Harrison et al . ' s contention that 
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cholethiasis is a frequent complication of artificial heart 
valve replacement. 
Initially it was believed that the haemolysis in patients 
with prosthetic heart valves always has a 'mechanical' or 
traumatic basis(2). There is evidence that the erythrocyte 
damage may not result simply from the mechanical trauma of 
poppet action on the red cells, but that haemodynamic 
disturbances, such as turbulent blood flow and shearing stress 
resulting from rapidly changing velocity and pressure, are the 
most important causes of traumatic mechanical damage(6,49,50). 
These factors and the interaction of red blood cells with the 
valve materials and with fibrin deposits around the valve, are 
probably all involved to some degree(Sl). 
The degree of urinary iron loss from continued 
intra-vascular haemolysis may be severe and may even lead to 
chronic iron deficiency and superimposed iron deficiency 
anaemia(36,52). Much less common after valve replacement is 
haemolysis of the auto-immune type, with a positive 
anti-globulin test. The cause of this haemolysis is 
unknown(53,54). 
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C . SUBVALVULAR LEFT VENTRICULAR FALSE ANEURYSM COMPLICATING 
MITRAL VALVE REPLACEMENT . 
Aneurysms of the left ventricle usually are a conseq u ence 
of myocardial infarction(l , 2) and the great majority are true 
aneurysms with myocardial remnants in their wall. Other causes 
of left ventricular aneurysm include trauma and rarities such 
as syphilis , tuberculosis , and mycotic aneurysms . False 
aneurysms may occur after non-fatal rupture of myocardial 
infarction . Idiopathic aneurysms in the submitral , subaortic 
or apical regions of the left ventricle have been reported , 
predominantly from Africa(3 - 5) . It has been suggested that the 
idiopathic aneurysms may develop because of defects in the 
attachment of the left ventricular myocardium or aorta to the 
fibrous mitral and aortic annuli . 
Valve replacement surgery may cause a similar loss of 
atria-ventricular continuity . Rupture of the heart at the 
atria - ventricular sulcus is a rare complication of excessive 
excision of the mitral annulus during mitral valve 
replacement(6-10) . Extension of valvular calcification into 
the annulus will predispose to this complication. Such 
disruption will lead to the formation of a sub-epicardial 
haematoma over the defect. Enlargement of the haematoma may 
compress the coronary sinus . In the absence of pericardial 
adhesions , rupture through the epicardium is likely . If the 
sub-epicardial haematoma undergoes organization instead of 
rupture , one may have the formation of a false cardiac 
aneurysm communicating with the left ventricle through the 
defect in the mitral annulus . Surgical repair of such an 
aneurysm diagnosed during life has been reported(ll-16) . 
Amongst the 272 autopsied patients with heart valve prostheses 
studied in this work , two patients were encountered who 
illustrate how excessive mitral ring excision may lead to the 
formation of a sub-epicardial haematoma and a sub-valvular 
false aneurysm . These two patients have been previously 
reported(lO) . A variety of surgical approaches have been used 




CASE 1 . 
A 5 4 -year-old woman had severe rheumatic mitral stenosis 
with mild mitral incompetence. The mitral valve showed some 
calcification and the orificial area was 0 . 4 sq . cm. Operation 
revealed thrombus lining the wall of a small left atrium . The 
stenotic mitral valve was split , but was not found to be 
salvageable . The valve was excised and replaced by a No . 19 
glutaraldehyde-preserved (Hancock) xenograft . Most of the 
thrombus was removed from the atrium . The patient did well for 
three hours post-operatively, but then arrhythmia developed 
followed by circulatory collapse resulting from massive 
intra-thoracic haemorrhage and the patient died. 
Autopsy revealed a 1.5 cm . wide defect at the left of the 
mitral annulus immediately inferior to the sewing ring of the 
prosthesis. A 2.5 cm . diameter sub-epicardial haematoma 
occupied the left atria - ventricular groove immediately over 
the defect (Fig . 17 . 4) . At the summit of the haematoma there 
was a small hole in the epicardium through which the fatal 
haemorrhage had occurred . Histology revealed fibrin deposition 
on the bare myofibres at the rupture site and an overlying 
sub-epicardial haematoma . Haemorrhage extended into the 
adjacent myocardium . There was no evidence of organization of 
the haematoma as death had occurred only 3 hours 
post-operatively. 
CASE 2. 
A 58-year-old woman had severe mitral stenosis and 
incompetence (mitral valve area 0 . 49 sq . cm . ) . The valve was 
calcified and so, too , was the wall of the left atrium. The 
chamber contained much thrombus . The mitral valve was excised 
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with difficulty because of extensive calcification of the 
posterior cusp. A 4M Starr-Edwards prosthesis was inserted. A 
tricuspid annuloplasty was also performed. Fresh thrombus and 
calcium were removed from the wall of the left atrium. Her 
post-operative course was uneventful. Death occurred four 
years post-operatively because of cerebral thromboembolism. 
At autopsy, bland thrombi were present on the sewing ring 
and struts of the Starr-Edwards prosthesis. Immediately below 
the posterolateral portion of the sewing ring was an 8-mm. 
diameter rounded ostium that communicated with a 
fibrous-walled aneurysm (Fig. 17.5). The latter occupied the 
left posterolateral atria-ventricular groove and was filled 
with blood. The aneurysm measured 4 X 3 X 2 ems and lay within 
the epicardium. It had displaced the left circumflex coronary 
artery slightly downward without compressing the vessel. The 
coronary arteries were free of intrinsic disease. The aneurysm 
wall consisted of acellular collagen with foci of 
calcification. A thin layer of fibrin thrombus was present on 
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Figure 17 . 4 : Diagram of sub-epicardial haematoma in patient 
1, which resulted from excessive resection of mitral valve 





Figure 17.5 Intra-epicardial false aneurysm of patient 2 





The left atrial myocardium is normally totally separated 
from the left ventricular wall. It is the mitral ring together 
with the endocardium and pericardium that maintain the 
anatomical continuity between the left atrium and the left 
ventricle. It has been suggested(6,ll,12) that rupture of the 
left atria-ventricular sulcus during valve replacement is more 
likely to occur if mitral leaflet calcification involves the 
mitral ring too. Attempts at excision of all of the calcium 
may produce rupture. Fibrous distortion of the posterior 
mitral leaflet, coupled with organized left atrial thrombus, 
may obliterate the exact limits of the annulus. Delayed 
rupture of the mitral annulus may also be produced by 
localized tissue necrosis resulting from prosthetic sewing 
ring sutures being placed too deeply into friable myocardium. 
In excising the mitral valve in a patient with a small left 
atrium, the exposure may be poor and a portion of the annulus 
may be inadvertently excised. After the valve is replaced and 
cardio-pulmonary bypass is terminated, the stage is set for 
disruption of the atria-ventricular sulcus. 
Excessive removal of a laminated thrombus on the left 
atrial wall may also lead to perforation if excessive 
clearance is done, since the wall landmarks are often 
obscured. Selection of an oversize 
fit in the annular ring, 
annulus(l3,18). Re-excision of the 
valve, resulting in a tight 
may stretch or tear the 
annulus when removing a 
previously implanted mitral prosthesis can easily lead to 
perforation. Wolpowitz et al.(13) recommend that in such cases 
the prosthesis should be excised between the sewing ring 
cushion and its metal frame. Firmly embedded prosthetic cloth 
is left behind for use of placement sutures as if it were the 
annulus. The use of a curved metal instrument to define 
posterior chordal attachments may also cause a perforation of 
the ventricle next to the atria-ventricular junction. The 
post-surgical false aneurysm has the potential for expansion 
with pressure effects and perhaps rupture 
or into a cardiac chamber). 





post-surgical , subannular ventricular aneurysm and congenital 
submitral aneurysm . It is likely that both these types of 
aneurysm share a common pathogenesis , namely loss of 
attachment of the left ventricular myocardium to the fibrous 
mitral annulus. The cause of the loss of attachment in the 
so-called congenital aneurysm is unknown. Surgical trauma to 
the mitral valve ring is becoming more widely recognized as a 
possible cause of a intra-operative left ventricular wall 
rupture and a cardiac pseudo-aneurysm . Sub-valvular false 
aneurysm has also been described after aortic valve 
replacement (14 , 19) . 
The type of left ventricular wall rupture associated with 
mitral valve replacement described above has been referred to 
as type I rupture . The second type of rupture (type II) occurs 
in the posterior mid-portion of the left ventricle(l3,20-28) . 
Explanations for this problem(27) have included : (i) cutting 
too deep a plug and " button-holing " the ventricle during 
excision of the papillary muscle in a fragile , atrophic 
'mitral ventricle 1 (12 , 18 , 29 , 30). (ii) Dissection of blood into 
the papillary muscle wound(29) , (iii) trauma from apical 
venting(31) , (iv) epicardial adhesions , (v) impingement of a 
prosthetic valve strut(21 , 23 , 25 , 26,29 , 31) , (vi) intrinsic 
myocardial disease(l8) , and (vii) interruption of continuity 
between papillary muscle and mitral annulus . Cobbs et al . (27) 
suggest that a combination of factors may be important in the 
pathogenesis of this lesion . These factors included older 
patient age with associated coronary arterial disease , the 
size of the xenograft prosthetic valve , and the forceful 




more liable to 
render the heart more 
stretch-induced damage . The 
latter is favoured by excision of the mitral valve apparatus 
and too rapid weaning of the cardioplegic heart from bypass. 
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Cobbs et al(27) claim to have eliminated fatalities due to 
this complication by changing their operative technique to 
include a 30-minute period of empty beating after reversal of 
the cardioplegia. 
False aneurysms may also be encountered at other sites 
after open-heart surgery . Jutrin et al . (32) described a false 
aneurysm of the right atrium , which appeared after open-heart 
surgery and appeared to be due to loosening of a right atrial 
suture . Because of the low pressure in the right atrium , the 
danger of rupture seemed to be low , and conservative therapy 
was chosen . Becker et al . (33) reported a patient who presented 
12 months post-aortic valve replacement with a false aneurysm 
near the aortic cann u lation site. The patient refused surgery 
and died shortly afterwards . Autopsy revealed a smooth-walled 
1 cm . diameter defect adjacent to the cannulation site 
(presumably related to injury from a partial 
clamp). 
occl u sion 
Weesner et al . (34) described left ventricular aneurysms 
associated with intra-operative venting of the cardiac apex in 
32% of 50 children (average age 8 years) who were 
consecutively catheterized after surgical repair of congenital 
heart disease . The left ventricular apex had been vented by a 
sump during cardiopulmonary bypass in each patient . The 
aneurysms varied in size , but were generally small . Avereage 
dimensions were 7 . 5 X 6 . 8 mm . in the anterior-posterior 
projection . The wall of the left ventricular apex was thinner 
in patients with aneurysms than in age - and lesion-matched 
controls . All of the left ventricular aneurysm patients were 
asymptomatic during average follow-up of 4 years . The authors 
conclude that such aneurysms may be a potential source of 
complications and , when possible , alternate methods for 




At the time of writing (April 1984) I have just 
encountered a third autopsy patient with this complication . 
The patient was a 56-year-old female who underwent mitral 
valve replacement 7 years ago for calcific mitral stenosis due 
to repeated attacks of acute rheumatic fever . At the time of 
surgery the surgeon resected an excessive amount of the mitral 
valve ring and surrounding tissue and the circumflex branch of 
the left coronary artery was inadvertently damaged. The 
surgeon performed a saphenous vein coronary arterial bypass 
graft to the distal portion of the damaged vessel . The patient 
complied poorly with anticoagulant therapy and died of a 
cerebral haemorrhage with a pre - terminal prothrombin index of 
less than 10%. Autopsy revealed an inter-communicating , three 
chambered submitral false aneurysm in relation to the 
Starr-Edwards mitral prosthesis . The prosthesis had no annular 
tissue abutting against it at the site of the aneurysm . 
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D.INFECTIVE ENDOCARDITIS IN PATIENTS WITH PROSTHETIC HEART 
VALVES 
Infective endocarditis was encountered in 31 out of the 
275 patients with implanted cardiac valvular prostheses in 
this study and it accounted for 4 . 9% of the early deaths and 
18 . 2% of the late deaths . There were 16 females, 15 males , 17 
whites , 12 coloureds (mixed race) , and 2 black patients . The 
mean age was 41 . 9 years (S.D . = 13 . 6) with a ran g e of 15 to 67 
years. The mean post-operative survival was 332 days (S . D. = 
657) with a range of from 14 to 3285 days . The distribution 
was as follows : group 1 (early survivors) 7 (23 %) and group 2 
(late survivors) 24 (77%) . Thirty of the cases were patients 
with mechanical prostheses and only one involved a tissue 
valve . (The solitary patient with a fascia lata prosthesis 
excluded from this analysed core group also had an infected 
prosthesis) . The types of prosthetic valves affected are 
listed in Table 17.8 . The diagnosis of prosthetic valve 
infection had not been suspected in 4 patients (13 %) . 
TABLE 17 . 8 : TYPES & NOS . (%) OF INFECTED PROSTHETIC CARDIAC 
VALVES ENCOUNTERED AMONGST 275 PATIENTS WITH VALVE 
PROSTHESES . 
UNIVERSITY OF CAPE TOWN 16 (13 . 3%) 
LILLEHEI-KASTER 2 (12.5 %) 
BJORK-SHILEY 1 (6.7 %) 
STARR-EDWARDS 4 (8.5 %) 
St. JUDE MEDICAL 4 (13 . 8 %) 
MIXED TYPES OF VALVES 3 (5.8 %) 
CARPENTIER-EDWARDS 1 (2.6 %) 
Table 17.9 indicates the types of causative 
micro-organisms identified in these 31 patients with infected 
prosthetic heart valves . The commonest pathogens were 
Staphylococci , followed by gram negative bacilli and fungi . In 
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all of the patients with mechanical valves the infection was 
situated at the site of attachment of the prosthetic sewing 
ring to the native valve ring . The one infected 
(Carpentier - Edwards) tissue valve had in f ected vegetations on 
the cusps with minimal juxta-sewing ring inflammatory changes . 
Nearly all of the infected mechanical valves also had infected 
vegetations on the struts or cage. Ring abscesses were noted 
in almost one-third of cases (29 %) and one of the 9 such 
patients developed complete heart block due to inflammatory 
destruction of the bundle of His . 
TABLE 17 . 9 : CAUSATIVE MICRO-ORGANISMS IN 31 PATIENTS WITH 
PROSTHETIC VALVE INFECTIVE ENDOCARDITIS 
ORGANISM GROUP 1 GROUP 2 TOTAL 
STAPHYLOCOCCUS ALBUS 0 7(23 %) 7(23 %) 
STAPHYLOCOCCUS AUREUS 0 4 (13 %) 4(13 %) 
CANDIDA ALBICANS 2(7 %) 1(3%) 3(10%) 
CANDIDA PARASILOSIS 0 1(3 %) 1(3%) 
UNIDENTIFIED FUNGUS 1(3%) 0 1(3%) 
KLEBSIELLA SPECIES 1(3%) 0 1(3%) 
DIPHTHEROIDS 1 ( 3%) 1(3%) 2(7 %) 
COLI FORMS 0 1(3 %) 1(3%) 
ACTINOBACILLUS 0 1(3%) 1(3%) 
PSEUDOMONAS SPECIES 0 1(3 %) 1(3 %) 
BACILLUS CEREUS 0 1(3%) 1(3%) 
UNKNOWN 2(7 %) 6 (19 %) 8(26 %) 
Three out of the 31 patients with prosthetic valve 
infective endocarditis had a clinical history of pre-operative 
i nfective endocarditis . Upon examining the surgical records of 
the University of Cape Town Pathology Department of Pathology , 
I was able to find reports and slides of only 6 out of the 31 
patients who had their natural valves sur gically excised . None 
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of theses 6 cases showed evidence of infection 
microscopically . 
Seven of the patients with infected prostheses died due 
to malfunction of the prosthesis (5 had partially detached 
prosthetic valves, and 2 mitral prostheses were severely 
obstructed by vegetations). Ten patients died of systemic 
embolism ; 4 died of ruptured mycotic aneurysms, and 10 died 
of other causes e.g. , myocardial failure or pyaemic abscesses 
and toxaemia . 
COMMENT 
Not all bacteraemias in patients with prosthetic heart 
valves represent infection of the valve(l , 2), particularly 
when there is no haemodynamic instability or evidence of valve 
dysfunction and when the bacteraemia is due to a gram negative 
bacillus . Parker et al . (3) noted bacteraemia in 3.6% of 890 
patients after heart valve 
recovery period . Only 2 out of 
developed endocarditis. 
replacement in the hospital 
the 32 bacteraemic patients 
Leitersdorf et al.(4) have hypothesized that there is a 
close relationship between sub-clinical thromboendocarditis on 
the native valve and the early development of infective 
endocarditis on the implanted artificial valve. Others have 
observed that the organism presumed to be the cause of the 
prosthetic valve infective endocarditis (PVIE) was often 
different from the one isolated earlier as the presumed cause 
of the natural valve endocarditis(4a , 4b) . In the present study 
none of the 6 excised valves whose histology was available for 
re-examination showed signs of infection histologically . It is 
unfortunate that the bulk of the excised valves had evidently 
not been submitted for histopathological examination . Only 3 
out of my 31 patients with infected prosthetic valves had 
clinically apparent pre-operative infective endocarditis . The 
diagnosis of prosthetic valve endocarditis had been made 
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clinically in the majority of our patients (87%) . 
Regarding the pathogenesis of fungal infection on heart 
valve prosthesis, Robboy and Kaiser(S) made the controversial 
suggestion that foci of infection start on patches of 
neo - endocardium on the sewing cloth of the valve prosthesis 
and that it is the neo-endocardium , rather than the cloth or 
metal of the prosthesis which is the important predisposing 
factor . The early development of post-operative infective 
endocarditis is recognized as a distinct hazard and unique 
clinical entity differing from non-surgical infective 
endocarditis in the following aspects(6) (i) different 
organisms are involved 
infective endocarditis 
(ii) the typical clinical picture of 
is frequently lacking , and (iii) the 
fatality rate is unusually high . 
INCIDENCE 
The incidence of infective endocarditis after cardiac 
surgery varies in different series . The incidence is higher 
after surgery requiring cardio-pulomonary bypass than after 
"closed" intra-cardiac procedures(6) . The incidence of 
infective endocarditis after prosthetic valvular replacement 
varies among different medical centres and is determined by 
many factors(7) including the underlying condition of the 
patient at the time of operation , the skill of the surgeon , 
the type of prosthesis used , the duration of cardio-pulmonary 
bypass, the sterility of the heart-lung machine and the 
operating theatre , the use of prophylactic antibiotics, the 
incidence of extra-cardiac post-operative infection and the 
length of the follow-up period after surgery . The incidence of 
early PVIE , defined as that occurring within 2 months after 
valve implantation , varies from Oto 7 . 1% amongst different 
centres(2,8-27) . The reported incidence of late PVIE for 
patients followed up for at least 6 months after surgery 
varies from Oto 3.2% among different centres and the overall 
incidence of PVIE (all cases) varies from O - 9 . 5% , with an 
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average of 2 . 3%(7) . 
SOURCE OF THE ORGANISMS 
Primary intra-operative contamination appears to be 
responsible for most post-operative endocarditis(6). 
Contamination of the heart-lung machine by diphtheroids and 
Pseudomonas(ll) has resulted in endocarditis . The coagulase 
negative Staphylococcus , which was the commonest cause of PVIE 
in our patients , is ubiquitous in the air of operating rooms 
and on human skin . Ankeney(28) performed 1 , 555 intra-operative 
blood cultures during 383 open-heart operations and in 117 
(7 . 5%) Staphylococcus albus was cultured ; 153 (9 . 8%) grew a 
diphtheroid bacillus and 29 (1 . 9%) were other micro-organisms . 
Most positive cultures were obtained from the primed pump and 
the suction line during bypass , when the pump and blood were 
most exposed to air . In addition to intra-operatice 
contamination, the organisms may be introduced by diagnostic 
cardiac catheterization , the prolonged use of intra-venous 
catheters, indwelling urinary catheters and contaminated 
blood . The valve prosthesis may become secondarily infected in 
all of the above circumstances . Finally , intrinsic 
contamination of the valve prosthesis itself is another 
potential source of infection(7). Porcine aortic valves from 
one manufacturer have been contaminated by Mycobacterium 
chelonei and at least 2 patients developed infective 
endocarditis(29 , 30) . 
INCREASED SUSCEPTIBILITY TO INFECTION 
Many of the organisms producing PVIE are of a " low 
virulence ". Increased susceptibility to infection may result 
from both local and general factors . Elek(31) showed that the 
presence of silk sutures 
infection of the skin 
potentiated Staphylococcus aureus 
up to 10 , 000-fold . Foreign material 
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placed within the heart increases the pathogenicity of 
bacteria and also makes infection difficult to eradicate by 
antimicrobial drugs. It has been suggested that 
cardio-pulmonary bypass may reduce the host ' s resistance to 
bacterial infections(6). The phagocytic activity of 
neutrophiles is depressed for as long as 18 days after 
open-heart surgery(32), but this was disputed by another 
study(33) . Hairston(34) reported a significant lowering of IgG 
and total haemolytic complement during , and a few days after 
open-heart surgery and attributed this to denaturation of 
plasma proteins by the surface-polarizing forces at the 
blood-gas interface in oxygenators(35). 
MICROBIOLOGY 
The microbiology of PVIE is vastly different from that of 
natural valve infective endocarditis(7,36) . The types of 
micro-organisms involved in my 31 patients with PVIE are 
characteristic of the findings of others in PVIE . 
Staphylococcus albus is the single most important cause of 
both early and late PVIE, accounting for 27.4% of the early 
caes and 22 . 9% of the late cases(7) . This is in keeping with 
my finding that 23% of autopsied patients with PVIE were due 
to Staphylococcus al bus . In the literature(37-43), 
Staphylococcus albus has been inculpated in anywhere from 6% 
to 35% of cases of PVIE. Staphylococcus aureus is an important 
cause of early PVIE, accounting for 19.2% of early cases and 
only 11 . 4% of late cases(7). It has been claimed that 
short-term peri-operative prophylaxis with a cephalosporin may 
prevent Staphylococcus aureus PVIE(l8,27). Streptococci, which 
are the most important group of aetiological agents in 
infective endocarditis of natural valves , are not an important 
cause of PVIE, accounting for only about 7 . 5% of early 
cases(7) and were not encountered in my autopsy patients . 
However, Streptococci account for about 37% of late PVIE(7) 
and presumably have the same sources as in patients with 
infected natural heart valves. 
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According to Wilson et al . (44), gram-negative bacilli are 
the second leading cause of early-onset infections and are 
third in frequency among patients with late-onset PVIE. 
Gram-negative bacilli were the second most frequent pathogens 
in my 31 patients with fatal PVIE and accounted for 22% of the 
total . Gram-negative bacilli are a rare cause of infective 
endocarditis of natural valves except for intra-venous drug 
abusers(36) . A wide variety of gram-negative bacilli have been 
isolated in PVIE , including species of 
Pseudomonas(l0-12,45-47) , Haemophilus(48-51) , Escherichia 
coli(l0-12,17), Alcaligenes faecalis(17) and Eikenella 
corrodens(52,53) . Others include members of the genera 
Klebsiella(54) , Serratia(9 , 5 4-57), Enterobacter(l0 , 11 , 17) , 
Proteus(l0 , 17 , 54), and Hafnia(12). Other miscellaneous 
bacteria documented as causing PVIE include various species of 
diphtheroids(ll , 23 , 25 , 54 , 58) , Actinobacillus 
actinomycetemcomitans(59) , Nocardia asteroides(60) , Neisseria 
species(61-63), Mycobacterium chelonei(64 , 65) , Brucella(66) , 
Bacillus cereus(67) , Kingella kingae(68 , 69) , Q Fever(70), and 
Listeria monocytogenes(71-73) . 
Fungal infections , which comprised 16% of my cases , are 
said by Watanakunakorn(7) to be responsible for 9 . 6% and 4.3% 
of the early and late cases, respectively. Fungal endocarditis 
following heart operations was first reported by Koelle and 
Pastor(74) in 1956 , and by 1975 more than 120 cases had been 
reported in the English literature(75) . Norenberg et al.(75) 
reported a 13-20% incidence of fungal endocarditis following 
cardiac operations . Candida albicans plus other Candida 
species are important causes of PVIE(14,21 , 22 , 24 , 46 , 54 , 76-81) . 
Aspergillus is reported to be the next most important cause of 
fungal PVIE(7 , 14 , 45,54 , 79,82,83) . Other fungi causing PVIE 
include Histoplasma capsulatum(84,85) , Cryptococcus 
neoformans(79) , Mucor(86) , Paecilomyces(87-90) , Penicillium 




Although many reports are available on patients with 
fatal infective endocarditis of natural cardiac valves , there 
is limited information on the morphology of PVIE(94). Robinson 
et al . (95) reported on 16 autopsied patients with PVIE 
included in a larger series of patients with natural valve 
endocarditis, but gave no morphological details. PVIE may 
cause either obstruction or incompetence of the 
prosthesis(54 , 96) . Madison et al . (49) described large 
peri-valvular abscesses which loosened the attachment of the 
prosthetic valve in each of 16 patients with PVIE . The early 
development of aortic regurgitation was a bad prognostic 
indicator . Arnett and Roberts(54) analysed 22 necropsy 
patients with PVIE ; as in my patients , the Staphylococcus was 
the most frequent infecting organism . In each of their 
patients the infection was located behind the site of 
attachment of the prosthesis to the native valve ring . 
Prosthetic obstruction by vegetations occurred more commonly 
with an infected mitral valve prosthesis than with aortic 
prostheses . Anderson et al.(96) recorded a clinicopathological 
study of 22 patients with PVIE . Prosthetic valve dysfunction 
led to death in 45% of their patients and embolic events in 
23% . Ring infection , often believed to be universally present , 
and a contra-indication to surgery , was present in only 50% of 
their patients . 
In a later paper Arnett and Roberts(97) described their 
further experience with infective endocarditis of both natural 
valves and heart valve substitutes. Other key references for 
PVIE are given as references(98-103) in the present work . A 
number of papers deal with general(104-106) , 
clinico-pathological(107-109) or experimental aspects(ll0 , 111) 
of PVIE . Other authors address specific aspects of PVIE , 
including fatal obstruction to left ventricular inflow(112) , 
rupture of mycotic aneurysms(113), embolism(114) , 
bioprosthetic endocarditis(llS-119) , or surgical management of 
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prosthetic valve endocarditis(l20-126) . According to Schoen et 
al . (127), there is no apparent relationship to specific 
prosthetic valve type or design with respect to incidence or 
organisms . In most studies, the aortic site is involved more 
often than the mitral . Infection occurs within the first two 
months post-operatively (early onset) in approximately 
one-third to one-half of cases and later in the course (late 
onset) in the remainder . They state that the mortality rate is 
high , about 60% overall , being significantly higher for the 
early infection (73%) than for the late (45%). Since 
biomaterials themselves do not support the growth of infective 
organisms , the potentiation of infection by foreign bodies 
must involve an as yet poorly understood interaction of local 
physical and biological factors . A promising approach to 
prevention of PVIE is the incorporation of antibiotic into the 
valve prosthesis , to be slowly released during function(l28). 
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E.SMALL CORONARY ARTERIAL DISEASE IN PATIENTS WITH IMPLANTED 
HEART VALVE PROSTHESES 
The small coronary arteries (SCA) are often equated with 
intramyocardial coronary arteries. James(l) has pointed out 
that the two are not necessarily synonomous , since it is not 
unusual for a significant segment of a large coronary artery 
to course some distance within the myocardium . Conversely, 
most of the right ventricular small coronary branches lie in 
the epicardium and penetrate only a short distance into the 
myocardium. In the left ventricle the small coronary arteries 
are distributed throughout the myocardium and may also be seen 
in the epicardium. The small coronary arteries are important 
because they include important anastomoses, supply the 
conduction tissues, and may be involved by occlusive lesions 
in a variety of systemic diseases(2) . In the present study the 
small coronary arteries are defined as those with a diameter 
of less than 1 mm. 
Twenty-seven out of the 275 patients (18 . 6%) with 
valvular prostheses showed small coronary arterial 
abnormalities. Table 17 . 10 gives data regarding small coronary 
arterial disease in patients with valvular prostheses and 3 
groups of control patients. It will be observed that the great 
majority of the small arteries in all 3 groups of patients 
examined showed no significant abnormality . Organized 
thromboemboli (eccentric intimal thickening) and concentric 
intimal fibrous thickening were the commonest abnormalities 
observed in SCA of patients with prostheses, being present in 
2.7% and 2.3% of arteries respectively. However, the incidence 
of thromboemboli in patients with valvular prostheses did not 
differ significantly from unoperated patients with healed 
post-rheumatic valvular heart disease . Oedema of the arterial 
media was a feature of 6 . 7% of arteries in patients with acute 
rheumatic pancarditis, but was a neglible finding in the other 
patient groups . Foreign body emboli within small coronary 
arteries was noted only in patients with implanted valvular 
prostheses . Table 17.11 indicates the nature of the emboli 
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encountered in the latter patients . Three patients had more 
than one type of embolus within the small coronary arteries . 
TABLE 17 . 10 : SMALL CORONARY ARTERIAL DISEASE IN PATIENTS 
WITH VALVULAR PROSTHESES AND IN 3 GROUPS OF CONTROL PATIENTS 
PTS.WITH RHEUMATIC FEVER 
PROSTHESES ACTIVE HEALED 
No . of PATIENTS 
No . of ARTERIES 
NORMAL 






90 . 8% 
0 . 2% 
0 . 1% 
0 . 9% 
2 . 3% 
ELASTIFICATION NIL 
LOSS OF MURAL DEMARCATION 1 . 1% 
FRESH THROMBOEMBOLI 1.4% 
ORGANIZED THROMBOEMBOLI 
FOREIGN BODY EMBOLI 
ARTERITIS 
2 . 7% 
0 . 5% 
NIL 
676 
85 . 9% 






0 . 6% 
0 . 9% 
NIL 
0 . 3% 
1008 





2 . 6% 
1. 6% 
1. 5% 







96 . 6% 
0.4% 





0 . 5% 
0 . 4% 
NIL 
NIL 
TABLE 17 . 11 : TYPES OF SMALL CORONARY ARTERIAL EMBOLI IN 275 
PATIENTS WITH IMPLANTED CARDIAC VALVULAR PROSTHESES 






















SMALL CORONARY ARTERY DISEASE 
As regards the types of prostheses implanted in the 
patients with SCA disease , the University of Cape Town 
prosthesis (Table 17.12) showed the highest incidence of 
thromboembolism and concentric intimal thickening . It showed · a 
much higher incidence of emboli than did the other types of 
prostheses listed in Table 17 . 12 (p less than 0 . 025) and an 
even more significantly greater occurrence of concentric 
intimal thickening (p less than 0.0025) . The Starr - Edwards 
prosthesis also showed a greater (p less than 0.01) incidence 
of small coronary arterial embolism than did the other types 
of valves listed in Table 17 . 12 (excluding the University of 
Cape Town valve prosthesis). Patients with isolated UCT aortic 
valve prostheses(l3) showed a 35% incidence of SCA 
abnormalities . The most frequent changes noted were intimal 
fibrous thickening (25%) , medial hypertrophy (7 . 5%) and 
thromboembolism (17.5%). 
TABLE 17 . 12 : TYPES OF CARDIAC PROSTHETIC VALVES PRESENT 
IN PATIENTS WITH CERTAIN TYPES OF SMALL CORONARY ARTERIAL 
DISEASE 
VALVE TYPE EMBOLI (%) THICKENED INTIMA (%) 
UNIVERSITY OF CAPE TOWN 14 (5 . 1)* 15 (5.5)*-Y. 
CARPENTIER-EDWARDS 2 (0 . 7) 3 ( 1. 1) 
STARR-EDWARDS 6 ( 2. 2) 
MIXED 4 ( 1. 5) 
LILLEHEI-KASTER 2 (0 . 7) 
HANCOCK 1 (0.4) 
BJORK-SHILEY 1 (0 . 4) 
St. JUDE MEDICAL 2 (0 . 7) 
{} p less than 0.025 
*~~ p less than 0.0025 
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COMMENT 
It is apparent that small coronary arterial disease is 
not a major problem in patients with prosthetic heart valves . 
Only 29 out of the 275 patients (10 . 6 %) with implanted 
valvular prostheses studied showed evidence of embolism in 
these small vessels . The incidence of thromboembolism did not 
differ significantly from that 
rheumatic fever or routine autopsy 
noted in patients with 
controls . Abernathy and 
Willis(3) stress that rheumatic heart disease is a 
thromboembolic disease in its own right . Foreign body emboli 
were confined to patients with prosthetic valves and increased 
elastification of SCA was only encountered in unoperated 
patients with chronic rheumatic-type valvular heart disease . 
For some unknown reason, this change was not noted in the 
vessels of the patients with prostheses, most of whom had had 
similar pre - operative valvular lesions. Patients with healed 
rheumatic fever (mitral valve disease without Aschoff bodies) 
showed less medial oedema than those with Aschoff bodies . 
Grismer et al.(4) suggested that chronic occlusive rheumatic 
vasculitis may be a cause of the low output syndrome leading 
to mortality following corrective heart surgery for mitral 
valvular defects . Such an eventuality was a rare occurrence in 
the present study - one of our patients with this complication 
is illustrated as Figure 9 . 6 in a standard text(2) . 
While calcium embolism may accompany surgical resection 
of calcified left-sided heart valves(S) , Wigle(6) showed that 
calcific emboli could arise de novo from a heavily calcified , 
ulcerated aortic valve and also from a calcified valve after 
mitral valvotomy. There is a high risk of calcium microemboli 
in patients with a heavily calcified valve annulus who undergo 
valve replacement , since debridement of the calcified annular 
tissue is difficult(2) . The use of microfilters in the bypass 
circuit has reduced the incidence of this complication . Other 
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forms of foreign body microemboli related to cardiac surgery 
include cholesterol , suture material , silicone from the 
oxygenator pump(7) , Teflon from prosthetic valves(8 , 9) , and 
Dacron from the worn cloth covering of prosthetic valves. A 
diagnosis of cloth fibre emboli rather than thromboemboli may 
be favoured by the clinical manifestation of recurrent 
systemic arterial embolization more than 4 years after valve 
replacement and despite adequate anticoagulation(lO) . Platelet 
aggregates formed in the pump oxygenator may lodge as 
microemboli in small coronary arteries of patients undergoing 
cardiopulmonary bypass . Bone marrow emboli or adipose tissue 
as well as air embolization are also occasionally encountered . 
In the present series 19% of patients with cardiac 
valvular prostheses had small coronary arterial disease . 
Roberts et al . (11) found embolic material in the intramural 
coronary arteries of 9 % of patients dying after heart valve 
replacement . Silver(12) found foreign body emboli in about 10% 
of patients who died late after 
Many such emboli appeared as 
cardiac valve replacement . 
granulomata related to and 
involving SCA, but without an obvious associated foreign body. 
The number of emboli and granulomata found increase and become 
more widespread in distribution if there has been wear of the 
prosthesis . 
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F. PATHOLOGY OF THE MAJOR CORONARY ARTERIES 
The 275 patients with implanted cardiac valvular 
prostheses showed the following coronary arterial pathology 
THROMBOEMBOLISM 
Thromboemboli were encountered within the coronary 
arteries of 17 patients ; myocardial infarction was detected 
macroscopically in only 6 out of these 17 hearts . In 16 
patients the thromboemboli were lodged within epicardial 
coronary arteries , but in one patient a thromboembolus was 
found within a large septal perforator branch of the left 
anterior descending coronary artery. The patient died suddenly 
and unexpectedly . 
Figure 17 . 6 : Thromboembolus lies within a septal 
branch of left anterior descending coronary 
arteries are seldom examined at autopsy and , if 
perforator 
artery . Such 
the embolus 
had not been discovered , the patient ' s sudden death might have 
been attributed to arrhythmia . 
SEVERE ATHEROSCLEROSIS 
Seventeen patients (6%) had 
atherosclerosis , which was defined 
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severe coronary arterial 
as 75% or more reduction in 
luminal cross - sectional area of one or more of the major 
coronary arteries. Seven of these patients underwent saphenous 
vein coronary arterial bypass grafting at the same time as the 
valve surgery . Coronary atherosclerosis per se was a principal 
cause of death in only 3 of these patients . 
MISCELLANEOUS CONDITIONS 
Miscellaneous conditions were noted in 10 patients. Two 
patients showed surgical sutures penetrating their left 
circumflex coronary artery . Both of these arteries occupied a 
deeper than usual (intra-myocardial) situation at the site of 
involvement by the sewing sutures . I also encountered a 
patient who had a congenital early bifurcation of the left 
main coronary artery. This resulted in the coronary perfusion 
cannula entering the left anterior descending branch only , 
with occlusion of the non-perfused left circumflex coronary 
artery . 
Two patients with coronary arterial ostial stenosis both 
had coronary arterial bypass grafts (CABG) performed using the 
saphenous vein. One patient was known to suffer from syphilis , 
but the aetiology of the ostial stenosis was uncertain in the 
other , and was probably due to atherosclerosis. In a third 
patient a Lillehei-Kaster aortic valve prosthesis had been 
inserted in such a way so as to cause partial obstruction of 
both coronary arterial ostia ; the patient did not survive the 
operation . Another patient had redundant suture material from 
the sewing ring of an aortic valve prosthesis protruding into 
the left coronary arterial ostium , but no significant 
obstruction resulted. 
Three patients showed coronary arterial dissection in 
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one patient with aortic medionecrosis the coronary arterial 
involvement was due to extension of an aortic dissecting 
aneurysm , whereas in the other patient the coronary dissection 
was iatrogenic having occurred during coronary angiography. 
The dissection in the third patient was a complication of CABG 
for atherosclerotic coronary arterial disease. 
COMMENT 
Significant coronary arterial disease was present in only 
6% of the patients in the present study compared to 22% of the 
patients reported by Schoen et al . (l) from America . This 
difference may be related mainly to differences in the 
population undergoing operation in the two centres (Cape Town 
and Houston) . A large number of our patients were blacks , 
coloureds or young whites with chronic rheumatic valvular 
heart disease in whom atherosclerosis is infrequent . The 
Houston patients were generally older and rheumatic fever was 
probably a less common aetiological factor. Roberts and 
Hammer(2) noted severe atherosclerotic coronary arterial 
narrowing in 13 out of 46 patients with tilting disc 
prostheses and it was a major cause of death in 5 out of 33 
early post-operative deaths. 
Forty - one percent of our patients with severe coronary 
arterial atherosclerotic narrowing underwent CABG at the time 
of heart valve replacement . Operations for replacement of the 
aortic valve combined with coronary revascularization are time 
consuming and stress the strategies for protecting the 
myocardium . Lytle et al . (3) found that in-hospital mortality 
in such cases was increased by female sex, aortic 
insufficiency , and advanced age , whereas cardioplegia reduced 
it. The late survival rate was unfavourably influenced by the 
presence of moderately or severely impaired left ventricular 
function and double-vessel coronary arterial disease. The rate 
was enhanced for patients in the age-group from 50 to 59 years 
old, and was not influenced by the method of myocardial 
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protection . 
Unless dye contrast methods are used , significant lesions 
may be missed in the larger penetrating branches of the major 
coronary arteries . This is illustrated by the patient 
described above in whom a thromboembolus was discovered in a 
large septal perforator branch of the anterior descending 
coronary artery . The patient's sudden, unexpected death would 
have been attributed to an arrhythmia if the thromboembolus 
had not been detected . Coronary arterial dissection is a 
recognized complication 
surgical damage to the 
of CABG(4) and may result from 
posterior wall of the vessel at the 
site of incision into the coronary artery (anastomotic site) . 
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G. STATE OF THE MYOCARDIUM IN PATIENTS WITH PROSTHETIC HEART 
VALVES 
1 . HEART WEIGHTS 
Table 17 .13 indicates the mean heart weights in early 
(group 1) and late (group 2) survivors following heart valve 
replacement and also 
with and without the 
failure . Early and 
compares the heart weights of patients 
clinical features of myocardial pump 
late survivors showed no significant 
difference in mean heart weights . However , patients dying with 
myocardial failure had significantly heavier hearts than those 
without failure (p less than 0.05) . 
TABLE 17.13 : MEAN HEART WEIGHTS IN PATIENTS WITH 
IMPLANTED PROSTHETIC HEART VALVES WITH REFERENCE 
TO DURATION OF POST-OPERATIVE SURVIVAL 
AND CARDIAC FAILURE 
PATIENTS 
GROUP 1 (N=ll4) 
GROUP 2 (N =l21) 
PTS WITHOUT FAILURE 
(N=207) 
PTS WITH FAILURE 
(N=28) 





* p less than 0 . 05 
2 . MYOCARDIAL NECROSIS 
COAGULATIVE 
patients (7%) 
NECROSIS was observed 
it was transmural in 6 , 
naked eye in 20 
sub-endocardial in 3 
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and a mixture of these two patterns in 11 patients. 
CIRCUMFERENTIAL HAEMORRHAGIC SUB-ENDOCARDIAL INFARCTION(l , 2) 
of the left ventricle was observed in an additional group of 9 
patients, most of whom had a low cardiac output and survived 
less than one day post-operatively. All of these heart also 
showed concentric hypertrophy of the left ventricle with 
sub-endocardial focal replacement fibrosis and the heart 
weights ranged from 430 to 1172 grams , with a mean of 678 
grams (S.D.= 312). All of the patients with subendocardial 
necrosis had undergone aortic valve replacement and two 
patients underwent double valve replacement . Two patients had 
coronary arterial bypass grafts performed for severe 
atherosclerotic coronary arterial disease, with bypass times 
of 6 and 9 hours respectively . Only one out of the 9 patients 
was operated upon after 1977 , i . e . after the institution of 
cold cardioplegic myocardial protection during cardiopulmonary 
bypass. 
The "STONE HEART " SYNDROME(3) was encountered in three 
patients, all of whom were operated upon before 1977 . They 
showed massively hypertrophied hearts with severe concentric 
hypertrophy of the left ventricle. All three patients did not 
survive the operation. 
Scores for the 3 morphological forms of myocardial 
necrosis evaluated histologically , namely COAGULATIVE 
NECROSIS, CONTRACTION BAND NECROSIS and MYOCYTOLYSIS(see 
Methodology), are given in Tables 17.14-17 . 16 . No significant 
difference was found in the necrosis scores in comparing the 
total groups of 275 patients with valvular prostheses and the 
75 control patients with non-operated valvular heart disease . 
However , patients with Starr-Edwards prostheses showed 
significantly more myocardial necrosis (Table 17.14) than was 
seen in patients with other types of implanted prosthetic 
heart valves and this was most marked for coagulative necrosis 
in patients with Starr-Edwards mitral prostheses. 
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TABLE 17.14 : MYOCARDIAL NECROSIS IN AUTOPSIED PATIENTS WITH 
VARIOUS TYPES OF PROSTHETIC HEART VALVES AND IN NON-OPERATED 
CONTROLS WITH VALVULAR DISEASE,MEDIAN (RANGE). 
PTS. WITH TYPE OF NECROSIS (SCORED 0-3) 
PROSTHESES COAGULATTVE CONTRACTION BAND MYOCYTOLYSIS 
UCT-A 0 (0-3) 0 (0-1) 0 (0-1) 
UCT-M 0 (0-1) 0 (0-1) 0 (0-3) 
UCT-MULT 0 (0-3) 0 (O) 0 (0-2) 
S-E-MVR 0 (0-3)a 0 (0-2) 0 (0-3) 
S-E-AVR 0 (0-2) 0 (0-2)b 1 (0-2)c 
B-S 0 (0-3) 0 (O) 0 (O) 
SJM 0 (0-3) 0 (O) 0 (0-3) 
LILL 0 (0-3) 0 (0-1) 0 (0-1) 
HAN 0 (0-3) 0 (0-1) 0 (0-2) 
C-E 0 (0-3) 0 (0-3) 0 (0-3) 
COMBINED PTS 0 (0-3) 0 (0-3) 0 (0-3) 
(N=275) 
COMBINED 
CONTROLS 0 (0-3) 0 (0-1) 0 (0-1) 
(N=85) 
The differences are not significant except where 

































































































































































































































































































































































































































































































































































































































































































































Table 17.17 compares the necrosis scores of two groups of 
early survivors after valve replacement who were divided 
according to the form of intra-operative myocardial protection 
that was used . The first group of 45 patients was treated with 
intra-operative coronary arterial perfusion with blood from 
the oxygenator-pump machine with separate perfusion of the two 
coronary arteries , individual monitoring of pressure and flow 
plus cooling of the beating heart to 32 degrees Centigrade . 
The second group of 42 patients received cold cardioplegic 
solution and the heart was cooled down to about 15 degrees 
Centigrade and arrested in diastole by potassium 
administration . It is apparent from Table 17 . 17 that the 3 
forms of myocardial necrosis occurred with equal severity in 
the 2 groups of patients . 
Another aspect that was investigated (Table 17.18) was 
the state of the myocardium in patients who received 
intermittent versus continuous coronary arterial perfusion 
with blood during cardiopulmonary bypass and a similar 
evaluation was performed for patients with regularly beating 
hearts versus those whose hearts fibrillated continuously 
during bypass . No significant differences were found . I also 
found that group 1 patients , (presumably with myocardial 
lesions related to inadequate operative myocardial protection 
amongst other factors) , showed no significant difference in 
myocardial necrosis scores (Table 17 . 19) compared to group 2 
patients (who should be less affected by operative factors , 
and more influenced by thromboembolism and infection). 
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Figure 17 . 7 : Concentric haemorrhagic necrosis of the left 
ventricle in a patient with a Starr-Edwards aortic valve 
prosthesis . 
Figure 17 . 8 : Section of left ventricle shows sub-endocardial 
replacement fibrosis . Necrosis of adjacent myofibres is not 
apparent at this low power. (Haematoxylin-eosin, X 4) . 
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TABLE 17.17 : MORPHOLOGICAL ASSESSMENT OF MYOCARDIAL NECROSIS 
IN EARLY SURVIVORS WITH 2 DIFFERENT TYPES OF INTRAOPERATIVE 





TYPES OF NECROSIS (SCORED 0-3) 
COAGULATIVE 
0 (0-3) 
0 ( 0-3) 
CONTRACTION BAND 
0 (0-3) 




The differences are not significant. ICPBH=intermittent 
coronary perfusion with blood and a beatin g heart. CCA=cold 



























































































































































































































































































































































































































































3 . MYOCARDIAL FIBROSIS 
Twenty-one out of the 275 patients (8%) with implanted 
heart valve prostheses showed macroscopically recognizable 
sub-endocardial left ventricular fibrosis . Transmural fibrosis 
was observed naked eye in 8 patients (3%). Histological 
evidence of fibrosis was present in most patients . Morphometry 
showed no significant difference in the amount myocardial 
fibrous tissue in 275 patients with prostheses compared to 85 
controls with native valvular heart disease (Table 17.20). 
TABLE 17.20 : MORPHOMETRY OF MYOCARDIAL FIBROSIS IN PATIENTS 
WITH VALVULAR PROSTHESES AND IN NON-OPERATED CONTROLS WITH 
VALVULAR DISEASE , MEAN (STANDARD DEVIATION) . 
PATIENTS WITH VALVULAR PROSTHESES 
(N=275) 
CONTROLS WITH VALVULAR DISEASE 
(N=85) 
MORPHOMETRY (%) 
13 . 7 (13 . 4) 
10 . 3 (10 . 0) 
No significant difference is present 





interstitial, perivascular and 
with implanted prostheses and 
non-operated control patients revealed a significantly greater 
amounts of replacement and interstitial fibrosis in the 
combined group of patients with valvular prostheses (Table 
17 . 21) ; no difference was found with regard to the other 2 
types of fibrosis . 
Group 2 patients with University of Cape Town valvular 
prostheses (Table 17.22) showed more replacement fibrosis than 
did the group 1 patients . Patients with pre-operative aortic 
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stenosis showed no difference from matched controls with 
regard to morphological grading of fibrosis and morphometry. 
Patients with pre-operative aortic incompetence and patients 
with mixed aortic valvular disease both showed no significant 
difference in morphological assessment of fibrosis from 
controls, but there was a significant difference for in 
morphometric score for fibrosis in general compared to 
controls (Table 17.23). A similar evaluation of patients with 
UCT mitral prostheses and non-operated controls with mitral 
valvular disease (Table 17.24) revealed greater degrees of all 
4 forms of fibrosis in patients operated upon for mixed mitral 
stenosis and incompetence compared to controls. In patients 
with Starr-Edwards mitral valvular prosthesis (Table 17 . 25) 
those with pre-operative mitral stenosis as well as those with 
mixed mitral valvular disease also showed a greater amount of 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































valves whose function they aim to replace . This obstructive 
effect may be a factor in the persistence of cardiac 
hypertrophy post-operatively, especially with aortic valve 
replacement. It is clearly not the sole explanation for the 
persistent hypertrophy, since persistent left ventricular 
hypertrophy was also observed in hearts with isolated mitral 
valvular replacement for mitral incompetence . Myocardial 
fibrosis due to rheumatic fever or ischaemia may also play a 
role in this regard . 
NECROSIS 
Necrosis of the myocardium was more severe (Chi-square 
evaluation, Table 17 . 14) in patients with Starr-Edwards 
valvular prostheses compared to patients with other types of 
necrosis . The reason for this is .unknown . The combined group 
of 275 patients with implanted prostheses failed to show more 
necrosis than the 85 control patients with unoperated valvular 
disease. The control patients had a predominance of rheumatic 
heart disease and also probably suffered from reduced 
myocardial perfusion due to cardiac 
thromboembolism . 
failure and coronary 
In view of reports(6-ll) that cold cardioplegic cardiac 
arrest is a superior means of protecting the myocardium during 
cardiopulmonary bypass, it is surprising that this study found 
no significant difference with regard myocardial necrosis 
scores (Table 17.17) in the 2 study groups with and without 
cold cardioplegia. However , it should be noted that only one 
autopsied patient with a reperfusion-type , circumferential , 
haemorrhagic , sub-endocardial left ventricular myocardial 
infarction was encountered following the introduction of cold 
cardioplegic cardiac protection at our institution in 1977 , 
compared to 8 autopsy cases prior to that date . Most of these 
patients had a low cardiac output and died within the first 24 
hours post-operatively . Cardioplegia may thus play an 
important role in preventing this specific form of myocardial 
423 
MYOCARDIUM 
necrosis. A retrospective, non-randomised study comparing 
intermittent ischaemic cardiac arrest with cold cardioplegia 
showed a similar incidence of peri-operative myocardial damage 
in the 2 groups of patients(l2) . A different, randomised 
study(13) suggested that cardioplegia confers greater 
protection . 
All of our patients with reperfusion - type haemorrhagic 
infarcts of the left ventricle 




cases(l , 2) our 
patients had undergone either aortic valve or double valve 
replacement . Gotlieb et al . (1) describe 5 major histological 
changes which probably represent the sequential evolution of 
concentric haemorrhagic necrosis of the myocardium after 
cardiopulmonary bypass. These were contraction bands , 
sub-endocardial haemorrhages , coagulative necrosis , healing by 
granulation tissue and fibrosis. The location of the lesion 
coincided with the vulnerable region of the microcirculation . 
Patients with severe hypertrophy represent a high-risk 
group in cardiac surgery because of their reduced tolerance to 
induced myocardial ischaemia during cardiopulmonary 
bypass(14) . The existence of a post-operative 
low-cardiac-output syndrome has been denied by some , and other 
have referred to it by descriptive terms such as 
"post-operative heart failure " (lS-20) . A source of difficulty 
in identifying the syndrome clinically arises from inclusion 
within it of patients with a variety of intra-cardiac 
mechanical problems, such as valve prostheses of improper 
size , leakage around a valve, and subaortic outflow tract 
obstruction by mitral prostheses(lS) . Some(21) have even 
included patients with reduced cardiac output due to 
hypovolaemia and pericardial tamponade . 
Early reports(ll , 22 , 23) of the low-cardiac-output 
syndrome made no mention of myocardial necrosis . Then , in 1967 
Taber et al . (15) implicated left ventricular myocardial 
necrosis as a cause of fatal post-operative myocardial 
failure . They(lS) suggest that only low cardiac output due to 
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primary myocardial factors should be included in the syndrome. 
In the same year, Najafi et al.(4,24) showed that acute 
diffuse subendocardial myocardial infarction was frequent in 
patients dying soon after valve replacement and they suggested 
that it was related to intra-operative management of the 
myocardium. Later experience with coronary-artery-bypass 
grafting(25-27) led cardiologists and cardiac surgeons to 
observe even more clearly that current techniques of 
myocardial protection were inadequate. At about the same time, 
a rare and extreme form of ischaemic damage, "stone 
heart"(3,28) was recognized as essentially a massive 
myocardial infarction(29,30). 
Ischaemic myocardial contracture ("stone heart") is one 
of several forms of myocardial failure that may result from 
myocardial ischaemia during cardioplumonary bypass. Cooley et 
al.(31) list the following potential myocardial causes of 
post-operative heart failure subendocardial haemorrhagic 
contraction band necrosis, ordinary myocardial infarction, 
ultrastructural damage, ventricular arrhythmia and a flaccid, 
non-contractile heart as causes of pump failure after bypass. 
In 1972, Cooley et al.(3) first reported the "stone 
heart" syndrome. In its fully developed form it represents an 
uncommon complication of ischaemic cardiac arrest during 
cardiopulmonary bypass, is analogous to rigor mortis in 
skeletal muscle(30,32) and results from ATP-depletion rigor in 
the ischaemic myocardium. According to Silver(S) it may be 
produced reproducibly in several animal species by maintaining 
global ischaemia in a controlled normothermic setting and 
without a need for reperfusion. It may also be prevented under 
experimental conditions by moderate hypothermia(33). Isolated 
hearts given a calcium-free perfusion followed by a 
normocalcaemic reperfusion develop the ischaemic contracture 







also be prevented by 
firm to palpation, the 
(concentric hypertrophy) and 
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no cardiac output can be obtained on manual massage . 
Whilst Cooley et al . (31) stress that severe myocardial 
fibrosis and hypertrophy are usually present and recognizable 
myocardial necrosis is absent in most cases , others(l4 , 35) 
report that , as in our patients, the pathological basis of the 
stone heart syndrome is the presence of massive myocardial 
contraction band necrosis. This may go on to myocytolysis(36) . 
Hutchins et al . (35) confirmed that the stone heart syndrome 
appears to be simply the manifestations produced by 
contraction b a nd necrosis in a severely hypertrophied heart. 
The condition may occur even with normal coronary arteries . 
Ultiastructural examination of the stone heart myocardium 
showed features of an accelerated 





alterations that may accompany ischaemia and reperfusion in 
human hearts during cardiac surgery. It has been suggested(41) 
that direct mechanical trauma to the endocardium may play a 
role in the development of sub-endocardial haemorrhagic 
necrosis. 
In my patients there was no difference in necrosis scores 
between patients who received intermittent versus continuous 
coronary perfusion during cardiopulmonary bypass. This finding 
concurs with the experience of Kirklin et al(ll) who state 
that intermittent coronary arterial perfusion induces at least 
as much myocardial-cell death as does direct coronary 
perfusion . Balibrea et al.(42) reported that both intermittent 
and continuous coronary perfusion were effective in preventing 
anoxic damage during bypass . 
Several authors(43 , 44) describe deleterious effects if 
the heart is allowed to fibrillate during cardiopulmonary 
bypass there is an association with greater myocardial 
ischaemia and a higher early post - operative mortality rate . 
The present study revealed that beating hearts showed no 
significant difference with regard to necrosis compared to 
hearts that fibrillated during bypass . 
Levitsky and Feinberg(45) review the problem of 
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intra-operative myocardial protection during cardiopulmonary 
bypass , and they discuss the following therapeutic approaches 
(i) normothermic ischaemic arrest (ii) direct coronary 
arterial perfusion (iii) intermittent coronary perfusion ; 
(iv) induced electrical fibrillation of the heart (v) 
systemic hypothermia (vi) topical hypothermia (vii) 
potassium-induced cardioplegia and (viii) intra-aortic 
perfusion. Cardioplegia (induction of electromechanical 
arrest) as an aid to intracardiac exposure during cardiac 
operations was introduced by Melrose et al . (46) in 1955 . 
Bretschneider et al . (47) performed important early work in 
this regard . Several groups then showed that cardioplegia with 
myocardial cooling provided better myocardial protection than 
either procedure alone(7 , 8,48,49). Since then a voluminous 
literature on cardioplegia has developed(50-54) , most of which 
fall outside of the scope of this work. 
FIBROSIS 
Myocardial fibrosis was detected much more commonly in 
histological sections than was apparent to the naked eye . 
Morhometry (point-counting) revealed no significant difference 
between patients with prostheses and non-operated controls 
with regard to the amount of myocardial fibrosis . Assessment 
of fibrosis using a more subjective morphological scoring 
system showed replacement and interstitial fibrosis more 
commonly in patients with prostheses compared to the controls 
(Table 17.21). Replacement fibrosis was more extensive in late 
compared to to early survivors with UCT aortic valvular 
prostheses (Table 17 . 22). Comparison of functional classes of 
valvular disease revealed that patients with pre-operative 
aortic incompetence or mixed aortic valvular disease showed 
higher morphometric scores for fibrosis (17 . 23) compared to 
controls with similar valvular dysfunction . Patients with UCT 
valves inserted for mixed mitral valvular disease showed more 
replacement , interstitial and perivascular fibrosis than was 
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seen in the controls (17.24). Morphometry showed no difference 
between the same groups. Those with Starr-Edwards mitral 
prostheses appeared to have increased replacement fibrosis in 
patients who had mitral stenosis or mixed mitral valvular 
disease pre-operatively, but morphometry showed no significant 
differences (Table 17.25). 
The fibrosis observed in the myocardium of patients with 
implanted heart valves may have a multifactorial aetiology, 
including pre-existing rheumatic or ischaemic heart disease, 
bypass-induced necrosis(S), thromboembolism (due to rheumatic 
fever or from thrombi situated upon the prosthetic valve), and 
poor subendocardial perfusion due to heart failure. The 
general conclusion from the present study is that patients 
with implanted prostheses show a similar degree of myocardial 
fibrosis to that seen in non-operated controls with valvular 
disease. 
428 
H. POST - PERFUSION LUNG . 
Post - perfusion lung is the name given to the " adult " 
repiratory distress syndrome that may occur following heart 
valve replacement(l) , particularly if there is a prolonged 
bypass period. The pathogenesis of the condition is obscure ; 
suggested causes include platelet and leucocytic microemboli 
in the pulmonary micro-circulation with possible release of 
biologically active substances and circulatory obstruction. 
Resultant changes in surfactant levels may also play a 
role(2) . In this work I encountered 4 autopsied patients who 
had had features during life consistent with " post-perfusion 
lung " , which is characterized clinically by dyspnoea, arterial 
hypoxaemia with an increased alveolar-arterial oxygen 
difference , and increased fluid in 
tree(3) . 
outcome . 





lead to a fatal 
The 4 patients with post - perfusion lung were aged 25 , 36, 
20 and 31 years . The first had undergone aortic valve 
replacement with a Bjork-Shiley prosthesis , the second 
received St Jude Medical aortic and mitral valvular 
prostheses, the third a St Jude Medical mitral valve 
prosthesis and the remaining patient had a Starr-Edwards 
mitral valve prosthesis implanted . Symptoms had their onset a 
few hours after surgery . Patients one and three died of the 
effects of the post-perfusion lung syndrome (5 days and 36 
hours post-operatively respectively) ; in the other 2 patients 
the symptoms had been successfully reversed by treatment, and 
death was due to infection in one patient and myocardial 
failure plus pulmonary hypertension in the other. 
Histology of the lungs in these patients showed 
essentially similar features (less marked in the two treated 
cases) , namely many small areas of haemorrhage, oedema, scanty 
hyaline membranes , engorgement of small pulmonary blood 
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vessels and focal atelectasis. The appearances are similar to 
those of shock or those seen following excessive intravenous 
administration of fluids . I found it almost impossible in 
these patients to decide how much of the observed pulmonary 
changes were due to later respirator therapy . Pulmonary 
fibrosis was not observed in my patients . 
COMMENT 
Baer and Oiborn(4) encountered this complication in 70% 
of 41 patients dying after total cardiopulmonary bypass . They 
attributed the syndrome to overdistension of the left atrium 






foreign proteins or 
al . (S) suggested that 
pulmonary damage during open-heart operations is usually due 
to temporary over-filling of the pulmonary vascular bed with 
blood, leading to capillary damage . The pulmonary lesions 
observed following extra-corporeal circulation are similar to 
those found in adult respiratory distress syndrome caused by 
many other mechanisms(l) and long-surviving patients may show 
pulmonary fibrosis(6) . Others have also experienced the 
difficulty I encountered in trying to separate the 
histological changes of the post-perfusion pulmonary syndrome 
from those induced in the lungs by respirator therapy(6) . 
Barratt-Boyes et al . (7) state that the use of profound 
hypothermia and total circulatory arrest diminished the 
incidence of post-operative pulmonary complications. The 
implication of this is that a shorter period of bypass gives a 
smaller dose of whatever is the cause of the problem . Craddock 
et al . (8) found that during haemodialysis there was a 
selective loss of neutrophiles and monocytes from the systemic 
circulation with trapping in the lungs. Both of these cells 
have membrane binding sites for the complement anaphylatoxin 
CSa . The rabbit model of shock lung(9), which uses zymosan to 
activate complement, results in profound neutropenia followed 
by hypoxaemia , tachypnoea, and haemorrhagic pulmonary oedema. 
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The ultrastructural features in such animals is similar to 
that shown by electron microscopy of the lung after 
cardiopulmonary bypass(l0 , 11) . 
Westaby(3) set out to determine which components of the 
bypass circuit may trigger the complement cascade . Nylon , 
polyurethrane , polyethylene , polyvinyl chloride and 
polycarbonate form an important part of most bubble 
oxygenators and cardiotomy reservoirs. He found that all 
materials except polycarbonate activate complement to some 
extent and nylon was especially potent in this regard . 
Westaby(3) states that complement activation does not cease 
with the termination of bypass . Fragments of polyvinyl 
chloride tubing can be released by the action of the roller 
pump head on the tubing and as much as 7 . 8 mgs of plastic may 
be released during the first hour of pumping(l2) . It is thus 
possible that the post-perfusion syndrome is the direct result 
of a systemic inflammatory response caused by exposure of 
blood to unphysiological surfaces . The plastic bags used to 
store blood may also introduce plastic into the circulation 
e . g ., phthalate ester plasticizer has been documented as 
migrating into blood stored in polyvinyl chloride bags(l3) . 
Total circulatory exchange may introduce as much as 300 mgs of 
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F . ASSESSMENT OF PANCREATIC FIBROSIS 
Professor C . J . Uys and I had each independently gained 
the impression that patients with heart failure and/or 
implanted prosthetic heart valves showed a greater degree of 
pancreatic fibrosis than did patients who died of other 
causes . The present investigation was undertaken to determine 
whether one's impression of there being a greater incidence of 
pancreatic fibrosis in patients with implanted cardiac 
valvular prostheses compared to routine autopsy control 
patients was valid. Morphometry (point-counting) of 1210 
randomly selected points in the histological sections of 
pancreas of 112 patients with valvular prostheses and in those 
of 20 routine autopsy control patients yielded the following 
results : (i) the 112 valve replacement patients showed a mean 
fibrosis value of 7 . 0% (S . D . = 9 . 6) and (ii) the 20 control 
patients had a mean value of 4.3% (S . D . = 4.5) . The t statistic 
for the two means showed 
these 2 groups of 
no significant 
patients (p less 
difference between 
than 0 . 15) . This 
investigation thus failed to show an increased incidence of 
pancreatic fibrosis in patients with valvular heart disease. 
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OVERALL REVIEW OF THE PATHOLOGICAL FINDINGS IN PATIENTS WITH 
PROSTHETIC CARDIAC VALVES 
Table compares the cumulative survival rates and the 
cumulative embolism event-free rates of various heart valve 
prostheses implanted for 4 - 5 years (from 1976 onwards) in 
patients at Groote Schuur Hospital. 
A. NATIVE VALVULAR DISEASES LEADING 
REPLACEMENT 
TO CARDIAC VALVE 
Table 18.2 indicates the diseases of the natural cardiac 
valves for which the patients 
fever 
underwent heart valve 
an replacement. Rheumatic was pre-eminent as 
aetiological factor. The second commonest category was a 
miscellaneous group of valvular diseases including aortic 
dilatation (caused by syphilis, incompetence due to ring 
ankylosing spondylitis or 





chordal rupture and traumatic damage to a valve. Congenital 
valvular disease e.g., congenital bicuspid aortic valve, 
persistent truncus arteriosus, congenital aortic stenosis, 
parachute mitral valve and common atrioventricular canal 
defect with cleft mitral valve , was the third commonest group 
leading to valve replacement. In this group the calcified 
congenital bicuspid aortic valve was the most frequent lesion 
(14 out of the 22 patients). 
B. THROMBOSIS ON THE PROSTHESIS AND THROMBOEMBOLISM 
The number of prosthetic thrombi in patients with 
mechanical and tissue valves is compared in Table 18.3. The 
tissue valves showed significantly fewer thrombi and in 
general the latter were much scantier in amount than those 
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observed on the mechanical prostheses . (Five patients with 
both mechanical and tissue valves in the same heart are 














































































































































































































































































































TABLE 18.2 : AETIOLOGY OF VALVE DISEASE NECESSITATING 
VALVE REPLACEMENT WITH A PROSTHESIS IN 275 PATIENTS 
TYPE CONGENITAL RHEUM. FLOPPY I.E. SENILE OTHER TOTAL 
CALCIFIC 
MECHANICAL 21 170 4 7 6 17 225 
TISSUE 1 31 1 0 6 11 so 
TOTAL 22 201 5 7 12 28 275 
( %) (8.0) (73.1) ( 1. 8) ( 2 . 6 ) (4.4) (10.2) 
RHEUM=RHEUMATIC FEVER,IE=INFECTIVE ENDOCARDITIS, 
SENILE CALCIFIC=AORTIC NODULAR SCLEROSIS/TRICUSPID 
SENILE CALCIFIC AORTIC STENOSIS,FLOPPY=MYXOMATOUS 
DEGENERATION. 








NUMBER OF PROSTHESES BEARING THROMBI IN 
MECHANICAL AND TISSUE VALVE PROSTHESES 
No.PATIENTS 




INCIDENCE OF PR. 








Table 18.4 gives the incidence of infarcts in the body 
organs of patients with various types of prosthetic heart 
valves and Table 18.5 indicates the number of organ infarcts 
per patient per 100 days post-operative survival period in the 
mechanical and tissue valves. 
TABLE 18.4 : INCIDENCE OF ORGAN INFARCTS IN PATIENTS 
WITH VARIOUS TYPES OF PROSTHETIC HEART VALVES 
PROSTHESIS No. OF No.INFARCTS PER No.INFARCTS PER 
TYPE PATIENTS PATIENT (FATAL) 100 POST-OP.DAYS --
UCT 98 1.6(0.2) 0.4 
LILL 16 1.3(0.0) 0.3 
B-S 14 0.0(0.1) 0.0 
S-E 44 1.0(0.4) 0.2 
SJM 29 0.9(0.0) 1. 4 
MIXED 24 0.7(0.1) 0.5 
HANC 12 0.8(0.0) 0.6 
C-E 38 0.6(0.1) 0.3 
UCT=UNIVERSITY OF CAPE TOWN,LILL=LILLEHEI-KASTER, 
B-S=BJORK-SHILEY,S-E=STARR-EDWARDS,SJM=St JUDE 




TABLE 18.5 : NUMBER OF ORGANS WITH INFARCTS PER PATIENT 
PER 100 DAYS POST-OPERATIVE SURVIVAL AFTER HEART 
VALVE REPLACEMENT 
SYSTEMIC ORGANS PTS.WITH MECHANICAL PTS.WITH TISSUE 
VALVES (N=220) VALVES (N=50) 
BRAIN 0.02 0.03 
SPLEEN 0.02 0.03 
HEART 0.01 0.06 
KIDNEYS 0.02 0.05 
OTHER 0.01 0.00 
MEAN ( S. D.) 0.02 (0.01) 0.03 (0.02) 
LUNG INFARCTS 0.01 0.05 
The differences between the mechanical and tissue valves 
are not significant with regard to infarcts in the systemic 
organs. The 'other' infarcts referred to in Table 18.5 include 
infarcts e.g., of bowel and limbs. Tissue valves showed a 
significantly greater number of pulmonary infarcts. If the 
systemic and pulmonary infarcts are combined,then the greater 
number of pulmonary infarcts in the tissue valve group serves 
to create a statistically significant difference ( p less than 
0.05 ) between the 2 combined groups. 
Table 18.6 compares organ infarcts encountered in 275 
patients with valvular prostheses with those recorded in 103 
non-operated patients with natural valvular disease. Sixty of 
the control patients had predominantly mitral valvular disease 
and 43 had aortic valvular disease ; 87 % of the controls had 
chronic rheumatic-type valvular deformities. Patients with 
superimposed infective endocarditis were excluded. There was 
no significant difference in the incidence of renal infarcts 
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between operated patients and controls. Patients with 
prostheses showed significantly more infarcts (Chi-square 
evaluation) of other organs, particularl y of the brain and 
heart. Pulmonary infarcts were commoner in the non-operated 
patients, most of whom were in con g estive cardiac failure. 
TABLE 18.6 : ORGAN INFARCTS IN PATIENTS WITH IMPLANTED 
CARDIAC VALVULAR PROSTHESES AND IN NON-OPERATED 
CONTROLS WITH NATURAL VALVULAR DISEASE( %). 
PTS WITH NON-OPERATED 
PROSTHESES PTS p value --
(N=275) (N=l03) 
KIDNEY 69 (25 %) 25 (24 %) NS 
SPLEEN 59 (22 %) 17 (17 %) < 0.05 
BRAIN 58 (21 %) 14 (14 %) < 0.001 
HEART 47 (17 %) 6 (6 %) < 0.001 
OTHER 25 (9 %) 6 (6 %) < 0.05 
LUNG 23 (8 %) 25 (24 %) < 0.001 
MEANS 47 (17 %) 15 (14 %) 
C. PRINCIPAL CAUSES OF DEATH 
Table 18.7 compares the principal causes of death i n 275 
patients with heart valve prostheses divided as to whether a 
mechanical or tissue valve prosthesis was present. The 
prosthesis-related problems and the fatal complications 




TABLE 18.7 PRINCIPAL CAUSES OF DEATH IN 275 PATIENTS WITH 
IMPLANTED PROSTHETIC HEART VALVES 
CAUSE MECHANICAL TISSUE TOTAL* 
(N=220) (N=50) (N=275) 
ERROR PRE-OP. DIAGNOSIS 5(2.3%) 0.0 5(1.8%) 
ERROR OP. TECHNIQUE 25(11.4%) 7(14.0 %) 35(12.7%) 
PROSTHESIS PROBLEM 89(40.5%) 9(18.0%) 98(35.6%) 
POST-OP.COMPLICATIONS 46(20.9%) 5(10.0%) 52(18.9%) 
UNRELATED TO CARDIAC OP. 17(7.7%) 11(22.0%) 28(10.2%) 
UNKNOWN 38(17.3%) 18(36.0%) 57(20.7%) 
* Includes 5 patients with mixed tissue and 
mechanical valves in the same heart. 
TABLE 18.8 : DETAILS OF VALVE-RELATED PRINCIPAL CAUSES OF 




a)THROMBUS-RELATED 47(21.4 %) 3(6.0%) 
b)INFECTION 30(13.6%) 1(2.0%) 
c)DESIGN/STRUCTURE 12(5.5%) 5(10.0%) 
The percentages given in Table 18.8 refer to the 
percentage of all the principal causes of death for which that 
particular listed cause was responsible. Table 18.9 compares 
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the incidence of prosthesis-related principal causes of death 
in the various types of prostheses studied. In Table 18.10 a 
comparison is made between the principal causes of death in 
patients with pivoting/tilting disc or bileaflet prostheses 
and those with ball valves. 
Table 18 . 11 and Fig. 18 . 1 compare the early (less than 1 
month post-operatively, group 1) and the late (greater than 1 
month post-operatively , group 2) causes of death after cardiac 
valve replacement . Prosthesis-associated complications 
accounted for 13 % of the early deaths and 61 % of the late 
deaths . Deaths unrelated to cardiac surgery were responsible 
for 9.1 % of the early and 11 . 4% of the late deaths. Thus, 
pre-existing or associated cardiovascular diseases (error in 
pre-operative diagnosis),operative complications and deaths of 
unknown causes caused 77.9% of the early deaths and 27 . 6% of 
the late deaths. Table 18.12 compares the incidence of 
prosthesis-related deaths in the present series with that of 
other comprehensive pathological reports in the literature. 
The figures given for prosthesis-related complications in the 
reports cited in Table 18 . 12 are my own, being derived from 
study of the reports. I made an allocation as to the principal 
causes of death from these published reports using the same 
categories that I used in my patients . In these published 
series early deaths were those that occurred 
months post - operatively . 
less than 1-2 
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TABLE 18.9 : PRINCIPAL CAUSES OF DEATH IN 275 PATIENTS WITH 
VARIOUS TYPES OF PROSTHETIC HEART VALVES. 
VALVE TYPE NONPROSTHESIS-RELATED PROSTHESIS-RELATED 
DEATHS (%) DEATHS (%) 
UCT (N=98) 56 (57) 42 (43) 
LILL (N=l6) 9 (56) 7 (44) 
B-S (N=l4) 13 (93) 1 (7) 
S-E (N=44) 21 (48) 23 (52) 
SJM (N=29) 20 (69) 9 (31) 
MIXED (N=24) 17 (71) 7 (29) 
HAN (N=l2) 10 (83) 2 (17) 
C-E (N=38) 31 (82) 7 (18) 
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TABLE 18.10 : PRINCIPAL CAUSES OF DEATH IN PATIENTS WITH 
BALL-VALVES (STARR-EDWARDS) AND IN THOSE WITH PIVOTING/ 
TILTING DISC (LILLEHEI-KASTER,BJORK-SHILEY) OR BILEAFLET 
(St JUDE MEDICAL) VALVES 
BALL-VALVES DISC/ 
BI LEAFLET 
ERROR PRE-OP.DIAGNOSIS 2.4% 5.7% 
ERROR OP.TECHNIQUE 4.8% 17.0% 
VALVE PROBLEMS 53.6% 34.0% 
POST-OP.COMPLICATIONS 17.0% 15.0% 
UNRELATED TO CARDIAC OP. 9.8% 9.4% 
UNKNOWN 12.4% 18.9% 
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TABLE 18.11 : EARLY (GROUP 1) AND LATE (GROUP 2) 
CAUSES OF DEATH AFTER CARDIAC VALVE REPLACEMENT 
ERROR PRE-OP . DIAGNOSIS 
ERROR IN OP . TECHNIQUE 
GROUP 1(%) 
4 (2 . 8) 
ANAESTHETIC 9 (6 . 3) 
PROSTHESIS DEHISCENCE/DISPROPORTION 8 (5 . 6) 
PUMP/STONE HEART 7 (4.9) 
OTHER 2 (1 . 4) 




POST-OP . COMPLICATIONS 
GENERAL 
UNIQUE TO CARDIAC SURGERY 





1 (0 . 7) 
31 (21 . 7) 
4 (2.8) 
13 ( 9 . 1) 
47 (32 . 9) 
143 
GROUP 2(%) 
1 (0 . 8) 
3 (2 . 3) 
4 (3.0) 
1 (0.8) 
1 (0 . 8) 
40 (30 . 3) 
24 (18.2) 
16 (12 . 1) 
17 (12 . 9) 
0 
15 (11 . 4) 




TABLE 18.12 : INCIDENCE OF EARLY AND LATE PROSTHESIS-RELATED 
CAUSES OF DEATH AFTER CARDIAC VALVE REPLACEMENT 
AUTHORS(REF) VALVE(No.PTS) EARLY(%) 
ROBERTS&MORROW (143) S-E (20) 
ditto (144) S-E (64) 48 
ditto (145) S-E (98) 9 
STARR et al. (146) S-E (32) 
HERR et al. (14 7) S-E (53) 15 
STARR (148) S-E (87) 
COLAPINTO & S-E,B-S 
SILVER (149) (99) 10 
ROBERTS et al. (150) S-E(228) 10 
JOASSIN&EDWARDS(151) S-E (93) 8 
ditto (152) S-E (36) 
HENZE et al. (153) B-S (20) 13 
FISHBEIN et al.(154) HUFN(20) 57 
ditto (155) HAN (20) 7 
BARNHORSTet al.(156) S-E(231) 8 
ROBERTS&HAMMER (6) B-S (46) 9 
SCHOEN et al. (15 7) MIXED(279) 6 
PRESENT SERIES MIXED(275) 13 
S-E=STARR-EDWARDS,B-S=BJORK-SHILEY,HUF=HUFNAGEL, 

















The means of the incidences of prosthesis-related causes 
of death in early and late survivors listed in Table 18.12, 
(my patients excluded), were as follows : early deaths, 16.7% 
(S.D.=17.0) and late deaths,45.4% (S.D.=19.0). If the poorly 
durable Hufnagel trileaflet prosthesis(154) is excluded, then 
the means are 13.0% (S.D.=11.9) and 41. 8% (S.D.=14.0) 
respectively. The longest follow -up period in the patients 
with the Hufnagel prosthesis was 58 months, so the high late 
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mortality rate is not simply due to an unusually prolonged 
follow-up period. 
percentage method 
It should be noted that the simple 
lacks the important meaning afforded by 
including the length of follow-up(l58). A shorter follow-up 
time tends to generate a lower mortality or late complication 
percentage than does a longer period of post-operative 
evaluation. Unfortunately, the papers cited in Table 18.12 do 
not indicate follow-up periods in patient-years. In the 
present series the 275 autopsy patients with implanted heart 
valves had a total follow-up period of 684.1 patient years 
(Table 18.13). 
TABLE 18.13 : PATIENT-YEAR SURVIVAL AFTER CARDIAC 
VALVE REPLACEMENT IN 275 AUTOPSY PATIENTS. 








































































































































































































TABLE 18.14 : NON-FATAL ASSOCIATED CONDITIONS/DISEASES IN 275 
PATIENTS WITH IMPLANTED CARDIAC VALVULAR PROSTHESES 
CONDITION 
UNCORRECTED VALVULAR DISEASE 
MISCELLANEOUS 
SILICONE EMBOLI 
LUNG DISEASE (T.B.=2) 
75%+ CORONARY ARTERY NARROWING 
POOR ANTICOAGULANT CONTROL 
LESIONS OF CONDUCTING TISSUE 
RENAL PARENCHYMAL DISEASE 







SEVERE DIGITALIS TOXICITY 
















Table 18.4 summarizes 





the non-fatal associated conditions 
patients with implanted cardiac 
Uncorrected valvular disease 
abnormality, followed 






conditions as mediastinal emphysema, extra-dural abscess, 
acute pancreatitis, aortic dissection, subaortic stenosis due 
to a mitral prosthesis, etc. Widespread silicone embolism was 
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a feature of the earlier autopsies prior to the use of more 
efficient filters during cardiopulmonary bypass. Fourteen 
patients had significant coronary arterial atherosclerotic 
narrowing , but death had been attributed to some other cause . 
Poor anticoagulant control was mainly reflected as bleeding 
into non-vital organs in this group . Three patients were found 
to have an incidental malignancy at autopsy jejunal 
carcinoid tumour in one patient, and lung cancer and 
endometrial carcinoma respectively in the other two patients . 
DISCUSSION 
Few studies have analysed the autopsy determined causes 
of death in a large group of patients with implanted 
prosthetic heart valves . This investigation 
a large group of patients from a single 
is an analysis of 
institution , who 
underwent cardiac valve replacement and ultimately, autopsy . 
The range of prostheses studied in this work reflects the 
ongoing quest for the perfect artificial heart valve , which 
will have properties equal to , or nearly approaching that of 
natural human heart valves . The wide variety of heart valve 
substitutes presently commercially available indicates that 
this goal is still some distance away. 
It is apparent that there is a great potential for the 
prevention of acquired valvular heart disease in Cape Town , 
where there is still a high incidence of rheumatic fever . As I 
have shown in Chapter 3 , the rate of mitral stenosis at 
autopsy has not diminished over the 30-year period 1950-1979 . 
Since improvements have occurred in the socio-economic status 
of our community over this time period, the chronic rheumatic 
heart disease morbidity and mortality we are still witnessing 
may be a legacy of the past . Once a valve has been damaged by 
rheumatic fever , the structural alterations may become a 
self-perpetuating process due to repeated thrombus deposition 
and organization . Precedents for abnormal valves undergoing 
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progressive calcification and fibrosis are well known, as when 
bicuspid aortic valves develop stenosis(l). Further 
improvements in the socio-economic and in the general medical 
care of the poorer members of our community are still 
necessary. Hopefully, further improvements in the 
socio-economic status of the disadvantaged members of our 
population will result in the same low incidence of rheumatic 
fever that is a feature of the developed nations of Western 
Europe(l) and North America(2-4). In the present study 73% of 
the implanted heart valves were replaced because of chronic 
rheumatic heart disease (see Chapter 3 and Table 18.2 of the 
present Chapter). Only about 1 in 10 of such hearts showed 
Aschoff bodies at the time of valve surgery or at subsequent 
autopsy. This study confirms that rheumatic fever seldom 
causes isolated aortic valve stenosis. Since valve surgery is 
only palliative, prevention of rheumatic fever is the optimal 
goal. 
As specific comments have already been made after each 
particular type of valve prosthesis studied, I shall limit the 
present discussion to a broad overview of the obtained 
results. This study confirms the lower thrombogenicity (Table 
18.3) of tissue valves (despite the absence of long-term 
anticoagulant therapy), as compared to mechanical valves(5,6). 
However, the incidence of organ infarcts (Tables 18.4 and 
18.5) did not differ significantly between the two groups, if 
the slightly greater number of pulmonary infarcts observed in 
the tissue valves is excluded. Patients with Starr-Edwards 
valve prostheses showed the greatest number of fatal 
thromboembolic infarcts per patient (Table 18.4). 
Next, I should like to discuss the principal causes of 
death in the 275 patients with prosthetic valves, the 
identification of which was the major object of this study. It 
should be noted that 15 patients who form part of this work 
are excluded from this final analysis. Firstly, the 9 patients 
who received valved conduit tube grafts are not strictly 
analogous to the other 275 patients who underwent orthotopic 
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replacement of their cardiac valves and the tube conduits pose 
special problems of their own. Secondly, the 2 patients who 
died with formaldehyde-treated, locally manufactured, porcine 
aortic valve bioprostheses were excluded due to inadequate 
information regarding the extra-cardiac autopsy findings. The 
latter valves were never made commercially available. Other 
patients who are excluded from this final analysis include a 
solitary patient with an autologous fascia lata mitral valve 
prosthesis, together with the 3 patients with Ionescu-Shiley 
prostheses, all of which had been implanted at another 
hospital. 
Prosthesis-related problems (e.g., 
of the prosthesis, or design/structural 
the biggest single principal cause 
thrombosis, infection 
problems) comprised 
of death (36%) in all 
patients with valve prostheses (see Table 18.7). This was 
followed in descending order of frequency by unknown causes, 
post-operative complications, errors in operative technique, 
diseases unrelated to the cardiac operation, and errors in 
pre-operative diagnosis, which included unrecognized 
associated significant valvular disease. Separation of the 
principal causes of death in the patients according to whether 
a mechanical or a tissue valve had been implanted left one 
with 270 patients, once the 5 patients with both tissue and 
mechanical prostheses in the same heart had been excluded. 
The commonest principal cause of death in the mechanical 
prosthesis group (N=220) was prosthesis-related problems, 
whereas in the tissue valve group (N=SO) this cause ranked 
third in order of frequency (after unknown causes and diseases 
unrelated to valve surgery). In the mechanical valve group 
post-operative complications were the second commonest cause 
of death. There was an equal incidence of deaths attributable 
to errors in pre-operative diagnosis. Analysis of the 
valve-related principal causes of death (Table 18.8) shows 
that thrombosis and infection were more important in the 
mechanical group, whereas structural failure was more common 






one another with regard to prosthesis-related 
of death (Table 18.9), it is apparent that 
of Cape Town, the Lillehei-Kaster and the 
Starr-Edwards valve prostheses gave the worst results , 
the Bjork-Shiley, Carpentier-Edwards, Hancock and 
Medical valve prostheses (in that order) 





Surprisingly, patients with mixed prostheses in the same 
heart showed only a 29% prosthesis-related fatal complication 
rate . Valve-related fatal complications were more frequently 
encountered with the Starr-Edwards ball-valves than with the 
pivoting/tilting disc or bileaflet prostheses (Table 18 . 10), 
viz . 54% versus 34%. There was a higher incidence of deaths 
due to errors in operative technique and death due to unknown 
causes in the nonball-valve group . Roberts and Hammer(6) noted 
a similar difference in " prosthesis-related" deaths between a 
group of patients with ball-valves and another group with 
tilting/pivoting disc valves, which they ascribed to the 
higher incidence of disproportion with the ball-valves . In my 
patients with Starr-Edwards ball-valve prostheses 
disproportion was noted as a principal cause of death in only 
one patient, whereas thrombosis on the prosthesis appeared to 
be the major problem. Such thrombosis , often associated with 
thromboembolism, was the principal cause of death in 16 out of 
44 patients . The lower rate of disproportion in our patients 
with ball-valves may be related to the fact that these valves 
were inserted at a later time in most of our patients , by 
which time our surgeons had been alerted to this problem by 
the experience of others . Subjective observer error cannot be 
excluded as a factor either. 
When all of the patients with prostheses (both mechanical 
and tissue valves) are separated into early or late survivors , 
with 30 days postoperative survival as the cut-off point 
(Table 18.11) , prosthesis-related fatal complications were 
seen in 12.6% of the early survivors and in 60 . 6% of the late 
survivors. Prosthetic thrombosis and its related complications 
453 
REVIEW 
was encountered more often as a principal cause of death in 
the late survivors (30.3%) than in the early survivors (7.0%), 
and so too were infection and problems related to prosthetic 
design or structure. Deaths due to unknown causes were 
commoner in patients who died less than 30 days 
post-operatively. 
Amongst the vast current clinical literature, there are 
numerous reports (only some of which are cited here) detailing 
the in vitro(7-12), experimental testing(l3-17), 
clinical(l8-52) and haemodynamic(53-60) features of implanted 
heart valve substitutes, and specific complications of cardiac 
valve replacement e.g., haemolysis(see references 1-54 of 
Chapter 17, part B), thromboembolism(61-97), infection(see 
references 1-128 of Chapter 17, part D) and the durability of 
mechanical(98-113) and tissue valves(ll4-135). However, there 
are relatively few reports which primarily address the 
pathology of patient-prosthesis interactions. Even amongst 
such predominantly pathological reports on patients with 
implanted valve prostheses, many consist of general reviews 
(136-142) in which no specific data regarding autopsied 
patients are given. Other authors give data regarding specific 
complications (e.g.,myocardial necrosis), but do not indicate 
the major factors leading to the death of their 
patients(l36). 
I was able to find only 16 papers(6,143-157) in which a 
detailed description was given of the principal causes of 
death (based on both clinical and autopsy findings) of 
patients with cardiac valve prostheses, (see Table 18.12). The 
majority of these deal with patients with Starr-Edwards 
ball-valves. The longest follow-up period in the patients with 
an implanted Hufnagel prosthesis was 58 months, so their high 
late mortality rate is not simply due to an unusually long 
follow-up period. It should be noted that the simple 
percentage method lacks the important meaning afforded by 
including the length of follow-up (158). A shorter follow-up 
time tends to generate a lower mortality or late complication 
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percentage than does a longer period of post-operative 
evaluation. Unfortunately , the papers cited in Table 18 . 12 do 
not indicate follow-up periods in patient-years . My 275 
autopsy patients with implanted heart valves had a total 
follow-up period of 684.1 years. 
The series which most closely approximates my own (mixed 
types of valve prostheses) is that of Schoen et al.(157) . Six 
percent of their early deaths were prosthesis-related 
(compared to 13% of my patients) and 47% of their late deaths 
(compared to 61% of my patients) were due to 
prosthesis-related complications . These findings are 
consistent with the general trend found in the other detailed 
pathological reports cited in Table 18 . 12, with the exception 
of report of Fishbein et al . (154) which reflects the poor 
durability of the Hufnagel trileaflet prosthesis and that of 
Roberts and Morrow(l44) which had an unusually high rate of 
early prosthesis-related complications. 
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CHAPTER 19 CONCLUSIONS 
1. There is a high incidence of rheumatic heart disease at 
autopsy in Cape Town. Only time will tell whether this is 
still a late legacy of a previously high incidence of acute 
rheumatic fever or whether further improvements in the 
socio-economic status of our community are still needed. The 
latter is more likely. 
2. For optimal pathological examination and interpretation of 
surgically excised diseased cardiac valves the pathologist 
should be given adequate data regarding the pre-operative 
history of the patient, the appearance of the valve at 
operation and the clinically suspected aetiology of the 
valvular disease. 
3. Muscle-associated granulomas and lymphocytic aggregates may 
be confused with true Aschoff bodies. 
4. The wide variety of heart valve prostheses, which have been 
implanted in patients at Groote Schuur Hospital reflects the 
ongoing, as yet unfulfilled, search for the ideal cardiac 
valve substitute. 
5. Tissue valves showed a lower incidence of thrombosis on the 
valve prosthesis compared to mechanical valves, despite the 
fact that no long-term anticoagulation was given to patients 
with tissue valves. However, there was no significant 
difference at autopsy between these 2 groups of patients with 
regard to the number of systemic organs showing infarcts. 
Patients with implanted valvular prostheses did not show a 
greater incidence of organ infarcts than did non-operated 
controls with (mainly rheumatic) valvular disease. This 
emphasizes the fact that rheumatic fever is a thromboembolic 
disease in its own right(l). 
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6. Tissue valves are not suitable for use in children and 
young persons due to the problem of prosthetic cuspidal 
calcification. 
7. Prosthesis-related complications comprised the commonest 
patients with mechanical principal cause of death in 
prostheses, whereas in those with tissue valves it was third 
in frequency (after unknown causes and deaths unrelated to the 
cardiac operation). Prosthesis-related fatal complications had 
the highest incidence in patients with Lillehei-Kaster, 
University of Cape Town and Starr-Edwards prostheses, whilst 
those with Bjork-Shiley prostheses showed the lowest 
incidence. Thrombosis or infection of the valve prosthesis 
were more commonly encountered amongst the mechanical 
prosthesis group, whereas structural failure of the valve 
prosthesis was more often encountered in the tissue valve 
group of patients. Prosthesis-related fatal complications were 
more frequent in the late survivors compared to those dying 
within one month after surgery. Within the mechanical 
prosthesis group of patients, prosthesis-related fatal 
complications were more often encountered in patients with 
(Starr-Edwards) ball-valves than in those with tilting 
disc/bileaflet prostheses. 
8. Patients dying of myocardial failure had heavier hearts 
than those who died of other causes. No significant difference 
in myocardial necrosis scores was found between the following 
groups of pat i ents operated versus control patients with 
valvular disease ; patients who did and did not receive cold 
cardioplegia during bypass and those who received 
intermittent versus 
during bypass. Total 
continous coronary arterial perfusion 
groups of patients and controls showed 
equal amounts of myocardial fibrosis . 
9. Experimental in vivo evaluation of the Mitroflow bovine 
pericardial heart valve yielded less satisfactory results than 
were obtained with a small number of control Ionescu-Shiley 
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infarcted papillary muscle. 
Figure 3.3, page 143 : Aortic nodular sclerosis calcified 
congenitally bicuspid aortic valve histology of a 
transversely sectioned congenitally bicuspid aortic valve. 
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Figure 3.4, page 146 Aortic incompetence due to healed 
syphilitic aortitis ; aortic stenosis due to calcification of 
a congenitally unicuspid, unicommissural aortic valve. 
Figure 4.1, page 177 
valvular prosthesis. 
Partial dehiscence of a UCT mitral 
Figure 4.2, page 177 : Thrombus rests upon upper ring of UCT 
aortic valvular prosthesis. A thromboembolus lies within the 
left coronary artery. 
Figure 4.3, page 184 : Early model UCT prosthesis shows bobbin 
wear, lipid accumulation and variance. The crack in the 
bobbin's upper surface is shown better in the lower picture. 
Figure 5.1, page 206 Severe cloth wear of a Starr-Edwards 
mitral prosthesis. 
Figure 5.2, page 206 Portion of the bulky cage of a 
Starr-Edwards tricuspid prosthesis has become incorporated 
into the right ventricular free wall. 
Figure 6.1, page 225 : Bjork-Shiley prosthesis is immobilized 
by host tissue overgrowth, probably due to organized 
thrombus. 
Figure 7.1, page 239 
valvular prosthesis. 





Figure 8.1, page 252 
valvular prosthesis. 
a 
Thrombosed Lillehei-Kaster mitral 
Infected vegetations obstruct the 
Lillehei-Kaster mitral valvular 
Infected St Jude Medical aortic 
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Figure 9 . 1 , page 266 : Incompetent UCT formaldehyde-preserved 
porcine aortic valve xenograft prosthesis . 
Figure 9.2 , page 270 Regular periodicity is discernible 
within some of the collagen fibres of an unused UCT 
formaldehyde-preserved xenograft valve. 
Figure 9 . 3 , page 270 : Poorly preserved collagen fibres of a 
UCT xenograft , which had been implanted in patient 2 for 2 
months . Periodicity is lacking and the fibres appear to be 
disintegrating into amorphous , finely granular material . 
Figure 11 . 1 , page 299 Calcified Carpentier-Edwards 
prosthesis 23 months after clinical implantation . One cusp has 
2 tears in its substance. 
Figure 11 . 2 , page 299 Massive thrombosis of a 
Carpentier-Edwards aortic valve prosthesis . 
Figure 12.1, page 313 Calcified Hancock bioprosthesis . 
Figure 12.2 , page 313 Radiograph of a surgically removed 
calcified Hancock valve . 
Figure 12 . 3 , page 314 
valve . 
Histology of a calcified Ha n cock 
Figure 12 . 4 , page 31 4 : Ultrastructural appearance of early 
calcification within interstitium of Hancock cuspidal tissue. 
Figure 13.1 , page 323 : Sewing ring suture is looped around a 
supporting post of an Ionescu-Shiley mitral bioprosthesis . 
Figure 16.1 , page 351 Abundant thrombus is situated on 
inflow aspect of Mitroflow valve . 
Figure 16 . 2, page 351 
of Mitroflow valve . 
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Histology of thrombus on inflow aspect 
Figure 16 . 3, page 352 : Host tissue overgrowth on Mitroflow 
valve has led to cuspidal thickening and shortening . 
Figure 16.4 , page 352 : Host tissue covers both aspects of 
this Mitroflow valve cusp . 
Figure 16 . 5 , page 
had been implanted in 
35 4 : Control Ionescu-Shiley valve , which 
a baboon for 31 days , still shows 
regular periodicity of the collagen fibres. 
Figure 16 . 6 , page 354 : Mitroflow "Pilot Study " valve, which 
had been implanted in a baboon foe 71 days , shows loss of 
periodicity in many of its collagen fibres. 
Figure 17.1, page 361 Inter-atrial septal haematoma has 
reached the upper aspect of the atria-ventricular node . 
Figure 17 . 2 , page 371 : Abundant (+++) renal siderosis in a 
patient with multiple UCT prostheses. 
Figure 17 . 3 , page 371 Iron deposits are seen within the 
epithelial cells of the proximal convoluted tubules. 
Figure 17.4 , page 383 : Diagram of sub-epicardial haematoma in 
patient 1, which resulted from excessive resection of the 
mitral valve ring. 
Figure 17.5 , page 383 : False submitral aneurysm of patient 2 
communicates with the left ventricle. 
Figure 17 . 6, page 402 : Thromboembolus lies within a septal 




Figure 17.7, page 412 : Concentric haemorrhagic necrosis of 
the left ventricle in a patient with a Starr-Edwards aortic 
valve prosthesis . 
Figure 17 . 8 , page 4 12 
the left ventricle. 
Subendocardial replacement fibrosis of 
Figure 18 . 1 , page 447 : Early and late causes of death after 
cardiac valve replacement 1962 to 1982. 



























































































DATA ON CONTROL PATIENTS 
CONDITION NO. OF AGE IN YRS 
TESTED CONTROLS MEAN,(S.D.) FEMALES (%) 
ORGAN INFARCTS 103 46 (14.3) 49 
CONDUCTION TISSUE 14 51 (13.6) 55 
HAEMOSIDEROSIS 
VALVE DISEASE 32 44 (18.5) 52 
ROUTINE AUTOPSY 21 49 (16.1) 51 
SMALL CORON. ARTS. 
ACTIVE RHEUMATIC F. 13 36 (17.4) 58 
HEALED RHEUMATIC F. 26 47 (15.8) 53 
MYOCARDIUM 85 38 (15.0) 61 
PANCREAS 25 54 (14.2) 55 
